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Abstract
This project was designed, in partnership with Eli Lilly, Fegersheim, with the aim of developing a 
series of methodologies for the mutation and characterisation of trypsin variants with extended 
substrate specificities for certain amino acid combinations. This library of modified enzymes with 
enhanced specificity towards 4-aa 1° sequence motifs could then be used as efficient & ‘clean’ 
biocatalytic agents. The goal was thus to explore the tailoring of industrial bioprocess enzymes to 
better suit process criteria, thus lowering the overall cost. It was a principle aim of the project to 
design a practical method of directed evolution for the breeding of variants with novel or enhanced 
substrate specificities.
The organism on which this work was to be based was the Eli Lilly commercial 
recombinant bovine trypsinogen production strain, termed ELTRP-1. In order to devise a high- 
throughput assay suitable for screening a mutant library of 103* variants, it was essential to fully 
characterise a method of microwell fermentation, and also to engineer the recombinant protein for 
solubility, i.e render it available for assaying. A high-throughput screen such as this would have to 
involve the minimum number of process steps and be entirely microplate-based.
A microplate-scale solubilisation & refolding protocol for the r-trypsinogen inclusion bodies 
was developed that was successful for commercial enzyme but was impractical for use on 
recombinant inclusion bodies as the nature of the screen disallowed extensive purification, and 
thus the highly heterologous nature of the solutions appeared to inhibit refolding. Two variants of 
the enzyme, one with the prosequence removed, were cloned into a pET26b vector, behind a pelB 
leader, and all available fermentation parameters were experimented with. The construct plasmid 
was then subjected to a range of mutation rates using the XL1-Red mutator strain and variants 
were screened for increases in solubility. A series of mutants were obtained which demonstrated 
over 100^g/ml soluble mature enzyme after microplate fermentation, and enzyme translocation 
was monitored over 5ml & 100ml scale-up. Observed plasmid instability was due, in part, to the 
autotoxicity of the expressed enzyme and compounded by the fact that the T7 induction control 
mechanism of the strain appeared to have been disabled. These problems only manifested when 
the fermentation was scaled-up above microplate volumes and thus it appeared that the screening 
of the library for soluble mutant enzymes had been entirely successful by its own specific criteria, 
i.e. the isolated variants performed as required only when in well-culture.
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1 Introduction
1.1 Protein engineering for bioindustry
The unwitting use of enzymes as biocatalysts has been a key feature in chemical transformation 
reactions throughout history, underlying all ‘traditional biotechnology’ (e.g. baking and brewing), 
and now, applied with increasing finesse, forms the basis of many modem bioindustrial processes. 
These range from the bulk manufacture of commodity chemicals such as fructose or citric acid, to 
the synthesis of complex pharmaceutical intermediates (Cmegerand Crueger, 1990). 
Unsurprisingly, as most industrial biotransformation reactions seek to mimic cellular reactions, 
albeit on a vast scale, many enzyme families have proved to be excellent agents for industrial 
catalysis, with reaction rate accelerations of typically 105 - 108 (Schwienhorst, 2002; Zaks, 2001). 
The chiral nature of enzymes allows for extremely high degrees of regio- and stereospecificity 
when acting on a preferred substrates in native conditions and the majority of biocatalytic reaction 
procedures have been designed and built with the aim of exploiting these properties by supplying a 
favourable chemical environment (Crueger and Crueger, 1990). Problems frequently arise in that 
the conditions required for activity in industrial applications are often sufficiently dissimilar to the 
enzymes’ native environment as to cause a loss of functionality, be it activity, stability or specificity. 
As metabolic tools which have evolved over billions of years to perform precise functions within a 
self-regulating environment, many enzymes exhibit traits that further complicate their industrial 
usefulness, such as product inhibition, co-factor requirements or appreciable rates of 
autohydrolysis, which maintain the metabolic feed-back bops so essential for cellular homeostasis, 
and which can severely limit industrial product yield (Bomscheuer and Pohl, 2001; Zaks, 2001).
As the number of targets and potential markets for modem biotechnology expands, so 
does the urgent need for new biocatalytic agents and for technologies that may rapidly assess both 
an enzyme’s activity and the suitability for industrial work. The natural world is, of course, the 
ultimate source of protein diversity, with current estimates of the number of microbial species in 
existence (at any one time) standing between 1x106 and 1x108, with currently only approximately 
5,000 species being described in the literature (Daniel, 2002). The construction and subsequent 
screening of vast environmental libraries remains the classic method for searching for an enzyme 
activity or property to satisfy a new industrial need, but poses considerable problems for modem 
companies, because of the length of time and expense required, difficulty in culturing diverse
18
Chapter 1: Introduction Edward Hibbert
species and, finally, because many natural enzymes display the physiochemical ‘restrictions’ 
described above. A further consideration is that the substrate specificity of an enzyme may limit its 
synthetic utility, examples being the relatively loose specificity of many digestive proteases 
(Furlong et a/., 2002) or insufficient levels of enantioselectivity (Henke and Bomscheuer, 1999). In 
theory, a sufficiently large environmental library could provide an enzyme approximately suited for 
any synthetic reaction, but in practice, the optimisation of industrial processes frequently require 
activity under thoroughly unnatural conditions or specificities of a type that may not be selectively 
favourable in the wild. The ability to overcome these limitations and construct tailor-made 
biocatalysts, fine-tuned for optimal functionality under process conditions, is becoming increasingly 
possible with the advent of modem molecular biology. Knowledge of the amino acid sequence of 
an enzyme and its tertiary I quaternary structure from crystallisation, allows engineers to explore 
the physical basis of activities of interest through controlled substitution of selected residues. The 
success of a strategy of rational design hinged on relating structure to function, and thus relied on 
molecular modelling techniques to identify targets. Such a strategy could be described as a ‘top- 
down’ approach, predicting the structural disturbances caused by single amino acid substitutions, 
and is thus highly-information intensive. Although recent advances in the generation and solving of 
protein structures (Bomscheuer and Pohl, 2001; Rubingh, 1997) and significant improvements in 
the power of molecular modelling in such areas as free energy permutation and molecular 
dynamics calculations (Rubingh, 1997), now allow for considerable modem finesse in the 
modification of proteins, the complexity of the structure-function relationship and the lack of 
detailed data on most enzyme families means that rational design is not yet considered a practical 
method for the improvement of biocatalysts.
In contrast to this, the recent techniques of directed evolution (also called molecular or in 
vitro evolution), make no assumptions as to the nature of the required structural changes, beyond 
possibly delineating the region exposed to mutagenesis, and involves the construction of synthetic 
libraries of diversity from wild-type enzymes (Bomscheuer and Pohl, 2001; Tobin et al, 2000). The 
power of the technique is directly proportional to the size of the library generated, typically > 106 
mutant variants, with the diversity being generated through variations of random mutagenesis 
(Chen and Arnold, 1993) and homologous (Stemmer, 1994a) or non-homologous recombination 
(Lutz and Benkovic, 2000). The enzyme libraries are then characterised by the screening of each 
individual clone for the desired activity, the quantity of variants meaning that the libraries are only
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of practical use if they can be coupled to a system of small-scale fermentation and high-throughput 
screening (Schwienhorst, 2002). Wherever possible, an 'intermediate1 selection step would be 
introduced, coupling the desired activity of the mutant enzyme to cell viability, avoiding the need to 
screen functionally wild-type or disabled enzymes, and thus dramatically enhancing the size of the 
library which may be processed. This evolutionary methodology could thus be seen as a ‘bottom- 
up’ approach to protein modification, relying on a precisely designed screen working in conjunction 
with the high-throughput handling of clones to provide a protein with the required properties, 
irrespective of which mutations were required to achieve this. A crass analogy would be that this 
technology works to transform protein engineering from an irregular and unpredictable art, to a 
form which replaces the 'brains' of the process with ‘muscle’, allowing careful mutation and mass 
screening to replace precise, considered modification, and creating a scalable method of 
biocatalyst discovery suitable for industry, one where investment of resources linearly increased 
the chances of success.
The following sections summarise current evolutionary theory and detail all techniques of 
random mutagenesis characterised to date. Variations of the classic methods of in vitro 
mutagenesis are continually being developed as researchers seek to mimic different aspects of 
natural protein evolution, and thus each exhibits different bias and mutation rates, as well as 
varying complexities in experimental procedure (Section 1.4). Each method, and potential 
combinations of protocols, was thus considered in terms of practicality and published effectiveness. 
The enzyme which was to be the subject of this work was a variant of bovine trypsinogen and the 
reasons for its scientific and economic suitability as a target as well as current methods for its 
production, with reference to high-throughput microwell fermentation and screening, are discussed 
in Section 1.5-1.8.
1.2 Concepts of d irect evolution
1.2.1 Evolution of novel protein-coding genes in nature
Darwin attributed the forms of all living organisms on earth, from the base components upwards, to 
be products of blind design (Patthy, 1999). Incremental changes, accumulating over successive 
generations, allow proteins to perform slightly better at old tasks or under changing conditions. 
Environmental stress acted on populations as a whole to select the fittest variants, thus
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encouraging any number of solutions to arise from within the various systems providing that they 
enhance the total final activity. It is the in vitro simulation of this evolutionary adaptivness that has 
lead to the family of methodologies now termed ‘directed evolution’. Although there is a steady 
influx of data regarding the structural effects of sequence mutations on protein functionality (for 
recent examples, please see Table 1.1), by far the bulk of current knowledge regarding enzyme 
engineering comes from the continued study of natural mechanisms (Lutz and Benkovic, 2000). 
Understanding the principles and motives whereby new protein structures and functions emerge, 
can provide guidelines for molecular modification, and gives insight into mechanisms, the 
effectiveness of which have been refined for literally billions of years.
Ancestral sequence studies (where a phylogenetic tree was constructed based on regions 
of conserved sequence homology) have shown that nature employs two fundamental approaches 
in the generation of novel proteins. The first involves the de novo, or spontaneous creation of a 
protein-encoding gene through the rearrangement of repetitive simple structural elements. The 
emergence of such proteins is difficult to prove, with evidence being frequently contested, as only 
extremely tenuous ancestral paths can be constructed in such cases. Homology studies do appear 
to show that certain ‘structural-signatures’ have arisen independently several times during 
microbial evolution, with the commonest type being proteins which consist almost entirely of a 
single, repeated, secondary structure element (Patthy, 1999). Such repetitive sequences frequently 
form tightly coiled structures (e.g. fibrous proteins) or account for regions enriched for a certain 
motif (e.g. leucine-rich-repeat proteins), however the best characterised examples of de novo 
generation of a gene are the serum antifreeze glycoproteins (AFGPs) of Artie and Antarctic white 
fish. In both cases, these proteins, which act to preserve the fluidity of the serum at temperatures 
as low as -2°C, consist entirely of an iterative tripeptide unit, Thr-Ala-Ala. Although structurally 
identical, the two forms of AFGP differ in their origins, with those of Antarctic fish having arisen via 
recruitment of the 5’ & 3’ terminal ends of an ancestral trypsinogen gene (obtaining secretory signal 
and untranslated regions) and then by amplification of the repeated motif. The origin of AFGPs 
from artic fish is known to be separate but resists identification.
De novo evolution of enzymes, while an undoubted natural occurrence and the clear (long­
term) goal of in siiico modelling studies, does not currently represent a useful technique for 
laboratory-based enzyme engineering as the probability of creating a functional enzyme through 
the random association of common sequence elements is inversely proportional to its complexity.
21
Chapter 1: Introduction Edward Hibbert
Essentially de novo synthesis requires the screening of every conceivable combination of 
elements, and with the distribution of functionality in sequence space being so sparse, would 
require libraries of unimaginable sizes (Daniel, 2002). The most fruitful path for study and 
simulation is the second approach that nature uses for the evolution of novel proteins, namely the 
remodelling of existing protein scaffolds for altered functionality (Nagano et a/., 2002; Todd et a/., 
2002). The most common natural methods for the alteration of a protein-encoding gene are listed 
in Figure 1-1. Each involves the exploration of only local sequence space, the point of origin being 
a functional protein, and together comprise an effective set of methods for the slight alteration of 
structural or catalytic properties, or for the accommodation of environmental changes.
o
o
o
Gene duplication
Incremental
mutations
>oo 
> o
Gene fusion
o
o
Gene recruitment
(Fuction depends upon 
environmental factors)
Oligomerisation
>o o
w
Figure 1-1: Methods of altering protein functionality found in nature
Directed evolution tends to refer to the technique of accumulating point mutations over successive 
generation, culminate changes leading to modification of the physical properties of an enzyme. 
Figure adapted from (Arnold, 1996; Lutz and Benkovic, 2000).
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1.2.2 Examples and strategy
The individual methodologies of directed evolution are discussed in detail in subsequent sections 
(1.4.3 & 1.4.4), but an overview of a generic combined strategy for the mutation and screening of a 
protein-coding gene is presented in Figure 1-2. The principle underlying any whole protein system 
of directed evolution is that no assumptions are made as to regions of importance within the 
protein, essentially regarding the protein’s sequence as a ’black box’, and directing the bulk of the 
work into developing suitable environmental tests which would allow a variant with the desired 
fitness to emerge. Error-prone PCR, a low fidelity version of standard PCR that imposes an 
average mutation rate on the sequence being amplified, would commonly be used to ensure that 
protein mutants were generated at an accelerated rate and thus to produce a homologous gene 
library with a uniform, if low, level of diversity. DNA shuffling (also known as molecular 
recombination or breeding) is a recently developed technique designed to mimic the low level of in 
vivo gene shuffling which is believed to exist universally in biological systems (Minshull and 
Stemmer, 1999). In vitro recombination involves the random fragmentation of a library of gene and 
their reassembly by recombination with each other by ‘primer-free’ polymerase chain reaction 
(PCR) reaction. DNA shuffling acts as a complementary procedure to rounds of random 
mutagenesis and screening, allowing the concentration of beneficial mutations that have accrued 
on individual genes, while simultaneously providing a method by which mutations which impair 
protein function, and also ‘neutral’ amino acid mutations, can be identified and discarded from the 
final molecule. Neutral mutations are non-synonymous, i.e. result in amino acid substitutions (see 
Section 1.3.1), and can pose particular difficulty as they obscure functionally beneficial or co­
operative mutations, and thus can require increased amounts of subsequent validation before the 
results can be accepted (validation would occur by targeted substitution of all mutated amino acids, 
in every possible combination, screening for improvements or interaction effects). The process of 
DNA shuffling may also be used to add further diversity to a library by forcing the PCR based 
reassembly to proceed under low fidelity conditions, but this is generally considered unnecessary 
in a combined strategy, and analysis of results can be performed far quicker if epPCR and 
recombination are designed as separate mechanisms. Table 1.1 gives a list of recent examples, 
where proteins have had their functionality improved towards diverse targets (usually for use in an 
industrial context) by means of varied methods of directed evolution.
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A total strategy for improving protein functionality would most likely enlist both in vitro 
evolution and rational engineering of the targeted protein, using rational design to initially alter 
residues known to be important from previous studies, or using the information gained from the 
protein variants generated by directed evolution to adjust the primary sequence.
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Enzyme Evolved property Mutagenisis method Result Reference
Kanamycin
nucleotidyltransferase Thermostability
. . . .  . . >200-fold incr. in half-life 
Mutator strain @6Wi5-C (Liao et al 1986)
Esterase Stereoselectivity . . . .  . . 25-fold incr. in Mutator strain . , .. ..stereoselectivity (Bornscheuer et al 1998)
Subtilisin E Activity in organic solvents
Drn 170-fold incr. for activity in 
epHGK -60%DMF (Chen and Arnold 1993)
Subtilisin E Thermostability epPCR& shuffling 500-fold incr jn half-life @ (Miyazaki et al 2000)
Glutaryl acylase Substrate specificity p rp  5-fold incr. in activity on epruK adipyl-chains (Sio et al 2002)
Beta-Galactosidase Substrate specificity DNA shuffling Creation of an effiotentp- 3 fucosidase (Zhang et al 1997)
Paranitrobenzyl esterase Substrate specificity and activity in organic solvents
Up to 150-fold incr. in 
epPCR and DNA shuffling activity depending on
%DMF
(Moore and Arnold 1996)
Green fluoresoent protein Increased activity epPCR and DNA-shuffling Up to a 42"^ old v 3 improvement (Crameri et al 1996)
Table 1.1: Examples of protein functionality altered by direct evolution
Published directed-enzyme-evolution experiments that couple sequential generations of random mutagenesis and/or recombination with an 
appropriate selection or screening strategy.
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generate library o f 
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screen for combinations 
of positive mutants
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O  ~ Beneficial mutation 
B  -  Deleterious mutation
Figure 1-2: Combining epPCR & DNA shuffling
Illustrating the principle of a strategy of directed evolution, which combines random mutagenesis by 
error-prone PCR and DNA shuffling to generate and concentrate positive mutations. Adapted from 
(Kuchner and Arnold 1997). The techniques shown are discussed in detail in the following sections:
Random mutagenesis in section 1.4 
Mutagenic PCR in section 1.4.3 
DNA shuffling in section 1.4.4
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1.3 Mutation: concepts and terminology
1.3.1 Mutation types
Almost all discussion of mutations in this work will refer to replication-dependant mutations, i.e. 
those arising through an error in the process of DNA replication. Although the methods used to 
generate a fixed rate of mutation may give rise to any type of error, only point substitution effects 
are desired. These are simply where a single nucleotide is replaced by another and, importantly, 
results in no change in the reading frame of the sequence. Other types of mutations, such as 
additions and deletions, which result in the insertion or subtraction of one or more nucleotides from 
a given point in a sequence, would inevitably alter the reading frame (Patthy, 1999). A frameshift 
mutation results in a change in all downstream amino acids, changing the nature of the protein and 
also the length as the position of the stop codon would now be randomised. This almost certainly 
leads to the translation of a truncated and crippled protein, i.e. non-functional and randomly folded.
Regarding single point substitutions, there are two types which may occur, with the 
frequency of each being determined by the bias of the in vitro or in vivo mechanism. The first type 
is a transition event where a purine (adenine or guanine) is replaced by another purine or, similarly, 
a pyrimidine (cytosine or thymine) is replaced by a pyrimidine. Transversion events may also be 
seen, were a purine is replaced by a pyrimidine or visa versa. Error-prone PCR is known to 
promote transitions over transversions (Kuchner and Arnold, 1997) and this is one example of how 
mutational bias, inherent to some degree in all ‘random’ mutation’ methodologies, could limit the 
‘randomness’ of the variants obtained and thus the range of sequence space explored in a library.
Further terminology of nucleotide mutations is based on how they impact on the resultant 
protein sequence, an important issue as degeneracy within the genetic code means that gene 
sequence mutations can frequently have no post-translational structural effect If a mutation causes 
no amino acid change, mostly occurring at the third point of a codon, then it is termed a silent, 
neutral or synonymous mutation (Patthy, 1999). Nucleotide changes that alter the amino acid 
coded for are called non-synonymous substitutions and usually occur at the first and second 
positions of the codon. A missense mutation refers to a non-synonymous mutation that simply 
results in the substitution of one amino acid in the primary protein sequence for another. A 
mutation that changed a codon into a termination codon would be termed a nonsense mutation and 
leads to premature termination of the protein.
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1.3.2 Spontaneous & induced substitution mutations
An induced mutation would be defined as one that was proven to result from the exposure of an 
organism to certain natural mutagenic agents. Such agents may act on the DNA directly to change 
its template properties or may affect the machinery of replication, lowering fidelity and allowing the 
introduction of error (Patthy, 1999). Examples of directly induced DNA mutations would be the 
chemical modification of bases by DNA reactive chemicals (e.g. nitrous acid) and ultraviolet 
radiation (Watson et al., 1992). Nitrous acid acts by converting cytosine into uracil (a purine, which 
binds to adenine), thus altering the sequence on daughter strands from G -»  A, while intense 
doses of ultraviolet radiation are absorbed by the nucleotide chains, resulting in photochemical 
fusion of two adjacent pyrimidines.
Spontaneous mutations are frequently replication-dependant errors occurring (very rarely) 
as a result of the chemical nature of the nucleotides themselves. The most common form of 
naturally occurring spontaneous mutation results from the fact that amino and keto groups present 
on nucleotides can tautomerize (to imino and endol forms) and that these transient tautomers can 
give rise to base pairs possessing abnormal chemical properties (Watson etal., 1992). An example 
of this would be an imino tautomer of adenine binding with cytosine instead of the standard pairing 
with thymine (Patthy, 1999). The spontaneous deamination of cytosine to form uracil would be an 
example of a non-replication dependant mutation, and presents a problem for the long-term 
storage of nucleotides as well as propagating a point substitution into daughter strands if copied.
1.3.3 Mechanisms of error-repair
The majority of spontaneous or induced mutations occurring in vivo do not become permanently 
incorporated into the DNA of an organism. The majority of error-control mechanisms are 
incorporated into the polymerisation complexes involved in the synthesis of the complementary 
strand and thus errors can be corrected fractions of a second after they occur. The DNA 
polymerases themselves proofread the outcome of an polymerisation step before proceeding to the 
next one, and can remove and replace mis-incorporated nucleotides by means of a 3*—>5’ 
exonuclease function. Multiple enzyme complexes can be involved in large-scale excisfon-repair
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processes, where entire regions of mutated sequence can be excised and re-synthesised (Watson 
etal., 1992).
Despite the efficiency of the fidelity mechanisms, a steady trickle of mutation ensures a 
level of genotype (and phenotype) diversity within any given eukaryotic or prokaryotic population. 
Application of evolutionary theory leads to the tempting concept of an optimal mutation rate for all 
forms of life, determined by evolution and environmental stability. Too high a rate could lead to an 
excessive proportion of non-viable progeny, while perfect copying fidelity could lead to a static, 
homogenous population, vulnerable to new disease types and environmental upheaval. Of 
particular interest is the fact that many species of bacteria has been observed to upregulate their 
‘net* mutation rate in response to stress (chemical, starvation, etc), and certain types have been 
designated as mutators (Miller, 1998). A mutator strain is defined as a strain exhibiting a 
significantly increased, population wide mutation rate relative to closely related organisms. The first 
bacterial mutators were identified in the 1950s and were initially regarded as little more than 
genetically unstable curiosities, but are now recognised as essential tools for studies into 
evolutionary adaptation and mutation avoidance (Miller, 1998). Artificially engineered mutator 
strains, calibrated to impose a stable rate of mutation over their total genetic contents, are now 
finding increasing use as tool for direct evolution (Coia etal., 1997; Greener etal., 1996; Henke 
and Bomscheuer, 1999). Please see Section 6.1.2 for discussion of mutator strain application in 
directed evolution protocols.
1.4 Random mutagenesis methods
1.4.1 Optimal mutation rate
Random mutagenesis, as a tool for enzyme engineering, can be used in the absence of detailed 
structure-function knowledge of the protein, but with the uncertainty that the effect of positive 
mutations may be masked by non-specific disruption of the protein conformation caused by a 
second mutation (Kuchner and Arnold, 1997). The latter type is by far the most likely and so the 
probability that an enzyme will be improved in relation to wild-type activity decreases drastically as 
the mutation rate rises (Arnold and Moore, 1997). The practicalities of screening for functionality in 
local sequence space mean that directed evolution should only be used to attempt to develop 
properties, which are closely related to those of the parent protein, i.e. enhancement of existing
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features, which could be achieved by sequential accumulation of point mutations within the primary 
sequence. Accepted wisdom is thus that the mutation rate should thus be carefully limited with the 
aim of producing enzyme libraries with primarily single amino acid substitutions per protein, so that 
the individual effect of each substitution may be assessed (Arnold and Moore, 1997; Kuchnerand 
Arnold, 1997; Moore etal., 1997). As approximately one-third of DNA base substitutions are silent, 
the mutagenic target should be in the region of 2-3 substitutions per gene. DNA shuffling provides 
a method by which factorial combinations of multiple mutations may be quickly assessed, and this 
has led to the development of an alternate school of thought based on the creation of gene 
libraries, with each clone containing multiple mutations. The rationale to this is that certain fitness 
solutions (i.e. mutational adaptations to a particular task) may only be accessible through a number 
of simultaneous mutations in the protein’s structure. An extreme example of this would be the 
directed evolution of an aspartate aminotransferase with new substrate specificities, where an 
unscreened homologous library was recombined using the original error-prone protocol for DNA 
shuffling (mutation rate of 0.7-0.8% per base pair) (Stemmer, 1994b), with the result that the five 
clones identified to have the highest activity on the novel substrate (2-oxovaline) contained 23-28 
point mutations each (Yano et al., 1998). The nucleotide substitutions were distributed evenly over 
the gene and sequence analysis revealed that, on average, 10-14 were non-synonymous and that 
only 5 of these substitutions were conserved in all 5 mutants, suggesting functional importance. As 
shown by Equation 11.6, which charts the total possible number of sequence mutants arising from 
n simultaneous mutations, the limiting factor for the mutation rate should be the capacity of the 
screening ‘infrastructure’. In a highly complex library (average maximum laboratory-scale size 
without selection is 106 clones) incorporating multiple mutations per gene, it would be inevitable 
that only a tiny percentage of the total possible variants could be isolated and screened. A screen 
sensitive to slight increases in fitness (simplified if screening of novel substrate specificity as zero 
wild-type background activity) coupled with successive rounds of enrichment and backcrossing 
(recombining mutants with wild-type enzyme to help breed-out neutral mutations) would be 
essential if such a strategy were to succeed.
The required mutation rate would also be obviously dependant upon the length of the 
target gene and should take the bias of the method used into account (Matsumura and Ellington, 
2001). As a general rule, the researcher should design a mutagenic strategy with the aim of
30
Chapter 1: Introduction Edward Hibbert
generating as much functional diversity as possible while maintaining a minimum threshold of 
fitness, and constrained at all times by the physical capacity of the screen.
1.4.2 Methods of random mutagenesis
A list of the major current methods for generating a library of randomly mutated clones is presented 
in Table 1.2. DNA shuffling and epPCR are the two methods most commonly employed, because 
of their relative technical simplicity and also the growing body of experience in their use. Both 
methodologies carry disadvantages however, as indicated in Table 1.2 and as discussed further in 
Sections 1.4.3 & 1.4.4. Figure 1-3 gives a schematic strategy of directed evolution of protein 
encoding genes by epPCR, DNA shuffling and DNA shuffling incorporating backcrossing with the 
wild type gene.
Propagation of the vector in a mutator strain can be an attractive option as it removes the 
need for excessive gene manipulation, but the mutation rate in low-copy number plasmids means 
that successive rounds of subcloning may be required, possibly pushing the genetically unstable 
strain past its 'window of viability*. This is discussed further in Section 6.1.2. Beyond these principle 
methods, specialist strategies of direct evolution have been developed for tackling specific 
research problems. Of these, cassette mutagenesis is the simplest, being simply a variation of 
saturation mutagenesis, performed on a region of a few codons only. The strategy is based on the 
addition of oligonucleotides comprising random codons to defined points in a gene by means of the 
design and synthesis of a primer library, followed by low-stringency PCR (Miyazaki and Arnold,
1999). It is perhaps debatable as to whether this can really be considered a strategy of random 
mutagenesis as the primer library is usually rationally synthesised to contain each possible amino 
acid at a certain position (hence saturation mutagenesis), but it provides a useful tool for 
introducing and evaluation multiple non-synonymous mutations within a very short region of the 
gene. Amino acid positions to be mutated by this method are frequently identified as conserved 
mutations resulting from an initial library where the entire gene was subjected to epPCR (Miyazaki 
and Arnold, 1999) A relevant study, involving the investigation of the substrate specificity of a 
eukaryotic trypsin expressed in E coli using oligonucleotide directed mutagenesis, looked at the 
effect of substitutions of a region of 6 nucleotides (Evnin, Vasquez, and Craik, 1990). These 
corresponded to two amino acids at the base of the substrate binding pocket known to be
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significant from previous work (Graf et al., 1988). The mutagenesis strategy was designed as 
illustrated in Figure 1-2 except that the substitutions were designed into cassettes instead of 
randomly produced, and the mutants with partially preserved function were selected from the 
resultant library using a highly effective method of genetic selection. It is important to note that this 
study was not concerned with improving the activity of the protein, merely on investigating the 
effects of neutral and deleterious mutations on two amino acids thought to be essential in defining 
substrate specificity. Oligonucleotide directed mutagenesis could thus be used to intensively 
mutate a small region of a protein’s primary sequence and, when coupled to a selection strategy, 
allows every possible substitution to examined, but, by definition, limits the focus of the experiment 
to that region. Family shuffling refers to the technique of using DNA shuffling protocols to 
recombine a family of genes from diverse species, including functionally similar but structurally 
heterlogous ‘convergently evolved’ proteins (Crameri et al 1998). Please see Table 1.2 for further 
notes and discussion.
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Figure 1-3: Strategies of directed evolution
Basic strategies of directed evolution of ©  mutagenic PCR, ©  DNA shuffling and (D DNA shuffling 
incorporating backcross with the wild-type gene. Figure adapted from (Kurtzman et al., 2001).
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Method Principle Mutagenesis rate (%) Bias Application Disadvantages Reference
epPCR (Mn2+)
epPCR ([dNTP])
DNA Shuffling
Family Shuffling
Cassette
mutagenesis
Mutator strain (XL1- 
Red)
Hypermutagenesis
Low-fidelity PCR
Low-fidelity PCR
Variable, 
documented at 
up to 0.9
Variable, 
documented at 
up to 0.9
Transitions
Transitions
Fragmentation & reassembly 0.7 - 0.8 Transitions
Shuffling of natural 
homologues
Extension of oligonucleotides 
with random dNTPs
E. coli lacking certain 
repair/proofreading pathways
Low-fidelity reverse 
transcription
>0.7*
0 -75
0.05 
(dependant on 
plasmid copy 
no.)
0.5-10
Transitions?*
None
Lack of 
published 
data
Transitions
Adjustable frequency 
of mutation
Adjustable frequency 
of mutation
Concentration of 
beneficial mutations
Recombines 
divergent homologs
Randomises 1-8 
nearby codons
Technically simple 
method for 
generating diversity
High mutation rate for 
up to 200bp
Ligation and 
digestion steps 
required.
May require 
nucleotide analogues 
(if dPTP or 8-oxo- 
dGTP used) 
UseofTaq 
polymerase gives 
high basic mutation 
rate.
Technically difficult, 
high mutation rate.
Requires structural 
model.
Low mutation rate
Rate too high for 
whole gene 
mutagenesis
(Fromantet al 1995; 
Moore and Arnold 
1996)
(Zaccolo etal 1996)
(Stemmer 1994b)
(Crameri etal 1998) 
(Black et al 1996)
(Greener, Callahan, 
and Jerpseth 1996)
(Matsumura and 
Ellington 2001)
Table 1.2: Comparison of modern methods of random mutagenesis.
* The authors acknowledged the ambiguity of their data regarding a process of family shuffling and were thus unable to provide more than a rough 
estimate of mutation rate and bias. Mutational frequency is usually described as a percentage and target frequency can be calculated from the length 
of the coding sequence and the Ne of mutations desired. Table adapted from (Matsumura and Ellington, 2001).
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1.4.3 Mutagenic PCR (epPCR)
1.4.3.1 Theory
In mutagenic PCR, manganese (Mn2+) ions, excess magnesium (Mg2+) ions, unbalanced 
concentrations of nucleotides or the presence of synthetic nucleotide analogues in the reaction 
buffer are used to lower the fidelity of Taq polymerase (Matsumura and Ellington, 2001). This is 
thus a low-fidelity variant of standard PCR and contains the same basic steps, namely denaturation 
of the double-stranded template, annealing of sense & antisense primers and subsequent 
extension of the growing strand. It is during the extension step that mutations can occur when the 
polymerase allows non-complementary nucleotides to be incorporated into the growing chain. Taq 
is particularly suited for this work as it lacks a 3’-5’ exonclease proof-reading activity and thus 
exhibits a base mutation rate significantly higher than comparable prokaryotic polymerises. 
Although certain guidelines have been established for use of each factor, it is important that the 
mutation rate rate be optimised empirically on the target gene as even the base levels of enzyme 
fidelity have been shown to be influenced by factors such as sequence (partially melted secondary 
structure or GC rich regions), purity and quality of the template plasmid DNA, and the manufacturer 
of the enzyme (Keohavong and Thilly 1989). Table 1.3 lists examples of various routinely used 
thermo-stable DNA polymerises for PCR. Only enzymes resistant to temperatures in excess of 
95°C are used so to avoid the need for polymerase replenishment and, as indicated by the low 
error rate, Pfu polymerase is the clear choice for high fidelity amplification.
Enzyme
Error Rate (errors/bp) in optimal 
conditions
Reference
Pfu (Pymcoccus furiosus) 
Vent [Thermococcus litoralis)
Taq (Thermus aquaticus)
1.6X10-6 
2.4x1 O'5 
No published studied, but claimed 
to be higher than Vent 
5.1x10-5
Btwn 2x10-5- 2.1x104
(Keohavong and Thilly 1989; 
Tindall and Kunlel 2003) 
(Lundberg et al 1991) 
(Cariello et al 1991)
Deep Vent (Pyrococcus species)
KlenTaq (Thermus aquaticus) (Barnes 1992)
Table 1.3: Error rates for thermal resistant DNA polymerases
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As indicated by the bias shown in Table 1.2, epPCR does not create truly random nucleotide 
substitutions, favouring transitions over transversions and with a particularly high occurrence of A 
G substitutions (Fromant et al., 1995; Zhao et al., 1999). Bias affects thus the location of 
mutations (mutations introduced by Taq occur more often at AT base pairs than at GC pairs) and 
their type (Taq favouring purine transitions, A <-> G). The significance of bias in an experiment can 
only usually be determined after the sequencing of a representative sample of genes. Lowering 
Taq fidelity by means of unbalanced concentrations of dNTPs clearly introduces bias in favour of 
the over-represented nucleotide and, while a well characterised method, is generally regarded as 
less useful for this reason (Zhao and Arnold 1997a).
Mutation frequencies ranging from 0.11 -  0.49% per base have been accomplished by 
alterations of the [Mg]:[Mn] ratio (Matsumura and Ellington 2001). The total concentration of salts in 
a PCR reaction buffer is usually 0.1 -  3mM, being empirically altered for each template in order to 
optimise reaction yields. In a reaction using [total salt] of 7mM, mutation rates of ~ 0.1% atOmM 
MnCfeand -  0.5% at 0.5mM MnCb were recorded. A sample protocol of salt-mediated epPCR, 
which the researchers claim can deliver an overall mutation rate of -0.2% on purified plasmid DNA, 
is stated in Appendix B (Zhao et al., 1999). The overall mutational frequency in epPCR can thus be 
regarded as the product of three parameters: the error rate (fidelity) of the selected polymerase in 
the reaction conditions, the length of the gene being amplified, and the number of effective 
doubling cycles.
1.4.3.2 Muller’s ratchet & asexual reproduction
While epPCR provides a stable and controlled platform for the introduction of point mutations into a 
gene, its suitability for experiments likely to require successive rounds of mutagenesis decreases in 
inverse proportion to the number of cycles. The probability of epPCR continuously improving a 
gene through the addition of point mutations has been shown to decreases drastically with each 
round (Maranas, 1999), as the build-up of negative mutations typically masks beneficial 
substitutions. This phenomenon attends all forms of asexual reproduction and is referred to in 
population dynamics as ‘Muller’s ratchet1. Muller’s ratchet is a theory put forward to explain the 
prevalence of sex as a means of reproduction. Asexual reproduction offers an efficient method for
35
Chapter 1: Introduction Edward Hibbert
any organism to reproduce itself (100% probability of each parent gene being expressed in 
offspring) and effectively doubles the reproductive strength of a species by eliminating the need for 
males. The theory describes a series of modelling experiments into the accumulation of deleterious 
mutations in lineages/individuals under asexual reproduction, and showed that, over time, the 
‘most fit* class of an asexual population would be gradually lost to the accumulation of negative 
mutations (Patthy, 1989). With each successive generation, i.e. with each ‘turn of the ratchet*, 
further mostly deleterious and silent mutations would accumulate, irreversibly lowering the mean 
fitness of a population. The model showed that sexual reproduction, while energy expensive (cost 
of meiosis = cost of producing males), provides a method for gene shuffling and recombination, 
allowing the least-mutated class of each generation to be regenerated, and thus effectively 
countering the ratchet
The same model could equally be applied to the in vitro asexual generation of gene 
diversity by epPCR, showing that the accumulation of mutations on each gene would inevitably 
result in a lowering of fitness relative to the parent. DNA recombination is thus a naturally 
complementary method for epPCR, as well as being able to Introduce diversity in its own right with 
certain protocols, the gene shuffling allows potentially beneficial mutations to be screened 
factorially and in isolation, while back-crossing with the wild-type gene ensures negative and silent 
mutations can be edited out of the clones without the need for sequencing or rational involvement. 
DNA shuffling is discussed in detail in Section 1.4.4.
1.4.3.3 Modelling of mutagenic PCR
The modelling of mutagenic PCR requires initially a mathematical description of the polymerase 
chain reaction and, secondly, a robust method for the factoring in of the error-rate. Significant 
attention has been paid to developing a model of epPCR which can accommodate bias, primarily 
as such a model would provide a useful adjunct to the far more complex models of DNA 
recombination currently being debated. A simple equation for predicting the expected number of 
mutations of an epPCR protocol based only on the gross error rate is shown in Equation 1.1.
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Np 
J 2
Equation 1.1
Predicts overall error-rate (/) after N PCR cycles with a per cycle error rate of p. Equation proposed 
by (Eckert and Kunkel, 1990).
Equation 1.1 provides a useful rule-of-thumb for estimating the number of expected substitutions, 
but can provide no data beyond that as it only considers mutations as a group, with no reference to 
the bias of the method. For a more sophisticated model, one which treats individual mutations as 
nucleotide-dependant steps and thus would allow prediction of the types and locations of the 
expected mutations, it is first necessary to describe the PCR process more exactly. As the concept 
of lowering enzyme fidelity implies that the more frequently a sequence is copied, the more likely it 
is to acquire a mutation, it is important to note that after N cycles of PCR, not all sequences in the 
reaction mixture result from exactly N extensions of the original template (Moore and Maranas, 
2000). Figure 1-5 illustrates how many cycles of expansion were required to create each individual 
strand. A particular DNA strand is obviously sequenced only once, but the higher the number of 
synthesis steps occurring before it is produced, the higher the chance of a mutation occurring. It is 
evident that a mutation which entered the sequence of a newly synthesised strand particularly early 
in the reaction (e.g. N = 2) would be propagated throughput a large section of the population, 
possibly masking subsequent substitutions and appearing as a conserved feature in the library.
The relatively low mutation rates involved make this an unlikely situation however, and mutations 
would only be statistically likely to occur later in the reaction, when thousands of individual strands 
were being synthesised at once.
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A/= 3
Single strands = 2 * 2 W
A/ = 2
N= 1 
A/=0
Figure 1-4: Illustrating the exponential increase of DNA single strands using the polymerase 
chain reaction
N refers to the number of extension steps (i.e. stand synthesis cycles) undergone. At N = 3 the 
mixture would contain 16 single strands, 2 of which would be parental template (black), 6 of which 
would be the result of one extension step (red), 6 of which would be the result of two expansion 
steps (green), and 2 would be the result of three expansion steps (blue). Total single strands 
increase exponentially with each step according to embedded equation.
There was a need to express the relationship of newly synthesised strands to the number of 
extension steps required to form them (Figure 1-5) mathematically so that the relative probability of 
generating a mutation during synthesis could be calculated. Moore and Maranas, researchers from 
Pennsylvania State University, proposed the model shown in Figure 1-5, which defined the concept 
of ZNjn as representing the number of single strands which have been through n extension steps 
after N cycles of PCR (Moore and Maranas, 2000). Central to the model were the statements that, 
as two parental template strands were present at the beginning of the reaction and were not the 
result of an extension step, Zo,o = Zn , o  = 2, and similarly, after N PCR cycles are completed, no 
single strands will have been synthesised that are the result of more extension steps than N, i.e.
ZN,n= 0 for n > N. The authors took the combined statement of Znji = Z ^ ,n + Z ^ i^ i Figure 1-5 and 
constructed a proof by induction for Equation 1.2, validating the relationship by solving for n = 0,1, 
2 & 3.
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PCR cycle N  -1
_________Z A H  n
n extension steps 
n+i extension steps ---------------------
_________Zftf-t n -t
ft-1 extension steps | 
n extension steps ---------------------
Figure 1-5: Describing the number of strands that have been through n extension steps after 
N PCR cycles
Each strand in the mix can be classed as originating from a template (Zn,„) of one of two types: a 
strand synthesised prior to the PCR cycle A/-1 and thus has been through n extension steps 
(template referred to as Zam/i); or a comparatively new template strand, itself synthesised from a 
older template and thus having gone through n-1 extension steps (template referred to as Zn-i,«-i)- 
Figure adapted from (Moore and Maranas, 2000).
PCR cycle N
Z m/i = Z am n+Z^. j  n-j
n extension steps
Equation 1.2
The number of single strands (Zw>n) that have been through n extension steps after N cycles of 
PCR. Equation from (Moore and Maranas, 2000)
Combining Equation 1.2 with the exponential statement for the synthesis of single DNA strands 
presented in Figure 1-5, results in Equation 1.3, which relates Z/v,„to the total number of DNA 
strands synthesised at each stage of the reaction.
Equation 1.3
Fraction of sequences in mix after N PCR cycles that are the result of n extension steps. Equation 
from (Moore and Maranas 2000).
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A crucial aspect of the model was that it would not just accurately factor the number of extension 
steps required to synthesis each strand and thus the ‘window* for mutagenesis in each case, but it 
would also allow for the prediction of the type of mutation that would occur, thus enabling the 
model to compensate for any bias in the procedure. Mis-incorporation rates of polymerises were 
known to be nucleotide specific (e.g. Taq prefers A ->  G substitutions to any other type) (Fromant, 
Blanquet, and Plateau, 1995), and thus a per cycle mutation matrix (M) was proposed with 
elements M/j representing the probability of nucleotide / being substituted with nucleotide j  Equation
1.4 (Moore and Maranas, 2000). The probability associated with each individual element would 
need to be determined empirically and would be dependant upon the polymerase used, the 
sequence of the template and, crucially, the reaction conditions used.
M  at m ac m  AG
M ta M Tc M tg
M Ca M c T M cc ^ cg
M 0a M qt M ac ^GG j
Equation 1.4
Mutational matrix dealing with the individual probabilities of one nucleotide being replaced by 
another. Values to be determined empirically. Equation from (Moore and Maranas, 2000).
The per cycle mutation rate matrix M (Equation 1.4) was then be used to calculate the overall 
mutation rate matrix after n extension steps, known as Cn Equation 1.5. Cn could then used to 
determine the probable mutation rate of a sequence after n extension steps from the original 
parental template. A crucial point was that the occurrence of nucleotide substitutions introduced in 
each new strand during a synthesis step was independent of mutations that had occurred during 
previous cycles. Cnq (the probability of / being substituted by j  after n extension steps) was 
calculated in a recursive manner, i.e. calculated by necessity for each value of n.
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Sip n = 0 
q . =  M p  n =  1,
1 X ^ 1 ' 2
k = A ,C ,T ,G
Equation 1.5
Matrix describing the mutation rates of a sequence obtained after n extension events, starting from 
the original template. 5? refers to the two parental templates at n = 0 and therefore will equal 0 
unless i= j  (effectively no substitution) where it will equal 1. Equation from (Moore and Maranas, 
2000).
The final form of the model combines matrix Cnij (Equation 1.5), with its combined measurements 
of the distinct nucleotide substitution rates, with Equation 1.3, that describes the number of single 
strands produced and the relative probability of finding a mutation on any particular one 
(proportional to n extension events). The combined statement is shown in Equation 1.6.
Equation 1.6
Describing the probability (P^) of nucleotide / being substituted with nucleotide ]  after N PCR 
cycles. Equation from (Moore and Maranas, 2000).
The relationship shown in Equation 1.6 allows a researcher to calculate, a priori, the probable 
number and type of mutations that could be expected on a gene of a certain length, after a certain 
number of complete PCR cycles and in calibrated reaction conditions. The equation also provides 
the mathematical basis tor more involved forms that allow for calculation of the probability of 
obtaining a target sequence by mutagenesis of the original (Moore et al 2000; Moore and Maranas
2000). This is a particularly useful relationship to establish as, once calculated, extraction of the 
now desired mutation rate would allow the researcher to precisely tailor PCR reaction conditions so 
as to maximise the probability of the target sequence emerging in the screen.
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1.4.4 DNA shuffling
1.4.4.1 Theory
The importance of DNA recombination (i.e. sexual reproduction) in population dynamics has long 
been established as a means of generating variability while naturally eliminating deleterious 
mutations from an evolving population, thus avoiding the negative implications of Muller’s ratchet 
(see Section 1.4.3.2). The first in vitro method for performing DNA recombination of a pool of 
double-stranded genes, and which has formed the template for subsequent specialised variations, 
was designed by Stemmer in 1994 and involved the enzymic digestion of the genes into short 
fragments by incubation with Dnase I, followed by reassembly of the overlapping fragments into foil 
genes by means of a primer-free PCR reaction (Stemmer, 1994a). As the fragments are 
overlapping they are free during the PCR, to associate with complementary fragments from 
homologous genes, resulting in novel combinations of the mutations present in the initial library. A 
final high-fidelity PCR step can then produce large quantities of each variant for cloning and 
plasmid amplification in E  coli, and then transfer into a suitable expression strain if necessary 
(Arnold and Moore, 1997). The library would then be screened for enzymes with increased fitness 
towards a particular parameter, and a pool of variants, all of which would code for enzyme 
exhibiting fitness above a defined threshold, would then selected for the next round of 
recombination and screening (see Figure 1-3). In this way, DNA shuffling avoids the loss of 
different types of low-level beneficial mutations by selecting all to participate in the next level of the 
process. The mixing of mutations also acts to eliminate the risk of selecting a single active clone, 
which could in reality be stuck at a local fitness minimum, i.e. by the nature of the individual fitness- 
improving mutation acquired, it may be that no other single point substitutions could raise the 
fitness of the mutant any higher. In such a case, solutions could only be reached through multiple 
simultaneous amino acid substitutions, achievable by increasing the mutation rate of epPCR or 
through recombination of existing mutations (Lutz and Benkovic 2000)
An important factor to be considered when designing a strategy of directed evolution is that 
when Taq polymerase is used for the reassembly reaction, the act of forcing the polymerase to 
synthesise a foil length gene from the small fragment DNA pool can cause the introduction of point 
mutations into the sequence, with a relatively high substitution rate of approximately 0.5-0,7% (see 
Table 1.2) (Stemmer, 1994b; Zhao and Arnold, 1997a). Successful improvements of enzyme
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fitness have been reported using DNA recombination as a tool for both generating diversity and 
recombining the resultant mutations, for example brightness of a green fluorescent protein 
(Crameri et al., 1996) and the substrate specificity of an aminotransferase (Yano et al., 1998), but 
the unavoidably high mis-incorporation rate even under optimum conditions, means that the 
complexity and thus theoretical size of the library to be screened can deter researchers. Additional 
discussion as to optimum mutation rates can be found in Section 1.4.1. Replacement of Taq with 
the high fidelity Pfu polymerase (see Table 1.3 for error rates under standard PCR conditions) has 
been shown to lower the mutation rate of a shuffling protocol to 0.05% (Zhao and Arnold, 1997b). 
Use of this high fidelity recombination protocol means that initial diversity in a gene can be 
generated by means of epPCR with a carefully selected and controlled error rate, calculated to be 
optimal for the length of the gene and the capacity of the screen.
1.4.42 Variations of the standard recombination protocol
Beyond the high-fidelity variant of DNA shuffling (discussed in Section 1.4.4.1), other protocols 
based on Stemmer’s original technique have been developed, both for altered forms of 
recombination and for altered rates of mutagenesis. A list of the most significant types can be seen 
in Table 1.4.
The staggered extension primer process (SEP) is a technically simplified form of DNA 
recombination in that it eliminates the need for digestion of the strands with Dnase I and thus also 
enables the reaction to be performed in a single tube as the mix need not be purified after 
fragmentation (Zhao et al 1998). Essentially, StEP consists of the priming of the template 
sequences, followed by repeated cycles of denaturation and annealing, and then by extremely 
abbreviated polymerase catalysed extension cycles. The duration of the extension cycles is set so 
that the polymerase can only incorporate a set number of nucleotides into the growing strand per 
cycle (the number can be calibrated by the length of the gene and the amount of recombination 
required), before denaturation dissociates the double strand and polymerase complex. With each 
new annealing period, the growing fragments can anneal to different homologous templates based 
on sequence complementarity, and thus each PCR cycle can constitute a recombination event 
Key to the success of the process is that annealing (hybridisation of growing strand to new 
template) must be performed under high-stringency conditions to minimise the incidence of
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frameshift or indeed ‘domain-wandering’ mutation, and so, typically, Taneaiing > Tm -25°C, where ‘m’ 
equals the melting temperature of the initial primer (Zhao et al., 1998).Taq polymerase has been 
reported to exhibit a nucleotide extension rate of 100-150 nucletides per second at its optimal 
temperature of 72°C, and 25-38 nucleotides per second at 55°C (the temperature normally used) 
(Zhao and Arnold, 1998).
Standard DNA shuffling reactions are limited by their need to work with homologous 
libraries of genes and thus the potential benefit^ to be gained through the recombination of highly 
diverse sequence sets or recombining an existing library in a sequence-independent manner 
cannot be explored. Evolutionary studies generally find a higher degree of structure, rather than 
sequence, conservation between distantly related proteins, and thus methods for combinatorial 
homology-independent protein engineering may be able to access regions of functional diversity 
previously denied (Lutz and Benkovic, 2000; Lutz and Benkovic, 2002). The method of incremental 
truncation for the creation of hybrid enzymes (ITCHY) facilitates this by providing a means by 
which randomly truncated genes could be brought together end-to-end, thus requiring no form of 
hybridisation. Essentially, ITCHY involves the truncation of both strands of the parent gene by 
incubation with exonuclease in  (no internal sequence cuts), followed by the creation of a single 
cross-over library by means of ligation of the resultant N- and C- terminal fragments (Lutz and 
Benkovic, 2000). The hybrids generated would cover a range of sizes, both longer and shorter than 
the parent strands and this, combined with the naturally very high incidence of frameshift mutations 
occurring at the random ‘junction points’ means that a high proportion of the enzymes expressed 
would be inactive. A variant of ITCHY that involved the use of nucleotide analogues such as a- 
phospholhiate nucleotides (THIO-ITCHY) was developed and involved a significantly simpler 
experimental protocol and faster library generation times (Lutz et al., 2001a). Both ITCHY and 
THIO-ITCHY were limited in that only two parents could be joined at any one time, and thus each 
progeny hybrid carries only one junction. The high proportion of defective hybrids would also 
necessitate a selection scheme to avoid wasted screening work.
Sequence homology independent protein recombination (SHIPREC) is an alternative 
method of creating such single crossover libraries. The process creates an inverted fusion protein 
of the two parent strands (so as to protect the N- and C- terminus) and then subjects them to 
partial digestion with DNase I, before inverting them once more (Sieber etal., 2001).
44
Chapter 1: Introduction Edward Hibbert
The creation of hybrid libraries with multiple sequence-independent crossovers though a 
combination of ITCHY and DNA shuffling is termed SCRATCHY (Lutz et al., 2001 b), and would 
appear to be the logical conclusion in the development of such techniques. The process involves 
the creation of two complementary ITCHY libraries composing of hybrid sequences screened to be 
of parental size and in the correct reading frame, and recombines the libraries by means of random 
fragmentation and reassembly PCR. The mixing of structural elements means that, again, a high 
proportion of inactive enzyme would be expected and the process should be coupled to a selection 
step in an auxotrophic expression host if at all possible.
Two remaining methods stand apart from the others, while still being based on the concept 
of genetic recombination. The first, in vitro exon shuffling, represents an attempt to mimic another 
other form of gene recombination observed in natural systems. This involves the amplification of 
eukaryotic exons that encode protein domains by means of chimeric oligonucleotides and their 
subsequent rearrangement and PCR reassembly (Kurtzman et al., 2001). As this method involves 
the shuffling of entire structural domains, a high degree of fitness in the resultant clones would be 
expected. The second method is termed random chimeragenesis on transient templates 
(RACHITT) and is a technique based on DNA shuffling in which single-stranded parental gene 
fragments are annealed onto a full-length single-stranded template (Coco et al., 2001). The 
‘reassembled’ double-stranded template could then be treated with ligase to seal nicks in the 
sequence, before being amplified by high fidelity PCR.
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Method
StEP
ITCHY
THIO-ITCHY
SHIPREC
SCRATCHY
Exon shuffling
RACHITT
____________ Advantages____________
No need for DNA digestion; fragment 
purification.
Independent of sequence homology; random 
digestion allows distribution of junctions 
throughout gene.
Same pros as ITCHY but technically easier to 
perform.
Same pros as for ITCHY; allows selection of 
hybrids of parental size.
Independent of sequence homology; allows 
multiple parents per hybrid.
Independent of sequence homology; based on 
structural homology thus tends to maintain 
fitness.
PCR -free method thus avoids bias & 
introduction of new mutations; only very short 
regions of sequence homology (0-5 bases)
__________ Disadvantages__________
Reliant on sequence homology (similar to 
standard shuffling)
Hybrids limited to 2 parents of equal length; 
parent length not conserved; high rate of 
frameshift events thus high proportion of low 
fitness hybrids.
Same cons as ITCHY; use of dNTP 
analogues may present problems for future 
cloning/manipulation steps.
Cons as for ITCHY except that parent length 
may be conserved.
High rate of frameshift events coupled with 
overall low fitness of hybrids requires a 
selection step.
Restricted to intron-containing genes 
(eukaryotic origin); diversity is directly 
proportional to number of exons present.
Quality of DNA may be affected by process; 
process involves multiple cloning & 
preparatory steps.
 Reference______
(Zhao, Giver, Shao, 
Affholter, and Arnold 1998)
(Lutz and Benkovic 2000)
(Lutz, Ostermeier, and 
Benkovic 2001a)
(Sieber, Martinez, and 
Arnold 2001)
(Lutz, Ostermeier, Moore, 
Maranas, and Benkovic 
2001b) 
(Kurtzman, Govindarajan, 
Vahle, Jones, Henrichs, and 
Patten 2001)
(Coco, Levinson, Crist, 
Hektor, Damns, Pienkos, 
Squires, and Monticello
2001)required.
Table 1.4: Variations on the standard protocol of DNA recombination
All methods listed here are described in more detail in Section 1.4.4.2. Acronyms: StEP = Staggered Extension Process; ITCHY = Incremental 
Truncation for the Creation of Hybrid enzYmes; THIO-ITCHY = ITCHY with a-phosphoTHIOate deoxynucleotide triphosphates; SHIPREC = 
Sequence Homology Independent Protein RECombination; SCRATCHY = ITCHY plus DNA shuffling (?); RACHITT = RAndom CHImeragenesis on 
Transient Templates.
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1.4.4.3 Modelling of DNA shuffling
Constructing a model of the standard DNA shuffling procedure is extremely complex, as it requires 
the description of three fundamentally separate processes if the precise mechanics and 
probabilities of the recombination are to be understood (Moore et al., 2000). The first would be a 
model of the random fragmentation of the gene with DNase I. The model would have to factor in 
the distribution of digestion fragment sizes and the spread of mutations already present on the 
gene. The second model would describe the recombination of the fragments and the synthesis of 
complete genes, as well as the probability of mutations being introduced during synthesis (if Taq 
polymerase was used). The final section would involved a sequence matching model, which would 
use the recombination mechanics and fragment size distributions of the previous steps to calculate 
probability of a particular target gene (a product of x fragments from n sequences) arising so that 
oversampling of the library for screening could be adjusted accordingly. The three integrated 
models will not be discussed here, but the original calculations and full descriptions can be found in 
the year 2000 work of Moore and Maranas (Moore et al., 2000; Moore and Maranas 2000).
A simple statistical method does, however, allow the calculation of the probability of 
generating a sequence through recombination which contains a certain number of mutations 
present in the original strand (Moore et al., 1997). While this simplified model could not present a 
complete view of the process, it was sufficient to provide a guide for experimental design and to 
give an indication of the degree of oversampling required when screening clones. The model 
assumed that all mutations are unique and distributed close to randomly. Stating regular 
distribution would be a gross oversimplification, but here the assumption was that all mutations are 
far enough apart for recombination to occur freely between them.
The basic statistics of recombination can be stated as follows. Assuming a library of three 
genes, each containing a single different mutation, after fragmentation, the probability that any 
given mutation entering into a progeny sequence would be 1/3. Logically then, the chance of a 
progeny canying a wild-type sequence at any given mutation point would be 2/3. For any mutations 
in the initial library, there is thus a statistical preference for the absence of the mutation in the 
progeny. The probability of the shuffling event resulting in a completely wild-type sequence (no 
mutations) would thus be calculated per mutation: (2/3)3 = 0.3. Equally, the probability of 
generating a sequence with only one mutation through recombination (a regenerated parent
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strand) at each mutation point would be (1/3) x (2/3)2 = 0.15. As there are three parent sequences, 
combining the probability of their generation with that of the wild-type ( 0.3[0.15 x 3] = 0.75) leads 
to the conclusion that, of the shuffled library, fully 75% of sequences would be parental or wild- 
type, with only around 25% being novel recombinations of mutations (Moore et al., 1997).
The above probabilities allow the construction of the factorial expression in Equation 1.7, 
which describes the number of ways that a sequence with //-mutations could be generated in a 
system with M total mutations.
C U  M \
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Equation 1.7
The number of ways that a //-mutation sequence may be generated in a recombination system 
containing M total mutations. Equation from (Moore, Jin, Kuchner, and Arnold, 1997)
The logical progression was then to multiply the value from Equation 1.7 with the probability of 
generating any individual //-mutation sequence. A combined form of the equation is presented in 
Equation 1.8 and describes the probability (PM) of generating a //-mutation sequence in a system 
with n total sequences and M total mutations per strand.
f n a £ I ■fc
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Equation 1.8
The probability of arriving, through DNA recombination, at a //-mutation sequence in a system with 
n total sequences and M total mutations per strand. Equation from (Moore, Jin, Kuchner, and 
Arnold, 1997).
In a frequency distribution of recombined sequences, those with a single mutation predominate (N 
= M), while the rarest sequences to be generated are those with the most number of concentrated 
mutations. The probability of screening the least likely sequence (F^, containing all mutations (// = 
M), can be calculated as VNM (Moore, 1999;Moore et al., 1997).
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1.5 Project background
1.5.1 Industrial uses of recombinant bovine trypsinogen
Bovine trypsin has been characterised as a robust, digestive enzyme, with high levels of activity 
towards a relatively broad range of substrate sequences (for a comprehensive discussion of the 
substrate specificity of this enzyme please see Section 1.6.7) and as such, has found use as a tool 
for biocatalysis in many laboratory-scale and industrial procedures. The protease is widely used in 
mammalian cell culture (trypsinization) and is frequently used for the processing of recombinant 
constructs within the pharmaceutical industry, examples being the cleavage of fusion proteins 
(solubility or affinity tags) (Colman, 1997) and, crucially for this work, the processing of insulin and 
insulin-analogues. The production of biosynthetic human insulin (BHI) comprises a major, relatively 
stable part of Eli Lilly’s drug portfolio, with the current market being estimated at between 15,000 to 
25,000 kg per year, growing at an annual rate of 5% to 6% (Petrides et al., 1995). The related 
costs and mechanisms of insulin production, as well as the role of trypsin as a bioprocessing 
agent are analysed in Section 1.8. Essentially, recombinant bovine trypsin is used to separate the 
C-peptide from the immature insulin proprotein (please see Figure 1-15), allowing the A- & B- 
chains to associate with each other and assume the native conformation. The relatively broad 
substrate specificity of the enzyme means that a variety of mis-cleavage or undesirable products 
also result from the enzymatic conversion and a comprehensive strategy of multimodal 
chromatography is required for BHI purification (see Figure 1-17).
Briefly, the purification steps necessitated by this enzymatic cleavage step are, following 
initial concentration by diafiltration, passage through an ion-exchange column (to remove C-peptide 
and modifying enzymes) and subsequent use of reversed-phase high-pressure liquid 
chromatography to remove structurally similar contaminants, e.g. miscut insulin/proinsulin. Figure 
1-6 illustrates a breakdown of the process costs in terms of stage and equipment. Chemical 
modifications and intermediate purification steps (i.e. steps 3-6 on Figure 1-16), account for almost 
60% of the total cost, while the purification resulting from step 6 (enzymatic cleavage) reaches 
approximately 30%. Significant savings could thus be realised if the process of enzyme conversion 
could be optimised into a more efficient, ‘cleaner’ reaction, and so the development of technology 
that would enable the rapid tailoring of trypsin substrate specificity would be of immediate use in a 
large-scale industrial context.
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Figure 1-6: Operating cost per process section of BHI production
Operating cost of intracellular method of BHI production per process section and equipment 
category. Figure adapted from (Petrides, Sapidou, and Calandranis, 1995).
1.5.2 Project goals
The PhD project described in this thesis was proposed by Eli Lilly with the aim of developing a 
process for producing recombinant bovine trypsinogen (r-trypsinogen) in a manner that would allow 
the high-throughput screening of clones essential for a practical strategy of directed evolution.
Such trypsin variants would then be screened against a range of novel peptide library designs, 
structured in such a way as to enable the identification and characterisation of specificity 
mutations, leading to the development of more precise and hence more cost effective biosynthetic 
protein processing tools. The goal was thus to explore methods by which a serine protease could 
have its substrate specificity tailored to optimise a particular biocatalytic reaction and to create, if 
possible, a ‘tool-box’ of mutant proteases with altered and characterised substrate specificities. 
Trypsin was selected for this work, as it is an well-studied protease with a fully solved structure
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(Bode and Schwager, 1975) and it is currently used by Lilly in at least one large-scale 
bioconversion reaction (see Section 1.5.1) which could be used as a economic case study (see 
Section 1.8). Equally relevant was the fact that the activity and specificity of trypsin, while 
extensively explored through point mutation work (Evnin et a/., 1990; Hedstrom, 1996), have not 
previously been subjects of directed evolution experimentation. The reason for this was that 
mammalian trypsin, unlike related prokaryotic serine pnoteases, e.g. subtilisin (You and Arnold 
1994), is extremely difficult to express in soluble, active form, whether in yeast or bacterial host, 
with only a few successful experimental systems being reported (Hanquier et a/., 2003; Perona et 
a/., 1993).
Three main requirements have been recognised as essential for the implementation of a 
successful strategy for directed evolution. These are: 1) the functional expression of the enzyme 
within a microbial host (for ease of genetic manipulation). The protein should preferably be 
expressed in an active state; 2) the choice of an appropriate screening or selection strategy 
sensitive to the desired properties of the enzyme; and 3) selection of a practical evolution strategy 
(Kuchner and Arnold, 1997; Zhao et a/., 1999). While condition 1) should be considered 
mandatory, points 2) & 3) are closely linked, the type of screen appropriate being dependent on the 
amount of mutation exhibited by each clone (Moore et al., 1997).
1.6 Bovine trypsin: general data
1.6.1 Classification
Proteases are classified mechanistically in terms of the location of active sites, mechanism of 
action and three-dimensional structure. To date, four classes of proteases have been identified, 
and six families distinguished within them. The class of serine proteases are divided into two 
families (class I: Eukaryotic, class II: Bacterial) with bovine trypsin (EC 3.4.21.4) belonging to the 
first group along with other proteases of common ancestry such as chymotrypsin and elastase 
(Beynon and Bond, 1989). All members of the serine protease I possess common enzymatic 
mechanisms and active-site structures, and represent one of the most extensively characterised 
protease families. Although a degree of sequence variation exists within the family, the global 
conformation remains constant with all proteins exhibiting two similarly folded domains arranged 
around a two-fold axis of symmetry (Beynon and Bond, 1989; Lesk, 2001).
51
Chapter 1: Introduction Edward Hibbert
1.6.2 Sequence and secondary structure
A representative structure of a bovine trypsin is available on the public access Research 
Collaboratory for Structural Bioinformatics (RCSB) Protein Data Base (http://www.rcsb.org/pdb), 
file name: 1BJV or 1TGN. The sequence of the mature protease is identical to that of the 
recombinant Eli Lilly protein, however the propeptide (not shown here) differs by 3 amino acids at 
the 5! end.
Classification: Serine Protease
Source: Bos Taurus (bovine pancreatic extract)
Molecular weight (of mature trypsin): 23290 
Molecular weight (trypsinogen): 23978 
Number of Residues: 223 (+8 with prosequence)
Optimum pH: Approximately 8.0 
Extinction coefficient: 14.3
Letter Structure Element
H alpha helix (4-helix)
B residue in isolated beta bridge
E extended strand, participates in beta ladder
G 310 helix (3-helix)
I pi helix (5-helix)
T hydrogen bonded turn
S bend
1 i 1
1 V  G G Y T C G A N T V  P Y 0 V  8 L N S GY H F C G G 8 L 1 N S Q W V V  S A A  H CY K S G 1 O V A L
B E E T T T T T T E E E E E S S S B E E E E E B T T  E EE E G G G S S E E E E
0 E D N 1 N V V E  G N E Q F 1 S A S K S 1 V  H P 8 Y H S N T L N N D I M L 1 K L K 8 A A 8 1 N 8 R V
S S T T S S E E E E
' “ I
E S E E E E T T B T T T T B T E E  
r
E E E 8 S S 8 8 8
A S 1 S L P T 8 C A 8 A G T 0 C L 1 8 G WG N T K 8 S B T 8 Y P O V L K C L K A PI  L 8 D S 8 C K 8
E E 8 8 T T E E E E E E S B S S S B S S E E E E E E E H H H H H H
A Y P G Q 1 T S N M F
1
C A G Y L E G G K D S C QO D 8 G G P V V C  S OK L Q G 1 V  S WG S G C A O K
H T T T T T T  E 
1
E E E S T T S B T T  T T T E E E E T T E E E E E B S 8 S 8 B T
N K P G V r t K V C N Y V S Wl K Q T 1 A S N
T B E E E E E G G G G H H H H H H H H H T T
Figure 1-7: Sequence and secondary structure annotation of mature bovine trypsin.
Secondary structure nomenclature explained in embedded table. Black lines represent bonded 
cystine pairs. 3d structure of protein shown in Figure 1-8.
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Figure 1-8: Structure of bovine trypsin (PDB: 1TGN).
Cartoon ribbon with transparent molecular surface overlay. Beta sheets shown in yellow (arrow 
indicates direction), helices shown in red. Amino acids forming part of the catalytic traid or 
substrate binding regions (Section 1.6.3, Figure 1-9) shown in green. Model produced using Swiss- 
PDB viewer 3.7 and PovRay 3.5.
1.6.3 Specificity and catalytic regions
Considerable work has been applied to crystallising and solving the structure of trypsin and means 
the structural basis for the enzyme’s proteolytic activity is fairly well understood (Bode and 
Schwager 1975). Overall activity is usually considered as two separate components, enzymatic 
specificity and catalysis, with the various active portions of the enzyme being categorised 
according to type.
Substrate Specificity regions: The substrate binding pocket of bovine p-trypsin has been defined 
as residues 189-195,214-220 and 224-228 (Hedstrom, 1996). The specificity of the binding pocket
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for Arg/Lys is known to be primarily dictated by the presence of Asp189 at the base of the S1 site 
(Bode and Schwager, 1975; Hedstrom, 1996). The methylene groups of Arg & Lys (substrates) 
form hydrophobic interactions with the enclosing chains of the pocket (particularly with residues 
214-216 & 190-191) and it has been shown that the terminal side-chain ammonium group of Lys 
forms a salt-link with the carboxylate group of Asp189 (Bode and Schwager, 1975).
Catalytic regions: A catalytic triad of residues has been characterised, namely Seri95, His57 & 
Asp102 (trypsin numbering) (Perona etal., 1995) and are illustrated in Figure 1-9. These three 
amino acids comprise a charge relay system involving the aspartic acid residue being hydrogen- 
bonded to the histidine, which itself is hydrogen-bonded to the serine. This triad is found in all 
serine proteases, even those which are separated by vast evolutionary distance, such as the 
bacterial serine protease II, subtilisin (an example of convergent evolution).
Figure 1-9: Catalytic triad & substrate binding region of bovine trypsin
Catalytic triad of amino acids (1.6.3,1.6.6): Histidine (position) 57 shown in green; Aspartic acid 
102. blue; Serine 195, orange. Primary specificity determinant (S1): Aspartic acid 189, red; 
remainder of substrate binding pocket shown in pink. Hydrogen bonds depicted as dotted green 
lines. Model produced using Swiss-PDB viewer 3.7 and PovRay 3.5.
Histidine 57
Aspartic add 102
Aspartic acid 189
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1.6.4 Protease nomenclature
By convention, the binding site for the polypeptide substrate of an endopeptidase consists of 
‘protease-binding’ subsites, with the point of hydrolysis being at either the N- or C-terminus of the 
P1, depending on the enzyme in question. The complementary binding sites on the protease are 
termed ‘substrate-binding sites’. Note that substrate binding is frequently more complex than a 
simplistic one-to-one relationship, involving multiple interactions, especially at the extremes of the 
specificity determining regions (Fersht, 1999).
Endopepfidase
S3__________S2__________S1 SV__________SZ_________ S3'
P3 P2 P1XTPV P2‘ P3'
-NH-CH-CO- NH-CH-CO- NH-CH-CO- NH-CH-CO- NH-CH-CO- NH-CH-CO-
Siibstuve |
Hydrolysis
Figure 1-10: Illustrating the Schechter & Berger numbering system for peptidase & 
substrate residues
The scissile bond at which cleavage occurs is always located between residues P1-PT. Cleavage 
site shown at C-terminus of P1 to illustrate action of trypsin.
1.6.5 Mechanism of substrate binding and catalysis
All serine proteases catalyse the hydrolysis of peptide or synthetic ester substrates by means of a 
conserved charge relay system of three amino acids and via the formation of an acyl-enzyme 
intermediate. The structures of the complexes involved have been particularly well characterised, 
in terms of atomic positions and thus bond strength, as it was shown to be possible to freeze the 
enzyme in each transition state by complexing with various natural small peptide inhibitors (Bode 
and Schwager, 1975). Co-crystallisation of these complexes revealed that the binding of inhibitors 
(and apparently also polypeptide substrates) did not distort the conformation of the enzyme, 
allowing for the refinement of highly accurate crystal structures. The active site of trypsin was 
complementary to the transition state of the reaction, a conformation that forces the proximity of the
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Serf 95 residue and the carbonyl carbon of the substrate (Bode and Schwager, 1975; Fersht,
1999).
The five steps of substrate binding & catalysis by trypsin are illustrated in Figure 1-11 & 
Figure 1-12 and are described in the sections below. The specificity of the binding pocket is the 
first influential effect in this process as a substrate of the conect topology associates with the 
enzyme to form the non-covalent Michaelis (or enzyme-substrate) complex, the two molecules 
being held together by mixtures of hydrophobic interactions, salt-bridges and hydrogen bonds 
(Fersht, 1999) (see Figure 1-11 panel 1). Crystal structures predict that, at this stage, a degree of 
‘steric strain’ would exist between the P1’ amino acid (indicated by R’ on the figure) and the serf 95 
residue, acting to promote the distortion of the substrate chain and exposing the P1 carboxylic 
bond (Bode and Schwager, 1975).
After the physical binding of the substrate the reaction mechanism of the catalytic triad 
becomes crucial. For a foil discussion of this please see Section 1.6.6. Steric distortion of the 
substrate results in the positioning of the oxygen atom of the ‘targeted’ carbonyl group between the 
backbone NH groups of Serf 95 and Gly193 (Bode and Schwager, 1975; Copeland, 2000). The 
transition state forms by means of the attack of the hydroxyl of Serf95 on the carbonyl carbon. The 
resultant bond forces the reduction of the C=0 bond to a single bond and the negative charge 
forced on the oxygen atom enhances the strength (and thus shortens the length) of the transient 
bonds then formed between this atom and the NH groups of Serf 95 and Gly193 (see Figure 1-11 
panel 2). It is the formation of these short hydrogen bonds which is thought to stabilise the high- 
energy transition state relative to the Michaelis complex (Fersht, 1999). The hydrogen atom 
transferred from Serf 95 to His57 which allowed for the nucleophilic attack, now permits association 
of this NH group with the N’HR moiety, in preparation for bond scission.
The collapse of the tetrahedral intermediate to form the acyl-enzyme complex is triggered 
by the donation of the acquired hydrogen atom from His57 to the N’HR group and its replacement 
with a molecule of water (see Figure 1-11, panel 3). This completes the cleavage of the scissile 
bond and the leaving group (P1 ’ onwards of substrate) is expelled from the acyl-enzyme complex. 
The bind energies of the P1’-S1’, etc, interactions are apparently overwhelmed by the repulsive 
force generated by the proximity of the now complete amino group and the carbonyl carbon of the 
P1 residue (Bode and Schwager, 1975; Lesk, 2001).
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Deacylation of the complex forms the second tetrahedral intermediate (See Figure 1-12, 
panel 1) occurs in a similar manner with the His57 residue activating its newly acquired water 
molecule so that the hydroxyl group performs a nucleophilic attack on the carbonyl carbon. The 
collapse of this intermediate state to the enzyme-product complex is caused by the donation of the 
hydroxyl group and the subsequent expulsion of Ser195 from the complex (See Figure 1-12, panel 
2).
X^NH
NH Glyl 93
\  Gly193
Gly216
Asp189
\ ^ NH.
NH Glyl 93
Figure 1-11: Binding of substrate and formation of acyl-enzyme intermediate
(D Binding of substrate to binding pocket of enzyme, forming Michaelis complex; ©  Transition 
state of complex following attack of the hydroxyl of Ser195 on the carbonyl carbon of the P1 
substrate residue, 1st tetrahedral intermediate; ©  Collapse of tetrahedral intermediate to form acyl- 
enzyme and release of the leaving group (R’NHk). Figure adapted from (Copeland, 2000; Fersht, 
1999; Lesk, 2001).
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/  'HO^/  .NH
Si*>strat /193
/  'a t 3er19S
HI *67
S*r196
IS1
Asp189
H
/ S 1
Asp189
Figure 1-12: Formation of 2nd tetrahedral intermediate and release of product
®  Hydrolysis of acyl-enzyme by nucleophilic attack by the hydroxy group of a water molecule 
bonded to His57,2nd tetrahedral intermediate. (D Expulsion of Ser195 from complex, release of 
carboxylic acid product.). Figure adapted from (Copeland, 2000; Fersht, 1999; Lesk, 2001).
1.6.6 Natu re and action of catalytic triad
For a catalyst to successfully cause the hydrolysis of an amide bond, three chemical groups have 
been defined as essential (see Figure 1-13) (Price and Stevens, 1999):
1. A nucleophilic group, N, which attacks the carbonyl group on the P1 residue, leading 
to the formation of a tetrahedral intermediate.
2. A positively charged group, X+, held near to the oxygen atom of the P1 carbonyl group. 
This acts to increase the susceptibility of the group to nucleophilic attack and may also 
help stabilise the tetrahedral intermediate.
3. A proton donor, Y-H, which would act on the -NH leaving group.
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(2)
+
X
o
 C— N H -----
/  \
(1) N: Y— H (3)
Figure 1-13: Illustrating the essential chemical groups for a proteolytic catalyst.
All three features listed above may be found within the catalytic triad of the serine proteases. 
Histidine is frequently found in the role of a catalytic residue as it imidazole side-chain (a 
tertiary amine) has a pKa of 6.5-7.4 when the amino acid is unattached, which changes to a 
pKa of 7 when it is incorporated into a protein. This means that histidine is the only amino acid 
capable of exchanging protons at a physiological pH. It is believed that the imidazole ring 
increases the nucleophilicity of the Ser195 (N:) hydroxyl group by acting as a general-base 
catalyst. This hisitidine residue thus represents the X+group (2) on figure 1.13. The importance 
of the Asp102-His57 hydrogen bond has not been conclusively established but is believed that 
it may be a low energy barrier hydrogen bond, which may possibly assist catalysis by helping to 
stabilise the transition state. By acting in this manner, Asp represents the Y-H group. An 
illustration of the interaction between the three amino acids using trypsin numbering can be 
seen in figure 1.14 below.
Asp102 His57 Asp102 H js 5 7
V u  \  Ser195 \  \
CH O C /  CH o  C\  Seri 95/
CH0Y . - *  h2) = \  r v CH* \  \ /
0  H _ °  ° - H  N ^ N - H  -O
Figure 1-14: Interactions between catalytic triad
Illustrating the charge-relay system that exists between the catalytic triad of all serine 
proteases. This arrangement of the three side-chains allows for the partial ionization of the 
serine, resulting in a negatively charged oxygen atom that greatly enhances the nucleophilicity 
of the residue. Adapted from (Price and Stevens, 1999).
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1.6.7 S & S’ specificity of bovine trypsin
1.6.7.1 Description of S subsite specificity
Trypsin specificity is primarily determined by the need of the S1 site at the bottom of the binding 
pocket for a basic amino acid, namely arginine or lysine (see Section 1.6.3), but it has been 
demonstrated that as for all proteases, the adjacent binding sites play significant roles in substrate 
hydrolysis. Past work has shown that they may also be modified to enhance specificity. Specificity 
in enzyme catalysis has been defined as “a consequence of optimal transition-state interactions 
made by cognate, but not non-cognate, substrates”, the concept being that an enzyme binding 
pocket has evolved in such a way as to form sufficient electrostatic and apolar interactions with a 
desired substrate as to allow the energy barrier between basal and transition states to be 
overcome (Perona et ai, 1995). The energy released by substrate binding would then be turned to 
catalysis, the apparent rigidity of the binding pocket ensuring that little was lost in the process. 
Different portions of the binding pocket demonstrate varying degrees of specificity, raising 
questions as to the actual role of the components of the pocket and their interaction with each 
other and with more distal portions of the protein. The influence of the subsites has been probed 
through several studies, typically involving the calculation of the substrate-binding energy (AGs, 
calculated from Km values) and the activation energy (AGr, calculated from kcat I Km values) from 
the digestion of libraries of peptide substrates. Recent work has shown that each subsite may 
characteristically favour either substrate binding or catalysis depending on whether it favours native 
substrate or transition state binding respectively (Marana et a i, 2001).
The S1 specificity of trypsin is well studied: chymotrypsin is the closest homologue, cutting 
by the same process, possessing an almost identical tertiary structure and preferring Phe, Tyr &
Trp residues in the P1 site, and trypsin can discriminate between analogous substrates containing 
Lys & Phe by a factor 105 (in terms of relative kcat I Km values) (Hedstrom, 1996). Despite this, the 
specificity of the S & S’ sites appears quite broad, allowing the binding of a wide range of residues 
while still greatly influencing the reaction kinetics.
1.6.7.2 Description of S & S’ subsite specificity
S2 & 3 Detailed work has not been performed in determining the preference of these subsites in 
bovine trypsin but binding energy studies of rat and cockroach trypsin present a picture of
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relatively broad substrate acceptance, appropriate for an intestinal digestive enzyme 
(Marana et a/., 2001). The residues involved in binding the P2 & 3 sites on the substrate 
have long been identified as serine 214 and glycine 216, which form part of a loop that 
establishes a series of hydrophobic contacts with the substrate, anchoring it in position 
(Bode and Schwager, 1975). The P2 position appears to favour glutamic acid, lysine, 
leucine and threonine over other substrate amino acids by an approximate factor of two, 
while P3 demonstrates broad specificity overall, with a two to three fold preference for 
aspartic acid (Hedstrom, 1996; Marana et al., 2001). In both rat and cockroach trypsin, P2 
appeared to contribute more to substrate binding than catalysis, while for the P3 position, 
the reverse was tme (Marana et al., 2001).
S1 ’ Molecular modelling studies have shown that two surface loops, loop 40 (residues 33-41)
& loop 60 (residues 58-68) to be influential in determining S1’ specificity, both in trypsin 
and chymotrypsin (Kurth etal., 1998; Perona eta!., 1995). The side-chain of the basic 
amino acid Lys61 is believed to be the only group directly in contact with the P1 ’ residue of 
the substrate. The S1’ subsite has been shown to accept any aliphatic residues at P1’ 
(possibly because the Lys side-chain would interact well with bulky, hydrophobic residues), 
aromatic residues and positively charged residues at least partially. Only the amino acid 
proline is not accepted in the PV position, resulting in negligible hydrolysis, suggesting that 
a free NH group is a requirement.
S2’ P2’ appears to bind to the region of the binding pocket that is lined by His40 & Tyr151
(Schellenberger et al., 1994). As the P2’ side chain points in the opposite direction from 
the P1’ & P3’ chains, it has been shown that the pocket can accommodate fairly large and 
bulky residues at this position and the kcaf/Km of the reaction can be seen to increase 
proportionately with the size of the residue. Another significant feature was that in all 
binding studies, a hydrogen bond was found to form between the NH of the P2’ residue 
and the O of Phe41, once again ruling proline out of this position.
S3’ Crystal structures suggest the P3’ interacts with many of the same regions as P1’ and the
relationship between them has been clearly established by synthetic substrate studies. A 
large residue in either position (e.g. Tyr, Arg in P3’) appears to ‘crowd’ the other, with 
favourable reaction kinetics only occurring if that position holds a small amino acid (e.g.
Ala in PV) (Schellenberger et al., 1994). It is believed that large amino acids in these
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positions compete for contacts in the same region of the protein fold and that this explains 
the similarity between S’1 & S’3 specificities.
1.7 Prod uction of r-trypsinogen
1.7.1 Current Eli Lilly methods for the production of recombinant bovine trypsinogen
Until recently, bovine trypsinogen, along with many other mammalian enzymes, was produced by 
extraction from animal organs, specifically cow pancreas. Ethical awareness, response to 
shareholder pressure and, crucially, the rise of uncharacterised new disease ‘contaminants’ such 
as bovine spongiform encephalopathies and genomic retroviruses, have raised concerns regarding 
the use of animal products in the pharmaceutical industry, with alternative production solutions 
being sought. Fermentation in a suitable microbial host provided the obvious solution, allowing for 
the reliable production of industrial quantities of product not derived form animal raw materials and 
also, in the case of trypsin, free of contaminating pancreatic enzymes, such as bovine 
chymotrypsinogen (Hanquier et a i, 2003).
The current production process for the variant of recombinant trypsinogen, and hence 
trypsin, used by Eli Lilly relies on its fermentation in E. coli and subsequent accumulation as 
inclusion bodies. The insoluble but concentrated zymogen (mature enzyme + pro-protein region) 
could then be separated from bacterial membranes and the cytosolic fraction by differential 
centrifugation (Kung et a i,1990). A mature trypsin is achieved by means of enzymatic modification 
with enterokinase (an endoprotease, recognition site of [Asp]4-Lysi) in the presence of suitable 
buffers. While this method of inclusion body isolation and solubilisation provides a precisely 
characterised and well-understood set-up for recombinant enzyme production, associated 
problems, particularly regarding the yield of native protein from the in vitro refolding reactions, 
mean that there may be economic advantages in developing a system for the expression of soluble 
enzyme. Process-scale refolding of the zymogen is initiated by drip-feeding concentrated, 
solubilised inclusion bodies (8M urea used as denaturing agent) into a refolding buffer containing 
an oxido-shuffling couplet (for controlled but dynamic redox conditions) and appropriate co-factors 
(for full protocols, please see Chapter 4) (Buswell etal., 1995). Although precise recovery data 
may not be discussed here, internal company literature places the net yield of native (correctly 
folded enzyme, assessed by activity assay) protein at approximately 8-15% of the solubilised input.
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Mis-folded protein issuing from the refolding vessel would be removed from the product stream by 
rounds of packed or expanded bed chromatography (Petrides, Sapidou, and Calandranis, 1995).
1.7.2 Expression of r-trypsinogen from Pichia pas tons
An academic collaboration was established five years ago (1998) in order to develop a trypsin 
production process in the methylotrophic yeast Pichia pastoris, with the aim of obtaining soluble 
and properly folded trypsin secreted into the growth medium. P. pastoris was an attractive target 
for development as progressive work over the last 10 years had permitted the construction of 
numerous host-vector systems for the heterologous protein expression of both prokaryotic and 
eukaryotic targets (Hanquier et al., 2003). The presence of eukaryotic post-translational 
modification machinery and secretory pathways gives the yeast a relatively high success rate in the 
expression of soluble, correctly folded protein, frequently allowing the soluble expression of 
recombinant proteins that had proved intractably insoluble upon expression in £  coli due to a high 
number of disulphide bridges or other complicating factors (Venekei et al., 1996). The strain has 
formed the basis of several economically-competitive industrial systems, with high cell densities 
being achieved in inexpensive media, and with no major complications regarding scale-up 
(Cruegerand Crueger, 1990; Hanquier et al., 2003). An additional reason for optimism over this 
approach was that an unrelated Californian group had engineered the soluble expression of rat 
trypsin from the strain Saccharomyces cerevisiae to levels of 10mg/L with no apparent 
complications (for a full sequence & structure comparison of bovine vs. rat trypsinogen, please see 
Section 1.7.4) (Venekei, Graf, and Rutter, 1996). The Lilly research group concentrated on the 
expression of the proprotein behind the strong methanol-inducible promoter, aox1, but only trace 
levels of the zymogen were detectable under a range of fermentation conditions, suggesting that 
that the expression of wild-type bovine trypsinogen was toxic to the cells. Resent work by the group 
allowed the apparent autotoxicity of the protease to be bypassed by means of engineering the 
proprotein activation site (pro-section comprises 8 N-terminal amino acids, terminating with a lysine 
residue, see Section 1.6.2) to prevent the auto-activation of the enzyme (Hanquier et al., 2003). A 
single amino acid substitution proved sufficient, replacement of the position 8 lysine residue with 
asparagine removing the trypsin recognition site but still allowing controlled in vitro activation of the
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enzyme by means of specific exopeptidases, and the yields of 40mg/L in a 6L fermentor were 
obtained with the now ‘stable’ zymogen (Hanquier et al., 2003).
1.7.3 Autotoxicity issues associated with expression of mature proteases
A reported problem in the production of certain eukaryotic proteins in bacterial systems has been 
the toxicity of the proteins to the host with the result of low expression rates and high levels of 
plasmid instability. While the expression of certain fusion proteins (e.g. TEM-p-lactamase) has 
been shown to severely poison an £  coli culture through an unknown mechanism, presumably 
interfering with cellular metabolism in a manner beyond simple accumulation of a recombinant 
protein (Mujacic etal., 1999), the autotoxicity resulting from the high-level expression of an 
unregulated peptidase with relatively broad substrate range such as trypsin would appear easy to 
explain. The problem is exacerbated at high fermentation temperatures (~37°C) as, this the 
optimum temperature for trypsin activity, and also elicits the highest expression rates from many 
promoter systems. High levels of expression can act to ‘saturate’ translocation mechanisms and so 
cause protein intended for the periplasmic space to accumulate in the cytoplasm, enhancing any 
toxic effect and rapidly killing the culture (Perez-Perez et al., 1994). Although the expression of 
trypsinogen should theoretically result in the accumulation of inactive zymogen, work in yeast cells 
has shown that autoactivation does occur, leading to progressively higher levels of active enzyme 
(Hanquier et al.,2003). This leads to the second issue in the expression of active enzyme, that of 
autodigestion, which adds to the already high levels of proteolytic sensitivity shown by soluble 
recombinant proteins in £  coli cytoplasm (Wickner etal., 1991). Solutions must be determined 
empirically in each case, but proven experimental techniques include short periods (1-2hrs) of 
induction at low cell density followed by rapid harvesting, or by induction only at high cell densities 
at low temperatures (28°C) (Herber etal., 1991) and use of a low-temperature cspA-promoter 
system for reduced expression levels (Mujacic, Cooper, and Baneyx, 1999). A general set of rules 
would appear to be that the expression of toxic and proteolytically-sensitive enzymes should be 
carried out at low temperatures, so as to reduce both protease activity and expression rates; use of 
low-level promoters, e.g. trc or araBAD; and tight control of promoter ‘leakage’, i.e. non-induced 
expression, as this can interfere with both plasmid stability and stock viability.
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1.7.4 Comparison of bovine and rat trypsin
The structural basis of P1 binding were investigated in rat anionic trypsin by means of a strategy of 
nutritional selection and a series of rational oligonucleotides-directed mutations (Evnin et al., 1990; 
Evnin and Craik, 1988). This involved the growth of an expression strain auxotrophic for arginine 
on a minimal media where all arginine was sequestered in nitroanilide compounds, sensitive only 
to hydrolysis by mammalian trypsin. The genetic selection thus relied on the ability of an 
engineered £  coli strain to secrete soluble, active rat trypsin into the periplasm. The vector used 
was a pBR322 derivative which expressed recombinant rat trypsin under the control of a phoA 
promoter, and studies had shown that it appeared to secrete active, mature protease to a 
concentration of 1mg/L (Evnin and Craik, 1988). This successful work, combined with the 
knowledge that teams from Eli Lilly had experimented unsuccessfully with a similar set-up, made it 
interesting to compare the structures of bovine and rat trypsin, to see if any blatant structural 
differences were evident which could provide an explanation for the differing solubilities of these 
closely related enzymes.
Bovine and rat trypsin display an 87% amino acid primary sequence identity, with the 
majority of these differences being at least 20% exposed to solution. Of these, the most significant 
would appear to be the substitution of a folly surface-exposed valine in rat trypsin for phenylalanine 
at postion 181 (bovine trypsin numbering) and similarly the substitution of an exposed glutamic 
acid for a tyrosine at position 151. While the first substitution is seemingly mirrored by a 
downstream (bovine)Y 171 F(rat) exchange and rat trypsin actually possesses a greater share of 
bulky, hydrophobic amino acids, these are all orientated to project their chains into the molecule. 
While not of any guaranteed use, these observations may provide a possible route for the rational 
engineering of bovine trypsin should problems with insolubility appear insurmountable by other 
means.
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1.8 Evaluation of biosynthetic human insulin product with reference to potential 
improvements in enzymic conversions
1.8.1 Introduction
The following section details the current use of r-trypsin by Eli Lilly as a biocatalytic agent in the 
processing of mature human insulin, with reference to the potential economic gains that could be 
realised if the specificity of the enzyme could be tailored through directed evolution.
Diabetes mellitius, and its complications, is estimated to be the third largest cause of death 
in industrialised countries after cardiovascular diseases and cancer (Barfoed, 1987). Documented 
occurrences of the disease date back as far as the fifteenth century BC, and insulin, a mammalian 
hormone produced by the Islets of Langerhans in the pancreas, was first described in 1909, but it 
was not until 1922 that the link between the two became apparent Insulin mediates the 
metabolism of carbohydrates and is thus essential for the flow of energy through an organism; 
impaired production cripples the process and leads to the formation of the disease.
As a therapeutically important and well-characterised small protein, insulin was an obvious 
target to be the first mammalian protein produced in bacteria using recombinant DNA technology. 
Two major techniques for the production of recombinant insulin in E. coli (the two-chain and the 
proinsulin methods) and a more recent yeast expression system have been developed with only 
the proinsulin prokaryotic method & the yeast system being commercialised to date (Petrides, 
Sapidou, and Calandranis, 1995). The three methods are detailed below.
1) Two-Chain Method: Developed by Genentech. Inc. and scaled up by Eli Lilly and Co. 
The two insulin chains are produced separately as p-galactosidase fusion proteins 
within inclusion bodies, recombined after purification.
2) Proinsulin method (intracellular): Developed & commercialised by Eli Lilly and Co. 
Relies on a single fermentation for the production of the inactive Trp-LE’-Met- 
Proinsulin, which is purified from inclusion bodies and subjected to cleavage and 
refolding treatments.
3) Proinsulin method (secreted): Developed by Novo Nordisk A/S. Uses genetically 
engineered yeast cells to secrete BHI as a single chain insulin precursor.
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The proinsulin production was based on the expression of a precursor of proinsulin, a Trp- 
E fusion protein, and its subsequent digestion & activation by three additional enzymes, namely 
trypsin, carboxypeptidase I & a diamino-exopeptidase. The fermentation and enzymic conversion 
of the insulin molecule accounted feronly half of the total industrial production process, with the 
remainder consisting of an extensive purification scheme based on multimodal chromatography. 
The extreme degree of purity required in a therapeutic product before it can progress to 
formulation, dictated that insulin-like products resulting from mis- or partial cleavage of the 
proprotein be reduced to trace levels. The nature of the enzymes used meant that these insulin-like 
products came in two main varieties, those produced by cleavage at undesirable points in the 
proprotein, which differed from the product by 8-10 amino acids and thus acted to reduce the yield 
of the process, and those which differed by only a single amino-acid residue and were considerably 
harder to separate as a result. The ability to tailor and tighten the substrate specificity of these 
modifying enzymes could improve the process by rationally minimising the number of undesirable 
cleavage products and thus improving the ratio of proinsulin to insulin conversion, and also by 
reducing the levels of near-identical products. An increase in the purity of the post-enzymic 
conversion product stream, particularly regarding the levels of single amino-acid variants, would 
allow for increased chromatographic yields (Kroeff et ai, 1989; Ngiam et a/., 2001), possibly 
leading to the simplification of the process.
1.8.2 Structure of insulin
Mature insulin is an extremely small protein consisting of 51 amino acids arranged in two chains: A, 
with 21 amino acids; and B, 30 amino acids in length. In the native host, these chains are cut from 
the proinsulin precursor, resulting in the loss of the dividing region, the 34 amino acid C chain. The 
A & B chains are held in position relative to each other by two disulphide bonds and are simple in 
structure, consisting of two short alpha helixes and an internal disulphide bond, and a single alpha 
helix respectively (see Figure 1-15). In 1996, Eli Lilly and Co. made use of recent research to 
improve the recombinant insulin into a more therapeutically potent variant. The exchanging of 
positions of pro28 & Iys29 rendered aggregations of the molecule (now termed the KPB variant) 
considerably less stable. The individual insulin molecules of regular insulin dump together to form 
a hexamer. Only individual insulin molecules are biologically active, so the body must first break
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the bonds that hold the six insulin molecules together. Individual insulin molecules become 
available in about 30 minutes. The amino acid rearrangement in KPB results in hexamers that bind 
together so weakly that they break apart much faster than regular insulin, and are thus active 
immediately. The KPB variant was alternatively called insulin lispro, and was marketed under the 
brand name of Humalog®.
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Figure 1-15: Structure of the K28P proinsulin molecule (PDB ref: 1LPH)
Cleavage of C-chain at amino acids 31 & 65 releases the A & B-chains which associate with each 
other to form mature BHI (biosynthetic human insulin) (PDB ref: 1LPH). The arrows at Iys28 & 
pro29 denote where these two amino acids have been exchanged, swapping their positions from 
the native human insulin molecule to form the KPB variant. The legend indicating cutting sites to be 
either promoted or suppressed refer to specificity targets described in Section 1.8.5.
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1.8.3 Description of Two-chain and yeast BHI production methods
The two-chain method was the first successful process for the synthesis of BHI, being developed 
by Genentech Inc. (San Francisco, CA) and subsequently scaled-up by Eli Lilly and Co. 
(Indianapolis, IN) (Petrides, Sapidou, and Calandranis, 1995). The A and the B chain were 
expressed as p-galactosidase fusion proteins within two separate recombinant strains of E  coli, 
under the control of the Trp operon. The two polypeptides accumulated as inclusion bodies in 
individual fermentations, were purified, and then combined in the appropriate redox conditions to 
yield mature human insulin. The principal drawback to this method was the obvious need for two 
parallel fermentations and primary purification runs.
The secretion of proinsulin from cultures of Saccharomyces cerevisiae was engineered by 
Novo Nordisk A/S. A single-chain precursor was secreted and purified, and then converted to 
mature insulin by means of a transpeptidation reaction in organic solvent in the presence of trypsin 
and a threonine ester (Petrides, Sapidou, and Calandranis, 1995). The product then underwent de- 
esterification and further purification. The clear advantage of this method was the unassisted 
solubility of the product, the reduced levels of host contamination and the option to reuse the cells 
by means of a continuous bioreactor-cell separator loop.
1.8.4 Description of the intracellular proinsulin method of BHI production
Eli Lilly currently produces BHI by means of expression of the product as a single proinsulin-fusion 
protein within an E coli fermentation. An overview of this process is presented in Figure 1-16. The 
overexpressed product, a Trp-LE’-Met-proinsulin fusion protein accumulates in the cellular 
cytoplasm as inclusion bodies over the course of an 18hr fermentation, eventually comprising a 
level no less than 20% of the total dry cell mass, and with each inclusion body consisting of 
approximately 80% product (Petrides, Sapidou, and Calandranis, 1995). After cell distruption, the 
inclusion bodies are fully solubilised in a chaotrophic, reducing environment containing urea & 2- 
mercaptoehtanol. The Trp-LE’-Met signal sequence of the chimeric protein would be cleaved by 
the addition of CNBr (cyanogens bromide), yielding the denatured matuie insulin. The proprotein is 
then fully unfolded by a process of oxidative sulfitolysis, which acts to break all disulphide bonds 
within the molecule that may have reformed since the initial denaturation, and adds S O 3  moieties to
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all the sulphur residues on the cysteines, effectively preventing any uncontrolled dimerisation. 
Refolding of the proinsulin is accomplished at an undisclosed dilution factor at 8°C in the presence 
of mercaptoethanol, which acts to create a reducing environment, allowing the interchange of 
disulphide bond partners and thus the exchange of the SO3 groups for the relevant cysteines 
(Winter et al., 2002). The purified and native-state proinsulin would then be activated by means of 
an enzymatic reaction involving trypsin & carboxypeptidase B. Trypsin being used to create mid­
sequence cuts at the C-terminii of arginine & lysine residues, and the exopeptidase 
carboxypeptidase B being then used to remove basic amino acids with exposed 3’ termini, the 
result being active and structurally-native human insulin.
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Figure 1*16: Industrial production of intracellular BHI
Schematic illustrating the current Eli Lilly process for the large scale production of BHI within E. coli 
by means of the fermentation and subsequent processing of an intracellular proinsulin molecule.
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1.8.5 Proposed improvements to E. coli intracellular production process by means of 
specificity engineering of trypsin
1) Examination of the insulin molecule (see Figure 1-15) revealed that two particular
species of contaminant are produced by trypsin digestion of proinsulin, these are a) an 8-aa 
peptide cut from the B-chain by undesirable cleavage at arg22/gly23; and b) the possibility 
that it might cleave at Iys64/arg65 faster than at arg65/arg66, resulting in an A-chain 1aa too 
long, essentially reducing this fragment to an insulin-like contaminant. Eli Lilly’s proposed 
that the following substrate specificities be tightened in trypsin to the exclusion of others. 
Certain specificities were to be evolved against minimising cutting at these points. In all 
cases, a defined motif of four amino acids was stated, as the final goal of this project was to 
develop a system for the mutation of trypsin which would take advantage of its known 
substrate preferences at residues P2, P1’ & P2’ and breed highly selective cutting tools. To 
be improved: arg31-arg32/glu33-ala34 & Iys64-arg65/gly66-phe67 (improve ‘clean’ release 
of A & B chains); to be reduced: glu21-arg22/gly23-phe24 (prevent unwanted cutting 2/3rds 
of the way through the B chain), thr30-arg31/arg32-glu33 and thr27-lys28/pro29- 
thr30(promote ‘clean release of B chain).
2) With the use of directed evolution to explore the specificity of trypsin, it may be
possible to dispense with the use of the enzyme carboxypeptidase, resulting in a significant 
lowering of the process costs. This would require the evolution of the following substrate 
specificity: pro29-thr30/arg31-arg32.
The feasibility and significance of these two goals will be examined in this chapter with reference t 
both the plausibility of engineering the required mutants and also to the impact that each alteration 
would have on the efficiency and process costs of BHI production.
1.8.6 Simulation of large-scale BHI production
The BHI fermentation process currently in use by Eli Lilly and Co. (see Figure 1-16) was analysed 
using the SuperProDesigner software, version 5.0 (Intelligen, lnc.)(Petrides, Sapidou, and 
Calandranis, 1995). This software allows a dynamic analysis of the progressive steps in a large- 
scale industrial biosynthetic process, modelling the efficiency of the reactions in each fermentation,
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conversion or purification unit operation, and calculating an economic evaluation based on the yield 
and the pre-programmed operating costs and market prices. The complete BHI production process 
was modelled by the designer using published developmental literature from Eli Lilly and utilises 
cost & sales figures correct as of 2000 (Petrides, Sapidou, and Calandranis, 1995)(On-line 
documentation atwww.intelligen.com).
The portion of the process which was of interest to this work, was that immediately 
downstream from the enzymatic conversion vessel, where proinsulin was converted to insulin plus 
‘protein contaminants’ by the combined action trypsin and carboxypeptidase B (Figure 1-17). The 
program uses a set stoichiometric reaction to simulate the digestion of proinsulin, and then the 
crude protein contaminants and insulin-like molecules are progressively removed from the product 
stream by means of two packed-bed chromatography steps and a gel filtration. The levels of 
protein contamination entering the conversion vessel (diafiltered product stream from an HIC 
column) were as shown in Table 1.5. The simulation works on the assumption that proinsulin was 
converted into mature insulin and ‘contaminating proteins’ (namely the C-chain) in a ratio of
0.61:0.39 respectively, figures which exactly correlate with the size of the C-chain in proportion to 
the A & the B-chains combined. In other words, the model predicts that the enzymatic conversion 
acts at 100% efficiency and that all proinsulin fed into the vessel is converted into precisely cut A, B 
& C-chains. Insulin-like contaminants are factored to emerge from inclusion body processing and 
cellular disruption, but not from the marginal mis-cutting of the proinsulin by the modifying 
enzymes, resulting in chains differing in one or two amino acids. An attempt was made to introduce 
the insulin-like contaminants proposed in section 1.8.5 into the model in a variety of concentrations, 
evaluating their potential economic impact on the process and their significance on the 
downstream purification elements.
1.8.7 Economic analysis of a standard BHI production run
An economic analysis of the unaltered BHI production run was rendered using SuperPro Designer, 
version 5.0. In its entirety, the process consists of 30 principle units of operation, a summary of 
which was presented in Figure 1-16. In the enzymatic conversion step, proinsulin is converted to 
insulin and additional ‘contaminating proteins’ (i.e. the C-peptide). The general levels of 
contaminants present in the product stream as it is fed into the vessel are listed in Table 1.5. The
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released C-peptide is added to the contaminating proteins category, which must be considered a 
fully heterologous fraction, containing as it does, insulin-like proteins, polypeptides of only a third 
the molecular weight, like the C-chain, and assorted low-weight degenerative products. Following 
enzymatic digestion of proinsulin, the majority of these proteins, including those contaminants that 
differed from mature insulin by more than a few amino acids and the bulk of the remaining 
proinsulin species, are removed by S-sepharose chromatography. After concentration of the feed 
by diafiltration, a reversed-phase chromatography step is used to accurately purify BHI from the 
remaining homologous solution of insulin-like contaminants. The key points of the economic report 
generated by the model are shown in Table 1.6.
Substance
Flow Rate 
(kg/batch)
Cone. (g/L) Origin
Cont Proteins 0.321 0.0738
At this stage, mainly inclusion body contaminants 
& degraded protein from CNBr treatment.
Insulin 0.000 0.00
Proinsulin 30.5 7.03 Product from refolding vessel.
Denatured
Proinsulin 0.222 0.0511
Majority is denatured protein from CNBr step 
which failed to respond to sulfitolysis.
Proinsulin-
SS03 1.01 0.232
Proinsulin which failed to exchange -S03 moiety 
during refolding reaction.
Trp-Proinsulin 0.0188 0.00434
Fusion-tagged proinsulin that failed to respond to 
CNBr treatment.
Table 1.5: The protein composition of the product stream entering the enzymic conversion 
vessel
The process steps immediately up-stream comprised of an HIC column & a subsequent 
diafiltration. Additional elements in the product stream, not shown in the table were: acetic acid; 
sodium chloride & ultra-pure water.
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Figure 1-17: Process steps in BHI purification
Schematic of the enzymatic conversion step and down-stream chromatography elements from the 
Eli Lilly BHI production process. Produced using SuperPro Designer software, version 5.0 
(Intelligen, Inc.).
Total Capital Investment 79410000$
Operating Cost 73970000 $/year
Production Rate 1810 kg/year of Product
Unit Production Cost 40875 $/kg of Product
Total Revenues 135697000 $/year
Table 1.6: Summary of the economic evaluation report generated from the current BHI 
production process (year 2000 prices)
1.9 Alteration of enzymic conversion efficiency
As discussed in the previous section, the simulation assumes 100% efficiency in the enzymatic 
conversion step, with the complete mass of proinsulin being converted into BHI and C-peptide.
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Figure 1-18 illustrates the potential economic impact of factoring in the emergence of the mis- 
cutting contaminant species proposed in section 1.8.5 in increasing quantities. The two types of 
contaminants predicted were a highly insulin-like product, differing only in the presence of an 
additional arginine at position 65, and a second two-chain product, but where the B-chain was 
truncated from arginine 32 onwards. For the purposes of Figure 1-18, both types have been 
classed together as ‘Cutting-Byproduct T (CB1), incorrectly modified BHI molecules which lower 
the product yield without impacting on the quantity of C-peptide released.
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Figure 1-18: Economic impact of trypsin mis-cutting
Illustrating the economic impact of increasing the rate of trypsin mis-cutting of insulin into insulin­
like contaminants differing by only 1 amino acid or chemical group Cutting Byproduct 1). The 
percentage scale denotes the percentage of insulin (cut from proinsulin, excluding mass of C- 
chain), which was considered to now be contaminant.
The simulation of the BHI production process showed that the production (per batch & per year) fell 
in a strictly proportional manner with the increase in the percentage of insulin forming CB1. For 
example, a 4% drop in insulin yield in the conversion step resulted in a final yield of 1737.6 kg/year, 
a 4% drop from the original.
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1.9.1 Expanded project goals
In light of the project aim, which was, in short, to explore methods by which r-trypsinogen could be 
mutated for enhanced substrate specificities, the following technical goals were decided upon. The 
end result would be a practical and flexible strategy of directed evolution for the rapid adjustment of 
enzyme specificity, capable of being performed at a relatively small, laboratory scale while 
delivering an acceptable probability of success.
1. The initial part of the work would focus on developing an ‘activatable’, soluble trypsinogen in 
the periplasm of E. coli, as this would be essential for later experiments. This could possibly 
be achieved through the manipulation of the fermentation conditions of the Lilly production 
strain ELTRP-1 or through the use of an alternative strain. A proven strategy would be the 
attachment of a signal sequence into the plasmid at the N-terminus of the gene in order to 
allow the transport of the protein into the periplasm (Evnin and Craik, 1988). Mutagenic PCR 
would be used to alter the primary sequence if necessary to enhance solubility. See 
Chapters 3 & 4 for the majority of this work.
2. Rapid results could only be generated through the use of microwell scale assays, which 
would allow the performance of high-efficiency assays in screening for a variety of proteolytic 
activities. The detection test for such assays could be based on the principle of a 
spectrophotometric assay using various peptide-pNA substrates (cf. BAPNA/BANA/TAME 
assays) and on the cleavage of non-nutritious substrates (e.g. arg-p-naphthylamide and lys- 
p-naphthylamide), proteolysis resulting in the release of the free amino-acid. Chapter 2 
details high-throughput assay development, while the practicalities of nutritional selection are 
discussed in Chapter 6.
3. Mutagenesis would then be performed in E. coli with the aim of producing variants with 
increased site specificity for unique primary sequence motifs, e.g. RR, KR, or other 
sequences (of up to approximately 4-5 residues in length) to be determined. Techniques 
used would primarily involve mutagenic PCR (epPCR) or use of an E. coli mutator strain to 
generate the initial generations of mutants and then subsequent DNA-shuffling. The 
efficiency, practicality and mutational bias of all methods used would then be characterised. 
Mutational work is presented in Chapter 6.
4. Results generated would be used to construct a mutant library consisting of banks of 
recombinant trypsin genes and related proteases. The challenge would then be to devise a
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complementary library of assays capable of screening for an increase in specificity (as 
opposed to simple activity) in a high-throughput manner. Library theory, design and 
synthesis methodologies comprise Appendix A.
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2 High-throughput assay development
2.1 Introduction
2.1.1 General strategy
As discussed in Section 1.7.1, the current Eli Lilly commercial production procedure for 
recombinant bovine trypsinogen involves the solubilisation and refolding of the enzyme from 
insoluble inclusion bodies. Standard activity assay were available for trypsin purified in this 
manner, but an effective strategy of directed evolution demanded that soluble protein be assayable 
directly upon expression from a culture, so as to limit the processing steps required in the screen 
and thus enhance the practical maximum size of the library. Cloning work with the aim of achieving 
soluble enzyme from microplate cultures can be found in Chapters 5 & 6. An activity assay 
therefore needed to be developed which could reliably detect low levels of trypsin activity in the 
presence of live culture, cellular lysate and lysis agent
A practical screening strategy for directed evolution should rely on assays that can be 
performed in microtitre plates (96 or 384 well) because of the large numbers of clones involved. 
Direct assays such as fluorimetric, colour change or turbidity measurements should be used if 
possible because of the ease of reading. A proven screen for the degree of trypsin activity involves 
digestion of 0.4mM f-Boc-Leu-Gly-Arg/Lys p-nitroanilide and then monitoring the release of p- 
nitroanilide at 405 nm (Evnin et a/., 1990). The activity assay required by Eli Lilly involves the use 
of p-toluenesulphonyl-L-arginine methyl ester (TAME). This substrate is known to have a high 
affinity for trypsin and involves monitoring the release of the ethyl ester @ 247nm. The TAME 
assay was to be used for this work in parallel with any others developed, principally so that the 
activity of variants generated could be directly compared against Eli Lilly batches, as this was the 
standard test used internally by Eli Lilly to assess the activity of their product. Trypsin variants 
generated by mutagenesis would have their specific activity rate on this substrate measured after 
promising isolates had been identified & characterized, but the method is impractical for a high- 
throughput screen because of the ultraviolet wavelength required (to which all acryl-plastic plates 
would be opaque). A gel overlay technique can be used to measure cleavage of fos-arginine 
methyl ester and tos-lysyl methyl ester substrates (Perona et a/., 1993)
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The aim was to develop a basic assay for the activity of a trypsinogen protein expressed, 
in varying degrees of solubility, within the cytoplasm or periplasm of an E. coli ceil and the assay 
would thus require the lysis of the cells and the possible purification of the soluble protein from the 
lysate. Activation of the zymogen would also be necessary and this could be accomplished either 
by addition of trace quantities of commercial trypsin (allowing gradual autoproteolysis and thus 
autoactivation) or via addition of the more efficient enterokinase (secreted by mammalian 
pancreatic cells for the activation of trypsinogen as it passes into the gut). As this assay should be 
suitable for use on thousands of clones, the key aspect was that it contained the minimum number 
of process steps, so as to speed up the generation of results and limit (fatigued) operator error.
The initial gross activity assay would be based on the ability of the enzyme to catalyse the release 
of a chromogenic group from a single amino acid substrate containing only one scissile bond. 
Spectroscopic measurement would yield readings as to the kinetics of substrate cleavage and thus 
the activity of the variant. It was important to consider that any increase in this gross activity over 
the wild-type could be due to a number of factors namely: increase in cytoplasmic solubility; 
enhancement in periplasmic translocation (if targeted); increase in expression rate induced by 
transformation; or increase in enzyme activity, i.e. catalytically significant mutation in binding 
pocket or surface loop.
2.1.1 Choice of substrate
In a synthetic substrate for protease cleavage, the amino acyl residue (or peptidyl residues if a 
peptide is used) determines selectivity and specificity. In a single residue substrate, the substrate 
specificity screened for would be relatively broad, i.e. any protease capable of cleaving the bond at 
the carboxy terminus of the designated residue would release the marker. As explained before 
(see Section 1.4), trypsin is an endopeptidase and the design of a simple artificial substrate should 
naturally reflect this. The single residue (be it Arg or Lys) must be blocked at the N-terminus and 
with a suitable chromogenic group bound to the C-terminus.
The choice of substrates was restricted to those liberating a chromogenic residue upon 
enzymatic hydrolysis as equipment restrictions precluded the use of fluorogenic substrates. This 
was not considered a handicap as a particularly high-sensitivity assay was not necessary in this 
instance and might even have required the dilution of the expressed enzyme, forcing more process
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steps. It is worth noting that while fluorogenic detection is, on average, many times more sensitive 
than spectrophotometric measurement, the relative sensitivity (rates of autohydrolysis when 
experiencing minor environmental fluctuations, e.g. temperature or pH) of certain substrates may at 
times negate this. For example, the extreme sensitivity of the thioester bond to enzymatic 
hydrolysis is such that lower concentrations of elastase have been assayed with a peptidyl- 
thioester substrate than with a fluorescent group (Keasling et a/., 2002).
Trypsin has the highest affinity for thiobenzylester (-SBzl) and 4-nitroanilide (-NHPhNCb) 
substrates (see Table 2.1).
Substrate pH M s -1) K4\iM) kcat/Km (m A fV 1)
Z-Lys-SBzl 8.0 75 50 1500
Z-Arg-SBzl 7.5 94 5.3 18000
Tos-Gly-Pro-Arg-
7.5 17 4000
NHPhN02
69
Table 2.1: Showing three examples of chromogenic peptide substrates for trypsin
Abbreviations: Z- = benzyloxycarbonyl-; -sBZI = -thiobenzylester; Tos- = tosyl-; -NHPhN02= -4- 
nitroanilide. Adapted from (Sterchi and Stocker, 1999).
Previous work involving the molecular engineering of trypsin had used —nitroanilide substrates due 
to their low cost and relative stability. Thioester substrates, when hydrolysed, are released as free 
benzyl thiols which must react with either 5,5’-dithiobis(2-nitrobenzoicacid) (Ellman’s reagent) or 
4,4’-dithiopyridine to generate a signal at412nm (Grassetti and Murray, 1967; Sterchi and Stocker, 
1999). Nitroanilide substrates need no additional reagents to produce a signal and the freed 
nitroaniline group can be read directly at 410nm. If the resulting yellow colour is not sufficiently 
distinguishable from the background then the released chromophore may be diazotized and 
coupled to A/-(1-naphthyl)-ethylene diamine to generate a red azo dye which may be read at 
546nm (Sterchi and Stocker, 1999). This may be useful if the natural colour of the media (LB in 
particular) masks the signal.
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2.1.2 Design of single peptide substrate
Endoprotease activity is dependant upon the absence of any free amino- or carboxy-termini and 
thus, assuming that the marker group is affixed to the C-terminal end of the target amino acid, a 
suitable a-amino-terminal blocking group must be chosen unless the synthetic peptides extends for 
a least 5 amino acids up-stream of the cutting site (Corey et al., 1995). The choice of blocking 
group is dependant on the aim of the assay as studies have shown them to have a pronounced 
effect on the sensitivity of the substrate to hydrolysis (see Table 2.2, Figure 2-1 for examples) 
(Somorin etal., 1978a; Somorin et al., 1978b).
Commonly used N-terminal blocking (protection) groups for Arg & Lys
Name Abbrev. Formula Residue wt. Ref.
Acetyl Ac C2H3O 43.046
t-Butoxycarbonyl Boc C4H9O2 101.126
Benzoyl B C7H5O9 105.117
Benzyloxycarbonyl Z C8H7O2 135.144
(Somorin, Tokura, 
Nishi, and Noguchi 
1978b) 
(Perona, Evnin, and 
Craik 1993)
Noguchi 1978a)
Table 2.2: Blocking groups
Terminology and chemical structure of commonly used blocking groups for arginine and lysine 
containing substrates.
h 3c
0
I
c h 3
hLC —C —ChL3  j 3
0
I
c = o c = o
Benzyl (B) Benzyloxycarbonyl (Z)Acetyl t-Butoxycarbonyl 
Figure 2-1: Structure of blocking groups
Illustrating the biochemical features of commonly used blocking groups for arginine & lysine 
containing substrates.
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The relative rates of trypsin-catalysed hydrolysis of arginine-p-nitroanilide substrates, each 
incorporating a different a-amino-terminal blocking group can be seen below (Table 2.3).
Table 2.3: Describing how blocking groups can affect the relative cleavage rates of 
substrates
Adapted from (Somorin et al., 1978b). Abbreviations: ‘DL’ refers to the fact that racemization was 
allowed to occur during substrate synthesis. DL-BAPNA = A/-benzoyl-DL-arginine-p-nitroanilide, L- 
AAPNA = A/-acetyl-L-arginine-p-nitroanilide, L-BAPNA = N-benzoyl-L-arginine-p-nitroanilide, L- 
ZAPNA = N-benzyloxycarbonyl-L-arginine-p-nitroanilide, L-BPVAPA = A/-benzoyl-L-phenylalanine- 
L-valine-L-arginine-p-nitroanilide, L-ZPVAPNA = A/-benzyloxycarbonyl-L-phenylalanine-L-valine-L- 
arginine-p-nitroanilide. Reaction Conditions: Tests 1-4 were performed in 1% DMF (v/v). DMF has 
been shown to enhance the sensitivity of single residue substrates to hydrolysis by trypsin, with the 
greatest increase being the initial jump from 0-1% (v/v) and becoming inhibitory to enzyme activity 
above 10% (v/v) (Somorin et al., 1978b). Reaction 14 contained 667mM substrate & 10|ig/ml 
enzyme. Reaction 5 & 6 contained 15.6mM substrate & 0.99jj.g/ml enzyme.
The sensitivity of the synthetic substrates to hydrolysis clearly increase from 1 ->6. Note that in 5 & 
6, additional amino acids were placed between the protecting group and the target residue and 
these were found to dramatically enhance the affinity of the peptide for trypsin. A highly labile 
substrate would, however, not be particularly advantageous for the latter stages of this project, 
where the assay would be directed towards measuring substrate specificity. A highly sensitive 
substrate would likely release its chromogen even if poorly bound by the enzyme, making an assay 
for determining relative substrate specificity’s unworkable.
A comparison of Km & /(cat values of substrates 4 and 6 (L-ZAPNA & L-ZPVAPNA) 
illustrates the higher level of enzyme-substrate complex dissociation with the single residue 
substrate (Table 2.4).
Substrate Relative rate
1 DL-BAPNA
2 L-BAPNA
3 L-AAPNA
4 L-ZAPNA
5 L-BPVAPNA
6 L-ZPVAPNA
1.0
3.4
9.0
10.0 
1177 
1200
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Substrate Parameters
1 L-ZAPNA
2 L-ZPVAPNA
Km (M*10^) /Ccat (M*S)1
2.1 1.31
0.357 14.49
Table 2.4: Hydrolysis rates related to substrate size
Illustrating the high rates of activity obtained with peptide as opposed to single residue substrates. 
Adapted from (Somorin et al., 1978b).
The benzoyl blocking group was selected for the initial work in this project, namely to be 
incorporated in the simple synthetic substrates which would form the base of the screening 
reactions. It was chosen on the grounds that it was well characterized and did not appear to overly 
enhance substrate sensitivity. The apparently highly labile nature of synthetic peptides is a factor 
that must be considered when designing the larger peptide substrates with which to screen the 
enzyme variants for increased substrate specificity. It is, however, perfectly possible that the 
heightened rate of catalysis with peptide substrates occurs because they present a more natural 
binding site to the enzyme, allowing it to demonstrate the true level of activity that it would show 
against a similar target site in a whole protein. The lower levels of activity seen with single residue 
substrates could thus indicate a higher Km in the enzyme-substrate complex or simply lower 
binding affinity.
2.1.3 Na-Benzoyl-L-arginine-p-nitroanilide
The single amino-acid substrate selected for the initial simple activity assays was Na- 
benzoyl-L-arginine-p-nitroanilide (Synonyms: L-BAPNA, L-BANA, BANI). This compound has been 
used for previous similar work involving the engineering of recombinant trypsin (Evnin, Vasquez, 
and Craik, 1990; Evnin and Craik, 1988) and was relatively inexpensive. There were no reported 
problems with specificity or stability, but gradual autolysis was known to occur at pH > 8.
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Point of 
cleavago
0
ii
Benzyl blocking L-Arginine -4- Nitroanilide
grp
Figure 2-2: Structure of L-BAPNA
Molecular formula: C19H22N6O4 HCI. Molecular weight: 434.9. CAS number: 21653-40-7.
2.1.4 Other assay components
The assay would obviously only be capable of detecting trypsin that was both soluble & activated, 
and its success when working initially with the Eli Lilly commercial production strain, ELTRP-1, 
would rely on the assumption that not all of the recombinant trypsinogen expressed was bound as 
insoluble inclusion bodies within the cytoplasm. Data suggests that in such cases, at least a certain 
percentage would fold correctly within the interior of the cell and it is the catalytic activity of this 
fraction that would be assessed for the purposes of screening. The first significant aim of this 
project was to increase this fraction by means of altered fermentation conditions, molecular 
engineering or by random mutation.
The key to a successful screening assay is to use the smallest possible number of 
handling steps and, in this particular case, the problem lay in extracting and activating a cytosolic 
or periplasmic zymogen while avoiding the use of any complex purification steps. The first step was 
that the cells must be lysed. Ideally this step should rely on either the addition of a single 
compound or a fully automated process, and lyse the cells in as gentle a manner as possible. With 
this in mind, two possibilities were examined, namely the B-PER™ Bacterial Protein Extraction 
Reagent (Pierce), a mild, non-ionic detergent which has been developed specifically for soluble 
protein extraction, and the well-characterized freeze-thaw method. It was decided that assay 
development would first focus on the use of B-PER as it was by far the most rapid option (also 
requiring less handling of the plates by the operator) and had shown to be effective at extracting 
active soluble protein and inclusion body purification from total cell lysates. Other mechanical
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methods of cell disruption, such as sonification, were not considered because of their impracticality 
on a microplate scale.
It was believed that LB medium might raise the baseline absorbance at 495nm 
(wavelength at which nitroaniline release is read) to unacceptable levels, masking signal from low 
quantities of protein. As the expected expression level was not known the sensitivity required in the 
assay could not be predicted, but it seemed prudent to develop the assay using a relatively 
optically clear medium in parallel with LB. The growth medium arrived upon consisted of defined 
M9 salts, complex casein amino acids and glucose and was termed M9 semi-defined (M9SD). The 
medium was adapted from M9 minimal media (Sambrook et al, 1989).
2.2 Materials & methods
2.2.1 Enzyme storage
A trypsin (Sigma) stock solution was of 1 mg/ml was made in 20mM Tris-HCI, pH 7.5 & frozen in 
1ml aliquots @ -20°C. Concentration was confirmed by measuring absorbance at A280 applying the 
Beer-Lambert relationship:
A2S0 (blanked)
c =  e * i
c = enzyme concentration (mg*mM)
e = extinction coefficient (absorption coefficient) in units of M-1crrr1. £280 of trypsin = 1.41.
/ = optical pathlength of solution, 1 cm for a standard cuvette.
2.2.2 Na-benzoyl-L-ariginine-p-nitroanilide (L-BAPNA) activity assay
Basis for Assay:
In a single residue protease activity assay, an N-protected 4-nitroanilide is hydrolysed to release 
free 4-nitroaniline, the accumulation of which can be measured spectrophotometrically at405nm. 
A405 will increase when pH > 3.5. Nitroanilide compounds are known to autolyse gradually in 
solutions with pH > 8, therefore the substrate solution (pH 7.5) must be made up immediately prior 
to the experiment.
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Reagents:
Substrate Buffer (1X): 50mM Tris-HCI (Sigma), 20mM CaCfe (Sigma), 1% DMF (Sigma), pH 8.0, 
make as 10X concentrate.
Substrate Solution for Microplate Assay: 0.4mM L-BANA (Sigma) in final assay volume (200jjJ). 
Substrate soln. volume per well = 180^1, make 0.44mM soln. Made fresh on day of use, mixed 
well.
Substrate Solution for Cuvette Assay: 0.4mM L-BANA in final assay volume (1ml). Substrate soln. 
volume per cuvette = 500pJ, make 0.8mM soln. Made fresh on day of use, mixed well.
Equipment
Reader Setup: Microplate Assay. Reader (Dynatech MR7000) was set to measure at a single 
wavelength of 405nm and take 1 reading per minute for 10 minutes, with an initial 5s shake and 
immediate start to measurements.
Reader Setup: Cuvette Assay. Time-drive protocol was created on spectrophotometer (Uvikon 
922), set to measure @ 405nm, taking 1 reading per minute for 10 minutes.
Procedure:
Microplate Assay: 180jxl of substrate solution pipetted into all wells. 20jjJ of enzyme solution 
pipetted onto lip of each test well. Readings started immediately.
Cuvette Assay: 500pJ of substrate soln. pipetted into both cuvettes (sample & blank). 4000jnl of 
substrate buffer pipetted into both cuvettes. 100^ 1 enzyme solution added to sample, mixed either 
by inversion (apply film to top & invert quickly three times) or with vial stirrer. Readings started 
immediately.
2.2.3 P-Toluenesulphonyl-L-Arginine Methyl Ester (TAME) Based Trypsin Activity
Basis for Assay:
In this single residue protease activity assay, the N-protected substrate is hydrolysed to release the 
methyl ester, causing an increase in absorbance when read at 247nm. Protein concentration is 
determined by following Beer’s Law and reading at A280. Due to the low wavelength at which the
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reaction is followed (A247). it may only be performed at a cuvette scale (UV quartz cuvettes 
required) and not at microtitre scale.
Reagents:
Reaction Mixture: 0.001 M TAME (Worthington Biochemicals) & 10mM CaCfc (Sigma), 40mM Tris- 
HCL (Sigma), pH 7.8 - 8.2. The reaction mixture is purchased as lyophilized aliquots from 
Worthington Biochemical corporation, with each vial being reconstituted with 6.5ml RO water. 
Mixture volume required = 2.9ml per vial.
Equipment
Reader Setup: Cuvette Assay. UVIKON 922 Spectrophotometer was used. Time-drive protocol 
was created, set to measure @ 247nm, taking 1 reading per minute for 10 minutes. No calculation 
option was selected UV quartz cuvettes must be used for this assay.
Procedure:
Dissolved content of an appropriate number of vials with 6.5ml reagent grade water. Pipette 2.9ml 
into sample & blank cuvettes. 0.1ml trypsin solution added to the test cuvette and mixed rapidly, 
either by inversion (cover with film & invert quickly three times) or with vial stirrer. Readings started 
immediately.
2.2.4 Activity units
For the purposes of this work, one unit of enzyme activity was defined as the amount required to 
release 1 ^ mol of chromophore per minute under the specific conditions used. Each set of 
experiments was represented by two graphs, the first illustrating the pmols of substrate released 
per litre as a function of time, the second showing the specific activity of the enzyme in the sample.
Calculation for substrate catalysis:
pm ol *  L  1 =
/  A '410_ *106
, £ * l .
A = blanked absorbance reading of sample at specific time, no units. Read @ 410nm for L- 
BAPNA or @ 247nm for TAME.
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e = extinction coefficient (absorbtion coefficient) in units of M-1cnrr1.4-nitroaniline S410 =
8800L*moles-1*cnr1; p-tolunenesulfonyd-L-arginine S247 = 540L*moles*1cnr1.
I = optical pathlength of sample, units in cm. 1cm for standard cuvettes, empirically
determines to be 0.63cm for 200pJ of solution in a Starstedt microplate.
Calculation for specific activity of tested enzyme:
U = A|imol*mM*min-1, ^mol substrate released per minute,
c = enzyme concentration (jig*ml'1).
2.2.5 Media preparation
Luria-Bertani (LB) media: (per litre of deionised H2O) 10g bacto-tryptone (Merck); 5g bacto-yeast 
extract (Merck); 10g NaCI (Sigma). Adjust pH to 7.0 with 5n NaOH (Signa). Sterilized by 
autoclaving for 20 minutes at 15 Ib/sq. in. on liquid cycle.
M9 Semi-Defined (M9SD) media: (per litre of deionised H2O) 100ml 10x concentrate M9 salts (see 
below); 10g casein hydrolysate (Merck). Sterilized by autoclaving for 20 minutes at 15 Ib/sq. in. on 
liquid cycle. After autoclaving add: 2ml 1M MgS04 (Sigma) and 0.1ml 1M CaCl2 (Sigma) (both 
autoclaved separately as stocks); 20ml 20% glucose (Merck)(prepared on day, sterilized by 
filtration); 1ml 0.1% thiamine (Sigma)(filter sterilized in solution).
M9 salts: (10x concentrate, per litre of deionised H2O) 128g Na2HP04-7H20; 30g KH2PO4; 5g 
NaCI; 10g NH4CI. Sterilized by autoclaving for 20 minutes at 15 Ib/sq. in. on liquid cycle. All salts 
purchased from Sigma.
2.2.6 Microplate centrifugation
A series of experiments was performed to assess fraction separation & cell pelleting in a microwell 
format and to determine whether these procedures could be used as a step in a high-throughput 
screen. All work was done with a Sorvall RC-5C centrifuge using a ST-H750 rotor (radius from 
centerline of rotor to sample = 15.02cm) and standard round-bottomed 96-well microplates 
(Starstedt). Microplates with all 96 wells filled with infected LB media (A600 = ~ 1.0) were loaded
c
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according to manufacturer's protocols, and wene centrifuged at the maximum permissible speed for 
the rotor 4300rpm, generating a relative centrifugal force (RCF) value of 3102. Assessment of 
cellular and lysate precipitation was performed by comparison of the turbidity (A600) of the well 
supernatant before and after centrifugation.
2.2.7 Test of B-PER lytic efficiency at increasing dilution
In order to test for the lowest effective dilution of the B-PER detergent (Pierce) (essential for cost 
purposes if the reagent was to be applied to possibly thousands of well-cultures), it was necessary 
to monitor the release of soluble protein into the media from treated cells. Initially, it was attempted 
to follow the extent of lysis by measuring the absorbance of the media (clarified by 15min 
centrifugation @ 13,000rpm) at A280, but the errors involved proved unacceptably high. The Lowry 
assay provided a simple method for estimating the quantity of soluble protein released, with the 
added advantage that the reagents could be prepared in-house. The buffer compositions & assay 
protocol are described in Appendix 2. Experiments were performed with the M9SD medium as this 
was known to demonstrate a lower background with the assay. Cell cultures of E. coli DH5a were 
grown overnight in M9SD at 37°C, 200rpm and then diluted to an A600 (blanked) of 1.500|J of 
culture was then added to a 1 ml cuvette, with B-PER then being added to the appropriate dilution 
and the remainder being filled with MilliQ water. Cell suspensions were then vortexed for 5 
seconds. All experiments were performed at room temperature and, after vortexing, cultures were 
gently agitated (shaker platform at ~ 20rpm) for 10min to prevent settling and encourage 
dissociation of cellular fragments and debris.
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2.3 Results
2.3.1 Basic Kinetics of Trypsin on Single Residue Substrates in Optimal Buffered 
Conditions
Initial standard curves for the unit activity and the specific unit activity of commercial trypsin on both 
the L-BAPNA (Figure 2-3) and TAME (Figure 2-4) substrates were prepared in order to assess the 
lower detection limit offered by each substrate. Buffer conditions were optimal, prepared as 
recommended by the manufacturer (See Sections 2.2.2 & 2.2.3). For each activity assay, the 
specific unit activity (Ux^ig*1) was calculated as future mutation work may impair (or conceivably 
enhance) enzyme activity, and thus records o f‘wild-type’ performance were crucial.
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Figure 2-3: Kinetics of commercial bovine trypsin on 0.4mM L-BANA in 100mM Tris-HCI, pH 
8.0.
Enzyme concentrations denote amount of enzyme in 1 ml reaction volume. Key: A (-■ -) = 2jig 
trypsin; B ( - * - ]  = 1 fig; C ( ) = 0.5fig; D ( - o - )  = 0.1 ^ g. Reactions were blanked against
substrate and reaction buffer without enzyme. Upper graph: pmols per litre of product released 
(pNA group) at each enzyme concentration. Units pNA released per litre per min) for each 
concentration (determined from linear region): 2jj.g = 0.703; 1jrg = 0.262; 0.5jng = 0.154; 0.1 jug =
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0.001. Lower graph: Specific molecular activity (Units of trypsin activity per pg of enzyme) 
detected.
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Figure 2-4: Kinetics of commercial bovine trypsin on 0.001 M TAME in 0.04M Tris buffer, pH 
7.8 - 8.2
Enzyme concentrations denote amount of enzyme in 1 ml reaction volume. Key: A (-■ -) = 2.5jig 
trypsin; B ( - * - )  = 1 fj.g; C ( ) = 0.2^ig. Reactions were blanked against substrate and reaction
buffer without enzyme. Upper graph: pmols per litre of product released (pNA group) at each 
enzyme concentration. Units (pmol pNA released per litre per min) for each concentration 
(determined from linear region): 2.5^g = 66.6; 1 jj.g 34.3; 0.2(rg = 6.23. Lower graph: Specific 
molecular activity (Units of trypsin activity per pg of enzyme) detected.
91
Chapter 2: High-throughout assay development Edward Hibbert
2.3.2 Incorporation of media into the assay
A high-throughput assay would require the activity of soluble enzyme to be assessed without 
purification or processing of the microwell cell culture. A series of tests were thus run to examine 
the sensitivity and reproducibility of the L-BAPNA assay in sterile (Figure 2-5, Figure 2-7) and 
inoculated (Aeoo = 1) (Figure 2-6, Figure 2-8) LB and M9SD (optically clear) media.
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Figure 2-5: Kinetics of commercial bovine trypsin on 0.4mM L-BANA in uninoculated LB 
medium
Key: A (-■ -) = 2jng trypsin; B ( + )  = 1 jj.g; C ( ) = 0.5jig; D (-«>-) = 0.1 ng- Concentrations
denote the amount of enzyme added to 200pl, /.concentrations: 2pg = lO^g/ml, 1|ig = 5jj,g/ml, 
0.5ug = 2.5p.g/ml & 0.1 fig = 0.5pg/ml. Reactions were blanked against substrate and uninoculated 
medium without the addition of enzyme. Upper graph: pmols per litre of product released (pNA 
group) at each enzyme concentration. Units (nmol pNA released per litre per min) for each 
concentration (determined from linear region): 2^g = 2.54; 1pg = 2.44; 0.5ng = 0.52; 0.1 ng = - 
0.36. Lower graph: Specific molecular activity (Units of trypsin activity perpg of enzyme) detected.
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Figure 2-6: Kinetics of commercial bovine trypsin on 0.4mM L-BANA in inoculated LB 
medium (O.D. 1 @ 600nm)
Key: A (-■ -) = 2pg trypsin; B ( - * - )  = 1 jo.g; C ( ) = 0.5|ng; D (-«>-) = 0.1 ^ g. Concentrations
denote the amount of enzyme added to 200^1, .-.concentrations: 2^g = lO^g/ml, 1 p.g = 5^g/ml, 
0.5ug = 2.5^g/ml & 0.1 ^ g = 0.5|Ag/ml. Reactions were blanked against substrate and inoculated 
media without the addition of enzyme. Upper graph: pmols per litre of product released (pNA 
group) at each enzyme concentration. Units (pmol pNA released per litre per min) for each 
concentration (determined from linear region): 2^g = 2.02; 1pg = 0.942; 0.5jxg = 0.506; 0.1 jig = 
0.225. Lower graph: Specific molecular activity (Units of trypsin activity per pg of enzyme) 
detected.
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Figure 2-7: Kinetics of commercial bovine trypsin on 0.4mM L-BANA in uninoculated M9SD 
medium
Key: A (-■ -) = 2pg trypsin; B ( - * - )  = 1 jag; C ( ) = 0.5pg; D (-<>-) = 0.1 pg. Concentrations
denote the amount of enzyme added to 200pl, .-.concentrations: 2pg = 10pg/ml, 1pg = 5p,g/ml, 
0.5ug = 2.5pg/ml & 0.1 jj.g = 0.5^g/ml. Reactions were blanked against substrate and inoculated 
media without the addition of enzyme. Upper graph: pmols per litre of product released (pNA 
group) at each enzyme concentration. Units (pmol pNA released per litre per min) for each 
concentration (determined from linear region): 2jig = 1.58; 1pg = 1.02; 0.5|ug = 0.541; 0.1 pg = 
0.08. Lower graph: Specific molecular activity (Units of trypsin activity per pg of enzyme) detected.
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Figure 2-8: Kinetics of commercial bovine trypsin on 0.4mM L-BANA in inoculated M9SD 
medium (O.D. 1 @ 600nm)
Key: A [ - * - )  = 2pg trypsin; B ( - * - )  = 1 jj.g; C ( ) = 0.5pg; D (^>-) = 0.1 pg. Concentrations
denote the amount of enzyme added to 200pl, .-.concentrations: 2pg = 10pg/ml, 1pg = 5pg/ml, 
0.5ug = 2.5pg/ml & 0.1 pg = 0.5pg/ml. Reactions were blanked against substrate and inoculated 
media without the addition of enzyme. Upper graph: pmols per litre of product released (pNA 
group) at each enzyme concentration. Units (pmol pNA released per litre per min) for each 
concentration (determined from linear region): 2pg = 2.02; 1pg = 0.941; 0.5pg = 0.506; 0.1 pg = 
0.225. Lower graph: Specific molecular activity (Units of trypsin activity per pg of enzyme) 
detected.
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2.3.3 Assessing the impact of incorporating a cell lysis step using the B-PER reagent
The sensitivity and stability of L-BAPNA was assessed in the presence of a chemical lysis agent, 
the B-PER detergent, and the resultant cellular lysate, so that the practicality of lysing the well- 
cultures to access soluble cytoplasmic protein in a single step could be established.
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Figure 2-9: Kinetics of commercial bovine trypsin on 0.4mM L-BANA in the presence of 
inoculated LB media (O.D. 1) and B-PER (1 in 4 soln)
To examine effect of lysis agent dilution on enzyme activity, 2ug of enzyme was also tested in the 
presence of neat B-PER. Key: A (-■ -) = 2pg trypsin; B ( - * - ]  = 1 jj.g; C ( ) = 0.5pg; D (-o -) =
2pg trypsin in neat B-PER. Concentrations denote the amount of enzyme added to 200pl, 
.-.concentrations: 2pg = 10pg/ml, 0.5ug = 2.5pg/ml & 0.1 pg = 0.5pg/ml. Reactions were blanked 
against substrate and inoculated media without the addition of enzyme. Upper graph: pmols per 
litre of product released (pNA group) at each enzyme concentration. Units (pmol pNA released per 
litre per min) for each concentration (determined from linear region): 2pg (1:4 B-PER) = 1.27; 2pg 
(neat B-PER) = 1.43; 0.5pg = 0.3; 0.1 pg = 0.02. Lower graph: Specific molecular activity (Units of 
trypsin activity per pg of enzyme) detected.
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Figure 2-10: Kinetics of commercial bovine trypsin on 0.4mM L-BANA in the presence of 
inoculated M9SD media (O.D. 1) and B-PER (1 in 4 soln).
To examine effect of lysis agent dilution on enzyme activity, 2ug of enzyme was also tested in the 
presence of neat B-PER. Key: A (-■ -) = 2jig trypsin; B (-■>-) = 1jig; C ( ) = 0.5^ig; D (-o-) =
2^g trypsin in neat B-PER. Concentrations denote the amount of enzyme added to 200[il, 
.-.concentrations: 2^g = 10jj.g/ml, 0.5ug = 2.5^g/ml & 0.1 ^ g = 0.5^g/ml. Reactions were blanked 
against substrate and inoculated media without the addition of enzyme. Upper graph: pmols per 
litre of product released (pNA group) at each enzyme concentration. Units (jimol pNA released per 
litre per min) for each concentration (determined from linear region): 2jxg (1:4 B-PER) = 1.77; 2^g 
(neat B-PER) = 1.37; 0.5|ig = 0.391; 0.1 ^ g = 0.05. Lower graph: Specific molecular activity (Units 
of trypsin activity per pg of enzyme) detected.
97
Chapter 2: High-throughout assay development Edward Hibbert
2.3.4 Assessing the lytic efficiency of B-PER
The manufacturer's protocols for the use of B-PER state that, for optimal results, pelleted cells 
must be resuspended in neat solution and subsequently shaken for 1 minute. As lytic efficiency 
was unlikely to be based on a ‘trigger1 concentration, a series of experiments were performed using 
increasing dilutions of B-PER and extended incubation times (cultures now shaken for 10 minutes) 
in order to establish whether use of the agent a higher dilution might be equally effective.
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Figure 2-11: Lytic efficiency of B-PER
Illustrating the absorbance obtained from the Lowry protein concentration assay after addition of B- 
PER solutions of decreasing concentration to inoculated M9SD medium (O.D. 1 @ 600nm, then 
diluted 1:10 for assay). Control was inoculated medium without B-PER. B-PER solutions were 
diluted with RO water and each reaction was blanked against a tube containing a 1:10 diluted 
mixture of uninoculated medium & B-PER soln (@ appropriate diln) and which had undergone the 
full Lowry assay. The control was blanked against a reaction tube in which the protein soln was 
uninoculated media + water. No standard curve was run and thus no attempt was made to apply 
concentration values to absorbance, results were indicative only.
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2.3.5 Use of microplate-centrifuge to pellet cells & insoluble fractions
A series of experiments were earned out to assess the usefulness of the Sorvall RC-5C centrifuge 
with the ST-H750 microplate carrier in pelleting cells from liquid culture and also in the separation 
of the insoluble fraction of the cells from the soluble fraction after lysis. Efficiency was assessed by 
filling wells with 300jliI of culture, taking absorbance readings at A600 & A280, centrifuging for a 
specified time and speed, and then extracting the uppermost 200pl and re-measuring the 
absorbance at both wavelengths.
The ST-H750 rotor limited the centrifuge to a maximum of 4000 revolutions per minute 
(rpm). The arm length (radius) of the rotor was 15.02cm and thus the maximum relative centifugal 
force that could be generated was 2684. A series of tests involving infected LB and M9SD media 
showed that centrifugation for 20min @ 4000rpm served to pellet approximately 70% of the cells 
from suspension in both media. Centrifugation for a further 20min increased this value to 
approximately 92%, with a clear pellet forming at the bottom of the wells. After lysis of a cell 
culture, even an hour of maximum speed centrifugation produced no significant alterations in the 
readings. It was important to note that the Starstedt microplates suffered from increasing physical 
stress when centrifuged at an ref of 2684 for 30min or longer. Plates frayed severely around the 
edges and faint discolorations began to appear in the main body of the plate, presumably due to 
stressing of the plastic.
2.4 Discussion
2.4.1 Assay development
Figures 2.9 & 2.10 show the sensitivity achievable using the final form of the proposed high- 
throughput assay in infected LB & M9SD media respectively (blanked A6oo = 1) and in the presence 
of the lysis reagent The optically-clear M9SD medium offered obvious benefits in terms of 
minimum detection levels, with the signal (A405) evolved from enzyme concentrations below 
10pg/ml presumably being masked by the yellow colouration of the LB culture, but initial tests (see 
Chapter 3) showed that ELTRP-1 growth was significantly slowed in the semi-defined medium.
This suppression of growth rate would not, in itself, present a problem, but it was not known 
whether it may impact on r-trypsinogen overexpression, possibly requiring altered time of induction 
away from the Eli Lilly standard fermentation protocols, or whether it would pose a problem for the
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microwell fermentations which were to form the backbone of the high-throughput screen. It was 
decided that testing of the production strain, ELTRP-1, was to continue using both media in 
parallel.
Use of a microplate centrifuge proved to be effective in pelleting cells out of suspension in 
both media, despite the limited ref generated. A potential improvement to the sensitivity of the 
assay could thus involve centrifuging the cells and resuspending in MilliQ water prior to lysis. This 
would enable the researcher to benefit from the high-growth rate of LB medium within well cultures 
and being able to separate the cells in each plate in a sigle, simple process step. Centrifugation 
was however a lengthy step, requiring at least 40min, and thus a certain bottleneck when 
processing a library of isolates, and also appeared to mildly damage the microplates. There always 
existed the potential that such damage could result in spillage of infected medium into the 
apparatus, the subsequent cleaning of which could result in severe delay and the waste of possibly 
hundreds of well cultures. As the sensitivity of the L-BAPNA assay with even LB media was still 
relatively high, it was decided that such a centrifugation step was not necessary unless detection 
levels became clearly critical.
The proposed form of the high-throughput assay would thus involve the overnight 
fermentation of isolates within shallow or deep 96-well plates, the transfer of perhaps 100^ 1 of 
mixed culture to an assay plate and the immediate reading of activity after the addition of 
enterokinase. Such an assay would require only one transfer of material and thus a clear minimum 
of process steps and researcher intervention. Activity would be read over 10 minutes if possible, 
but an adequate estimate of enzyme concentration could be established from only two readings if 
they lay within the linear region of the reaction slope. The 2nd & 6th minute would be appropriate in 
this case.
2.4.2 Comparison of substrates
Na - benzoyl - L - Arg p-nitroanilide (L-BANA) and p - toluenesulphonyl - L - Arg methyl ester 
(TAME) differ in both their N-terminal blocking & C-terminal chromogenic groups. Release of the 
methyl ester following hydrolysis of the scissile bond results in a signal which is, on average, 3-4 
times stronger than that generated by the nitroanilide group. The reaction rate of the enzyme for 
TAME appeared to be in the region of 110x higher than for L-BAPNA, with substrate depletion
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effects occurring after 9min for2,5ng/ml trypsin (Figures 2.3 & 2.4). Blanks remained constant over 
time, showing that signal was not caused by substrate instability, and so this heightened affinity of 
the enzyme for TAME shows why the assay was adopted as an industrial standard.
Although the basic TAME assay had to be assessed so that the protease variants 
produced could be compared against the trypsin data held by Eli Lilly, it was known that it would be 
impractical for use in a high-throughput assay because of its UV absorbance spectrum (max A @ 
247nm). Only the L-BANA substrate was therefore tested for compatibility with the other elements 
of the screen.
2.4.3 Examining the lytic efficiency of B-PER
The standard Pierce protocol calls for B-PER to be used neat on a resuspended pellet of cells. As 
mentioned before, this was unacceptable, both in terms of the requirements of the assay and in 
terms of cost, and so it was desirable to establish a curve of dilution vs. activity. All assay 
development work was done using B-PER at a 1:4 diln, added 1:1 to a cell suspension, i.e. a 1:8 
diln of the protocol recommended concentration. Figures 2.9 & 2.10 examine the impact of adding 
neat B-PER to the cellular suspension, as opposed to the 1:4 soln. In LB medium, this control 
demonstrated higher variability and a decreased absorbance profile while maintaining the virtually 
the same rate of reaction. The neat B-PER soln thus appeared to interfere with the precision of the 
assay while not retarding enzyme activity over the effect already observed.
Figure 2-11 used the Lowry assay to attempt to establish the effectiveness of the reagent 
in terms of the assay and appears to show a reproducible curve, demonstrating decreasing 
efficiency with increasing dilution. No trypsin was added as the test was purely to monitor the 
increase in soluble protein in the media upon lysis and the blanks used were thus uninoculated. 
This may explain the negative value obtained with the control (inoculated media without B-PER) as 
it is possible that the cells and cell debris sequesteres much of the free protein within the media, 
rendering it inaccessible to the Lowry assay. The results appear to show a tailing off of efficiency 
after the 1:4 dilution, but visual inspection of the samples provided ample proof of lysis (slight 
clarification of media, presence of large insoluble aggregations). It was decided that a 1:8 dilution 
of the lytic detergent would prove a adequate compromise providing that the well cultures were
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gently shaken for 10min after the addition of the agent, to allow full lysis of the cells and the 
gradually disassociation of the cellular components.
2.5 Conclusions
In optimized conditions the catalysis of L-BAPNA and TAME could be detected clearly and 
reproducibly at minimum levels of 0.5^g/ml by the standard activity assays tested in this chapter. In 
uninfected LB media, this sensitivity rose to 2.5jj,g/ml for L-BAPNA (TAME was not tested in 
microwell format) and to 5|xg/ml in infected media. The specific activity of the commercial trypsin 
remained identical in infected & uninfected medium, indicating that the enzyme was not to any 
significant degree inhibited by extracellular proteins or lysis products.
Experimentation with the optically clear medium M9SD resulted in a considerable 
improvement in sensitivity. Minimum detection levels were reduced to 0.5pg/ml in uninfected 
medium and 2.5^g/ml for infected medium. The specific activity of the controls was not affected.
The addition of theaelected lysis agent, B-PER, appeared to depress trypsin activity by 
approximately 0.5 units on average, both diluted and neat, and in both media types. This was not 
considered to be a significant effect.
While the errors involved in assessing B-PER activity at progressive dilutions were high 
(Figure 2-11) and the assay involved tracked cellular lysis only indirectly, the data suggested that 
using B-PER at a 1:4 dilution with a 10min standing time provided an acceptable rate of lysis.
Centrifugation of the microplates using available equipment could be used as an effective 
step for the pelleting of cells from well cultures following a microwell fermentation in a standard, 
shallow Starstedt 96-well plate. The maximum ref that could be generated was, however, clearly 
insufficient to precipitate inclusion bodies from suspension afterculture lysis.
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3 Initial ELTRP-1 characterization & fermentation work
3.1 Introduction
This section details the preliminary work done with the Eli Lilly r-trypsinogen production strain 
ELTRP-1 after it was received on the 28th September 2000. The questions that needed to be 
addressed before formulating any mutagenic or protein-engineering strategy were related to 
extending our knowledge of the strain’s characteristics and thus suitability for the proposed 
mutagenesis and subsequent high-throughput screen. Growth and expression levels in complex 
medium (LB) were first to be assessed along with the degree of fine control available over 
induction. It was then useful to test whether growth on the optically clear M9SD growth medium 
significantly affected either growth or expression. M9SD had been tested as an alternate growth 
medium to LB using E. coli DH5a as a test strain, as this media allowed for greater sensitivity in 
the L-BAPNA activity assay, where aliquots of cell culture were added directly to the assay reagent 
(see Chapter 2). Eli Lilly had worked with the assumption that following induction and overnight 
(16hr) incubation, 100% of the recombinant protein had aggregated as inclusion bodies with no 
residual native activity remaining. For the sake of fully characterizing the ‘wild-type’ strain and to 
establish the background for the future work, it was necessary to assay for trace levels of trypsin 
activity within the various fractions of the cell (insoluble, soluble cytosolic, periplasmic & 
supernatant) during the course of a standard fermentation.
Preparatory molecular work on the pHKY603 plasmid involved enzymatic digestion to 
confirm identity and the optimisation of PCR conditions both for confirmation of gene sequence and 
as preparation for the planned gene modification work (prosequence deletion, leader sequence 
attachment, site-specific mutations) (see Chapter 5 & 6). Standard PCR conditions also needed to 
be established so as to provide a basis for future work with mutagenic PCR, if it was decided that 
this method of directed evolution was most suitable for developing the planned mutant libraries.
3.1.1 Characteristics of the ELTRP-1 production strain
The host-expression vector system used by Eli Lilly for the production of (recombinant trypsin) r- 
trypsin) consisted of a derivative of E. coli K12, RV308, as the host, and a derivative of the plasmid 
pBR322, termed pHKY603, which codes for the production of methionyl-phenylanalyl-bovine
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trypsinogen (biosynthetic Met-Phe-bovine trypsinogen) as the expression vector. The resulting 
strain RV308:pHKY603 was called ELTRP-1. For an abbreviated plasmid map of pHKY603, please 
refer to Figure 3-1 .The strain carried plasmid encoded tetracycline resistance and genome 
encoded streptomycin resistance, both genes expressed constitutively.
The product gene (met-phe-trypsinogen) was under the control of a temperature sensitive 
promoter. The identity and type of this promoter was not released by the company, but the 
behaviour of the strain indicated that it was a repressor system, where an inhibitory factor, linked to 
the temperature-sensitive promoter, was expressed at high levels and blocked the binding of 
transcription factors to met-phe-trypsinogen. Temperatures below 36.5°C were classed as 
‘permissive’ and allowed the expression of the inhibitor, while 36.5°C and above were ‘restrictive’, 
preventing inhibitor expression and thus allowing the transcription of met-phe-trypsinogen. 
Company literature suggested that the induction temperature should be considered to have a 
range of 35°C-38°C, with the accepted temperature for non-induced growth being 32°C.
Sal I  - 900
pHKY603 
6260 bp Xba 1 -1 6 0 8  N d e I -1 6 5 5  
Kas I  - 1703
MetPhe Trypsinogen 
1658-2353  
685bp______
Sac I -2 1 2 0
Bam H I  - 2354 
Nco I  -  2450
Figure 3-1: Abbreviated structure of the pHKY603 plasmid
Source Eli Lilly company literature.
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3.1.2 Industrial fermentation conditions
Detailed conditions & feeds, as well as precise descriptions of the vessels used could not be stated 
here for reasons of company confidentiality. No data was provided for small scale fermentation & 
expression work and available protocols detailed a 2000L production run of ELTRP-1.
Fermentation volumes were scale-up from 500ml to 250L after inoculation with frozen master- 
stock, with the latter volume forming the inoculum for the 2000L vessel. Growth conditions were 
held at 29-31 °C, 6.9-7.1 pH with the induction point being determined by monitoring of glucose 
depletion rates. Glucose concentration could be measured either on-line using a continuous 
glucose analyser or by analysis of off-line samples at the appropriate frequency. Induction would 
be set to occur when the glucose concentration fell below 10g/l and involved the raising of the 
vessel temperature to 36.5°C. Under the specific conditions used, the culture was induced on 
average 8-10 hours after inoculation.
The end point of the fermentation was typically determined by time, with harvesting 
occurring approximately 8 hours after induction. The length of the peak production period of the 
fermentation was known to be influenced by the operating parameters. At the completion of the 
fermentation, the broth was inactivated (no viable £  coli detectable) by standard measures. The 
broth was heated in situ to a minimum of 58°C, and this temperature was held until 18 Fss had 
been accumulated.
Protocols for the recovery and purification of Met-Phe-trypsinogen were not released, but it 
was surmised that they followed the standard form for the treatment of an insoluble, inclusion-body 
bound recombinant protein. Centrifugation of batches of the media would allow the dense inclusion 
bodies to be recovered in the heavy phase, with the resultant slurry (which would contain 
approximately 20% solids w/w) being washed with sterile water and detergent prior to solubilisation 
in a suitably reducing, chaotrophic environment. An in-depth discussion of the refolding steps 
available and an analysis of the Eli Lilly method may be found in Chapter 4.
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3.2 Materials & methods
3.2.1 ELTRP-1 genotype & phenotype
Strain is a derivative of E. coli K12, RV308. Plasmid is termed pHKY603, a derivative of pBR322. 
Phenotype: TcR, SmR, Lac.
3.2.2 Upon receipt of strain
A stab culture of ELTRP-1 was received from Eli Lilly (Fergersheim plant) on 28.09/00. 
Immediately on arrival, the culture was used to inoculate 10mls of sterile selective LB media 
(tetracycline @ 10pg/ml, streptomycin @ 100pg/ml: Antibiotics were at stringent plasmid 
concentration as recommended in Eli Lilly literature). The liquid culture was grown for 16hrs at 
30°C. 200rpm and was used to create streak plates (LB agar tet. 10jj.g/ml, strep. 100 jag/ml) and 
10 aliquots of 15% glycerol stocks which were then stored at-80°C. Agar plates were grown for 
20hrs at 32°C and then single colonies were picked to inoculate 10ml cultures of selective media 
which was grown in the same conditions as before. Small-scale plasmid extractions were 
performed on each of the overnight cultures using the QIAprep Spin Miniprep kit (Qiagen). The 
plasmid preparations were measured at A260 using a quartz ultra-micro cuvette (Bellman) and an 
ATI Unicam UV/Vis Spectrometer (Model UV2). The DNA samples were diluted appropriately to 
give readings of between 0.1 and 1.0. A 0.8% agarose gel was run at 80V, 50mA for 2hrs to verify 
the plasmid size and purity.
3.2.3 Testing relative growth rates on LB & M9SD media
Single ELTRP-1 colonies were picked and used to inoculate 3x 100mls of LB and M9SD in 500ml 
baffled shake-flasks (tet 10pg/ml, strep. 100jig/ml). These were then grown at 32°C, 200rpm for 
16hrs with 1ml samples being taken for the first 7 hours. Readings were taken on the ATI Unicam 
UVA/is Spectrometer (Model UV2) and were blanked against uninfected media of either type. 
Media temperature was monitored rigorously by means of a thermometer within a control flask of 
uninfected media to ensure that it did not approach 35°C. Eli Lilly literature stated that induction 
occuned at temperatures between 36.5-37.5°C and that 35°C must be considered with the range 
of error. So as to achieve comparative data for growth rates after induction, the experiment was
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repeated but the temperature of each culture was raised to 37°C at the end of exponential growth 
(in LB: 4hrs, M9SD:6hrs).
3.2.4 Testing for soluble rTrypsinogen
Single ELTRP-1 colonies were picked and used to inoculate 10mls of LB and M9SD in 50ml falcon 
tubes (tet lOptg/ml, strep. 100jig/ml). These seed cultures were grown at 32°C, 200rpm overnight 
and then 1ml of each was used to inoculate 2x 100mls of LB and M9SD in 500ml baffled shake- 
flasks (tet 10|ig/ml, strep. 100jj,g/ml). These were grown at 32°C, 200rpm until the end of 
exponentional growth (in LB: 4hrs, M9SD: 6hrs) and then one set was raised to the induction 
temperature (37°C) and then grown for a further 16 hours. The second set (uninduced control) was 
held at 32°C for the identical time.
The aim of the experiment was to test tor the presence of soluble (and thus activatible) 
trypsinogen in the supernatant or the cytoplasm (released with the lysis agent, B-PER) and so the 
experiment was set up in the following manner using standard, shallow 96-well microplates 
(Starstedt) and a microplatereader (Dynatech MR7000). Data was collected and analysed using 
BioLinx software, version 2.0 (Dynatech laboratories, inc).
For each media type the experimental wells below were repeated with both uninduced and 
induced cell cultures. Each well was filled with 300jxl and activation of the recombinant trypsinogen 
was effected by the addition of 1^g enterokinase (to a final well conc. of 3.3|xg/ml) and allowing the 
plate to stand at room temperature for 5min. The substrate solution was added last, immediately 
prior to reading.
Blank 120jjJ induced/uninduced culture + 140pJ MilliQ-water + 40jxl 0.4mM L- BAPNA
Activity Control 120|jJ induced/uninduced culture + 120jjj MilliQ-water + 40^10.4mM L- 
BAPNA + 20nl trypsin stock 1 (@ 50ng/ml 1 jxg added)
Supernatant Activity 120^ 1 induced/uninduced culture +120^1 MilliQ-water + 40jxl 0.4mM L- BAPNA + 20|j.l trypsin stock 2(@ 500ng/ml 10ng added)
Cytoplasmic Activity 
(trypsin)
120jjJ induced/uninduced culture +120^1 B-PER + 20pJ MilliQ-water + 
40|xl 0.4mM L-BAPNA
Cytoplasmic Activiy 
(trypsinogen)
120jxl induced/uninduced culture + 120jjJ B-PER + 40^10.4mM L-BAPNA 
+ 20pi trypsin stock 2 (@ 500ng/ml /. 10ng added)
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Experimental setup: Blank -  used to measure the baseline absorbance reading with intact cells, 
also would indicate if active rTrypsin was present in supernatant or if mix was acting to hydrolyse 
the substrate. Control 1 -  used to provide a standard signal from 1 ^ g trypsin in the presence of 
intact cells. Supernatant Activity -  shows whether rTrypsinogen was present in the supernatant 
using 10ng trypsin as an activator (the uninduced culture wells will provide a standard signal for the 
added enzyme). Cytoplasmic Activity (trypsin) -  shows whether rTrypsin is present in the 
cytoplasm. Cytoplasmic Activity (trypsinogen) -  tests whether rTrypsinogen is present in cytoplasm 
(with commercial trypsin as activator). The substrate used was L-BAPNA with a final assay 
concentration of 0.4mM. For activity profiling of this substrate, buffer composition and the 
calculation of activity units see Chapter 2, sections 2.2.2,2.2.4 & 2.3.3).
Reading conditions: Wavelength = 420nm; Shaking = 10s initially, 5s prior to each 
subsequent reading; Temperature control = off (ambient); Intervals = 1 reading/min for 10min.
3.2.5 Comprehensive testing of ELTRP-1
The following protocol was designed to test for the presence of soluble, active trypsin in an ELTRP- 
1 fermentation under a variety of conditions. The experiments were extended variants of those 
described in 3.2.4, and refer to the results shown in Figure 3-11.
Cell culture was prepared as described in 3.2.4 and a 100jjJ aliquot was transferred to an 
assay plate, where additional reagents were added (total well volume of 200^1). Substrate (L- 
BAPNA, with a final well concentration of 0.4mM) was added immediately prior to the start of 
measurement in each case. Assay components were as follows:
1 Basic activity (no lysis, no denaturant): Induced culture + L-BAPNA
2 Periplasmic activity: Induced culture + L-BAPNA + 0.5pg/ml lysozyme
3 Total soluble activity: Induced culture + B-PER + L-BAPNA.
4 Insoluble activity: Induced culture + B-PER + 200jog/ml lysozyme + 0.1 M urea + L-BAPNA
5 Insoluble activity: Induced culture + B-PER + 200pg/ml lysozyme + 0.5M urea + L-BAPNA
6 Insoluble activity: Induced culture + B-PER + 200pg/ml lysozyme + 1M urea + L-BAPNA
7 Insoluble activity: Induced culture + B-PER + 200pg/ml lysozyme + 2M urea + L-BAPNA
8 Insoluble activity: Induced culture + B-PER + 200pg/ml lysozyme + 5M urea + L-BAPNA
9 Controls: Uninduced culture + L-BAPNA +0.1,0.5,1,2^g commercial trypsin.
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All experiments were blanked against their exact counterparts, run with uninduced medium. The 
purpose of this was to firstly generate the clearest results possible in terms of genuine r-trypsin 
activity, and also to probe for possible hydrolysis of the substrate in uninduced cultures under 
particular conditions. A positive result in the latter case could indicate a degree of leakage from the 
repressor system, allowing very low levels of trypsin to be expressed without condensing as 
inclusion bodies. Activity units as well as calculations for substrate depletion can be found in 
section 2.2.3.
3.2.6 Establishing PCR conditions
Positive and negative sense primers (referred to as P & N respectively) were designed for 
pHKY603, flanking rtrypsinogen and providing ‘protection’ of the start & stop codons and the pro­
sequence of the zymogen. In this case ‘protection’ means that these aspects of the sequence are 
included in the primers and thus are safe from mutagenesis/miscopying. Oligonucleotides were 
ordered via custom synthesis from Amersham Pharmacia.
Positive sense primer (P)
Nde\
 I____
5' AAT AAT CAT AT GTTT GT GG AT GAT GAT GAT AAG 3*
Start codoni______________________________
Pro-sequence
Properties: 33nt, Tm= 64.2°C
Negative sense primer (N)
Bam  H1 
 i____
3' ATCCTAGGGCGCTCCGACTCG 5’
Stop codon
Properties: 21 nt, Tm= 67.0°C 
Figure 3-2: Amplification primers for rtrypsinogen on pHKY603
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For the initial test, PCR reaction conditions were set as standard for the amplification of a 1 kb gene 
(Sambrook etal., 1989). Thermocyler settings: Initial denaturation (5min @ 94°C); [ Denaturation 
(60s @ 94°C); Annealing (90s @ 60C); Extension (60s @ 72°C) ] cycle x28; Final extension 
(10min @ 72°C); Holding temperature (4°C). Temperature ramping was set to max and the heated 
lid was set to 100°C.
100 pmol required for a typical reaction. Oligonucleotides (Amersham Pharmacia Biotech) supplied 
at the following levels:
P: 27.8nmol/285.9 i^g resuspend in 500pJ MilliQ-water => 2pJ = 110pmol 
N: 62nmol/396.0|ig resuspend in SOOjjJ MilliQ-water => 1 pi = 120pmol 
Reagents used: Template = approx. 20-50ng in 1pJ; reaction buffer 10X = 10pl; dNTP (10mM each 
nucleotide stock) = 2pi (0.2mM/nucleotide); primer P = 2pl; primer N = 1 jol; MgCb (25mM stock) = 
6(xl; MilliQ-water = 78jjJ. Total volume = 100pl. All PCR reagents purchased from Promega.
When the initial reaction yielded no signal, the reaction conditions were varied in a number of 
ways, namely: Stringency of the reaction was lowered by decreasing annealing temp, to 55°C. 
[MgCh] was varied to low (0.8mM) & high (2mM).
[dNTP] increased to 0.8mM/nucleotide (8pl from 10mM/nucleotide stock). 
[Template] increased: Miniprep from initial work @46ng/pl concentrations used: 
46ng = 1pl; 92ng = 2pl; 138ng = 3jnl.
Other reagents & conditions were held as before and each reaction was made up to 100pl with 
MilliQ-water. Exact conditions used for each experimental variant are listed in the Results section.
3.2.7 Cellular fractionation, inclusion body purification & washing and SDS-PAGE
SDS-PAGE gels were used as a direct visual test for the presence of overexpressed protein. The 
procedure for the separation of ELTRP-1 cultures into soluble & insoluble protein fractions was 
adapted from the standard Pierce B-PER Mini-Scale Bacterial Protein Extraction protocol. This was 
designed for use on 1 -2mls of overnight cultures (ODeoo 1.5-3.0) and allows for the fractionation of 
the cell into soluble (total cytosolic & periplasmic) protein and inclusion bodies. For increased 
purification of the inclusion bodies it was recommended that lysozyme be used to further digest 
cellular debris, but that was considered unnecessary for this relatively crude assay. Protease 
inhibitors were also omitted.
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The method was as follows: 1ml of overnight culture (induced & uninduced) was spun 
down for 10min @ 13,000rpm so as to pellet the cells. Supernatant was retained for further 
analysis, cells were resuspended in 2 0 0 jliI neat B-PER and vortexed vigorously for 1 minute until 
the solution appeared homogeneous. The solution was centrifuged again for5min @ 13,000rpm 
and supernatant was retained as ‘soluble fraction’. Pellet was resuspended in 200|jJ diluted B-PER 
(1:10 dilution with MilliQ water), vortexed for 1 minute and then centrifuged for a further 5 minutes. 
Pellet ‘washed inclusion body* was resuspended in 200|J MilliQ water. Samples were either 
analysed on same day or stored at-20°C. All SDS-PAGE reagents were purchased from National 
Diagnostics and gels were prepared and run according to manufacture’s protocols.
3.3 Results
3.3.1 Characterization of ELTRP-1 in various media
After the initial culturing of the Eli Lilly ‘stab culture’ and the creation of glycerol stocks from single 
colonies, the growth rate of the strain was tested in both LB and M9SD. Results shown overleaf in 
Figure 3-3.
I l l
Chapter 3: Initial ELTRP-1 characterisation & fermentation work Edward Hibbert
2 . 5 -
2 .0 -
<d 1- 5 -
JXL
Cro
jQ
o  1 ° -  
o
CO<
0 .5 -
0 .0 -
0 2 6 8 10 12 14 16 182 4
Time (hours)
Figure 3-3: Growth of ELTRP-1 in LB & M9SD (both Tc+, St+) without induction
Key: A (-■ -)  = ELTRP-1 grown in LB; B ( - * - )  = ELTRP-1 grown in M9SD. Reactions performed
in triplicate & conditions held @ 32°C, 200rpm throughout.
Plasmid DNA was purified from the overnight culture in LB using the Qiagen MiniPrep procedure 
and run on an agarose gel against a supercoiled ladder in order to confirm the presence and size 
of the pHKY603 plasmid. The purified plasmid appeared to approximately 1Kb smaller than the 
documented size of pHKY603 (6260 bp), but despite this the strain appeared to exhibit the correct 
phenotype (Tcr, Stf). The growth rates were compared against those where the cultures were 
raised to the restrictive temperature of 37°C at the end of exponential growth (in LB: 4hrs, M9SD: 
6hrs) and then at the beginning of exponential growth (in LB: 2hrs, M9SD: 4hrs). These two 
induction points were designed to test the Eli Lilly assertion that maximum levels of rTrypsinogen 
would be achieved if the cultures were induced at the beginning of the stationary phase.
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Figure 3-4: Growth of ELTRP-1 in LB & M9SD with induction times before and after 
exponentional phase
Key: •••«••• = A; —a — = B; = C ;- • * "  = D; =E; <  =F.
Plots A & D show the uninduced growth in both media as drawn previously in figure 1; B & E chart 
growth with late induction (in LB: 4hrs, M9SD: 6hrs) in LB & M9SD respectively; C & F show 
growth with early induction (in LB: 2hrs; M9SD: 4hrs) in LB & M9SD respectively. All reactions 
were performed in triplicate with 100mls infected media within 500ml baffled flasks, initial growth @ 
32°C, 200rpm, induced by raising temperature to 37°C, 200rpm.
It seemed evident that no great metabolic load was being placed upon the cultures after induction, 
irrespective of the point at which applied. A transient dip in the growth rate would have provided 
indirect evidence for recombinant protein overexpression and thus provided both further proof of 
the strain’s identity and a convenient method for roughly testing the lower range of the heat- 
inducible promoter. The logical next step was to assay for specific trypsin activity in induced 
cultures using the final assay method described in Chapter 2.
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3.3.2 Testing for soluble r-trypsinogen
Replica flasks of LB & M9SD cultures were grown until the onset of stationary phase and then 
raised to induction temperature and grown for a further 16hrs. Various tests and controls were 
prepared for microplate assay (as described in Methods) with the aim of determining whether any 
soluble recombinant trypsinogen (or indeed trypsin) was present in either the supernatant or 
soluble fraction of the cell. A positive signal at this stage would have been highly useful as it would 
have served to confirm the identity of the strain and would also have shown whether any physical 
or genetic manipulation of the culture would be necessary, or whether it was already a suitable 
platform tor directed evolution (i.e. if soluble protein be obtained from the fermentation in a manner 
appropriate for a high-throughput screen). Please refer to section 3.2.4 for exact protocol.
No trypsin activity was detected in the soluble fraction of either induced or uninduced 
culture grown in either media, and thus only PCR and plasmid digestion remained as paths tor 
strain confirmation.
3.3.3 Amplification & digestion of r-trypsinogen
With the identity of the strain still unconfirmed, in so far as there was no apparent metabolic load 
upon induction, direct confirmation seemed essential and there were three obvious routes for 
achieving this, namely: amplification of the target gene (rtrypsinogen) via the polymerase chain 
reaction (PCR); digestion of the pHKY603 plasmid with appropriate restriction enzymes to produce 
a specific digest pattern; and SDS-PAGE of the cellular fractions (supernatant periplasm, soluble 
cytoplasm & insoluble cytoplasm) to visualize if a protein of the correct molecular weight was being 
overexpressed. Sequencing would have provided the most direct method of inspection, but was 
delayed until PCR results demonstrated that the primers used could generate a signal from 
pHKY603 as the sequencing process would be dependant upon this reaction unless universal 
pBR322 primers were acquired.
The initial reaction conditions were set as standard for a 1kb gene (Sambnook et a/., 1989): 
Template (from frozen plasmid preparation run on a 0.8% agarose gel previously to confirm quality) 
= approx. 20-50ng in 1|jJ. The PCR product was left unpurified and was run on a 1.2% agarose gel 
& visualized using EtBr. Using the custom positive & negative sense primers described in Methods, 
3.2.6, a product of approximately 700bp (723bp exact calculated length) was expected.
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No signal was detectable from the first two reactions but initial failure in the amplification of 
a gene is not uncommon, as variables such as the nature & source of the target gene, the supplier 
of the various reagents and the sequence (length & predicted secondary structure) of the primers 
can all require that the optimal reaction conditions be determined empirically. Easily adjusted 
elements include the total salt concentration in the reaction, the annealing temperature and the 
concentration of the template plasmid and so each of these was varied in turn with simple 
continued aim of verifying the rtrypsinogen gene. In each experiment the reaction tubes were 
collected immediately after cooling from the final cycle and the putative product was then purified 
via spin column. Subsequent PCRs thus examined template concentration and salt levels in a 
combinatorial manner, with [template] ranging from 55ng to 0.5ng, and an [MgCh] of between 
0.5mM and 3mM. Still no signal was obtained, despite the effectiveness of ail reagents being 
confirmed by the amplification of a control plasmid. The final experiment involved the alteration of 
the annealing temperature for low stringency in the hybridisation step, the result of which can be 
seen in Figure 3-5.
115
Chapter 3: Initial ELTRP-1 characterisation & fermentation work Edward Hibbert
PCR products 
4 3 2 1
p 500bp
400bp
300bp
•Mr- . ■ 200bp
100bp
* •  •
Figure 3-5: PCR products from r-trypsinogen on pHKY603 amplified using varying annealing 
temperatures
1.2% agarose gel was run at 100V, 120mA, 1.5hrs. Primers P & N have predicted TmS of 64.2 & 67 
respectively. Lanes: 1 -  Annealing temp, of 50°C; 2 -  Ta of 55°C; 3 -  Ta of 60°C; 4 -  Ta of 64°C.
Thus no alteration in reaction conditions resulted in amplification of the r-trypsinogen gene and 
attention turned towards the confirmation of plasmid identity by means of digestion at unique sites 
to create a signature fragment pattern.
Cutting of pHKY603 using two unique restriction sites, at least one of which should lie 
within the target gene would constitute a definitive test for strain identity. The enzymes selected 
were Sal I (approximately midway through the tetracycline resistance gene, see Figure 3-1) and 
Sac I (398 nucleotides into rtrypsinogen). A plasmid-free version of the ELTRP-1 strain, termed 
RV308, was received from Eli Lilly at this time for future use as a transformation host. The strain 
was grown in LB @37°C, 200rpm for 16 hours and then the culture was subjected to the MiniPrep 
procedure in order to confirm that no plasmid was present.
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Figure 3-6: Double digestion of pHKY603
Digestion of pHKY603 with Sal I & Sac I and also plasmid purification from RV308.0.8% agarose 
gel was run at 100V, 120mA, 1.5hrs. lanes: 1 -  plasmid purification from RV308; 2 -  90ng 
supercoiled pHKY603; 3 -  pHky603 digested with Sal I; 4 -  pHKY603 digested with Sac I; 5 -  
pHKY603 digested with Sal I & Sac I.
From Figure 3-6, it seemed evident that while digestion with Sal I had linearised the plasmid (easily 
visible when compared to the supercoiled signal), digestion with Sac I had no effect and the double 
digestion produced only linearised plasmid instead of the two bands (1220bp & 5040bp) which 
were predicted. The cutting of Sal I within the plasmid as expected seems to confirm the presence 
of the tetracycline resistance gene, although this had already be proved by the resistant phenotype 
of the strain. The failure of Sac I to cut, although according to Eli Lilly documentation it is situated 
within r-trypsinogen, provided further evidence that the false strain had been received.
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3.3.4 SDS-Page analysis of protein expression
An SDS-PAGE gel of the total cellular protein at various stages of an ELTRP-1 fermentation was 
used to directly check for overexpression upon induction. The culture was grown in LB and induced 
at the end of exponential growth. Samples were taken hourly for seven hours after the restrictive 
temperature was reached and the weight of the constituent proteins were analysed by comparison 
with commercial trypsin. No protein bands were visible that were not also present in the uninduced 
lanes and thus the experiment cast further doubt onto the identity of the strain.
The final characterization experiment involved a total protein SDS-PAGE comparison 
between ELTRP-1 and RV308 cultures in LB, both of which were raised to induction temperature at 
the end of logarithmic growth. The RV308 strain had been shown to carry no plasmid of any size 
and was documented by Eli Lilly to produce no genome encoded comparable proteases to trypsin.
118
Chapter 3: Initial ELTRP-1 characterisation & fermentation work Edward Hibbert
________ELTRP-1_______  ________ RV308_________
1_____  2 3 4______ 5__  6 7 8 9 10 11
'*■ ' : i f
Figure 3-7: SDS-PAGE of total protein from induced ELTRP-1 & RV308 cultures
15% acrylamide gel with 4% stacking gel, run @ 80V for 40min then @ 150V for 120min. Both 
cultures grown in LB for4hrs @ 32°C, 200rpm, then raised to 37°C. Lanes: 1 -  15pg commercial 
trypsin; 2 -  7.5pg commercial trypsin; 3 -  ELTRP-1 (To- immediately prior to induction); 4 -  
ELTRP-1 (T2-  2 hours after induction); 5 -  ELTRP-1 (T4); 6 -  ELTRP-1 (T6); 7 -  RV308 (T0); 8  -  
RV308 (T2); 9 - RV308 (T4); 10 - RV308 (Te); 11 -  7.5pg commercial trypsin.
The size markers in lanes 1,2 & 11 failed to run correctly, most likely due to overlong storage of 
the trypsin stock solution and thus the occurrence of advanced autoproteolysis. Nevertheless, no 
unique bands were visible in the ELTRP-1 samples, giving an identical banding profile to that of 
RV308.
The strain of ELTRP-1 received on 28.9.’00. could thus be said to have failed every 
conveniently available identity test for the presence of the r-trypsinogen gene. While exhibiting 
tetracycline (plasmid encoded) and streptomycin (genome encoded) resistance, the plasmid was 
approximately a kilobase below the expected 6kb, it then failed to cut in a manner consistent with
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pHKY603 and the strain did not appear to overexpress any protein specifically upon induction. A 
further direct identity check would have involved attempting to sequence the region of the plasmid 
believed to contain r-trypsinogen using the P & N oligonucleotides. As these closely flanked the 
gene even a successful reaction would only have achieved good resolution over the center of r- 
trypsinogen, but this would have enough to confirm its presence. However, as the PCR 
experiments had failed to produce a product under any condition, it was believed that attempting to 
optimise a sequencing reaction would prove futile. A toll copy of all details was sent to Eli Lilly, 
Fergersheim, and, after a review period, a second ELTRP-1 stab culture was dispatched.
3.3.5 Receipt of new ELTRP-1 culture
On the 23rd February 2001 a new stab culture of ELTRP-1 was received from Eli Lilly. The new 
stock was immediately cultured & preserved in the same manner as the original. From cultured 
isolates from selective plates (tc+, sV) the identity of this strain was queried by means of agarose 
gel electrophoresis of the purified plasmid, double-digestion with Sail & Sac I and SDS-PAGE of 
induced culture. Product can be seen in Figure 3-8 overleaf).
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Figure 3-8: Agarose gel of pHKY603 from new isolates plus Sal I & Sac I digest products
Lanes: 1- 5pl pHKY603 (isolate 1a); 2 - 5pl pHKY603 (isolate 1b); 3 -  20pl digestion mix: pHKY603 
from ‘1b’ with Sal I; 4 - 20pl digestion mix: pHKY603 from ‘1b’ with Sac I; 5 - 20pl double digestion 
mix: pHKY603 from ‘1b’ with Sal I & Sac I; 6 -  5pl pHKY603 (isolate 2a); 7 -  5pl pHKY603 (isolate 
2b); 8 -  20pl digestion mix: pHKY603 from ‘2b’ with Sal I; 9 - 20pl digestion mix: pHKY603 from 
‘2b’ with Sac I; 10 - 20pl double digestion mix: pHKY603 from ‘2b’ with Sal I & Sac I
The supercoiled purified pHKY603 samples were of the correct molecular weight (approximately 
6kb) with the relaxed form visible immediately above. The plasmid appeared to be linearised after 
digestion with Sal I or Sac I and the double digestion yielded 2 bands of approximately the correct 
size (direct sizing not possible due to the linear nature of the cut DNA and the supercoiled marker). 
The DNA from isolate 2b appeared of comparatively high quality and so this isolate was selected 
for further work. To search for overexpressed protein after induction the culture was grown and 
induced as before and fractionated 4 & 6hrs after induction.
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Figure 3-9: SDS-PAGE of fractionated ELTRP-1 culture 6hrs after induction
15% acrlyamide gel with 4% stacking gel, run @ 80V for 40min, then @ 150V for 90min. Lanes: 1 
-  7.5ug commercial trypsin; 2 -  3.75pg commercial trypsin; 3 -  15pl total protein soln. (T6 -  6 hrs 
after induction); 4 - 15pl total protein soln. (T4 -  4hrs after induction); 5 -  15pl soluble fraction (Te); 
6  - 15pl soluble fraction (T4); 7 -  15pl insoluble fraction (Te); 8  - 15pl insoluble fraction (T4); 9 -  
3.75pg commercial trypsin.
From Figure 3-9, overexpressed protein, of approximately the correct molecular weight (24.2 kDa) 
could clearly be seen in the insoluble fraction of the induced cells.
23kDa-
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Figure 3-10: Agarose gel showing PCR products from pHKY603 under conditions of 
increasing [MgCfe]
1.2% agarose gel run @ 100V, 120mA for 1 hr. 17.7ng Plasmid MiniPrep used for each reaction. 
Annealing temp, of 55°C used. In each lane the concentration of MgCI2 was altered (25mM stock, 
final reaction volume of 100pl). Lanes: 1 -  OmM MgCfe; 2 -  0.2 MgCI2; 3 -  0.4mM MgCb; 4 -  
0.6mM MgCI2; 5 -  1mM MgCI2; 6 -  1.2mM MgCI2; 7 -  1.6mM MgCI2; 8 -  2mM MgCI2; 9 -  2.4mM 
MgCb; 10-2.6mM MgCb; 11 -3m M  MgCI2.
From Figure 3-10, strong signal of the correct size (723bp expected weight of product) was visible 
at two distinct salt optima. A comprehensive activity test measuring signal in the presence of lysis 
& denaturing agents was performed on induced ELTRP-1 culture. Readings were blanked against 
those from uninduced culture in the presence of the identical reagents. Results can be seen in 
Figure 3-11, refer to Section 3.2.5 for exact protocol.
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Figure 3-11: Activity of ELTRP-1 on 1mM L-BAPNA in various conditions, 4hrs after 
induction
Cultures were grown at 37°C. 200rpm, and induced after 3hrs (A6oo = 0.85, blanked against 
uninfected medium). All samples were incubated at room temperature with the various reagents & 
gently shaken to prevent settling. Addition of substrate was performed immediately prior to reading. 
All activities were calculated after blanking against the specific uninduced sample blank. All 
experiments were performed at least in triplicate.
Experimental Key (From Figure 3-11). U (nmol pNA 
released*min-1 /ml-1
Upper graph:
Basic activity (no lysis, no denaturant): Induced culture + L-BAPNA A  (—■—) 1.91 x K T 6
Periplasmic activity: Induced culture + L-BAPNA + 0.5ng/mi 
lysozyme B (—* - ) 2.48 x  10‘5
Total soluble activity: Induced culture + B-PER + L-BAPNA. C (  ) 1.58 x  KT4
Insoluble activity: Induced culture + B-PER + 200pg/ml lysozyme + 
0.1 M urea + L-BAPNA D ( - o - ) -1.83 x  10'4
Insoluble activity: Induced culture + B-PER + 200jig/ml lysozyme + 
0.5M urea + L-BAPNA E (■-—-) 8.20 x  10‘5
Insoluble activity: Induced culture + B-PER + 200ng/ml lysozyme + F ( — ) 1.87 x  10"4
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1M urea + L-BAPNA
Insoluble activity: Induced culture + B-PER + 200jig/ml lysozyme +
2M urea + L-BAPNA G (-■■■) -3.57 x 10^
Insoluble activity: Induced culture + B-PER + 2(%g/ml lysozyme +
5M urea + L-BAPNA H ( —0 —) 2.05 x 10^
Lower graph:
Control: 0.5^g commercial trypsin. ■ H *-> -3.37 x 10^
Control: 1|ig commercial trypsin. J ( ) 4.15 x 10"4
Control: 2pg commercial trypsin. K ( - * - ) 1.34 x 10^
Control: 5^g commercial trypsin. L(— ) 5.31 x 10-3
3.4 Discussion
3.4.1 Strain identity
Eli Lilly provided no details that could explain the mis-performance of the first strain received. If it is 
assumed that the culture was correct when dispatched then the only explanation would be that the 
plasmid picked up a number of critical mutations before the glycerol stocks were made. A point 
mutation within the gene could distort the Sac I site and, if either an insertion or deletion could 
disrupt the reading frame of the protein, likely leading to early termination. A mutation forming a 
premature stop codon would have the same consequence, although neither of these theories 
would explain why the plasmid appeared approximately 1 kb smaller than expected and also why 
the PCR consistently failed even under low stringency conditions. The spontaneous deletion of a 
significant portion of the gene could account for both results but would seem highly unlikely given 
the short time elapsed between receipt of the culture and the creation of stocks.
The two most likely explanations for the behaviour of the behaviour of the first ELTRP-1 
strain were: a) that the strain received was a control strain used by the Eli Lilly molecular
biology department, i.e. the plasmid was in its ‘pre-alteration’ state, correct in all essentials but 
without the addition of met-phe-trypsinogen. Such a strain (RV308:pBR322 variant) could have 
been shipped due to a confusion about the nature of the project
b) That the glycerol stab cultures shipped were heterologous in composition, 
containing control variants and deletion mutations in suspension along with ELTRP-1. One of these 
could thus have been selected for the basis for this work due to identical resistances & 
(presumably) growth rates. It should be noted that, before returning to the company with the 
request for a second shipment of ELTRP-1, the original stocks were cultured three times, with
125
Chapter 3: Initial ELTRP-1 characterisation & fermentation work Edward Hibbert
random colonies selected for propagation, in an attempt to culture a strain with the correct 
characteristics.
3.4.2 Testing for soluble r-trypsin
The Eli Lilly assumption that all expressed r-trypsinogen was sequestered as inclusion bodies, with 
none reaching either the cytoplasm or periplasm, or leaking into the supernatant upon individual 
cell death was shown to be correct The metabolic load placed upon the culture on induction was 
shown to temporarily depress growth, but overnight fermentation allowed the cell density to 
achieve the same level as the uninduced control, showing that no autotoxicity was evident. A 
degree of autotoxicity may possibly be expected if even minute quantities of correctly folded and 
thus soluble & active trypsinogen were expressed into the soluble fraction. In mammalian cells, the 
route of activation of the zymogen is via enterokinase secreted from the surfaces of the pancreatic 
cells, however autoproteolysis, and thus autoactivation will occur at a comparatively slow but 
appreciable rate (Fersht, 1999).
The inflexibility in the expression vector (essentially a simple on-off switch, with no 
gradation possible) relates to its function as an industrial production strain. The heat-activated 
promoter allows a simple, cost effective mechanism of induction without the addition of reagents to 
the primary vessel, but was designed for maximal yields of an inactive & insoluble protein.
The total lack of trypsin activity present in the soluble fractions of the ELTRP-1 cultures 
made it seem unlikely that any increase in solubility could be effected by simple alterations in 
fermentation conditions. The nature of the promoter meant that, essentially, the only parameter that 
could be altered was the point of induction, but initial work in this direction (induction after 2hrs in 
LB, the beginning of exponential growth) had shown this to be an unpromising approach. Two lines 
of research presented themselves for the problem of generating soluble, active protein by simple 
methods suitable for a high-throughput screen, these were: a) the design of a microplate-based 
procedure for the solubilisation & refolding of r-trypsinogen (see Chapter 4); and b) the use of 
molecular methods to attempt to engineer translocation to the oxidising environment of the 
periplasm by means of a signal sequence, or transfer of the gene to a vector with a more flexible 
promoter system (see Chapter 5).
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3.5 Conclusions
The now successful amplification, coupled with the plasmid size & digestion and, crucially, the 
apparent overexpression of a 24kDa protein upon induction, all suggested that the strain was a) 
the Eli Lilly commercial production strain ELTRP-1 and; b) was genetically dissimilar to the first 
strain tested.
Fractionated SDS-PAGE (Figure 3-9) indicated that protein was accumulating as insoluble 
inclusion bodies in the course of a standard fermentation. Comprehensive activity testing revealed 
no active enzyme in any fraction, and the rigid induction controls (linked to growth conditions) gave 
no indication that this could be altered.
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4 High-throughput refolding of r-Trypsinogen from 
ELTRP-1
4.1 Introduction
4.2.1 Aims
The failure to achieve active r-trypsin from the soluble fraction of ELTRP-1 (Chapter 3) left only two 
choices available: the use of an alternative expression strain which would allow for comprehensive 
manipulation of fermentation conditions; or the development of a high-throughput methodology for 
the solubilisation and refolding of the insoluble protein. Eli Lilly had specified that they would prefer 
all options with the original host strain to be exhausted before alternative vectonhost systems were 
explored, and so work proceeded with the aim of standardising a microplate-based refolding 
screen for trypsin activity.
4.2.2 Inclusion body formation by recombinant proteins
In the early nineteen seventies, C.B. Anfinsen published a series of experiments which established 
as fact one of protein sciences’ then most promising theories (Anfinsen, 1973). He demonstrated 
the reversible denaturation of two small proteins, namely ribonuclease A and staphylococcal 
nuclease, specifically their spontaneous refolding into an active conformation after chemical or 
thermal denaturation in the absence of any additional cellular protein. This proved that the 
information for both the activity and folding pattern of these simple structures was encoded within 
their amino-acid sequence, seemingly providing a neat path fiom the native protein back through 
the primary sequence to the gene itself. The folding of native and recombinant proteins into desired 
conformations is of major significance to the modem bio-industries, and over two decades of work 
has shown that, if a set of general principles does exist by which proteins encode their individual 
folding pathways, then its complexity and interactions with the native environment defy a simple, 
universal set of guidelines (Dobson, 2000).
In a prokaryotic expression system, the formation of inclusion bodies by a recombinant 
protein is a precipitation reaction indicating extreme mis-folding of the nascent polypeptide. Simply
#
put, recombinant proteins enter such a state as they have evolved to fold into their correct 
conformation within a specific set of native conditions, and these conditions are frequently
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incompletely met in their new host. Examples of such conditions would be the absence of specific 
chaperone groups (Leroux and Hartl, 2000), the absence of required modifying or translocation 
pathways (Kohno, 1990), the overexpression of the protein at a temperature higher than that of its 
native strain (Kohno, 1990), and attempting to told an extracellulariy-targeted protein within the 
reducing environment of the cytoplasm (Creighton, 2000). In certain circumstances, conditions may 
be deliberately manipulated to produce an accumulation of insoluble, inactive enzyme, as 
eukaryotic proteins can frequently prove toxic to bacterial systems in overexpressed 
concentrations. From an engineering perspective the formation of inclusion bodies can prove 
beneficial as these highly concentrated and relatively pure protein granules can be easily purified 
as the insoluble fraction from a fermentation culture.
In designing an industrial strategy for isolating & refolding a recombinant protein that has 
precipitated into inclusion bodies, there are three steps to consider. Firstly, the protein aggregates 
must be at least partially purified by centrifugation, and then solubilised in a suitably denaturing 
solution. The second step required that the solubilised protein be diluted into an environment that 
favours the formation of the native, active structure. Finally, as no biological process, particularly 
an artificially induced one involving many thousands of potentially stable transition states, can ever 
be 100% efficient, a method is required by which the residual, partially incorrectly folded protein is 
removed. An example detailed in this thesis would be the refolding and purification of biosynthetic 
human insulin, discussed in Section 1.8.4.
Cytoplasmic solubility of recombinant proteins has been achieved via random mutagenesis 
where the substituted amino acid was a hydrophobic and/or bulky surface-exposed loop residue 
but this approach is uncertain by definition. Successful rational approaches include the use of 
fusion proteins, e.g. thioredoxin (enhance solubility and ease of purification) or signal-sequence 
tags (e.g. hisJ, pelB) which cause the polypeptide to be translated into the oxidative environment of 
the periplasm; stimulating co-overexpression of chaperone proteins via a particular stress- 
response (e.g. heat, starvation); and lowered rates of expression (Kim, 1999; Kohno, 1990; Kung, 
1990).
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4.2.3 Strategy required for processing of r-Trypsinogen from ELTRP-1 culture
In the ELTRP-1 strain, the inflexible two-state promoter precluded any improvement in the solubility 
of r-Trypsinogen by means of reducing expression or fermentation temperature (as discussed in 
Chapter 3) and thus a simple solubilisation and refolding protocol was sought, based upon that 
already in use by Eli Lilly (Buswell etal., 1995). While a method comprising of all the three steps 
mentioned in the above section posed no problem for large-scale industrial cultures, a high- 
throughput microplate-screen demanded both a simple and reproducible assay, and dilution steps 
into secondary plates increase both experimental errors and processing time. The limitations 
imposed upon the method by the need for a high-throughput screen were that a minimum of 
process steps and dilution-replica plates be used and, equally significantly, that all processing of 
the sample be done within a microwell format. This severely limited the number of techniques by 
which the inclusion bodies could be purified from the other cellular fractions and fragments, 
effectively blocking the use of filtration and limiting centrifugation to the force that could be 
withstood by a microplate. The sensitivity of the L-BAPNA assay was also an issue, with the 
production levels of r-Trypsinogen from ELTRP-1 not yet established and a possible progressive 
series of dilutions necessary to allow correct folding, it was essential to monitor protein 
concentration at each step to ensure that it remained within detectable limits.
4.2.4 Eli Lilly protocol for rTrypsin purification, solubilisation & refolding
The industrial protocols by which Eli Lilly isolated & cleaned the inclusion bodies from an ELTRP-1 
fermentation, and detailing the solubilisation and subsequent refolding of rTrypsin were not 
released for reasons of confidentiality. The composition of the solubilisation & refolding buffers 
could be inferred from a paper written by a chief Eli Lilly engineer in association with the University 
of Cambridge (Buswell etal., 1995). Inclusion bodies formed of recombinant trypsinogen were 
solubilised in a urea buffer (5.5M urea, 10mM EDTA, 100mM cysteine, pH 9.5,8°C) for 1hr. 
Refolding was initiated by injection of solubilised material into a 100ml reaction vessel with a 4- 
blade Rushton impeller containing the refolding buffer (50mM CaCfc, 5mM Tris, 3mM cysteine,
1mM cystine, pH 9.0,8°C). The study was designed to test the importance of mixing as a 
parameter in the refolding process, varying the impeller between 60 and 300rpm. Their results 
showed that the speed of the impeller did not appear to affect the yield of native trypsinogen, but
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that the yield was improved by increasing the concentration of solubilised trypsinogen in the initial 
buffer. Significantly, it was not mentioned in the paper to what degree the inclusion bodies were 
purified prior to solubilisation, and also the dilution factor used for the refolding work was not 
stated. In these apparently optimised conditions, the researchers achieved a yield of native 
trypsinogen of 11.0 -11.6% (on stirring range of 60-300rpm) from a solubilisation buffer of 
1.4mg/ml pure trypsinogen. When the concentration in the solubilisation buffer was increased to 
2.8mg/ml, the refolding yield rose to 13.6 -14.5%. The dilution factor was altered according to the 
concentration of solubilised protein so that the final concentration of enzyme in the refolding buffer 
was held at 60pg/ml. The team concluded that the denaturant (urea) had possibly a negative 
impact on the refolding of the zymogen and that an increased dilution factor was thus beneficial.
4.2.5 Solubilisation & refolding strategies
Insoluble aggregates of overexpressed proteins can be solubilised by a variety of denaturing 
agents. The use of elevated temperatures, detergents and high concentrations of inorganic salts or 
organic solvents have been proven as effective agents in breaking down most forms of secondary 
or tertiary organisation in a protein, resulting in a soluble, disorganised polypeptide (Fersht, 1999). 
Low or high pH has also been used, possibly acting to increase electrostatic repulsion between 
protein molecules, thus discouraging aggregates (Kohno etal., 1990). The 'denaturing strength’ of 
an agent varies with the individual nature of the molecule, but as a rough guide, the following may 
be arranged in order of decreasing effectiveness: Guanidinium chloride (GdmCI)>urea>SDS>high 
temp>pH shock>high hydrostatic pressure. The presence of a strong reducing agent is also 
necessary to ensure full disassociation of all disulphide bonds, and DTT or p-mercaptoethanol is 
usually employed in millimolar quantities.
The key requirements for the refolding of a protein to be initiated are that aggregates have 
been dissolved and that all disulphide bonds have been oxidised. The denaturing agent would then 
be removed by means of dialysis or progressive dilution and the redox conditions of the buffer 
changed so as to encourage dynamic interactions between cysteine residues. Disulphide bonds 
act to stabilise tertiary structure and thus conditions should allow them to form as the protein 
passes through transition states, but each cysteine could conceivably bond with any other, holding 
the protein in mis-folded state, and thus a couplet of reduced & oxidised thiols would be used to
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promote the exchange of bond partners. The appropriate ratio of the disulphide pairs and their 
oxidised counterpart must be determined empirically. Commonly used conjugate thiols include 
oxidised glutathione (GSSG) & glutathione, cysteine & cystine, and reduced & oxidised DTT.
Solubilisation methodologies
Initial work focused on using GdmCI as the denaturing agent for the inclusion bodies of 
rTrypsinogen derived from ELTRP-1 culture. Standards of commercial trypsin added to the buffers 
then demonstrated near total loss of activity, indicating that GdmCI was a potent inhibitor of bovine 
trypsin. The reason for this effect was obvious upon study of the molecules’ structure, as it possess 
a strongly basic guanidinyl group, identical to the side-chain of arginine, and it is this moiety which 
binds to the base of the substrate pocket of the enzyme. While extensive dialysis could possibly 
have removed the GdmCI from the enzyme-inhibitor complex, depending on the strength of the 
salt-bridge formed, fora microplate-based assay the molecule had to be considered an irreversible 
inhibitor and subsequent work focused on the use of urea as the denaturant
The solubilisation step was not believed to be temperature sensitive, but the procedure 
was done at 8°C so as to imitate the work done by Buswell et al. (Buswell et al., 1995). Factors to 
be investigated in this step were the optimal concentration of solubilised protein and the 
effectiveness of the buffer at solubilising relatively crude inclusion bodies from bacterial culture.
Although the final form of the assay was to be fully microplate-based, and could thus 
involve no purification steps, i.e. the inclusion bodies would not be able to be separated from the 
cellular lysate before addition of the solubilising buffer, for the initial experiments it seemed 
sensible to work with cleaned inclusion bodies. Successful optimisation of solubilisation and 
refolding protocols for purified and washed inclusion bodies would be taken as proof of concept for 
the refolding of partially purified recombinant trypsinogen.
Refolding methodologies
Temperature was known to be a critical factor in the kinetics of protein folding and the work was 
thus performed at 8°C and room temperature for comparison. Additional factors, which needed to 
be investigated in this step, were optimal dilution factor for the solubilised protein and also the rate 
of protein loss at low concentrations. Early work had shown a slight, but steady, loss in protein in
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the microwells over time. This problem was insignificant prior to the dilution step, but after dilution, 
when protein concentrations were near the lower detection limits for the activity assay, any loss 
needed to be minimised. Two alternative plates were thus investigated in addition to the work done 
in the standard plastic microplate. One was the standard Starstedt plate which was blocked (in a 
manner similar to the blocking of a plate prior to an ELISA) by incubation overnight at room 
temperature with a 1 mg/ml powered milk solution. The second plate tested was an Ultra Low 
Binding plate (Colstar), the wells of which were coated with a high-water content gel so as to 
minimise protein adsorption to the plastic.
4.2.6 Importance of co-factors in protein refolding
A successful in vitro refolding process is one in which the researcher successfully provides the 
solubilised protein with conditions which mimic those of its native environment While in particularly 
intractable cases this may involve the addition of chaperone proteins, the literature shows that, in 
the main and when coupled with a suitable dilution step, the approximation of the appropriate 
chemical environment and careful manipulation of the redox balance is sufficient to retold a 
proportion of the solubilised protein. Simple and inexpensive methods for improving the yield by 
approximating the host environment can include adding trace amounts of the enzymes’ natural 
substrate to the buffers, empirical adjustment of pH, ensuring that any incorporated metal or 
mineral ions are present in excess and adding simple sugars and amino acids to the mix. The 
presence of a high-affinity calcium ion binding loop in bovine trypsinogen and the ion’s documented 
importance for the conformation of the molecule (Bode and Schwager, 1975) dictate that calcium 
chloride, or an alternative source, be present in a refolding buffer. Optimal quantity appears to have 
been determined empirically in each case but is always in concentrations of 50mM or higher.
The second strategy for the improvement of in vitro refolding yields is to experiment with 
the addition of certain small organic and inorganic molecules, solvents and surfactants, which, 
while not an attempt to predict the cellular environment, have been reported to interact favourably 
with solubilised large molecules. The effects involved are frequently ill defined but it seems likely 
that most act to negate charges on molten loops & domains, overcoming repulsion effects in 
secondary and tertiary structure which could bar the molecule from certain transition states, and 
possibly minimising attractions between molecules, thus limiting aggregation. Literature suggests
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that all these chemicals are highly specific in which protein refolding reactions they assist, acting as 
retardants with structurally similar proteins, and also that interactions between co-factors can 
dramatically enhance or depress effects Favourable co-factors must thus be determined 
empirically for the molecule of interest, with a factorial screen, in which the effects of each potential 
combination are analysed, being both the simplest and the most comprehensive method available.
4.2.7 Fractional & fully-factorial analysis of co-factor interaction
This section of the work was performed with James Myers, another EngD student from the 
Department of Biochemical Engineering, UCL, and built upon similar co-factor studies that he had 
performed using commercial lysozyme.
Design of the fractional and fully factorial screens was performed using Minitab, version 
13.32 (Minitab Inc.). 11 potentially beneficial co-factors were identified from the literature and their 
individual effects and combined interactions were evaluated using a 2-level fractional factorial 
screen, i.e each factor was screened at 2 levels of concentration (1 & 0): a molarity which had 
proved to be beneficial in similar work and in their absence. A full factorial analysis of the 
interactions of the 11 factors would require 211 = 2048 separate experiments, a prohibitive number 
of runs even for a microplate based assay. A fractional factorial screen can reduce the number of 
runs in two ways, the first being to exclude certain factor-level combinations. This leads to certain 
results being approximated from analysis of related results sets and thus not being able to be 
evaluated independently. Co-dependant results such as these are said to be aliased, and the 
overall term is that certain aspects of the data set are confounded. The second method involves 
limiting the resolving power of the design, by exploring only the lowest orders of interaction, i.e. 
only interactions of two or three separate factors at a time would be tested. The potential beneficial 
effects brought from a combination of 4 or 5 factors would not be detected by such a screen, but 
the lower order data would be free of confounding effects.
For the 11 factor initial 2-level screen used here, only first order interactions were 
examined, i.e. no more than two factors tested in each experiment and, as the two-level design 
simply analysed the presence or absence of each factor, many of the potential interactions could 
be deduced from the control runs, further condensing the number of runs required. The final design
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required 72 well experiments, performed as per section 4.3.6. Main effect & interaction plots 
against enzyme activity were generated using the Minitab programme.
4.3 Methods
4.3.2 Fermentation & induction of ELTRP-1
Conditions were held identical to those used in Chapter 3. Briefly, these were as follows. A single 
discrete colony was used to inoculate a 100mls of LB and M9SD in 500ml baffled shake-flasks (tet 
10|o,g/ml, strep. 100pg/ml). These were then grown at32°C, 200rpm until the end of exponential 
growth (LB: 4hrs, blanked ODeoonm of approximately 1.5; M9SD: 6hrs, blanked ODeoonm of 
approximately 1.0), whereupon the temperature was raised to 37°C, 200rpm. The fermentation 
was then allowed to proceed overnight for approximately 16hrs.
4.3.3 Solubilisation protocol
The solubilisation buffer composition was derived from previous Eli Lilly work and also from 
additional literature (Buswell etal., 1995; Fersht, 1999). Solubilising buffer(1x): 5.5M Urea, 100mM 
DTE, 10mM EDTA, pH 9.5. All reagents purchased from Sigma. The inclusion bodies were 
obtained and washed as follows. Cells from 1ml of induced overnight cultures of ELTRP-1 were 
pelleted by centrifugation at 13,000rpm for 15min at room temperature. The cells were then lysed 
by resuspension in 100jJ neat B-PER and, after being allowed to stand for 10min with periodic 
agitation, were centrifuged again at 13,000rpm for 10min. For the initial work (Figures 4.1 - 4.3), 
this pellet was then resuspended in solubilisation buffer and diluted accordingly. For the second set 
of work (Figures 4.4 - 4.7), an attempt was made to purify the inclusion body fraction more 
thouroughly by means of repeated washings. The supernatant was disposed of and the pellet was 
resuspended in 100jxl B-PER (at a 1:4 dilution with MilliQ water) and then re-pelleted under 
identical conditions. Finally the pellet was resuspended in either 100^ 1 or 50jil of solubilising buffer 
and allowed to stand for 1 hour at 8°C, with occasional vortexing. Protein concentration was 
measured by reading at A280, blanking against sterile buffer.
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4.3.4 Refolding protocol
The refolding buffer was derived from the same sources as the solubilising buffer (Buswell et al., 
1995; Fersht, 1999) and was composed as follows. Refolding buffer (1x): 5mM Tris, 50mM CaCb, 
1mM GSSG, 10mM Glutathione, pH 9.0. All reagents purchased from Sigma. Prior to refolding, the 
low-binding plates (Colstar) were allowed to soak in refolding buffer for 2hrs at room temperature. 
To initiate refolding, an aliquot of the solubilised protein would be injected into the refolding buffer. 
The dilutions used for this work were 1:30 & 1:60 and so typically, 20pJ of protein solution would be 
added to 580|xl or 1180pJ of refolding buffer. Care must be taken that, after dilution, the 
concentration of protein remained within the minimum detection level of the L-BAPNA activity 
assay. In an optically clear solution, which did not act to impair trypsin activity, enzyme 
concentrations of 1 pg/ml could be easily detected over a 10 minute period on 1mM L-BAPNA (see 
Chapter 2). The temperature at which refolding occurred was typically held at 8°C, but higher 
temperature were also experimented with (indicated at specific points within Results).
Refolding was allowed to proceed for a number of hours, with samples being taken for 
assaying usually after 2,4 & 16 hours. Protein concentration was recorded at each step by reading 
at A280 as before.
4.3.5 Activation and assaying
Samples of possibly refolded r-trypsinogen needed to be activated by removal of the prosequence 
prior to assaying. The prosequence was removed by addition of either commercial trypsin (to a 
final concentration of 0.5^g/ml) orenterokinase (to a final concentration of 5jj,g/ml). Both enzymes 
were purchased from Sigma. Samples were then allowed to stand for 5 minutes at room 
temperature before mixing with a 2x substrate solution of 2mM L-BAPNA (Sigma). Reading 
proceeded immediately at Atos, blanking against substrate buffers with activating enzymes added. 
In the experiments depicted in Figure 4-2 - Figure 4-5, concentration of enzyme in sample was 
determined by running a range of standards of commercial trypsin in the refolding buffers, but it is 
important to note that these standards were not subjected to the refolding process. The 
concentration of active enzyme detected in these experiments has been multiplied by the dilution 
factor to allow direct comparison, in terms of refolding yield, with the initial solubilised protein 
concentration.
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4.3.6 Experimental procedure for co-factor evaluation
The effects of the following cofactors were evaluated on the refolding of pure, commercial trypsin 
(Sigma): L-Arginine (Sigma), stock solution = 0.574M, used at 0.250M; Ammonium sulphate 
(Sigma), stock solution = 1.136M, used at 0.5M; Sucrose (Sigma), stock solution = 0.876M, used at 
0.250; Glucose (Sigma), stock solution = 0.832M, used at0.5M; Glycerol (Sigma), stock solution = 
0.217, used at 0.05M; PEG300 (Sigma), stock solution = 0.067M, used at 0.0201 M; PEG3350 
(Sigma), stock solution = 0.006M, used at 0.00201; Ethanol (Sigma), neat stock, used at 20% v/v; 
L-BAPNA (substrate)(Sjgma), stock solution = 3.33M, used at 0.333M; 2-Pentanol (Sigma), stock 
solution = 0.114M, used at 0.01 M; Cyclohexanol (Sigma), stock solution = 0.101M, used at 0.01 M.
For each experiment, commercial trypsinogen (1 mg/ml in MilliQ water) was solubilised in 
the solubilisation buffer (Section 4.3.3 above) @ 17°C and was allowed to stand for two hours.
30pJ of the enzyme solution was added to each buffer well (filled to a volume of 300jjJ) and 
enterokinase (Eli Lilly) was added to a final concentration of 1 mg/ml. The wells were allowed to 
stand for 5% hours @ 17°C with occasional gentle agitation to prevent settling. Activity assays 
were performed by the addition of 100pJ of well solution to 100^ 1 of 4mM L-BAPNA and 
commencing reading absorbance at405nm immediately.
4.4 Results
4.4.2 Protein concentrations & activity after refolding
The interactions of initial inclusion body concentration, dilution factor (1:30,1:60,1:90 & 1:120) and 
temperature (8°C, 20°C) were investigated using methodologies described in Sections 4.3.3 & 
4.3.4. Care was taken that, after dilution into refolding buffer, protein concentration did not fall 
below 6p,g/ml (3jj.g/ml being minimum detection limit of L-BAPNA assay). This limit was thought 
necessary as the ‘purity1 of the inclusion bodies was not known and this would allow trypsin activity 
to remain detectable if 50% of the aggregate was comprised of heterologous protein. One problem 
that became immediately apparent was the progressive drop in protein concentration over the 
course of the solubilisation and refolding incubations, due presumably to adhesion of protein to the 
plates, and thus the effects of using ‘blocked’ microplates and low-binding plates were investigated 
(See Section 4.2.5). Enzyme activity was calibrated by means of commercial enzyme standards
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run in refolding buffer, but these standards were not subjected to the solubilisation/refolding 
process, i.e. were added only immediately prior to assay.
No activity was detected from the inclusion-body bound recombinant enzyme under any of 
the solubilisation/refolding conditions tested. The concentration of solubilised inclusion-body of a 
1ml aliquot from a 100ml, 37°C fermentation, induced overnight ranged from 1.9-2.7mg/ml when 
solubilised in 50pl of buffer. The use of ‘blocked’ and low-binding plates did prevent protein toss 
from solution (see Figure 4-1) and the use of the blocked plates did not result in an increase in 
background noise of the assay (a possible consideration).
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Figure 4-1: Total protein concentration over 60-fold diln.
Investigation of protein concentration during a solubilisation & 60-fold dilution experiment at a 
variety of protein concentrations, and using blocked & un-blocked plastic microplates and the 
Costar low-binding plate. Key: ‘S’ refers to incubation time in solubilisation buffers, ‘R’ refers to 
incubation time in refolding buffers. A [ - * - )  = refolded in blocked plates, activated by 
enterokinase; B ( - o- )  = refolded in un-blocked plates, activated by enterokinase; C ( ° ) =
138
Chapter 4: High-throughput refolding of r-trypsinogen from ELTRP-1 Edward Hibbert
refolded in low-binding plates, activated by enterokinase. The experiment was performed at 8°C.
All expts. used the insoluble fraction from a ml of LB culture, resuspended in 100jjJ of solubilising 
buffer. Aliquots from all expts. activated by treatment with enterokinase before assaying. No activity 
was detected from any sample in this experiment and commercial trypsinogen added to blank 
(uninduced samples) and similarly processed also failed to generate signal.
In Figure 4-1, the average final protein concentration was in the region of 5.7|ig/ml, sufficient to be 
detected by the activity assay. No activity, however, was recorded from any of the samples taken 
at Refold 0 (approximately 2 minutes after dilution), Refold 2 (2 hours after dilution) & Refold 16 (16 
hours after start of refolding). Commercial enzyme standards run in the relevant buffers were 
unaffected.
4.4.3 Analysis of temperature, dilution & activation agent on process
Following the failure of this earlier work to generate any detectable signal from the recombinant 
refolded & activated trypsinogen, a semi-factorial series of experiments was planned to attempt to 
discover a viable set of operational conditions. Factors screened against each other were: the 
temperature of the process; the dilution factor of the refolding step; the concentration of the initial 
solubilised inclusion body sample; and the choice of activating enzyme. In graphs Figure 4-2,
Figure 4-3, Figure 4-4 & Figure 4-5, the process steps referred to are as follows: Initial 
solubilisation of the washed inclusion bodies (S); the sample immediately upon dilution into the 
refolding buffer (in realistic terms, at least 2-3 minutes would pass before assaying) (RO); then the 
time in hours from RO, i.e. R1, R2, etc. The activity in the four graphs represents the blanked 
activity detected, multiplied by the dilution factor. As only levels of trypsin activity fractionally above 
the baseline were detected, it was assumed that no significant levels of substrate hydrolysis were 
occurring above background noise, a fact confirmed by the fact that correcting for dilution factor 
resulted in a staggered profile in each case (Figure 4-2).
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Figure 4-2: Concentration of soluble inclusion bodies in a range of dilution factors for the 
refolding step
Key: A (-■ -) = solubilised concentration of 1-4mg/ml total protein, refolding dilution of 1:30; B 
( - * - )  = solubilised concentration of 1-4mg/ml total protein, refolding dilution of 1:60; C ( ) =
solubilised concentration of 1-4mg/ml total protein, refolding dilution of 1:90; D ( -o - )  = solubilised 
concentration of 1-4mg/ml total protein, refolding dilution of 1:120. All runs were held at 8°C for the 
duration of the experiment. Activity of active trypsin in the standards was established by 
comparison with a range of commercial trypsin standards added to the appropriate process buffers 
at the point of assay, i.e. the standards were not subjected to the solubilisation & refolding process. 
Dilution factors were corrected for in the determination of the enzyme concentration.
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Figure 4-3: Concentration of solubilised inclusion bodies vs. temperature of process 
Key: A (-■ -) = solubilised protein concentration of 1 mg/ml, refolded at room temperate (~ 20°C); B 
( - * - )  = concentration of 2mg/ml, refolded at room temperature; C ( ) = concentration of
3mg/ml, refolded at room temperature; D (—o—) = concentration of 4mg/ml, refolded at room 
temperature; E (--♦- ) = concentration of 1 mg/ml, refolded at 8°C; F ( ° ) = concentration of 
2mg/ml, refolded at 8°C; G ( )= concentration of 3mg/ml, refolded at 8°C; H ( )  =
concentration of 4mg/ml, refolded at 8°C. Concentration of active trypsin in the standards was 
established by comparison with a range of commercial trypsin standards added to the appropriate 
process buffers at the point of assay, i.e. the standards were not subjected to the solubilisation & 
refolding process. Dilution factors were corrected for in the determination of the enzyme 
concentration.
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Figure 4-4: Assessment of the effects of activation agents on the refolding of trypsinogen 
Key: A ( - * - )  = 1:30 refolding dilution, activated by trypsin; B ( - * -  ) = 1:30 dilution, activated by 
enterokinase; C ( )= 1:120 dilution, activated by enterokinase; D ( -o - )  =1:120 dilution,
activated by enterokinase. All experiments were held at 8°C for the duration of the process. 
Concentration of active trypsin in the standards was established by comparison with a range of 
commercial trypsin standards added to the appropriate process buffers at the point of assay, i.e. 
the standards were not subjected to the solubilisation & refolding process. Dilution factors were 
corrected for in the determination of the enzyme concentration.
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Figure 4-5: Solubilisation & refolding of commercial trypsin
Comparison of commercial trypsin standards subjected to refolding process with those added to 
the appropriate buffers at the point of assay. Key: A ( - * - )  = commercial trypsin solubilised at 
30^ig/ml; B ( - * - )  = commercial trypsin solubilised at 60jng/ml; C ( ) = commercial trypsin
solubilised at 90pg/ml; D (-□ -)  = commercial trypsin solubilised at 120^g/ml; E (--♦-•) = 
commercial trypsin solubilised at 300jig/ml. All experiments were held at 8°C and the dilution 
factor used for the refolding step was 1:60. Dilution factors were corrected for in the determination 
of the enzyme concentration
4.4.4 Refolding of recombinant trypsinogen
The series of experiments aimed to evaluate the process conditions required for the refolding of 
active recombinant trypsinogen from partially washed inclusion bodies purified from ELTRP-1 
fermentation met with very little success. Figure 4.1 was intended to demonstrate that the protein 
concentration in each experiment remained above the lower detection limit for the assay after the 
various dilution steps, despite generating no detectable signal. Figures 4.2 -4 .4  describe a second 
set of experiments, conducted with extensively washed inclusion bodies, where the interactions of 
temperature, one-step dilution factors and initial soluble concentration were extensively examined
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for any positive effect on the yield of refolded, active enzyme. Although trace activity levels, relative 
to unactivated trypsinogen, were recorded, these were in the order of 2.5-5% of initial inoculum 
(working on the simplistic assumption that recombinant trypsinogen comprised 100% of the 
inclusion bodies). The activity detected did not appear to be reproducibly affected by any single 
factor and extremes of dilution & temperature failed to produce any significant trends in the results. 
The conformity of the results (in the mean range of 0.2 -  0.5pg/ml), particularly in regard to their 
apparent insensitivity to the various dilution factors used, would seem to indicate that they are not 
significant, and do not represent the genuine refolding of any of the recombinant enzyme. Similarly, 
the activity apparently detected from the refolded commercial trypsin standards was only barely 
detectable above the baseline and should not be regarded as truly indicative of enzyme 
regeneration.
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4.4.5 Factorial analysis of folding co-factors
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Figure 4-6: Co-factor main effect plot
Main effects plot for activity of the 11 co-factors evaluated for the in vitro refolding of commercial 
trypsinogen. Graph shows individual effects of the presence (1) and absence (0) of each factor on 
the activity (and thus yield) of refolded enzyme. The dotted red line indicates the overall mean of 
the response data.
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Figure 4-7: Co-factor interactions
Interaction effects of each potential co-factor plotted against the mean activity. An interaction plot 
shows the impact that changing the settings of one factor has on another factor. Interpretation is 
simple - for each cell: the name of the principle factor being evaluated is shown at the bottom, the
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concentrations of which are shown on the X-axis at the top of the cell; the name of the interacting 
factor is shown to the left, with the concentrations being shown in the key immediately below it. A 
significant interaction between two factors would be revealed by two lines of differing slope.
Pareto Chart of the Standardized Effects
(response is Activity, Alpha = .05, oniy 30 largest effects shown)
A: Sucrose 
B: Glucose 
C: Glycerol 
D: PEG300 
E: PEG3350 
F: Sii)strat 
G: 2-Pentan 
H: Cydohex
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
Figure 4-8: Pareto chart of standardised effects
A Pareto chart used to compare the relative magnitude and statistical significance of both the main 
and interaction effects. The dotted red line indicates the alpha value of 0.05m, all effects that 
extend past this reference line were held to be significant by the model. It is important to note that 
weighting and normal distribution of the model has been unbalanced by the exclusion of several 
large (negative) effects (see section 4.4.6).
4.4.6 Evaluation of refolding co-factors
The main effect plot illustrates the blanked activity of refolded & activated commercial trypsinogen 
in the presence of each of the 11 co-factors. Data means of the activity in the presence and 
absence of each factor were plotted and provided a rough guide as to which factors influence the 
response and the relative strength of the effects. A significant effect was present when the mean
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response changed across the levels of a factor, and thus the pitch of the slope indicated the 
magnitude of the effect. The graph indicated that the presence of glycerol, PEG300 & PEG3350, 
substrate (L-BAPNA), 2-pentanol and cyclohexanol all had slight beneficial effects on the yield, but 
the magnitude of these enhancements were small when measured against the inhibitory effects of 
L-arginine, ethanol and ammonium sulphate. Caution should be taken when attempting to apply 
precise figures to each event due to the small number of replications involved and the fact that an 
individual set of controls was not run in each refolding buffer solution, and these results should only 
act to serve as a pointer for further work.
All results were fitted to a model that used an analysis of variance to determine which sets 
of effects were statistically significant. For the initial screen, the a-level value (the probability of 
making a type I error, i.e. incorrect rejection of the null hypothesis) was set to 0.1 and only the 
three inhibitory effects were calculated to be significant in relation to the data set Upon reduction 
of the model to discount those negative effects and an increase in the a-level selectivity to 0.05 to 
compensate for the decreased range in the data, sensitivity was increased such that all the single 
factor main effects except for sucrose & glucose were deemed to be significant interactions.
An interaction plot was used to determine whether any two of the tested co-factors 
interacted in their effects on activity and to compare the relative strengths of the effects. The two 
lines of the graph illustrate the change in the activity mean from the low to the high level of a factor 
depending on the level of a second factor. The greater the degree of departure of the lines from 
being parallel, the stronger the interaction effect.
The Pareto graph (Figure 4-8) shows that the following 6 factor-factor interactions had the 
greatest impact on activity, ranked from highest downwards: PEG300 -  Substrate (L-BAPNA); 
PEG300 -  2-Pentanol; PEG300 -  Glycerol; PEG300 -  PEG3350; PEG300 -  Cyclohexanol; 
Glycerol -  Cyclohexanol. From Figure 4-8, the co-factors which produced the strongest interactive 
effects when combined with any other factor (excluding L-arginine, ammonium sulphate or ethanol) 
were PEG300 and glycerol. With the a-level discrimination set at 0.05, these effects lay just below 
the significance threshold, but it should be remembered that this was set at an arbitrarily high level 
in order to attempt to rank the data coming from an unbalanced design. The screening of selected 
beneficial co-factors in a full-factorial model, with suitable controls in each buffer, would achieve far 
more reliable discrimination between effects.
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4.5 Discussion
4.5.2 Refolding of recombinant trypsinogen
The persistent failure of the refolding work, using inclusion bodies of recombinant trypsin from 
ELTRP-1 fermentation, to return an unambiguous signal was puzzling, particularly as it was 
designed to closely mimic a proven methodology (Buswell et a/M 1995). Deviations from the 
published methods were: 1) the use of the use of glutathione and GSSG as the redox exchange 
couplet in the refolding buffer in the place of cystine and cysteine; 2) the extraction and purification 
protocols for the inclusion bodies (which were not known, although if these follow the Eli Lilly 
standard for the primary recovery of recombinant enzymes then the steps involve high-pressure 
homogenization and then centrifugation, with subsequent washing of the inclusion body slurry with 
a 0.66% w/w Triton-X-100 detergent solution, 3) the addition of DTE to the solubilisation buffer in 
order to act as a reductant; and 4) undoubted differences in the dilution factor of the refolding step 
and the impracticality of implementing an injection process. To clarify, an injection process was 
used by the previous research team to initiate refolding by progressively ‘injecting’ small volume of 
solubilised enzyme info the refolding buffer, up to a set concentration. Such a method was not 
suitable for use in a high-throughput microplate screen as it would place a considerable demand on 
both operator precision and work load, and was thus not tested. The nature of screen required 
placed added limitations on the work, namely that potentially refolded protein could not be 
concentrated for assay purposes.
The results generated in those experiments based on partially purified & washed inclusion 
bodies (Figures 4.2 -  4.4) appeared to show slight activity from refolded enzyme, but should not be 
held as a proof of concept Enzyme concentration data was multiplied by the dilution factor so as to 
provide an at-a-glance yield comparison with the initial inoculum, but only extremely small signals 
were generated by all experiments, frequently only barely distinguishable from the blank (refolded 
inclusion bodies without the addition of activating enzyme). The results generated were thus open 
to considerable doubt and could not be regarded as the basis for an assay.
The solubilisation and refolding protocols used in this work were, in themselves, unsuitable 
fora high-throughput screen, involving, as they did, a multiple high-speed centrifugation steps and 
a series of washes. The final form of the screen would have, of necessity, involved cellular lysis 
followed by the solubilisation of the inclusion bodies without any separation from the soluble
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fraction (microplate centrifugation using available equipment having been shown to be unable to 
generate the required ref to pellet inclusion bodies, see Section 2.3.5). It was predicted that 
additional problems would arise before the screen could be fully implemented in the screening of a 
mutant library, the most significant of which would be whether the specific level of insoluble 
enzyme produced by a 1 ml microplate well-culture would be sufficient to be diluted and remain 
within the detection limits of the assay.
4.5.3 Potential alterations to methodology
The incompleteness of the bulk of this work is evident and it is possible that a workable refolding 
strategy for recombinant trypsinogen could have been developed with further careful testing. 
Additional work would include the optimization of the process using just commercial trypsinogen 
(instead of adding to an inclusion body mix), the testing of other oxidizing & reducing agents 
(notably cysine/cysteine) and experimentation into the optimal redox balance, and experimentation 
with steped dilutions. Whether any of these strategies would have resulted in a method suitable for 
the high-throughput screen described was not known, but time restraints on the work encouraged 
the exploration of other avenues to protein solubility, particularly the use of N-terminal signal 
sequences, with which promising work had been done with analogous enzymes (Clare et a l, 2001; 
Evnin et al., 1990) (see Chapter 5).
4.5.4 Evaluation of folding co-factors
While the lack of controls and an accurate standard curve in these screens (Figure 4-6 - Figure
4-7) mean that accurate values should not be assigned to the effects, the broad results of the tests 
appear valid and significant Suitable controls would indicate whether ethanol & ammonium 
sulphate actually retarded the refolding process, but it is far more likely that the negative impact of 
L-arginine at least was due to binding to Asp189 of trypsinogen and thus the blocking of the 
binding pocket. The positive effects of PEG300 and glycerol on the refolding process were 
pronounced and were worthy of further study. The researcher with whom this work was performed 
had plans for a 3 level, full factorial screen of the effects of PEG300, glycerol, 2-pentanol and 
substrate on the refolding of commercial trypsinogen, coupled with a full suite of controls and 
standards run in each buffer. Such work will aim to fully elucidate the effects and interactions of
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each factor, and may even make a microplate-based assay of recombinant trypsinogen from well- 
cultures a practical possibility.
4.6 Conclusions
Under the conditions tested, no signal could be detected from recombinant trypsinogen solubilised 
from unwashed inclusion bodies produced by a 16hr ELTRP-1 fermentation. Total protein 
concentration in the refolding buffers remained within the limits of activity assay detection at all 
points.
Use of the Costar Ultra Low-Binding plate or the blocked standard microplate 
demonstrated advantages over the use of an un-blocked standard microplate in that they acted to 
prevent the gradual loss of soluble protein by absorption during refolding incubations.
Work with inclusion bodies purified from the bulk of the insoluble fraction by repeated 
washing with B-PER solutions appeared to generate marginal signal from the refolded & activated 
trypsinogen, but the activity was slight and indistinct, barely distinguishable from the baseline, and, 
if genuine, would represent only a 2.5-5% refolding yield of active enzyme.
Refolding yield appeared sensitive to temperature, with work at 8°C producing results 2-3 
fold higher than the near-undetectable signal generated by work conducted at room temperature. 
No other factors (initial soluble concentration, dilution of factor of refolding step, choice of activating 
enzyme) appeared to influence results in a reproducible fashion.
The addition of quantities of commercial trypsinogen to low-concentration inclusion body 
solutions, which were then solubilised and refolded under standard conditions, showed that the 
refolding efficiency of this process was extremely poor, even when increasing quantities of purified 
protein were added to the system. Slight signal was detectable from the added standards, but 
represented an increasingly low yield of the solubilised enzyme, with only 5% of the 0.3mg/ml 
standard apparently being regenerated.
The fraction factorial experiment revealed that purified, commercial trypsinogen appeared 
considerably more amenable to refolding, responding to a variety of co-factors with a clear 
increase in signal. PEG300 and glycerol were shown to be highly beneficial to the reaction, 
producing the greatest effects when used singularly, but with significant effects when combined 
either with each other or with the bulk of the remaining factors.
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Ethanol, L-arginine and ammonium sulphate were shown to be either detrimental to the 
refolding reaction or inhibitory to the action of enterokinase or trypsin.
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5 Signal sequence work -  Strain construction
5.1 Introduction
5.1.1 General strategy
As it did not appear possible to achieve correctly folded recombinant trypsinogen from a culture of 
ELTRP-1 by means of a microplate-scale solubilisation & refolding protocol (Chapter 4), three 
remaining routes of manipulation remained open. The attachment of a signal sequence (a short N- 
terminal polypeptide which directs the translocation of the unfolded protein into the periplasm) to r- 
ttypsinogen in pHKY603, the ligation of the entire target gene into a vector more suitable for 
experimental expression work (the pET series from Novagen would allow variation of expression 
rates independent of temperature, which could be used as an additional variable), or the subjection 
of the entire gene to random mutagenesis with the aim of screening via activity for any increase in 
solubility. Eli Lilly had expressed the preference that the gene remained in the original strain and 
plasmid until all other options had been exhausted, so as to simplify their evaluation and possible 
use of any enzyme mutants generated. The construction and insertion of a suitable leader 
sequence into pHKY603 was thus presented as the next logical step.
This chapter details the synthesis and testing of three plasmid constructs: pHKY603(T) & 
pHKY603(M), which consisted of a pelB leader sequence inserted at the N-terminus of the genes 
for the zymogen and mature protease respectively in the original plasmid; and pET(T), where the 
gene for mature trypsin was inserted into a pET26b(+) plasmid and expressed in the BL21(DE3) 
lysogenic strain. The aim in all cases was to achieve soluble, active enzyme from a conventional 
fermentation with a minimum number of processing steps. Stable expression of detectable levels of 
mature trypsin would represent a significant benefit, as it would remove the need for an activation 
step and could allow for the implementation of a nutritional selection strategy.
5.1.2 Signal sequence theory
A signal (or leader) sequence could be defined as a short polypeptide which directs the 
translocation of a nascent or completed protein into or across the plasma membrane (Martoglio & 
Dobberstein, 1998). These relatively simple peptides are specific enough to target a protein
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towards a number of distinct membrane bound transport mechanisms and contain the information 
of whether the protein was to be inserted into the membrane or fully translocated across it. While 
signal sequences show a high degree of sequence diversity, they are characterised as a group by 
possessing a common pattern of charge and hydrophobicity. A generic leader sequence is 
illustrated below in Figure 5-1. Signal peptidases have a tripartite structure consisting of: a central 
hydrophobic h-region; and hydrophyllic N- & C-terminal regions (Martoglio & Dobberstein, 1998), 
referred to as the n- & c-regions respectively The sequences may range between 15 to over 50 
residues in length, with the polar and positively charged n-region being responsible for most of the 
variation. If the precursor protein were targeted for translocation across the membrane then the 
polar c-region would contain a further conserved motif at its point of contact with the protein 
targeted for export. The -3 and -1 positions always appear to contain a small, uncharged residue, 
such as alanine or lysine, with a larger residue, e.g. methionine, at the -2 position. This ‘small- 
large-small’ pattern forms the recognition site for the signal peptidase, which allows the release of 
the attached protein. Immediately upstream from this motif lie varying numbers of proline and 
glycine residues which serve to break the helical conformation of the chain, presumably to provide 
a more accessible site for the signal peptidase.
Signal Sequence Precursor protein
N - - n h c _ C -
terminus terminus
SPase sile
Figure 5-1: Illustrating the tripartite structure common to all signal sequences
The hydrophobic h-region is flanked by the hydrophilic, potentially membrane translocated n- & c- 
regions. The SPase cutting site is located at residues -1 ->  -3 of the c-region.
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5.1.3 Expression of recombinant proteins into the periplasmic space
Work done by Evnin et al. (Evnin & Craik, 1988) demonstrated that the attachment of a signal 
peptide to the N-terminus of rat anionic trypsinogen would allow the transport of the recombinant 
protein across the plasma membrane and subsequent folding and accumulation in the periplasm in 
sufficient levels to allow a selection strategy and activity screens. The signal sequence used was 
hisJ and a controlled level of expression of the protein was achieved by use of a tac promoter 
within a pT3 plasmid. The work proposed in this project would attempt to duplicate these results 
using, initially, a pelB signal sequence and a pET-20b (+) ribosome binding site, both inserted into 
the Eli Lilly production strain vector pHKY603. If similar results were obtained the formation of 
insoluble inclusion bodies could be greatly reduced and the protease pre-cursor could be 
harvested from the periplasm using a 25% sucrose/1 OmM Tris-HCI, pH8.0/5mM EDTA solution as 
described by Vasquez et al (Evnin et al., 1990) or by established variants of this extraction protocol 
(Clare et al., 2001; Cooke et al., 2001).
The periplasm of gram-negative bacteria, such as E. coli, differs profoundly in its 
chemical composition from the rest of the cell in that it is intimately linked to the external 
environment, due to the permeability of the outer membrane to small organic molecules. As a 
direct result of this, the periplasmic space cannot be said to have a regulated pH or maintained 
ionic balance, and contains no thiol or disulphide compounds (Creighton, 1992). Such a system 
tends towards an oxidizing environment, thus encouraging the formation and dynamic interchange 
of disulphide bonds and making it ideal for the establishment of the correct conformation of densely 
bonded, robust extracellular catalytic enzymes. A class of periplasmic chaperones, termed DsbA to 
G, all containing the relatively unstable bond-forming thioredoxin fold, have recently been 
characterized, and may also interact with translocated recombinant proteins (Van Straaten et al., 
1998). In their 1988-90 work Evnin & Craik (Evnin and Craik, 1988; Evnin eta!., 1990) supposed 
that it was the reducing environment of the cytoplasm that retarded the correct folding of rat trypsin 
by preventing the formation of disulfide bonds. Allowing the protein to accumulate in the cytoplasm 
would also leave it vulnerable to the wide varieties of cytoplasmic proteases and, conversely, may 
help to limit any autotoxic effects arising from the high-level expression and proteolytic action of the 
mature enzyme. Added to this, the fact that protein localised in the periplasm would be 
considerable easier to extract, it seemed clear that, for the purposes of this work, a similar strategy 
should be pursued.
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5.1.4 Design of constructs: pelB, pHKY(M), pHKY (T)
The signal sequence chosen for this work is pelB from the pET-20b (+) plasmid (Novagen). This 
particular leader sequence was selected simply on the basis that its action was well characterised 
within E. coli and there was considerable in-house experience with its use. The signal sequence 
was to be inserted as a sticky-ended oligonucleotide between the Xba I & Nde I sites of the r- 
trypsinogen gene. The oligonucleotide insert was designed so that, upon ligation, the signal 
peptidase recognition site of the leader sequence will lie immediately upstream of the first 
methionine codon of the gene, thus preserving the reading frame and avoiding the addition of any 
‘foreign’ amino acids at the N-terminus of the protein after signal sequence cleavage. The 
ribosome-binding site to be used was copied from the pET-20b (+) plasmid and preserved in the 
same position relative to the start codon of the signal sequence.
The pelB insert was formed by the slow annealing of 6 oligonucleotides to form a 85bp 
‘sticky ended’ construct, as shown below (Figure 5-2). The sequence of the leader sequence & of 
the ribosome binding site were taken from pET20b (Novagen).
Xba I rbs j Met 2
TC TA G A  GAAGGAGATATACATATGAAATACCTGCTGCCGACCGCTGCT 
A G A T C T  CTT CC TC TA TATG TATA C TTTATG G AC  GACGGCTGGC GAC GA
1------------------------------------------------------------------------------------------------------"-----------------------------------------------B---------------6 I
i  Nde I
 .. -  1
GC TGGTCTGC TGCTCCTCGCTGCCCAGCCGGCGATG G C TA TG
C GAC CAGAC GAC GAG GAG C GAC G GGT C G GC C GC T AC CGA T  A C------------------------------------------------ II--------------------------------------------------------------------------------------------------------- 1
4
Figure 5-2: Showing the design of the pelB insert
Numbers show length & alignment of component oligonucleotides: 1 (22mer); 2 (30mer); 3 
(33mer); 4 (26mer); 5 (30mer); 6 (26mer). Sequence shown in red was not part of construct, ‘rbs’ 
denotes the ribosome binding site, ‘Met’ shows the location of the methionine start codon for pelB 
transcription. Xba I = T'CTAG_A, Nde I = CATA_TG.
One of the considerations at this point was the possible advantage of engineering the removal of 
the pro-sequence from r-trypsinogen. Expression of mature trypsin would remove the need for the 
activation of the zymogen, thus simplifying the assay, and possibly allowing for some form of
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nutritional selection when screening the future libraries. Overexpression of a highly active, 
unregulated and ‘foreign’ protease into the cytoplasm of an £  coli would doubtless have a severe 
autotoxic effect, however, the introduction of a signal sequence means that (in theory) the enzyme 
could be sequestered in the periplasm, allowing it to accumulate to assayable levels away from the 
bulk of cellular processes. A group attempting to probe serine protease specificity by means of 
rationally- designed mutants (Evnin and Craik, 1988) managed to express active rat trypsin into the 
periplasm up to an approximate concentration of 1 mg/L without any visible autotoxicity effects on 
the cell. The cutting site for enterokinase is DDDDK^ (Asp4-Lys) and removal of the pre-cursor 
would cut 8 amino-acids from the mature sequence. If the signal sequence insert were altered so 
as to fit immediately upstream of the first residue of the mature sequence (lie), then it was possible 
that a similar level of expression could be achieved. No data appeared to exist on the level of 
autotoxicity that bovine trypsin caused in prokaryotic cells, but it seemed reasonable to assume 
that high-level expression would have a significant impact on the health of the culture. It was 
proposed that initial work with the system would rely on the leakiness’ of the pHKY603 
temperature sensitive promoter. It was not known to what degree the promoter leaked, i.e. what 
level of protein was expressed at a non-activation, i.e. repressor permissive, temperature 
(<36.5°C), but if an assayable level of protein was produced then it would eliminate the need for an 
activation step after purification. An expression level of 1 mg/L may not be useful for industrial 
purposes (such a reduction in yield may not allow a profitable process, despite removing the need 
for enterokinase), but would be sufficient for the selection and screening tests proposed in this 
work.
Two constructs were thus proposed: pHKY (T) -  which would code for the complete r- 
trypsinogen gene and have the leader sequence inserted between the Xba I  & Nde I  (Figure 5-3); 
and pHKY (M) -  where the 8aa prosequence was removed and the leader sequence ligated 
directly on the N-terminus of the mature protein gene (Figure 5-5). The plasmid (pHKY603) would 
be cut with Nde I  & Kas I, and the ‘bridging’ oligonucletides would replace the sequence between 
the Kas I  site and the lysine of the activation site (Figure 5-4). A single nucleotide substitution was 
needed to convert this lysine into a methionine, and the signal sequence could then be inserted in 
the same manner as in pHKY (T).
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PHKY603
X b a I Nde I
\  \  proprotein mature protein
— 1—
Inaart, Iw L .
rt>s I 
s igna l 
s e q u e n c e
Structure o f  insert
pelB Leader
ACTCAA TCTAGA GAASGAGAT Sequence GCGATG GCTATG TTTGTG
TOAOTT AOATCT CTTCCTCTA COCTAC COAT AC AAACAC
PHKY603 xb a  I  pET 20b <♦) I Nde I  r  - try p s in o g e n
sequence rbs I w  ^ 1 proaequence
Ala Met Ala 
SPase cutting site
Figure 5-3: Design of pHKY (T)
Sequence shown in red was original plasmid pHKY603, sequence in blank comprised the leader 
sequence insert. Xba I = T'CTAG_A, Nde I = CA'TA_TG.
N d e l K asI
Oligo 1 5’-3’ Sticky: TAtGATCGTTGGCGGCTACACCTGTG
Oligo 2 3'-5' Sticky: aCTAGCAACCGCCGATGTGGACACCGCG
Properties: 1: 26nt, Tm = 74.6°C 
2: 28nt, Tm = 84.1°C
Figure 5-4: Design of Nde IIKas I ‘bridging’ sequence
Nucleotide letters in small case indicate where a deliberate mutation was introduced -  here an 
adenine (5-3’) was replaced by a thymine to convert a lysine residue into a methionine. Restriction 
sites marked show only the portion of the site contained within the construct: Nde I = CA'TA_TG, 
Kas I = G'GCGC_C.
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pHKYSO] 
K as 1
X b a  I  A /d e l
m a tu re  pro te in
X b a  I Bridge
signal
s e q u e n c e
Leader Bridging oligo KasI
sequence
r-trypsin
Figure 5-5: Design of pHKY (M)
Sequence shown in red was original plasmid pHKY603, sequence in black comprised the Nde 
IIKas I bridging insert. Nde I = CA'TA_TG, Kas I = G'GCGC_C. Note that although the bridging 
insert was designed with an N-terminal overhang complementary to an Nde I cut site, this 
restriction site would be destroyed upon ligation with the leader sequence.
5.1.5 Construction of pET (T)
As the work with pHKY (T) & pHKY (M) was to prove inconclusive, and the general unsuitability of 
the ELTRP-1 strain for molecular work became evident, the decision was made to take the next 
logical step and transfer the target gene into a vector which would allow for flexible, temperature 
independent, control of expression rates. The pET series from Novagen are based upon a viral T7 
promoter tied to the lac operon, in which the 17 polymerase is genome encoded within the 
lysogenic E. coli strain BL21(DE3) (Studier and Moffatt, 1986). This 17 polymerase can only be 
expressed when the constitutively expressed lac repressor is bound by IPTG (the inducing 
molecule -  analogue of allolactose in original system). Unlike systems based on E. coli promoters 
(e.g., lac, tac, p i), the bacteriophage T7 promoter is used by the pET system to direct the 
expression of target genes. Since E. coli RNA polymerase does not recognize the T7 promoter, 
there is virtually no transcription of the target gene in the absence of a source of T7 RNA 
polymerase and the cloning step is thus effectively uncoupled from the expression step. The 
advantages of using such a strain over ELTRP-1 were thus: temperature independent control of 
expression rates; easy establishment of maintenance strains (transforming the modified plasmid
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into a host other than BL21 (DE3) will prohibit any expression; the host strain is protease deficient 
(both Ion and ompTj and bred specifically for molecular work; tight control over expression. The 
relative ‘leakiness’ of ELTRP-1 was never established, but temperature based promoters are 
notoriously difficult to use reprodudbly at lab scale (effective restrictive temperature cut-off point, 
poor heat transfer within incubators, etc). A pET vector should provide for tighter control of 
expression and, if an uninduced basal expression rate proves a problem, protocols exist for 
inexpensive enhancement of lac openon repression (e.g. enriching the medium with 1-2% glucose), 
use of pLysS/E ‘double repressor systems (Novagen).
It was decided that the plasmid pET26b(+) would be used for this work (T7 promoter, 
kanamycin resistance, f1 origin, pBR322 origin, pelB coding sequence immediately upstream of the 
multiple cloning site, see Figure 5-6) and that only the section of r-trypsinogen coding for mature 
trypsin would be cloned, creating a construct called pET (T). There were two steps to this work, the 
first involved the introduction of an Nco I  site at the activation site of r-trypsinogen by means of a 
mutagenic primer (Figure 5-7), and the second exploited this new restriction site, cutting out the 
trypsin gene by means of Nco I & Bam H I and ligating it into pET26b(+) directly behind the pelB 
sequence in such a way that the reading frame was conserved and no extra amino acids were 
added between the Spase site and the methionine of r-trypsin (Figure 5-8). For the correct 
formation of the Nco I  site, a non-synonymous mutation had to be introduced and Ile2 was 
converted into Val2. This was considered acceptable, as both were non-polar aliphatic amino acids 
of similar molecular weight (113.16Da to 99.133Da respectively) and, while partially surface 
exposed, were sufficiently distant from the active site & binding pocket for any impact on activity to 
be unlikely.
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Bain HI 198
Nco I 220 
Nde I - 288 
< 1 -  Xba I 326
pET26b{+) 
5360 bp
pBR322 origin 
(3277)
Figure 5-6: Simplified structure of pET26b(+)
Plasmid supplied by Novagen. Characteristics: T7/ac, Hisotag, f1 ori, pelB, kanr
Nco I
Forward primer 5’-3’ GATGATGATGccAtGgTCGTTGGCGGCTACACC
Properties: 33nt, Tm = B2.0"C meture enzyme *
Reverse primer 5 ' - 2 '  GCTCAGCCTCGCGGGATCCTAATTGGAAGC
stop
Properties: 30ntr Tm = 78.5 C Codon
Figure 5-7: r-trypsinogen mutagenic primers
The mutagenic primers designed to prepare r-trypsinogen on pHKY603 for insertion into 
pET26b(+). Nucleotides in small case indicate deliberate mutation, in this case required to form the 
Nco I site. Methionine (ATG) indicated in yellow and stop codon (CTA) highlighted in pink. Nco I = 
C’CATG_G, Bam H I = G’GATC_C.
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pET26b i>:
T7 promoter 
rbs
T7 terminator
Nco I  Ran? HI K eoR l Sac  I
I
p e lB
Insert
PCR " p ro d u c t  o f
 r_-r. n_______ I
t
N c o l
I
Ram HI
Structure of insert
Nco I  t - t r y P * 1”  Ram HI
GAT GATGAT Gc cAtGgTCG J AATSW^ATCCCGCGAGGCTGAGC 
CTACTACTACggTaCcAGC ~ TTAATCCTAGGGCGCTCCGACTCG
Figure 5-8: Design of pET (T)
Nucleotides in lowercase denote nucleotide substitutions from original. Methionine (ATG) indicated 
in yellow and stop codon (CTA) highlighted in pink. Nco I = C’CATG_G, Bam H I = G’GATC_C.
5.2 Materials and methods
5.2.1 Strains & vectors used
RV308 (Eli Lilly): (ELTRP-1 = RV308 + pHKY603) Strain was a derivative of E. coli K12. Fully 
genotype not released by company. Resistance: Smr.
BL21 (DE3) (Novagen): derivative of B strain, F-, ompT hsdSs (rE me) g a l dcm (DE3)
XL1-Blue (Stratagene): recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’ proAB lacfrZAM15 
Tn 70 (te^)]
pHKY603 (Eli Lilly): a derivative of pBR322. Fully sequence not released by company. Resistance: 
TcR,
pET26b(+) (Novagen): T7/ac, His»tag, f1 ori, pelB, kanr
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5.2.2 Enzymes and oligonucleotides
All digestive and modifying enzymes along with appropriate buffers were purchased from Promega. 
Oligonucleotides were synthesised to order by Amersham Pharmacia Biotech.
5.2.3 Construction of pelB insert & Nde I IKas I  ‘bridging’ sequence
Plasmid (pHKY603) prepared by miniprep (Qiagen) from a 5ml LB culture grown at 37°C, 200rpm 
for 16hrs. Purified plasmid eluted into 50jjJ of sterile MilliQ water and ~70ng was digested with Nde 
I  and Xba I  for both pHKY(T) & pHKY603(M), and Nde I and Kas I for pHKY(M), for 4hrs, 
according to manufacture’s protocols. Cut plasmid would then be separated from the excised 
fragment by means of spin-column (Qiagen). The 6 oligonucleotides comprising the pelB insert 
(Amersham Pharmacia Biotech) were resuspended in 500pl MilliQ water to form stock solutions of 
78-164jiM. For the annealing reaction, all oligonucleotides were pooled into a 250pJ solution so 
that each was present at 10j iM. A water bath was heated to 95°C, then, with the vial containing the 
solutions suspended within it was sealed shut and turned off. The water was allowed to return to 
room temperature over the course of 4-5hrs and the solution of annealed fragments was retrieved. 
The mixture of fragments was run on a 0.8% agarose gel to determine the degree of purity and a 
region corresponding to the approximate molecular weight of the insert was excised and purified by 
gel-extraction kit (Qiagen). The insert would then be ligated with the purified plasmid overnight at 
4°C in the appropriate buffer.
5.2.4 Fermentation of 5ml or 100ml BL21(DE3):pET (T) cultures
A 5ml seed-culture of BL21 (DE3):pET (T) was grown overnight in selective media (LB or M9SD, 
Karr 30pg/ml unless stated otherwise) at the temperature required for the subsequent induction 
run (28°C, 32°C or 37°C). A 1/100 inoculation of this culture was made into either 5mls or 100mls 
of selective broth and the cells were grown to the induction point of ODeoonm- Induction of rTrypsin 
expression was achieved by adding IPTG to the culture to a final concentration of 1mM. The cells 
were then grown overnight at the appropriate temperature, 200rpm, with 1ml samples being taken 
throughout the course of the fermentation. Samples were either frozen immediately at -20°C or
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fractionated and then frozen in order to prevent excess cross-contamination of the soluble fractions 
due to ffeeze-thaw lysis.
5.2.5 Fractionation of E. coli culture
In order to obtain a detailed picture of the levels of recombinant protein expressed, the solubility & 
point of accumulation of this protein and the subsequent percentage of that which was folded into 
an active state, it was necessary to fractionate the cultured cells and test each segment 
individually. As a coarse test, cell culture would be divided into three fractions, namely the 
supernatant, the soluble fraction (periplasm & cytoplasm) and the insoluble fraction (composed of 
inclusion body proteins, nucleic acids & lipids). More detailed work required the soluble fraction to 
be resolved into the individual periplasmic and cytoplasmic samples. If suitable controls were used 
to monitor the activity of commercial trypsin in the buffers at each stage, then the sum of the 
activity in each test fraction should equal the total trypsin activity of the cell. The protocol for this 
work was adapted from two sources, one in-house team working on a related system (Cooke et al., 
2001) and from a team who had developed and tested a strain for the expression of a soluble 
trypsin-streptavidin fusion protein (Clare et al., 2001).
5.2.5.1 Preparation of ‘soluble’ & ‘insoluble fractions from BL21 (DE3):pET (T) culture
Samples intended for fractionation were processed immediately in order to minimize soluble 
fraction contamination due to lysis of the cells. 1ml of culture was centrifugation for 10min at 
13,000rpm, room temperature. The supernatant was drained and frozen at-20°C, labeled as 
‘Culture supernatant’. The pellet was resuspended in 200pl neat B-PER and allowed to stand at 
room temperature for 10min, with mild agitation to prevent settling. The sample was centrifuged 
again for 15min at 13,000rpm and the supernatant was removed, frozen, and labeled as 'Soluble 
fraction’. The pellet was resuspended again in a washing solution of 1:4 B-PER to MilliQ-water, and 
centrifuged for a further 15min. The supernatant was discarded and the pellet was resuspended in 
MilliQ-water, subsequently frozen and labeled as ‘Insoluble fraction’.
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5.2.52  Preparation of ‘periplasmic’, ‘cytosolic’ & ‘insoluble’ fractions from BL21 (DE3):pET
(T) culture
The ‘Supernatant’ sample was collected as described in 5.2.5.1. The resultant pellet was 
resuspended in 200jil of the periplasmic extraction buffer, containing: 20% sucrose, 50mM Tris, 
1mM EDTA, 50pg/ml lysozyme. Buffer was chilled on ice prior to addition and resuspended sample 
was allowed to stand for 15min with mild agitation to prevent settling.
The cells were then centrifuged for 10min at 13,000rpm, and the supernatant was carefully 
drained, frozen, and labeled as 'Periplasmic fraction’. The pellet was resuspended in 200pl neat B- 
PER and allowed to stand at room temperature for 10min, with mild agitation to prevent settling. 
The sample was centrifuged again for 15min at 13,000rpm and the supernatant was removed, 
frozen, and labeled as ‘Cytosolic fraction'. The ‘Insoluble fraction’ was prepared in an identical 
manner to that in 5.2.5.1.
5.2.6 Transformation protocols
Competent E. coli cells were prepared for CaCb transformation in the manner described by 
Sambrook (Sambrook et al., 1989). Transformation of DNA (typically 50ng or less in 10pJ) was 
added to 200pl of ice-chilled competent cells and allowed to stand for 45 seconds. The tubes were 
then heatshocked for 45 seconds and then incubated on ice for 5 minutes before 45 minute 
incubation in non-selective media at 37°C. For low stringency protocols, non-selective incubation 
time was increased to 90 minutes and the initial quantities of DNA were substancially increased 
(see individual Results sections for specific quantities).
5.3 Results
5.3.1 Construction of pHKY (T) & pHKY (M)
A pelB signal sequence, constructed from 6 complementary nucleotides and adapted, along with 
control elements form pET20b(+), was to be inserted into pHKY603, at the immediate N-terminus 
of r-trypsinogen. This plasmid would be termed pHKY (T). A second construct, pHKY603 (M)
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(Mature protease) would have the prosequence of the zymogen edited out and the pelB sequence 
cloned in as before (see Figure 5-3 & Figure 5-5).
In order to establish the pHKY (M) construct, approximately 75ng of plasmid was then 
digested with Nde I & Kas I according to standard protocols. The product was then purified by spin 
column and analysed by electrophoresis. Direct sizing was impossible due to supercoiled structure 
of ladder, but the plasmid had clearly been linearised if compared to supercoiied pFIKY603 and a 
faint double cut fragment was visible. The digested plasmid appeared, however, to be far smaller 
than it should be considering that only 40nt were excised. The digestion was redone using 
approximately 120ng of DNA and allowed to proceed for only 1 hour before heat inactivation & spin 
column purification (see Figure 5-9 below).
uncut pHKY603 
5ul
M l  - 2 07kt>
Figure 5-9: Gel showing products from second Nde I IKas I digestion
0.8% agarose gel, run at 100V, 120mA for 1 hr.
In Figure 5-9, the cut plasmid again appeared to be far smaller than expected when compared to 
the supercoiied pFIKY603 (considering its linearised nature and the relatively small section of 40nt
cut pHKY$03 SC ladder
lOut perweH 52ng/band
‘ ' i t
-705M)
- 6 03ko
- 5 Olkb 
■ 3 99kb
- 2 99kb
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excised), but the reaction was performed with all care from fresh stocks of both pHKY603 and 
enzyme and so it appeared to be a genuine resuit. Reexamination of the pHKY603 plasmid map 
provided by Eli Lilly revealed no design error on the experiment in that the Nde I  & Kas I  sites 
were indeed unique.
The oligonucleotides forming the Kas VNde I  bridge fragment (see Figure 5-4) were 
allowed to slowly hybridize by incubation at approximately 5°C below their Tms (69°C for 2hrs, then 
60°C, allowed to cool to room temperature -  see Methods, Section 5.2.3), and then approximately 
2pg was then ligated into 170ng of cut pHKY603. The product was analyzed by agarose gel 
electrophoresis.
The digestion reaction was run fora final time, using fresh plasmid, purified in the morning 
of work, and was allowed to proceed for only 30 minutes before heat inactivation and column 
purification. 200ng of this digestion product was then ligated with approximately 3pg of hybridized 
insert with the reaction running overnight at 4°C. Digestion & ligation products shown in Figure
5-10 below).
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ligation product 
20ulperwel
cut pHKY603 
20ul each well
uncut pHKY603 SC ladder
5ul 24ng/band
- 7 05kb 
-6 03kb 
-5 01kb
- 3 99kb
m  -299kb
m  - 2 OTkb
Figure 5-10: pHKY603 Nde 11 Kas I digestion & ligation products
Gel showing a miniprep of pHKY603 and the second ligation attempt of the Nde IIKas I pHKY603 
digestion product & ligation with the hybridized bridge insert. 0.8% agarose gel run at 100V, 
120mM, 1hr.
Figure 5-10 showed a similarly weighted digestion product as before and no trace of a ligated 
plasmid. The complete absence of even cut, linear plasmid in the ligation lanes (recircularization 
would be theoretically impossible due to the asymmetric digestion) could be explained.
The pHKY (T) construct was being developed in parallel with this work and the initial step 
required the digestion of pHKY603 with Xba I & Nde I. The digestion reaction was calculated to 
release a 52nt fragment. The reaction was run for an hour before heat inactivation, spin-column 
purification and concentration. Product shown in Figure 5-11.
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(B) cut pHKY603 (A) cut pHKY6Q3 SC ladde?
2Dul each well 20ul each well 24ng/band
I 03kb- 5 01kb 
-3 99kb
-2 99kb 
-207kb
Figure 5-11: Showing the pHKY603 Xba 11 Nde I digestion product
0.8% agarose gel run at 100V, 120mM, 1hr.
The Xba VNde I digestion fragment appeared to be approximately the expected size in that it ran 
slightly higher than the 6kb of the supercoiied plasmid.
The pelB insert was prepared from the 6 complementary oligonucleotides (see Figure 5-2) 
by means of the slow hybridization of a solution containing 10pM of each (see Methods, Section 
5.2.3). The resultant mix of hybridized fragments was analysed by electrophoresis. The size of the 
correctly hybridized construct would be 85bp.
Approximately 170ng of the pHKY603 Xba llNde I digestion product (the basis for pHKY 
(T)) was ligated with 200ng of the hybridized pelB insert. A new pHKY603 Nde IIKas I digestion 
was prepared from stocks, cleaned & concentrated and then immediately ligated with the Nde 
I IKas I bridge fragment. Products from both reactions can be seen in Figure 5-12.
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pHKY603 pHKY603 (M) pHKY603fT) pHKY603(M)
Ndel/Kasl digestion previous ligation ligation ligation uncut pHKY603 SC ladder 
5ul 5ul 5ul 5ul Sul 24ng/band
*
*
m
- 7 05kb 
-6  03kb
- 5 01 kb
-3  99kb
- 2 99kb
- 2 07kb
Figure 5-12: pHKY(M) & pHKY(T) ligations
Gel showing the new pHKY (M) & pHKY (T) ligations versus a previous pHKY (M) ligation, 
pHKY603 cut with Nde I & Kas I and a pHKY603 miniprep. 0.8% agarose run at 100V, 120mM for 
1hr.
Figure 5-12 showed that the pHKY (T) ligation resulted in a clear product of approximately the 
correct size (although a portion of it could still remain as linearised plasmid). The pHKY (M) ligation 
(pHKY603 cut with Nde I & Kas I, ligated with the bridge insert) showed as a faint band of a similar 
size and no conclusions as to the success of the ligation could be made at this stage. This ligation 
mix was cleaned & concentrated and then cut with Xba I & Nde I and ligated with an approximately 
3 fold molar excess of the pelB insert. The resultant product was then tested, along with the pHKY 
(T) ligation product in the transformation of competent RV308.
Stocks of RV308 (the ELTRP-1 E. coli strain without the pHKY603 plasmid) were prepared 
for CaCL competency by means of the standard protocol (see Methods). The cells were then 
transformed with approximately 20ng of each cleaned ligation and subjected to heat shock @ 42°C 
for 90s. No commercial transformation control was used but, in its place, 10ng of minipreped 
supercoiied pHKY603 was used, and a further control involved a vial in which no DNA was added 
to competent cells although they were subjected to heat-shock. The importance of this was that no
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transformants wens visible after 24 hours growth on the selective plates. The ‘blank* aliquot of ceils 
also failed to grow on non-selective agar and thus it appeared that RV308 did not survive the 
transformation protocol. As a commercial production strain, designed for bulk expression, its 
unsuitability for molecular work and its sensitivity to certain strenuous protocols was to be 
expected. The transformation protocol was thus progressive altered to reduce its stringency and 
thus impact upon the strain. The temperature of heat-shock was seen as unalterable, but the 
period of heat-shock was reduced from 90s to 60s and then finally 30s. Similarly, the period of 
recovery in non-specific SOB media was increased from 30min to 1h. The concentration of 
tetracycline & streptomycin in the plates was reduced to stringent plasmid levels (10pg/ml each) 
and the transformants were gently concentrated prior to plating.
After three attempts at increasing lower stringency, and with the cells being prepared fresh 
from glycerol stocks each time, viable transformants were achieved. By this point XL1-Blue was 
also being used as an alternative host due to its documented higher competency. The projected 
aim of this was to use XL1-Blue as a transformation intermediate strain, receiving modified, linear 
plasmid and yielding supercoiied plasmid for transformation into the lower competency RV308. A 
problem existed in that XL1-Blue carried genome encoded tetracycline resistance, but it was hoped 
that by increasing the concentration of the antibiotic in the plates to 100pg/ml, there should be a 
selective pressure favoring those cells with two copies of the gene, thus enriching for the plasmid. 
Competent DH5a cells, prepared in house, were also used as a further test Transformation 
efficiencies resulting from XL1-Blue & DH5a transformation with ligation products, and the 
subsequent transformation of RV308 with plasmid from XL1-Blue are shown in 
Table 5.1 below.
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Approximatenuoi
Strain Vector Result transformation efficiency
(cfu/fig)
XL-Blue pHKY (M) Approx. 300 very small, white colonies. 6 x  104/jj.g DNA
pHKY(T) Approx. 300 very small, white colonies. 6 x lO4/ ^  DNA
Control (pHKY603) Approx. 300 very small, white colonies. 6 x  104/p.g DNA
Blank (no DNA 
added)
No growth N/A
DH5a pHKY (M) Faint lawn. N/A
pHKY(T) Faint lawn. N/A
Control (pHKY603) Faint lawn. N/A
Blank (no DNA 
added) No growth. N/A
RV308 pHKY (M) Approx. 40 small, white colonies. 8 x  103/pg DNA
pHKY(T) Approximately 210 small, white colonies. 4.2 x  104V g  DNA
Control (pHKY603) Almost confluent growth. N/A
Blank (no DNA 
added) No growth N/A
Table 5.1: Transformants of pHKY (M) & pHKY (T)
Concentration and type of antibiotics in media was strain dependant. RV308: plates contained 
tetracycline & streptomycin @ lOpg/ml; DH5a: plates contained tetracycline @ 10pg/ml; XL1-Blue: 
plates contained tetracycline @ 100pg/ml.
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SC ladder pHKY603 pHKY (T) pHKY(M) X11-Blue (M) XL1-Blue(T)
24ng/band 5ul Sul Sul Sul Sul
* ‘ * M  * I t ■ t I n  M  I ! i j
5.01 kb- 
3,99Kb-
2.99kb-
2.07kb-
Figure 5-13: Plasmid isolated from successful transformants
Showing plasmid purified from single colonies picked from the transformants in 
Table 5.1.0.8% agarose run at 100V, 120mM for 1hr.
Figure 5-13 shows the purified plasmid from isolates grown overnight in liquid media from the 
previous transformation. The DH5a colonies failed to grow in selective media and the 
RV308:pHKY (M) grew only very poorly. From the gel, it was evident that only the RV308:pHKY (T) 
clone had produced a plasmid of approximately the correct weight (6345bp as opposed to the 6260 
of unmodified pHKY603). The broad molecular weight smears from the XL1-Blue transformants 
were indicative of Dnase activity, despite the genotype of the strain, and appeared to show that the 
attempt to select for a gene held on in both the vector and the host had been unsuccessful.
Confirmation of the identity of the constructs was sought by PCR using the standard 
trypsin amplification primers & primers that originated within the pelB sequence. Amplification was 
attempted at the two salt optima determined by work on unmodified pHKY603 (see Chapter 3, 
Section 3.3.5), results can be seen in Figure 5-14.
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8 7 6 5 4 3 2 1
pHKY603 i>HKY6Q3 pHKY(T) pHKY(M)
10ul (P2) 10ul (P1) IQuI (P2) 10ul (P2) 10obp ladder
H L H L H L H L 20ng/l>af)d
( » • «
-1kb
-900bp
-800bp
-700bp
-600bp
-500bp
-400bp
-300bp
-200bp
-100bp
Figure 5-14: PCR products from pHKY (M), pHKY (T) & pHKY603
1.2% agarose gel run at 100V, 120mA for 50min. P1 indicates the use of the standard trypsin 
amplification primers (see Figure 3-2), while P2 indicates the use of the pelB-rtrypsinogen 
amplification set (see Figure 5-2). A newly digested & ligated pHKY (M) construct was used for this 
reaction. H & L refer to high and low [salt], 2.8mM & 0.8mM respectively. Lanes: 1 -  pHKY (M) @ 
0.8mM MgCI2 using P2; 2 -  pHKY (M) @ 2.8mM MgCI2 using P2; 3 -  pHKY (T) @ 0.8mM MgCI2 
using P2; 4 -  pHKY (T) @ 2.8mM MgCI2 using P2; 5 - pHKY603 @ 0.8mM MgCI2 using P1; 6 -  
pHKY603 @ 2.8mM MgCI2 using P1; 7 -  pHKY603 @ 0.8mM MgCI2 using P2; 8 -  pHKY603 @ 
2.8mM MgCI2 using P2.
The plasmid purification & PCR reaction apparently proved that the pHKY (T) construct had been 
stably replicated and was a structure distinct from pHKY603 in that it was shown to contain the 
pelB coding sequence. The existence of a faint product of pHKY (M) at 2.8mM MgCI2 was 
confusing as the ligated construct was particularly difficult to form and consistently failed to 
transform competent cells.
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The presence of the gene thus being confirmed, the nature of the recombinant protein was 
then determined by means of a 5ml 32°C, 200rpm fermentation, followed by cell-fractionation, 
activity testing and SDS-PAGE of the fractions (see Methods, section 5.2.5). Induction was 
achieved by raising fermentation temperature to 37°C at Aeoo = 0.61. Fermentation samples were 
collected and process 2 & 4 hours after induction, with the total soluble & insoluble fractions being 
shown in Figure 5-15, and the soluble fraction being separated in supernatant, periplasm & 
cytoplasm in Figure 5-16.
1 2 3 4 5 6
Figure 5-15: Soluble & insoluble fractions from RV308:pHKY(T) 2 & 6 hours after induction
SDS-PAGE run as 15% acrylamide gel with 4% stacking gel, run @ 80V for40min, then @ 150V 
for 120min. Lanes: 1 -  7.5pg commercial trypsin; 2 — (T2 — 2hrs after induction) soluble fraction; 3 -  
(T2) insoluble fraction; 4 -  7.5pg commercial trypsin; 5 — (T6 — 6hrs after induction) soluble fraction; 
6 — (T6) insoluble fraction).
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Figure 5-16: Soluble fractions (supernatant, periplasm, cytoplasm) from RV308:pHKY(T) 2 & 
6 hours after induction
SDS-PAGE of the supernatant and periplasmic & cytosolic fractions from a RV308:pHKY (T) 
fermentation. 15% acrylamide gel with 4% stacking gel, run @ 80V for40min, then @ 150V for 
120min. Lanes: 1 -  7.5pg commercial trypsin; 2 -  (T2 -  2hrs after induction) supernatant; 3 — (T2) 
periplasm; 4 - (T2) cytoplasm; 5 -  {Je -  6hrs after induction) supernatant; 6 — (Te) periplasm; 7 -  
(T 6> cytoplasm.
SDS-PAGE analysis of the fractions (see Figure 5-15, Figure 5-16) appeared to show moderate 
expression at the correct molecular weight in the insoluble fraction, but activity testing with L- 
BAPNA revealed no detectable signal in any of the fractions (for activity testing protocols, see 
Methods, Section 5.2.6. Activation of trypsinogen was by treatment with enterokinase). Although 
more rigorous testing of the pHKY (T) & pHKY (M) was possible at this stage (namely DNA 
sequencing and a better designed series of protein gels), the limitations placed upon the work by 
the heat-inducible promoter system and the apparent failure of the signal sequence to influence
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protein accumulation, meant that it seemed prudent to move swiftly with a more flexible vector 
system.
The manipulation of r-trypsin required for insertion into the pET26b(+) vector is 
detailed in Figure 5-7 & Figure 5-8. Briefly, the gene segment corresponding to the mature protein 
only was to be amplified by PCR with mutagenic primers for the insertion of an Nco I site at the N- 
terminus (results shown in Figure 5-17), the ligation into pET26b(+) cut with Nco I & Bam H I (initial 
product shown in Figure 5-18) and the subsequent transformation of BL21(DE3).
rttypwogen pET insert 10<*p ladder
6 5 4 3 2 1 20ng/band
- 700bp
- 600bp
m m  m
Figure 5-17: Amplification of r-trypsinogen with standard & mutagenic primers
1.2% agarose gel run at 100V, 120mM for 70min. Lanes 1-3 hold r-trypsinogen amplified 
‘pET26b(+) insert’ mutagenic primers (see Figure 5-7), lanes 4-6 hold r-trypsinogen amplified with 
standard primers (see Figure 3.1). PCR products of 715bp (lanes 1-3) & 723bp (lanes 4-6) 
expected. Lanes: 1 -  r-trypsinogen amplified @ 0.8mM MgCfc; 2 -  r-trypsinogen amplified with @ 
1.5mM MgCb; 3 -  r-trypsinogen amplified @ 2.8mM MgCL; 4 -  r-trypsinogen amplified @ 0.8mM 
MgCfc; 5 -  r-trypsinogen amplified @ 1.5mM MgCL; 6 -  r-trypsinogen amplified @ 2.8mM MgCL.
The PCR product was cleaned & concentrated via spin column and was then digested with Nco I & 
Bam HI. Commercial pET26b(+) was also double digested with the enzymes and, after spin-
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column purification of the reactions, approximately 410ng of the gene insert was ligated with 
1.04pg of vector (Product shown in Figure 5-18 below).
SC ladde- 
_2____ 1_ 24ng/band
*
- 7 05kb
- 6 03kb
^  -501kb
- 3 99kD 
-299W)
*  - 2 07kb
Figure 5-18: pET (T) ligation product
0.8% agarose gel run at 100V, 120mA for 1hr. Lanes: 1 -  5pl ligation product; 2 -  supercoiled 
pET26b(+).
The ligation product visible in Figure 5-18 was of approximately the correct size (pET26b(+) + 1kb) 
in relation to the unmodified plasmid. Direct sizing was not possible due to the supercoiled nature 
of the ladder & plasmid. Following this work, the product was purified by spin-column and then 
transformed into commercially competent BL21(DE3) cells in parallel with the induction 
control/transformation control plasmid pET20b(+). Transformation was performed at medium 
stringency (see Methods, Section 5.2.6) and, while the induction control yielded strong growth on
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the appropriate selective plates, BL21(DE3):pET (T) grew only as faint lawn of tiny (0.5-1 mm 
diameter) white colonies. Single colonies were picked from each, grown overnight in LB and 
subsequently used as seed for a series of 100ml fermentations to assess the growth rate of 
uninduced cultures. Novagen literature recommended induction with IPTG to a final concentration 
of 0.4mM at /W  0.6-1 (blanked against uninfected media) and the initial induction work followed 
this guideline. Initial growth profiles shown in Figure 5-19.
2 . 5 -
A&B
C&D
2 .0 -
<
0 . 5 -
0.0
200 4 0 0 6 0 0 8 0 0 10000
Time (minutes)
Figure 5-19: Growth rates of induced & uninduced cultures of putative BL21(DE3):pET (T) 
strain in LB at 30°C & 37°C
Key: A (-■ - )  = uninduced culture, grown at 37°C; B ( - * - )  = induced culture grown at37°C, 
200rpm; C ( ) = uninduced culture grown at30°C; D (—«>—) = induced culture grown at 30°C.
Induction with 0.4mM IPTG at 150min (37°C) & 240min (30°C). Error bars indicate standard error 
over three individual fermentation runs for each condition.
No increased metabolic load upon induction was evident and standard activity assays using L- 
BAPNA revealed no enzyme activity in either the supernatant or soluble fractions of the induced 
cultures. The separated cellular fractions were then examined by SD-PAGE in order to attempt to 
establish whether r-trypsin was at least accumulating on the insoluble fraction of the cells or
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whether the cloned vector had been flawed in a more fundamental manner. An induced culture of 
the induction control (BL21(DE3):pET20b(+)) was used as the blank for this work (instead of an 
uninduced experimental culture) so as to provide a clear contrast for the trypsin, avoiding any 
issues arising from the documented slight leakiness of the T7 promoter. The pelB + trypsin 
construct had a calculated weight of 25.5kDa. The supernatant, soluble & insoluble fractions of the 
cultures can be seen in Figure 5-20.
1 2  3 4  5 6  7
-
2 3 *0 3
--
a »
Figure 5-20: Cellular fractions of the putative BL21(DE3):pET (T) culture
SDS-PAGE run as 15% acrylamide gel with 4% stacking gel, run @ 80V for 40min, then @ 150V 
for 120min. Lanes 2-4 hold fractions from induced BL21(DE3):pET (T) and lanes 5-7 hold fractions 
from BL21(DE3):pET20b(+). Both cultures were grown @ 37°C, 200rpm, and were induced with 
0.4mM IPTG at approximately A6oo = 0.6 (blanked against uninfected medium), sampling & 
fractionation occurred 4hrs after induction. Lanes: 1 -  7.5pg commercial trypsin; 2 -  supernatant; 3 
-  soluble fraction; 4 -  insoluble fraction; 5 -  supernatant; 6 -  soluble fraction; 7 -  insoluble fraction; 
8 -  7.5pg commercial trypsin.
From the protein fraction gel in Figure 5-20, no overexpression of any 25.5kDa protein in lanes 2-4 
was visible and, indeed, there appeared to be no differential in the banding patterns between
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BL21(DE3):pET(T) and the induction control in lanes 5-7. The only conclusion possible was that 
the experimental strain was not expressing recombinant trypsin in any form. Plasmid was extracted 
from an overnight culture and linearised by digestion with A/co I in order to assess the weight in 
comparison with similarly linearised, but otherwise unmodified, pET26b(+) and thus determine 
whether r-trypsin was present. A double digestion with Nco I  & Bam H I also performed in order to 
release the inserted gene, if present. All products were compared by agarose gel electrophoresis 
and it was evident that linearised pET (T) had the same molecular weight as linearised pET26b(+) 
and that digestion of pET (T) with Nco I & Bam H I seemed not to alter the weight of the plasmid 
and also did not release a second fragment (insert was 715bp). The initial ligation reaction was 
thus be seen as a failure and the transformation of BL21 (DE3) must have occurred with 
recircularised plasmid despite the asymmetric cutting sites.
In order to dismiss the chance that the colony picked for the expression gels (Figure 5-20) 
was not representative of all the transformants, i.e. that a few authentic BL21 (DE3):pET (T) clones 
had been successfully created but were effectively masked by the preponderance of those 
containing recircularised plasmid, 36 more colonies were picked and tested. The testing took the 
form of growing the colonies in overnight cultures, followed by plasmid extraction & size 
comparison with commercial pET26b(+).AII supercoiled plasmids appeared to be of approximately 
the same molecular weight as the supercoiled wild-type (~5300bp) and thus it was concluded that 
the flaw lay in the ligation product rather than in under-sampling of the transformants.
The ligation reaction was twice repeated using fresh material grown from glycerol stocks and 
agarose gel extraction of the digested plasmids, but the ligation product always appeared similar to 
that in Figure 5-18, i.e. similar in size to linearised commercial pET26b. Transformations into 
BL21(DE3) were performed and in each case yielded poor growth as compared to the 
transformation control with only a faint lawn of tiny (0.5-1 mm in diameter) white colonies grown 
after 20 hours. Although the colony physiology appeared abnormal and similar to that achieved in 
the previous transformation, approximately 30 colonies from each reaction being tested by plasmid 
size comparison, but, in each case, the extracted plasmid proved to be probable recircularised 
wild-type.
The repeated failure of the experiment appeared to indicate that the ligation step was 
being inhibited by one or more of the following factors: incorrect ratio of vector to insert (1:3 used 
previously); poor quality enzymes (no ligation control used to test ligase efficiency); conditions
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appeared to favor plasmid recircularisation. The work was repeated using fresh material & 
enzymes, variations of the ligation reaction and dephosphorylation of the digested vector using calf 
intestinal alkaline phosphatase to prevent recircularisation.
pETfO ligation (1 Oul) pET26b pET26b pET26b
_______V j______ d dd dp 3ul SC Ladder
1:8 1:4 1:2 2ul 2ul 20ng/band
—7.05kb 
—6.03kb
-5.01 kb
— 3.99kb
Figure 5-21: Vector to insert molar ratio variation
0.8% agarose gel run at 50V, 80mA for 40min. Lanes 4-6 contain pET (T) ligation product at 
different ratios of vector (V) to gene insert (I), lanes 2 & 3 contain digested pET (T) for weight 
comparison. Lanes: 1 - 2jj.I supercoiled pET26b(+); 2 - 5jil pET26b(+) digested with Nco 11 Kas I, 
dephosphorylated; 3 -  5^1 pET26b(+) linearised with Bam HI; 4 -  10jil pET (T) ligation product, V:l 
of 1:2; 5 - 10fil pET (T) ligation product, V:l of 1:4; 6 - 10|il pET (T) ligation product, V:l of 1:8.
From Figure 5-21, all ligation products appeared to be approximately the same weight as the 
linearised vector, despite the dephosphrylation of the 5’ termini, which should prevent 
recircularisation. The presence of faint bands of a higher molecular weight suggested that larger
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products may have present in small quantities and so a gel extraction was performed on the 
regions of the lanes from (as measured by supercoiled ladder) 7 -11 kb). 50ng of the purified 
plasmid was used to transform commercially competent BL21(DE3) cells. The result was poor 
growth (as compared to the transformation control) with a faint lawn of small (0.5-1 mm) white 
colonies grown after 20hrs. 20 colonies were picked and grown overnight in LB @ 37°C, 200rpm. 9 
isolates failed to grow on liquid culture entirely. Plasmid was extracted using the miniprep method 
and analysed by electrophoresis. Of the remaining 11,10 showed no evidence of plasmid, 
indicating that these colonies were either contaminants or perhaps severely poisoned BL21(DE3) 
cells. The sigle plasmid band obtained was of approximately 5.3kb and was thus considered to be 
‘unmodified’ or recircularised pET26b(+).
The persistent failure of the method for pET (T) construction appeared to indicate some 
terminal flaw in either concept or execution. While the successful creation of the ligation product 
was far from assured, an additional step that was proven to assist the uptake & replication of 
heavily modified or ‘damaged’ plasmids was that of a cloning intermediate strain. XL1-Blue was 
selected due to its easy availability, proven use in such methods & high transformation efficiency. 
The ligation reaction was repeated in the same form as before, involving the 1hr digestion & 
subsequent gel purification of vector & insert; the 30min dephosphorylation of the vector followed 
immediately by heat & EDTA inactivation; and a 16hr ligation reaction. The resultant ligation 
product can be seen in Figure 5-22.
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SC ladder
5 4________ 3 2 1 24ng/band
- 8.06kb
- 7.05kb
- 6.03kb 
-5.01 kb
- 3.99kb
- 2.97kb
- 2.06kb
Figure 5-22: New pET (T) ligation product vs linearised plasmid
0.8 % agarose gel run at 50V, 80mA for 40min. Lanes: 1 -  2pl supercoiled pET26b(+); 2 - 5pl 
pET26b(+) digested with Nco I & Bam HI; 3 -  5pl pET (T) linearised by digestion with Bam HI; 4 
& 5 - 10jaI pET (T) ligation product.
In Figure 5-22, the ligation product did appear to be approximately 500+bp larger than the 
linearised unmodified pET26b(+) plasmid. The bands were purified by gel extraction & 50ng were 
transformed into commercially competent XL1-Blue cells. Growth was weak compared to the 
transformation control, with approximately 400cfu/ml. Colonies were distinct, white & 1-2mm in 
diameter. 20 discrete colonies were picked and grown overnight in 5ml LB @ 37PC, 200rpm. 
Plasmid was extracted & analysed by electrophoresis (results shown in Figure 5-23).
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SC ladder SC ladder
24 ng/band 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 24ng/band
• m  m m
-  i  %  %  m  £ ■  4 -  k
* 6.03kb 7 05kb 
-5.01 kb
- 3.99kb
- 2.97kb
- 2.06kb
Figure 5-23: XL1-Blue:pET(T) minipreps
Multiple minipreps from XL1-Blue:pET (T) isolates vs pET26b(+) & pET (T) ligation product. 0.8% 
agarose gel run @ 50V, 80mA for 40min. Lanes: 1 -  2 jil supercoiled pET26b(+); 2 - 5^1 pET (T) 
ligation product; 3 - 5pl pET26b(+) digested with Nco I & Bam HI; 4 -  5|il pET (T) linearised by 
digestion with Bam HI; 5-16 - 5jil pET (T) transformant minipreps.
Although the majority of plasmids appeared to be the same weight as unmodified pET26b(+), 2 
isolates (lanes 10 & 14) were sufficiently closer to the target size of 6.1 kb to be worthy of further 
study. Both isolates were replated and 4 colonies from each isolate were cultured separately. 
Extracted plasmid was analysed by gel electrophoresis and direct sizing of the extracted plasmids 
revealed that they were approximately 6kb in weight, which corresponded well with the 6.1 kb 
calculated size. As a conclusive test for the presence of the r-trypsin gene, a PCR designed to 
amplify only the target gene was used on the 2 prospective successful isolates, 2 isolates 
determined by sizing to have failed and the original pHKY603 plasmid. As the primers (see Figure 
5-7) overlapped the gene at both termini and thus contained elements of sequence specific to 
pHKY603, the reaction was performed at low stringency to allow annealing with the putative pET 
(T) plasmid. Isolates ‘4’ & ‘13’ from the previous transformation (see Figure 5-23) were used as 
negative controls for this reaction. A product of 693bp was expected. Results shown below in 
Figure 5-24.
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SC ladder SC ladder
24 ng/band 10 9 8  7 6 5  4 3 2 1  24ng/band
Figure 5-24: PCR products from pET (T), pET26b(+) & pHKY603
1.2% agarose gel run at 50V, 80mA for 40min. Lanes 1-5 were amplified using 1.5mM MgCh. 
Lanes 1 - pHKY603 PCR product; 2 -  isolate ‘10’ PCR product; 3 -  isolate ‘14’ PCR product; 4 - 
isolate ‘4’ PCR product; 5 -  isolate ‘13’ PCR product; 6 - pHKY603 PCR product; 7 -  isolate ‘10’ 
PCR product; 8 -  isolate ‘14’ PCR product; 9 - isolate ‘4’ PCR product; 10 -  isolate ‘13’ PCR 
product;
The successful amplification of the gene confirmed the identity of isolates ‘10’ & ‘14’ as XL1- 
Blue:pET (T). Both isolates were propagated as maintenance strains and 50ng of purified plasmid 
from both was used to transform commercially competent BL21(DE3) cells. Both transformations 
resulted in good growth in relation to the transformation control, with transformation efficiencies of 
approximately 2.4 x 1 (M u/jig . Colonies were white & 1-3mm in diameter. 6 discrete colonies from 
each isolate plate (‘10’ & ‘14’) were picked and grown overnight in LB media @ 37°C, 200rpm. 
Plasmid from each was extracted and purified, then analysed by electrophoresis with all 
supercoiled extracts proving to be of the correct size (6.1 kb).
Analysis of the now confirmed BL21(DE3):pET (T) strain was continued with growth & 
expression profiling and fraction activity testing. Colonies of isolate ‘10’ were picked, grown 
overnight in 5mls LB @ 37°C, 200rpm, then 1ml of this seed culture was used to inoculate 100mls
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of LB in baffled 500ml shake flasks. Experimental fermentations were divided into those grown at 
37°C, 200rpm and those grown at 30°C, 200rpm, and subdivided into those induced early (A600 of 
0.6, blanked against uninfected media) and those induced late (A600 of 1.0). Growth profiles shown 
in Figure 5-25.
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A,B2.0 -
T3<D
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Figure 5-25: Growth of putative BL21 (DE3):pET(T) cultures
Growth of induced & non-induced BL21(DE3):pET (T) cultures in 100ml LB @ 30°C & 37°C, early 
& late induction, 200rpm. Induction was with 0.4mM IPTG. Key: A (-■ -) = early induction (120min, 
A600 = 0.61), grown at 37°C; B ( - * - )  = late induction (150min, A600 = 0.98), grown at 37°C; C 
( ) = non-induced culture, grown at 37°C; D ( - 0- )  = early induction (240min, A600 = 0.71),
grown at 30°C; E (--♦-■) = late induction (270min, A600 = 0.85), grown at 30°C; F ( a ) = non- 
induced culture, grown at 30°C. All A600 values blanked against uninfected media. Error bars 
represent standard error from three separate fermentations, run concurrently.
The cultures in Figure 5-25 incurred an obvious metabolic load upon induction, but overnight 
incubation showed comparable cell densities, which argued against the expression of an autotoxic 
product In order to visually test for the accumulation of an enzyme of the correct molecular weight 
(23Kda), a series of SDS-PAGE gels were performed, which ran the total cellular protein of 
induced and uninduced cultures against a commercial trypsin marker. Cultures were grown at 30°C
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and 37°C to investigate the influence of fermentation temperature on enzyme localization, with the 
effects of early & late induction (A600 = 0.6, beginning of exponential growth, /W  = 1.0, mid to end 
of exponential growth) also being factored. The annotated test sample gel for growth at 30°C & 
37°C with early in induction is shown in Figure 5-26, growth at both temperatures with late 
induction being shown in Figure 5-27. The gel of uninduced cultures at both temperatures is shown 
in Figure 5-28.
1 2 3 4 5 6 7 8 9 10 11 12
19kDa
Figure 5-26: Total protein from BL21(DE3):pET(T) grown at 30°C & 37°C, early induction
Total protein SDS-PAGE of BL21(DE3):pET (T) cultures induced early with 0.4mM IPTG at 
approximately A600 = 0.6, grown at 37°C & 306C. 15% acrylamide gel with 4% stacking gel, run @ 
80V fbr40min, then @ 150V for 120min. Lanes 3-8 contain the total protein of culture grown at 
37°C, lanes 9-11 contain the total protein of culture grown at 30°C. Lanes: 1 -  commercial protein 
mid-weight size ladder; 2 -  7.5^g commercial trypsin; 3 -.T1 (1hr after induction), 4 — T2; 5 — T3; 6 — 
T4; 7 -  T5; 8 -  T6; 9 -  T1; 10 -  T2; 11 -  T3; 12 -  T4.
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1 2  3 4  5 6 7  8 9 10 11 12
19k Da 4mm
Figure 5-27: Total protein from BL21(DE3):pET(T) grown at 30°C & 37°C, late induction
Total protein SDS-PAGE of BL21(DE3):pET (T) cultures induced late with 0.4mM IPTG at 
approximately A6oo = 1.0, grown at 37°C & 30°C. 15% acrylamide gel with 4% stacking gel, run @ 
80V for 40mm, then @ 150V for 120min. Lanes 3-8 contain the total protein of culture grown at 
37°C, lanes 9-11 contain the total protein of culture grown at 30°C. Lanes: 1 -  commercial protein 
mid-weight size ladder; 2 -  7.5^g commercial trypsin; 3 -.Ti (1hr after induction), 4 -  T2; 5 -  T3; 6 -  
T4; 7 — T5; 8 — T6; 9 — Ti; 1 0 -T 2; 11 - T 3; 12 — T4.
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1 2 3 4 5  6 7 8 9  10 11 12
25Kda
23Kda
19Kda
Figure 5-28: Total protein from BL21(DE3):pET(T) grown at 30°C & 37°C, no induction
Total protein SDS-PAGE of BL21 (DE3):pET (T) non-induced cultures, grown at 37°C & 30°C. 15% 
acrylamide gel with 4% stacking gel, run @ 80V Ibr40min, then @ 150V for 120min. Lanes 3-8 
contain the total protein of culture grown at 37°C, lanes 9-11 contain the total protein of culture 
grown at 30°C. Lanes: 1 -  commercial protein mid-weight size ladder 2 -  7.5^g commercial 
trypsin; 3 -.Ti(1 hr after induction), 4 — T2; 5 — T3; 6 — T4; 7 — T5; 8 — T6i 9 — Ti; I O - T 2; H - T 3; 12 
- T 4.
Although, in the absence of a specific test for r-trypsin concentration (e.g. a suitable ELISA), the 
23.5KDa band visible in the induced cultures could not be positively identified as r-trypsin, its 
density, as compared with the faint band visible in the uninduced cultures, was interpreted as a 
positive sign. The logical next step involved exploring the location of the overexpressed protein 
within the cell by means of fractionation and subsequent SDS-PAGE. The insoluble and soluble 
fractions of the culture were separated by the methodology described in Methods, section 5.2.5. As 
with the previous gels, cultures were grown at 30°C and 37°C and with early and late induction. 
Figure 5-29, Figure 5-30 & Figure 5-31 show samples run from cultures grown at 37°C and 
induced early, induced late and non-induced respectively. Figure 5-32, Figure 5-33 & Figure 5-34 
show samples grown at 30°C and induced early, induced late and non-induced respectively.
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1 2 3 4 5 6 7  8 9  10 11
23kOa
Figure 5-29: Fractionated BL21(DE3):pET(T), grown at 37°C with early induction
SDS-PAGE of fractionated induction run of BL21(DE3):pET (T) induced early with 0.4mM IPTG at 
approximately A6oo= 0.6, grown at 37°C. 15% acrylamide gel with 4% stacking gel, run @ 80V for 
40min, then @ 150V for 1 2 0 min. Lanes: 1 -  7.5pg commercial trypsin; 2 — (T2 — 2hrs after 
induction) insoluble fraction; 3 -  (T2) soluble fraction; 4 -  (T3) insoluble fraction; 5 -  (T3) soluble 
fraction; 6  -  (T4) insoluble fraction; 7 -  (T4) soluble fraction; 8 -  (T5) insoluble fraction; 9 -  (T5) 
soluble fraction; 1 0  -  (T16) insoluble fraction; 1 1 -  (T16) soluble fraction.
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1 2 3 4 5 6 7 8 9  10 11
Figure 5-30: Fractionated BL21(DE3):pET(T), grown at 37°C with late induction
SDS-PAGE of fractionated induction run of BL21(DE3):pET (T) induced late with 0.4mM IPTG at 
approximately A600 = 0.1, grown at 37°C. 15% acrylamide gel with 4% stacking gel, run @ 80V for 
40min, then @ 150V for 120min. Lanes: 1 -  7.5^g commercial trypsin; 2 — (T2 — 2hrs after 
induction) insoluble fraction; 3 -  (T2) soluble fraction; 4 -  (T3) insoluble fraction; 5 -  (T3) soluble 
fraction; 6 -  (T4) insoluble fraction; 7 -  (T4) soluble fraction; 8 -  (T5) insoluble fraction; 9 -  (T5) 
soluble fraction; 10 -  (T16) insoluble fraction; 11 -  (T16) soluble fraction.
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1 2 3 4  5  6  7 8 9  10  11
23k  Da
Figure 5-31: Fractionated BL21(DE3):pET(T), grown at 37°C without induction
SDS-PAGE of fractionated BL21(DE3):pET (T), non-induced, grown at 37°C. 15% acrylamide gel 
with 4% stacking gel, run @ 80V for40min, then @ 150V for 120min. Lanes: 1 -  7.5^g commercial 
trypsin; 2 — (T2 — 2hrs after induction of cultures in Figure 5-25) insoluble fraction; 3 -  (T2) soluble 
fraction; 4 -  (T3) insoluble fraction; 5 -  (T3) soluble fraction; 6 -  (T4) insoluble fraction; 7 -  (T4) 
soluble fraction; 8 -  (T5) insoluble fraction; 9 -  (T5) soluble fraction; 10 — (T16) insoluble fraction; 11 
— (T16) soluble fraction.
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Figure 5-32: Fractionated BL21(DE3):pET(T), grown at 30°C with early induction
SDS-PAGE of fractionated induction run of BL21(DE3):pET (T) induced early with 0.4mM IPTG at 
approximately A6oo = 0.6, grown at 30°C. 15% acrylamide gel with 4% stacking gel, run @ 80V for 
40min, then @ 150V for 120min. Lanes: 1 -  7.5pg commercial trypsin; 2 — (Ti — 1hr after induction) 
insoluble fraction; 3 — (Ti) soluble fraction; 4 -  (T2) insoluble fraction; 5 -  (T2) soluble fraction; 6 -  
(T3) insoluble fraction; 7 -  (T3) soluble fraction; 8 -  (T16) insoluble fraction; 9 -  (T16) soluble fraction.
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Figure 5-33: Fractionated BL21(DE3):pET(T), grown at 30°C with late induction
SDS-PAGE of fractionated induction run of BL21(DE3):pET (T) induced late with 0.4mM IPTG at 
approximately Aeoo= 1.0, grown at30°C. 15% acrylamide gel with 4% stacking gel, run @ 80V for 
40min, then @ 150V for 120min. Lanes: 1 -  7.5|ig commercial trypsin; 2 -  (Ti -  1hr after induction) 
insoluble fraction; 3 -  (Ti) soluble fraction; 4 -  (T2) insoluble fraction; 5 -  (T2) soluble fraction; 6  -  
(T3) insoluble fraction; 7 -  (T3) soluble fraction; 8  -  (T16) insoluble fraction; 9 — (T16) soluble fraction.
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Figure 5-34: Fractionated BL21(DE3):pET(T), grown at 30°C without induction
SDS-PAGE of fractionated BL21(DE3):pET (T) non-induced, grown at30°C. 15% acrylamide gel 
with 4% stacking gel, run @ 80V for 40min, then @ 150V for 120min. Lanes: 1 — 7.5jj.g commercial 
trypsin; 2 -  (Ti - 1  hr after induction of culture in Figure 5-25) insoluble fraction; 3 -  (Ti) soluble 
fraction; 4 -  (T2) insoluble fraction; 5 -  (T2) soluble fraction; 6 -  (T3) insoluble fraction; 7 -  (T3) 
soluble fraction; 8 -  (T16) insoluble fraction; 9 -  (Ti6> soluble fraction.
The preceding fraction gels appeared to indicate that r-trypsin was accumulating within the 
cytoplasm as inclusion bodies after induction, but it was necessary to run a comprehensive series 
of activity assays against L-BAPNA in order to ascertain whether any soluble protein present in the 
cytoplasm, reaching the cytoplasm, or being released into the supernatant upon cell lysis under 
any of the fermentation conditions tested. Methodology for these experiments is stated in 5.2.5. All 
experiments with induced culture were blanked against an uninduced culture processed in exactly 
the same manner, with the sample reagents. Blank (uninduced) values for this strain on L-BAPNA 
were relatively high (as compared to ELTRP-1) and so unblanked & blanked results have both 
been shown in Figure 5-35 (culture grown at 37°C, 4hrs after induction) and Figure 5-36 (culture 
grown at 37°C, 16hrs after induction).
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StError
(in ug/ml)
1 0.0732
2 0.101
2 0.112
4 0.0900
E 0326
e 0.110
7 0.0487
e 0.187
c 0.0748
1C 0.176
11 0.0631
12 0.506
13 0.284
14 0454
i e 0.555
16 0.107
Figure 5-35: Activity of BL21(DE3):pET (T) in various conditions, 4hrs after induction
Cultures were induced with 1mM IPTG after 3.5hrs (A600 = 0.62, blanked against uninfected 
medium). All samples were incubated at room temperature with the various reagents & gently 
shaken to prevent settling. Addition of substrate was performed immediately prior to reading. All 
activities were calculated after blanking against the specific uninduced sample blank. All 
experiments were performed at least in triplicate and standard error refers to deviation between 
experiments from a single fermentation.
Experiment key for Figure 5-35 & Figure 5-36:1 - Basic activity blank (no lysis, no denaturant): 
Uninduced culture + L-BAPNA; 2 - Basic activity (no lysis, no denaturant): Induced culture + L- 
BAPNA. Blanked against (1); 3 - Periplasmic activity blank: Uninduced culture + L-BAPNA + 
0.5jag/ml lysozyme; 4 - Periplasmic activity: Induced culture + L-BAPNA + 0.5jig/ml lysozyme. 
Blanked against (3); 5 - Total soluble activity blank: Uninduced culture + B-PER + L-BAPNA.; 6 - 
Total soluble activity: Induced culture + B-PER + L-BAPNA. Blanked against (5); 7 - Insoluble 
activity blank: Uninduced culture + B-PER + 200pg/ml lysozyme + 0.1M urea + L-BAPNA; 8 - 
Insoluble activity blank: Uninduced culture + B-PER + 200^g/ml lysozyme + 0.5M urea + L- 
BAPNA; 9 - Insoluble activity blank: Uninduced culture + B-PER + 200jig/ml lysozyme + 1M urea +
Expt. no.
2
1
Cone. 1 
(ug/ml)
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L-BAPNA; 10 - Insoluble activity blank: Uninduced culture + B-PER + 200jig/ml lysozyme + 2M 
urea + L-BAPNA; 11 - Insoluble activity blank: Uninduced culture + B-PER + 200jig/ml lysozyme + 
5M urea + L-BAPNA; 12 - Insoluble activity: Induced culture + B-PER + 200^g/ml lysozyme + 0.1 M 
urea + L-BAPNA. Blanked against (7); 13 - Insoluble activity: Induced culture + B-PER + 200^g/ml 
lysozyme + 0.5M urea + L-BAPNA. Blanked against (8); 14 - Insoluble activity: Induced culture + B- 
PER + 200jj.g/ml lysozyme + 1M urea + L-BAPNA. Blanked against (9); 15 - Insoluble activity: 
Induced culture + B-PER + 200(ig/ml lysozyme + 2M urea + L-BAPNA. Blanked against (10); 16 - 
Insoluble activity: Induced culture + B-PER + 200^ig/ml lysozyme + 5M urea + L-BAPNA. Blanked 
against (11).
StError (in 
ug/ml)
1 0.0732
5 0.101
2 0.112
4 0.0900
£ 0.326
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11 0.0631
15 0.506
12 0.284
14 0.454
15 0.555
15 0.107
Figure 5-36: Activity of BL21(DE3):pET (T) in various conditions, 16hrs after induction
Cultures were induced with 1mM IPTG after 3.5hrs (Aeoo = 0.62, blanked against uninfected 
medium). All samples were incubated at room temperature with the various reagents & gently 
shaken to prevent settling. Addition of substrate was performed immediately prior to reading. All
1 .5 -
Cone.
(ug/ml)
0.5
-0.5
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activities were calculated after blanking against the specific uninduced sample blank. All 
experiments were performed at least in triplicate and standard error refers to deviation between 
experiments from a single fermentation.
Experiment key: As above for Figure 5-35.
5.4 Discussion
5.4.1 Construction of pHKY (M) & pHKY (T)
Although the construction of pHKY (T) plasmid (oligonucleotides coding for pelB inserted at N- 
terminus of r-trypsinogen) appeared to be confirmed by successful transformation & colony 
propagation, and by PCR (Figure 5-14) originating in the signal sequence, the reasons for the 
repeated failure of the pHKY (M) construct (pro- sequence excised, pelB insert at N-terminus gene 
for mature enzyme) were unclear. SDS-PAGE of insoluble & soluble fractions of pHKY (T) (Figure 
5-15, Figure 5-16) showed that protein of the correct size was accumulating as inclusion bodies 
upon induction in approximately similar concentrations as with ‘wild-type’ ELTRP (see Chapter 3). 
Single residue activity assays performed on whole cell culture and in the presence of lysis and 
denaturing agents yielded no signal above the baseline hydrolysis rate of L-BAPNA in the specific 
conditions. The addition of the denaturing agent in particular (urea) appeared to increase the 
lability of the substrate approximately three-fold. As insoluble, non-active inclusion bodies 
appeared to be the default destination for all recombinant protein overexpressed in RV308:pHKY 
(T) in the course of a standard fermentation, and as no alteration of fermentation environmental 
conditions and thus expression rate were possible, the decisions was made to proceed with a 
vector more tailored for this work.
5.4.2 Construction of pET (T)
The repeated failures in the ligation of the pET (T) plasmid and the subsequent transformation did 
not appear to be attributable to any one cause. It was likely that a number of factors contributed, 
namely: initially relatively low quantities of material were used for the reaction; the purity of the 
double-digested vector was far from optimal, allowing easily recircularised once-digested plasmids 
to dominate the sample; the early stage failure to dephosphorylate the cut vector, again allowing
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for increased levels of recircularisation. These issues were overcome by means of extended 
digestion reactions, precise agarose gel extraction of digested vector and the brief use of calf 
intestinal alkaline phosphate in treating the cut, purified vector. The introduction of XL1-Blue as a 
cloning intermediate was critical in achieving viable transformants and thus stable, supercoiled pET 
(T) for subsequent BL21(DE3) transformation.
The cultures did appear to sustain an increased metabolic load upon induction (Figure
5-25). Fractionated, induction SDS-PAGE gels (Figures 5.26-5.34) revealed the accumulation of a 
protein of approximately the correct molecular weight (25.5kDa) in the insoluble fraction of each 
culture, irrespective of whether the culture was induced early (A6oo = 0.6) or late (A6oo = 1.0), or 
whether grown at 30°C or 37°C. L-BAPNA activity assays performed on whole cell culture and in 
the presence of lysis and denaturing agents yielded no signal above the baseline hydrolysis rate of 
the substrate (Figure 5-35 & Figure 5-36).
The insolubility and thus inactivity of the expressed protein and the lack of an assay that 
would test specifically for trypsin in a quantitative manner (e.g. a commercially available anti-trypsin 
IgG to form the basis for an ELISA) means that the ‘leakiness’ of the T7 promoter system in 
uninduced cultures could not be accurately assessed. Faint bands of the correct molecular weight 
were visible in uninduced BL21(DE3):pET(T) cultures (Figure 5-31, Figure 5-34), but this could 
have been to due to the expression of native chromosomal proteins of a similar molecular weight 
Comparison of uninduced RV308:pET (T) cultures with the insoluble fraction of RV308:pET20b(+) 
(Figure 5-20) supports this hypothesis.
The failure of the BL21(DE3):pET(T) to yield soluble, active r-trypsin, apparently 
irrespective of fermentation conditions, meant that only two lines of research remained open for the 
goal of generating a viable high-throughput screen. These were:
a) the processing of the inclusion bodies produced by BL21(DE3):pET(T) under various 
conditions and subjecting them to a factorial screen of the refolding parameters and co-factors 
identified in Chapter 3. The aim would be to attempt to establish a simple, micnoplate-based 
solubilisation & refolding protocol, similar to that tested in Chapter 3 but based around a more 
flexible promoter system.
b) the use of error-prone PCR or a suitable mutator strain to generate a mutant library of 
BL21 (DE3):pET(T) with subsequent screening protocols based on the basic L-BAPNA activity 
assay. As any signal above the baseline would indicate the presence of soluble enzyme, false
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positives should be rare and a large number of variants could be generated and tested based on 
their performance. This procedure was explored in Chapter 6.
5.5 Conclusions
The construction of pHKY (T) was shown to be successful, but resulted in no detectable active r- 
trypsinogen, which continued to accumulate as inclusion bodies within the cytoplasm. No 
alterations in fermentation conditions proved effective in altering the solubility of the recombinant 
enzyme.
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6 Mutagenesis & microwell fermentations
6.1 Introduction
6.1.1 Aims
The establishment of the BL21(DE3):pET (T) strain was verified in Chapter 5. Expression and 
subsequent state of the pelB-r-trypsin gene fusion was tested by means of fractionated SDS-PAGE 
and fraction activity assay under a variety of fermentation conditions, involving early & late 
induction and altered temperature (30°C & 37°C). The recombinant mature bovine trypsin was 
shown to be being expressed in high concentrations upon induction, but with all detectable enzyme 
accumulating as inactive inclusion bodies within the cytoplasm, a state that did not appear to be 
amenable to improvement by alteration in either induction level or temperature of the fermentation. 
As rational methods had thus failed to solubilise the enzyme, the logical next step was to construct 
a mutant library based on a simple activity screen. The current baseline of no detectable enzyme 
activity added to the simplicity and sensitivity of this process, with the result that any signal from a 
library variant tested on L-BAPNA implied directly that a certain percentage of the protein would be 
present in soluble, active form.
The screening of even a small, low-success probability library (e.g. > 2000 mutants) 
demanded the use of both microwell fermentations (for the individual culturing of the variants) and 
a microplate based activity assay (developed in Chapter 2). Micro-scale fermentation work, on­
going within the department, had shown that small-scale fermentations (1L) could be could be 
simulated, with various degrees of accuracy, by fermentations with a 96 deep, square-welled 
microplate. Such plates could be filled to a maximum of one fifth of their total volume with media 
and the crucial limiting factor in micro-scale down, that of oxygen transfer, was improved by means 
of high agitation rates, in the region of 900rpm on an orbital shaker, with the comers of the square 
wells acting as baffles and thus creating turbulence and enhanced mixing. For BL21(DE3):pET (T) 
mutants to be evaluated in this way, it was essential to first chart the growth, expression levels & 
enzyme activity of the un-mutated ‘wild-type’ over the course of a microwell fermentation.
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6.1.2 Use of mutator strains
The efficiency and flexibility of PCR-based methods for introducing mutations into a defined region 
of DNA, had been demonstrated by numerous research teams (Arnold and Volkov ,1999; Minshull 
and Stemmer, 1999)). The process was moderately labour intensive however, as it required that 
the mutated gene be cloned back into the vector. E coli mutator strains have the potential to 
simplify the process of library generation by accumulating mutations over the uncut plasmid, 
requiring simply a pooled lysis step and the subsequent transformation step into the expression 
strain. The XL1-Red mutator strain, a derivative of XL1-MRA (Stratagene) was developed by 
Greener and Callahan (Greener et a/., 1996) with the aim of being able to generate single-base 
mutation in a gene of interest over the course of a single over-night fermentation. To achieve this, 3 
well defined DNA repair pathways were irreversibly disabled. These corresponded to the genes: 
mutS -  which contributes to the mismatch repair pathway; mutT -  part of the oxo-dGTP repair 
pathway; and rrnAD- repairs base substitutions and frameshifts by forming, in conjunction with 
dnaQ, the 3’-5’exonuclease epsilon subunit of DNA polymerase HI (Miller, 1998). The researchers 
claim that this gave the strain a base mutation rate approximately 5000 times higher than that of 
wild-type E. coli and that the spontaneous mutation rate on a pBluescript plasmid was now 
measured at 1 mutation/2kb cloned DNA after 30 generations of exponential growth. As a possible 
side effect to the extensive genetic manipulation of the strain, the doubling time of XL1-Red was 
now increased to 90 minutes at 37°C. In order to allow the plasmid to be propogated through at 
least 30 generations with an overnight fermentation, colonies were first plated, then pooled (see 
Methods, section 6.2.3).
The test plasmid pET(T) was far from optimal for this work as r-trypsin constituted only an 
approximate sixth of the plasmid’s total sequence, and the percentage chance of a single mutation 
landing within this region was correspondingly low. An additional wony was the relatively low copy- 
number of the pET(T) plasmid (pET vectors have a published copy number of 10-15, while the 
pBluescript on which the developers’ calculations were based has a copy number of 25) (Greener, 
Callahan, and Jerpseth, 1996). It was decided to attempt to construct a mutation calibration curve 
using XL1-Red:pET (T), continually rediluting the test culture for continued exponential growth and 
thus propagating the plasmid through 30,40,50,60 generations. The aims were to calculate the 
overall mutation rate of the strain, to compare the quantity of mutations within the target region with
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the theoretical predictions and to attempt to calculate the impact of plasmid copy-number in such a 
process.
6.1.3 Microwell fermentations
An effective strategy of colony screening would require standardizing the growth rate of the well- 
cultures so that all wells could be induced simultaneously at the identical cell density. Novagen 
literature and the previous characterization work with RV308:pET (T) (Chapter 5) had established 
an induction OD of approximately A6oo = 0.6 (blanked against uninfected media) to be optimal for 
this strain. The physical dimensions and the opacity of the 96 square deep-well plates (□-plate) 
prevented direct measurement of the cultures by any of the available spectrophotometers. Growth 
rates would thus be initially determined by means of sacrificial wells and, on experimental plates, 
by means of a single sacrificial ‘marker* well inoculated with ‘wild-type’ RV308:pET (T). A uniform 
growth profile across the plate would be dependant upon a standardized inoculum being given to 
each well. It has been proven that the concentration of cells transferred by a manual or automated 
colony pick can vary by up to two orders of magnitude, resulting in well cultures entering 
logarithmic growth at intervals separated by up to several hours (unpublished departmental work). 
A further problem arose in that the colony picker was unable to inoculate deep-well plates unless 
they were filled with over 1.5mls of media, withl ml being known to be the maximum fill level 
possible before splashing would occur at 900rpm. Both problems could be solved by means of an 
overnight incubation in a standard 'shallow* 96-well plate. Experimental transformants would be 
picked and inoculated into 100^ 1 of media in a standard 96-well plate which would then be covered 
by a gas-diffusible membrane and incubated overnight to allow all well cultures to achieve an 
approximately equal end-density.
Opportunities for cross contamination of wells were predicted to occur at various points in 
the fermentation/screening protocol and could have a significant impact on the efficiency of the 
process in terms of the masking of less fit mutants and the generation of false-positives. The 
impact of errors accumulating in this way would be exacerbated with any increase in library size 
and thus it was essential to attempt to model the various forms of contamination using initial control 
plates. The shallow-well 16-hour incubation plates would be covered with a gas-permeable 
membrane following colony picking and thus could be agitated at 900rpm without fear of cross-
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contamination. Removal of the membrane inevitably resulted in a slight splash effect across the 
plate. This was minimized by the use of only limited volume (100^1) in each well. The primary 
window for well cross-contamination was during the open square 96 deep-well fermentation. It had 
been shown that the use of the gas-permeable membrane during a fermentation involving a ml or 
more of culture severely retarded the rate of oxygen transfer, and thus growth (unpublished 
departmental work). Temperature control in the current generation of open thermomixers was also 
proven to be unreliable, with a significant gradient between the top & bottom of a well, the only 
suitable solution involved installing the thermomixer within a sterilized dedicated incubator. The 
fermentation would then be run with the incubator could providing uniform temperature control and 
the thermomixer providing the high agitation rates necessary. Although no splashing was visible 
above the lip of the wells when 1ml of culture was mixed at 900rpm, the aerosolization due to high 
agitation and evaporation made a degree of contamination inevitable.
62  Materials and methods
6.2.2 Strains & vectors used
RV308 (Eli Lilly): (ELTRP-1 = RV308 + pHKY603) Strain is a derivative of £  coli K12. Fully 
genotype not released by company. Resistance: Smr.
BL21(DE3) (Novagen): derivative of B strain, F*, om pT hsdSB (rB m s) g a l dcm  (DE3)
XL1-Red (Stratagene): endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac mutD5 mutS mutt, Tn10(tetr) 
XL1-Blue (Stratagene): recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F proAB lacftZAM15 
TnfO(tetO]
pHKY603 (Eli Lilly): a derivative of pBR322. Fully sequence not released by company. Resistance: 
TcR,
pET26b(+) (Novagen): T7/ac, His*tag, f1 ori, pelB, kanr
6.2.3 Use of XL1 -Red to generate r-trypsin mutant library
Transformation of pET(T) into XL1-Red and subsequent growth was performed as specified in the 
manufacture's protocol with additional reference to the developers' notes (Greener, Callahan, and
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Jerpseth, 1996). The critical points are summarized here. The Epicurian coli commercially 
competent cells were thawed on ice, with p-mercaptoethanol being added to a final concentration 
of 25mM. 10-50ng of mini-prep quality plasmid DNA was added, allowed to stand on ice for 30min, 
and then transformed by a 45sec heat-shock at 42°C. The mix was then rested on ice for 2min and 
then allowed 1hr of non-selective incubation in sterile SOC at 37°C. The mix was then plated on 
selective LB agar (kan- 30jxg/ml) and incubated overnight at 37°C. The following day, a suitable 
plate (containing £ 200 colonies) was used to create the starter culture for the overnight liquid 
media fermentation. The colonies were pooled by washing the plate with a ml of sterile LB, which 
was then added to a further 9ml of LB broth (kan+30pg/ml). The culture was grown for an initial 
15hrs to achieve the target of 30 XL1-Red generations and was then rediluted 1:1000 with sterile 
broth and grown fora further 15hrs to propagate the plasmid through a further 10 generations (90 
minute doubling time x 10 generations). This sub-culturing step was repeated as desired. Plasmid 
was recovered via standard mini-prep and transformed into XL1-Blue and subsequently plated (for 
propagation & analysis) and BL21(DE3) (for expression & testing of r-trypsin). In order to obtain 
plasmid isolates for sequencing and thus calibration of mutation rate, random discrete XL1-Blue 
isolates were selected after plating and used to infect an overnight 5ml culture. Plasmid DNA was 
isolated and concentrated via mini-prep and quality was assessed prior to sequencing by means of 
0.8% agarose gel electrophoresis & PCR using T7 promoter & T7 terminator primers (Novagen) 
under standard conditions.
6.2.4 Microwell fermentations
For the experiments involving the microwell fermentation of BL21(DE3):pET (T) and its library 
variants, the following protocol was devised, with occasional slight variations indicated at the 
relevant points in the Results section.
A sterile standard shallow 96-well microplate (Starstedt) had each test well filled with 100pl 
sterile medium (either LB or M9SD) with 70|xg/ml kanamycin. A colony picker (QPix) was used to 
inoculate each well with the appropriate strain from an agar spread plate infected no longer than 1 
week previously and stored at4°C. The plate would then be covered with Breeth Easy membrane 
(Sigma Aldrich) and secured within a standard orbital shaker-incubator. Conditions would be set at 
37°C, 200rpm and fermentation would be allowed to occur for approximately 16-20hrs. Growth of
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the well cultures in the plate would then be analysed in a microplate reader at A600, blanking 
against wells containing uninfected medium. The BreethEzee film had to be removed gently to 
avoid the creation of a partial vacuum above the wells, leading to aerolization of droplets. For the 
primary induction run of the cultures, a sterile square, 96-deep-well plate (n-plate) would be 
prepared with 1ml media (70p,g/ml kan) in each blank, control & test well. 20jil of inoculum from 
the appropriate well of the previous overnight plate would be transferred by multipipette and the □- 
plate would be secured on a thermomixer, which would then be placed within a sterilized, 
dedicated incubator. The orbital shaker on the thermomixer would be set to deliver 900rpm with the 
heating plate disabled, and the incubator would be set to 37°C. As these were ‘open fermentations’ 
the door of the incubator was sealed with lab tape. The fermentation was allowed to proceed until 
the cultures reached a blanked A600 of approximately 0.6-0.7 (time point determined empirically by 
means of sacrificial wells in control plates) and they were then induced with 10pl100mM IPTG 
(final conc. of 1mM). The fermentation then continued under the same conditions for approximately 
16hrs. At the termination of the run, 500pJ of each of the well cultures was processed (cellular 
fractionation, addition of lysozyme or reducing agents) and then either subjected to activity testing 
against L-BAPNA or denatured and run on an SDS-PAGE. The remaining 500^1 of each test 
culture would either be transferred into individual, sterilized eppendorf tubes and stored at-20°C 
(considered viable for up to one week after freezing), or have sterilized glycerol added to a final 
concentration of 20% and stored at -80°C.
6.2.5 5ml fermentation procedure
For the 5ml fermentation work, which was intended to characterize in greater detail the favorable 
BL21(DE3):pET (T) mutant variants identified through the microplate screening work, the following 
protocol was used.
A sterile 50ml falcon tube would be filled with 5ml sterilized media (kan 70pg/ml) and 
capped with a porous foam bung. This would be inoculated with the appropriate strain either from 
glycerol stocks or from a recently infected agar spread plate. This was placed within an orbital 
shaker-incubator, securing all tubes at an angle of approximately 45° and allowed to grow 
overnight at 37°C, 200rpm. For the primary induction run of the cultures, an identical tube would be 
prepared and inoculated with 50pl of the overnight culture. This fermentation would proceed at
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200rpm and a set temperature (either 28°C, 32°C or 37°C) until in reached a blanked OD of 
approximately 0.6-0.7. The test & control cultures would then be induced by addition of 50pJ 
100mM IPTG (final conc. of 1mM) and the fermentation would proceed under the same conditions 
for approximately 16hrs. Upon completion the cultures were processed and stored in a manner 
identical to that of the deep-well cultures (Section 6.2.4).
6.2.6 100ml fermentation procedure
100ml fermentations of the potentially interesting BL21(DE3):pET (T) variants indicted by 
microplate screening were performed in order to obtain greater quantities of material for analysis 
and explore the possibility of scale-up work. All 100ml fermentations were performed according to 
the following protocol.
A sterile 50ml falcon tube would be filled with 5ml sterilized media (kan 70jj,g/mi) and 
capped with a porous foam bung. This would be inoculated with the appropriate strain either from 
glycerol stocks or from a recently infected agar spread plate. This was placed within an orbital 
shaker-incubator, securing all tubes at an angle of approximately 45° and allowed to grow 
overnight at 37°Cf 200rpm. For the primary induction run of the cultures, a sterilized 500ml baffled 
flask would be filled with 100mls sterilized medium (kan 70jig) and capped with a foam bung. This 
would be inoculated with SOOjoJ of the appropriate overnight culture. These flasks would then be 
secured within an orbital shaker-incubator and the fermentation would proceed at 200rpm and at a 
set temperature (either 28°C, 32°C or 37°C). Induction would occur when the cultures achieved a 
blanked OD A6oo of approximately 0.6-0.7 and by the addition of 1ml 100mM IPTG (final conc. of 
1mM). The fermentation would then proceed for a further 16hrs under the identical conditions. 
Upon completion the cultures were processed and stored in a manner identical to that of the deep- 
well cultures (Section 6.2.4)
6.2.7 Cellular fractionation
The protocols for the separation of the E. coli cultures into periplasmic, cytosolic & insoluble 
fractions were the same as described in chapter 5.
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6.2.8 Activity assays
Each enzymic activity assay performed on the BL21(DE3):pET (T) cellular fractions used the 
FLUOstar optima plate-reader (BMG). The assay was set up & controlled via the proprietorial 
software version 1.10-0. All tests were run in standard Starstedt shallow, 96-well microplates. The 
assay read the absorbance of the well solution at A405, with the reading period defined as a single 
kinetic window with each of the 20 readings consisting of 3 flashes, and a total of 65s to process a 
complete cycle. The plate was initially agitated (internal orbital shaker, 5mm displacement) for 10s 
prior to the first reading. Each reaction plate was set up according to the individual needs of the 
experiment, but in each case final well volume was held at 200|J. Substrate concentration (L- 
BAPNA) was kept at 1mM, added immediately prior to reading as a 50pJ 4mM aliquot
6.3 Results
6.3.2 Microwell fermentations of un-mutated BL21 (DE3):pET (T)
Initially, it was critical to establish the growth rate & induction point of un-mutated 
BL21(DE3):pET(T) in a 96 square, deep-well microplate, and investigate general compatibility with 
the QPix colony picker. Growth of the cultures was measured in both LB and M9SD media and was 
assessed by means of sacrificial wells. The initial overnight inoculum plate was prepared by using 
the Qpix to pick BL21 (DE3):pET(T) colonies from recently infected LB agar plates (kan 70pg/ml) to 
inoculate 48 wells of LB media (kan 70 i^g/ml) and 48 wells of M9SD media (kan 70 i^g/ml) on a 
standard shallow, 96-well plate. Readings were taken at Aon once per hour with 3 wells being used 
for each data point.
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Figure 6-1: Growth of BL21(DE3):pET(T) in a n-plate in LB and M9SD media at 37°C, 900rpm 
Key: A (-■ -)  = Induced LB media; B (—•»-) = uninduced LB media; C ( ^ * - )  = uninduced M9SD. 
20(il from the overnight inoculum plate was used to inoculate 1 ml of media. Density of inocula well 
cultures (blanked against uninfected media) at point of induction: LB = A6oo of 0.579, StDev of 
0.215; M9SD = A6oo of 0.425, StDev of 0.152. LB cultures were induced with 1mM IPTG at4hrs 
(A6oo = 0.582), M9SD cultures failed to achieve the required density over the course of the 
experiment and were not induced. Error bars represent standard error from three separate well- 
cultures.
Activity profiles of the fractionated LB cultures were performed in the presence of the same lysis & 
denaturing agents as those performed on the 100ml fermentations of un-mutated 
BL21(DE3):pET(T) (see Figures 5-35 & 5-36). The assay was performed on samples harvested 
4hrs after induction and samples collected at the termination of the experiment, approximately 
16hrs after induction. Blank (uninduced) values for this strain on L-BAPNA were relatively high (as 
compared to ELTRP-1) and so both unblanked & blanked results have both been shown in Figure
6-2 & Figure 6-3 so as to illustrate this fact.
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StError 
(Mg/ml)
1 0.945
Conc. 2 0.894
(|ig/m l) 3 0.939
4 1.054
5 1.035
6 1.19
7 1.037
8 0.892
Figure 6-2: Activity of BL21(DE3):pET(T) 4hrs after induction
Activity profile (in terms of pg/ml trypsin) of BL21(DE3):pET(T) on 1mM L-BAPNA, 4hrs after 
induction of a microplate fermentation held at 37°C, 900rpm (see Figure 6-1). Key: Yellow bars = 
blanked positive results; purple bars = unblanked positive results; negative results shown in white. 
Cultures were induced with 1mM IPTG after 4hrs (blanked A6oo of approximately 0.579, based on 
previous work: Figure 6-1). Each test was blanked against a series of wells containing identical 
conditions and uninduced culture. All experiments were performed at least in triplicate, results 
pooled from 2 fermentations under identical conditions. Experiments: 1 - Basic activity (no lysis, no 
denaturant): Induced culture + L-BAPNA); 2 - Periplasmic activity (Induced culture + L-BAPNA + 
0.5mg/ml lysozyme); 3 - Total soluble activity (Induced culture + B-PER + L-BAPNA); 4 - Insoluble 
activity (Induced culture + B-PER + 200mg/ml lysozyme + 0.1M urea + L-BAPNA); 5 - Insoluble 
activity (Induced culture + B-PER + 200mg/ml lysozyme + 0.5M urea + L-BAPNA); 6 - Insoluble 
activity (Induced culture + B-PER + 200mg/ml lysozyme + 1M urea + L-BAPNA); 7 - Insoluble 
activity (Induced culture + B-PER + 200mg/ml lysozyme + 2M urea + L-BAPNA); 8 - Insoluble 
activity (Induced culture + B-PER + 200mg/ml lysozyme + 5M urea + L-BAPNA).
210
Chapter 6: Mutagenesis & microwell fermentations Edward Hibbert
Expt no.
4
Conc. 2 
(pg/ml) o 
-2 
-4 
-6
StErr
(ug/ml)
1 0.863
2 0.859
3 0.882
4 0.923
5 0.863
6 0.902
7 0.854
8 0.862
Figure 6-3: Activty of BL21(DE3):pET(T) 16hrs after induction
Activity profile (in terms of ^ig/ml trypsin) of BL21(DE3):pET(T) on 1mM L-BAPNA, 16hrs after 
induction of a microplate fermentation held at 37°C, 900rpm (see Figure 6-1). Key: Yellow bars = 
blanked positive results; purple bars = unblanked positive results; negative results shown in white. 
Cultures were induced with 1mM IPTG after 4hrs (blanked A6oo of approximately 0.579, based on 
previous work: Figure 6-1). Each test was blanked against a series of wells containing identical 
conditions and uninduced culture. All well experiments were performed at least in triplicate, results 
pooled from 2 fermentations under identical conditions. Experiments: 1 - Basic activity (no lysis, no 
denaturant): Induced culture + L-BAPNA); 2 - Periplasmic activity (Induced culture + L-BAPNA + 
0.5mg/ml lysozyme); 3 - Total soluble activity (Induced culture + B-PER + L-BAPNA); 4 - Insoluble 
activity (Induced culture + B-PER + 200mg/ml lysozyme + 0.1 M urea + L-BAPNA); 5 - Insoluble
activity (Induced culture + B-PER + 200mg/ml lysozyme + 0.5M urea + L-BAPNA); 6 - Insoluble
activity (Induced culture + B-PER + 200mg/ml lysozyme + 1M urea + L-BAPNA); 7 - Insoluble
activity (Induced culture + B-PER + 200mg/ml lysozyme + 2M urea + L-BAPNA); 8 - Insoluble
activity (Induced culture + B-PER + 200mg/ml lysozyme + 5M urea + L-BAPNA).
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An SDS-PAGE gel of the culture in both media, 4 & 16hrs after induction was prepared in order to 
provide direct evidence for the overexpression and accumulation of r-trypsin in either the soluble or 
insoluble fraction.
J______ 2________ 3______4______£_____ 6______I_____ §_____ 5______ !£,
23* Da
Figure 6-4: Soluble & insoluble fractions from BL21(DE3):pET(T) fermentation
SDS-PAGE of soluble & insoluble fractions from un-mutated BL21(DE3):pET (T) microwell 
fermentations in LB & M9SD medium. 15% acrylamide gel with 4% stacking gel, run @ 80V for 
40min, then @ 150V for 120min. Lanes 3-6 hold fractions from culture grown in LB medium, lanes 
7-10 hold fractions from culture grown in M9SD medium. Both cultures were grown in square, 96 
deep-well plates (1ml culture, 37°C, 900rpm), with the LB culture being induced with a final conc. 
of 1mM IPTG 4hrs after inoculation. Lanes: 1 - 15jng commercial trypsin; 2 -  7.5^ig commercial 
trypsin; 3 -  soluble fraction from LB culture, 4hrs after induction; 4 - insoluble fraction from LB 
culture, 4hrs after induction; 5 - soluble fraction from LB culture, 16hrs after induction; 6 - insoluble 
fraction from LB culture, 16hrs after induction; 7 - soluble fraction from M9SD culture, 4hrs after 
induction; 8 - insoluble fraction from M9SD culture, 4hrs after induction; 9 - soluble fraction from 
M9SD culture, 16hrs after induction; 10 - insoluble fraction from M9SD culture, 16hrs after 
induction.
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6.3.3 Generation of first BL21 (DE3):pET (T) mutant library
6.3.3.1 Activity of library on L-BAPNA after microwell fermentation
Plasmid was propagated through 30 generations of XL1-Red growth as described in Section 6.2.3. 
After lysis of the mutator culture, pET(T) was transformed into BL21(DE3) and spread onto 
selective agar plates (Kan+70^g/ml).
The initial whole cell activity test was performed by picking distinct colonies from the 
spread plates constituting the library and inoculating a shallow, 96-well microplate. This was then 
incubated overnight and subsequently used to infect a opiate (as described in Section 6.2.3). 
Growth rate and thus induction time were based on those determined empirically for un-mutated 
BL21(DE3):pET (T) (Figure 6-1). For each screening run, two 96-well plates were infected, a 
restriction necessary due to the availability of only two thermomixers which were essential for the 
induction fermentation.
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Figure 6-5: Top 20 isolates from plates A & C, 4hrs after induction
Average activity of top 20 performing isolates from plates A & C with un-mutated strain as control, 
4hrs after induction. Key: A (-■ -) = uninduced ‘wild-type’ pET(T):BL21(DE3); B ( -» -)  = induced 
‘wild-type’ pET(T):BL21 (DE3); C ( ) = top 20 isolates from plate A; D (-<>-) = top 20 isolates
from plate C. Deep-well cultures were inoculated from overnight plate and induced to a final conc.
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of 1mM IPTG after 4hrs, conditions held at 37°C, 900rpm. Whole cell culture was mixed with lysis 
agent (B-PER) for 10min and then assayed immediately upon addition of L-BAPNA to a final 
concentration of 1mM. Error bars on activity of un-mutated strain indicate standard error calculated 
over 3 separate fermentation runs; error bars on mutant activity refer to deviation between isolates 
in the initial screen.
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Figure 6-6: Top 20 isolates from plates A & C, 16hrs after induction
Top 20 performing isolates from plates A & C, with un-mutated strain as control, 16hrs after 
induction. Key: A (-■ -)  = uninduced ‘wild-type’ pET(T):BL21(DE3); B ( - * - )  = induced ‘wild-type’ 
pET(T):BL21 (DE3); C ( ) = top 20 isolates from plate A; D (^> -) = top 20 isolates from plate C.
Deep-well cultures were inoculated from overnight plate and induced to a final conc. of 1mM IPTG 
after 4hrs, conditions held at 37°C, 900rpm. Whole cell culture was mixed with lysis agent (B-PER) 
for 10min and then assayed immediately upon addition of L-BAPNA to a final concentration of 
1mM. Error bars on activity of un-mutated strain indicate standard error calculated over 3 separate 
fermentation runs; error bars on mutant activity refer to deviation between isolates in the initial 
screen. Isolates selected for both plates are indicated in bold in Table 6-1.
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Plate A (ng/ml trypsin)
A 1.75 1.98 4.36 1.32 5.47 2.82 -0.12 3.04 3.16 22.06 117.58 75.23
B 4.28 0.86 1.13 5.00 3.47 7.12 5.95 21.99 21.80 71.38 147.77 99.32
C 11.32 3.82 -0.29 -1.97 3.73 36.35 41.34 56.18 56.01 28.59 90.46 96.71
D 7.75 6.71 1.68 75.00 14.99 112.35 113.26 71.77 67.64 18.18 5.65 68.84
E 17.09 20.53 47.06 4.97 91.77 135.32 32.38 96.38 114.79 44.67 12.99 8.89
F 12.25 61.55 59.71 41.17 96.36 102.95 154.21 130.11 124.90 101.92 61.93 7.26
G 5.20 11.16 106.41 94.45 89.16 96.53 101.14 109.16 97.95 134.97 61.49 39.76
H 5.90 36.49 66.40 68.23 92.14 65.93 67.06 92.03 99.84 29.09 74.21 34.17
1 2 3 4 5 6 7 8 9 10 11 12
Plate C (ng/ml trypsin)
A 7.40 8.52 7.53 16.85 10.12 53.53 1.60 3.07 4.90 3.12 8.49 2.24
B 5.88 10.92 7.78 8.10 9.33 48.41 2.60 59.98 92.71 5.52 7.74 3.32
C 12.50 5.32 7.47 160.31 29.63 143.69 149.95 158.80 53.15 10.66 8.22 8.13
D 157.11 156.12 8.05 161.32 104.18 56.00 98.35 117.51 13.51 7.79 8.13 3.10
E 5.80 48.39 6.35 70.90 8.98 6.42 123.12 172.10 4.39 4.80 3.37 5.53
F 55.09 44.11 92.90 8.02 8.15 6.69 8.43 5.30 7.31 -1.62 7.45 2.95
G 112.93 112.18 4.69 8.42 7.74 68.54 41.72 7.05 8.70 1.43 8.95 2.28
H 6.73 4.38 8.16 7.46 7.42 17.07 11.14 3.93 8.36 3.95 8.10 1.54
1 2 3 4 5 6 7 8 9 10 11 12
Table 6-1 :Results from plates A & C from first library, 16hrs after induction of well cultures.
Results in pg/ml of trypsin activity, measured against standards of commercial trypsin rnn on a 
separate plate. Isolates in bold represent the twenty top performing mutants from each plate.
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Figure 6-7: Activity histogram from ‘A’ plate
Activity distribution of the 96 screened BL21(DE3):pET (T) variants from the ‘A’ library plate.
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Figure 6-8: Activity histogram from ‘C’ plate
Activity distribution of the 96 screened BL21(DE3):pET (T) variants from the ‘C’ library plate.
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Stringent testing of the best performing isolates was necessary in order to distinguish between 
genuine soluble mutants and false positives arising from the open deep-well fermentation. 10 from 
each plate were selected for further testing, including both the strongest performers and a sample 
of those in close proximity to them. Retesting involved the culturing of each clone from streak 
plates grown from original glycerol stocks, and growth in 6 individual deep-wells, separated from 
other well-cultures by at ieast a column of uninfected weiis. Mutants were blanked against induced 
& uninduced ‘wild-type’ pET(T):BL21(DE3) and activity was calibrated by the supplementation of 
uninduced wild-type cultures with commercial trypsin.
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Figure 6-9: ‘A’ plate Isolate retesting
Retesting of positive isolates from ‘A’ library plate by microwell fermentation in presence of 
appropriate controls. Activity read over 20min @ A405, blanked against induced activity of un- 
mutated BL21(DE3):pET (T). Whole cell culture was mixed with lysis agent (B-PER) for 10min and 
then assayed immediately upon addition of L-BAPNA to a final concentration of 1mM. X-axis label 
indicates the well position of the isolate on the initial library plate. Error bars refer to standard error 
from 6 individual well-cultures.
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Figure 6-10: ‘C’ plate isolate retesting
Retesting of positive isolates from ‘C’ library plate by microwell fermentation in presence of 
appropriate controls. Activity read over 20min @ A405, blanked against induced activity of un- 
mutated BL21(DE3):pET (T). Whole cell culture was mixed with lysis agent (B-PER) for 10min and 
then assayed immediately upon addition of L-BAPNA to a final concentration of 1mM. X-axis label 
indicates the well position of the isolate on the initial library plate. Error bars refer to standard error 
from 6 individual well-cultures.
6.3.3.2 Expression profile & activity of library on L-BAPNA after 5ml fermentation
Based upon the results from the further analysis of the positive isolates from library plates A & C 
(see Figure 6-9 & Figure 6-10 respectively), 5 variants from plate C were selected for further 
analysis. These were, in no order G1, D1, D2, D4, C4. So as to better characterize these variants 
in terms of expression levels, plasmid stability & growth rate with regard to the potential autotoxicity 
of the recombinant mature trypsin, a series of 5ml fermentations was performed. A profile of r- 
trypsin expression levels and activity in LB at growth temperatures of 28°C, 32°C & 37°C, 200rpm 
over the course of a 5ml fermentation was built by means of growth plots (Figures 6.12-14), L- 
BAPNA activity testing of cellular fractions (Figure 6-15: 28°C; Figure 6-20:32°C; Figure 6-25 
&Figure 6-26:37°C) & SDS-PAGE gels (Figures 6.16-19:28°C; .Figures 6.21-24:32°C; Figures 
6.27-30:37°C).
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Figure 6-11: Growth of un-mutated BL21(DE3):pET (T) in a 5ml LB culture at 28°C, 32°C & 
37°C
Key: A (-■ -) = culture grown at 37°C; B ( - ^ - )  = grown at 32°C; C ( ) = grown at 28°C.
Agitation held at 200rpm. Induction of cultures grown at 37°C with a final concentration of 1mM 
IPTG occurred after 360 minutes (blanked Aeoo of approximately 0.6); cultures grown at 28°C & 
37°C were induced 480 minutes after inoculation. Error bars indicate standard error from 8 
individual well-cultures.
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Figure 6-12: Growth rates of the 5 selected variants in 5ml LB cultures @ 28°C, 200rpm
Key: A (-■ -) = isolates G1 (induced & uninduced), D1 (induced & uninduced); B ( - * - )  = isolates 
D2 (induced & uninduced), D4 (induced & uninduced), C4 (induced & uninduced). Blanked against 
uninfected media. Isolates grouped for clarity, error bars refer to standard deviation between them.
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Figure 6-13: Growth rates of the 5 selected variants in 5ml LB cultures @ 32°C, 200rpm 
Key: A ( - • - )  = isolates G1 (induced & uninduced), D1 (induced & uninduced); B ( - * - )  = isolates 
D2 (induced & uninduced), D4 (induced & uninduced), C4 (induced & uninduced). Blanked against 
uninfected media. Isolates grouped for clarity, error bars refer to standard deviation between them.
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Figure 6-14: Growth rates of the 5 selected variants in 5ml LB cultures @ 37°C, 200rpm 
Key: A (-■ -) = isolates G1 (induced & uninduced), D1 (induced & uninduced); B ( - * - )  = isolates 
D2 (induced & uninduced), D4 (induced & uninduced), C4 (induced & uninduced). Blanked against 
uninfected media. Isolates grouped for clarity, error bars refer to standard deviation between them.
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Figure 6-15: Activity of 5ml cultures grown in LB @ 28°C, 200rpm
The terms U & I refer to uninduced and induced cultures respectively.
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Figure 6-16: G1 fractions, 5ml, 28°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant G1 during the course of a 5ml 
fermentation in LB, held at 28°C, 200rpm. Lanes 2-5 contain culture that was induced with IPTG to 
a final conc. of 1mM, lanes 6-9 hold culture which was not induced. Lanes: 1 -  7.5pg of 
commercial trypsin; 2 -  soluble fraction of culture, 3hrs after induction; 3 -  insoluble fraction of 
culture, 3hrs after induction; 4 -  soluble fraction of culture, 16hrs after induction; 5 -  insoluble 
fraction of culture, 16hrs after induction; 6 -  soluble fraction of culture, 3hrs after induction of test 
cultures; 7 -  insoluble fraction of culture, 3hrs after induction of test culture; 8 -  soluble fraction of 
culture, 16hrs after induction of test culture; 9 -  insoluble fraction of culture, 16hrs after induction of 
test culture; 10 -  7.5pg commercial trypsin; 11 - 15pg commercial trypsin.
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Figure 6-17: D1 & C4 fractions, 5ml, 28°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variants D1&C4 during the course of a 5ml 
fermentation in LB, held at 28°C, 200rpm. Lanes 2-9 hold samples from D1, lanes 9-12 contain 
samples from C4. Lanes 2-5 hold culture that was induced with IPTG to a final conc. of 1mM, lanes 
6-9 contain culture that was not induced. Lanes: 1 -  7.5pg of commercial trypsin; 2 -  soluble 
fraction of culture, 3hrs after induction; 3 -  insoluble fraction of culture, 3hrs after induction; 4 -  
soluble fraction of culture, 16hrs after induction; 5 -  insoluble fraction of culture, 16hrs after 
induction; 6 -  soluble fraction of culture, 3hrs after induction of test cultures; 7 -  insoluble fraction 
of culture, 3hrs after induction of test culture; 8 -  soluble fraction of culture, 16hrs after induction of 
test culture; 9 -  insoluble fraction of culture, 16hrs after induction of test culture; 10 -  (C4) soluble 
fraction of culture, 3hrs after induction; 11 -  (C4) insoluble fraction of culture, 3hrs after induction; 
12 -  (C4) soluble fraction of culture, 3hrs after induction of test culture.
224
Chapter 6: Mutagenesis & microwell fermentations Edward Hibbert
1______2 3 4 5 6 7 8 9 10 11 12
Figure 6-18: D2 & C4 fractions, 5ml, 28°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variants D2 & C4 during the course of a 5ml 
fermentation in LB, held at 28°C, 200rpm. Lanes 2-9 hold samples from D2, lanes 9-12 contain 
samples from C4. Lanes 2-5 hold culture that was induced with IPTG to a final conc. of 1mM, lanes 
6-9 contain culture that was not induced. Lanes: 1 -  7.5^g of commercial trypsin; 2 -  soluble 
fraction of culture, 3hrs after induction; 3 -  insoluble fraction of culture, 3hrs after induction; 4 -  
soluble fraction of culture, 16hrs after induction; 5 -  insoluble fraction of culture, 16hrs after 
induction; 6 -  soluble fraction of culture, 3hrs after induction of test cultures; 7 -  insoluble fraction 
of culture, 3hrs after induction of test culture; 8 -  soluble fraction of culture, 16hrs after induction of 
test culture; 9 -  insoluble fraction of culture, 16hrs after induction of test culture; 10 -  (C4) insoluble 
fraction of culture, 3hrs after induction of test culture; 11 -  (C4) soluble fraction of culture, 16hrs 
after induction; 12 -  (C4) soluble fraction of culture, 16hrs after induction of test culture.
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Figure 6-19: D4 & C4 fractions, 5ml, 28°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant D4 & C4 during the course of a 5ml 
fermentation in LB, held at 28°C, 200rpm. Lanes 2-9 hold samples from D4, lanes 9-11 contain 
samples from C4. Lanes 2-5 hold culture that was induced with IPTG to a final conc. of 1mM, lanes 
6-9 contain culture that was not induced. Lanes: 1 -  7.5pg of commercial trypsin; 2 -  soluble 
fraction of culture, 3hrs after induction; 3 -  insoluble fraction of culture, 3hrs after induction; 4 -  
soluble fraction of culture, 16hrs after induction; 5 -  insoluble fraction of culture, 16hrs after 
induction; 6 -  soluble fraction of culture, 3hrs after induction of test cultures; 7 -  insoluble fraction 
of culture, 3hrs after induction of test culture; 8 -  soluble fraction of culture, 16hrs after induction of 
test culture; 9 -  insoluble fraction of culture, 16hrs after induction of test culture; 10 -  (C4) insoluble 
fraction of culture, 16hrs after induction; 11 -  (C4) insoluble fraction of culture, 16hrs after induction 
of test culture.
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Figure 6-20: Activity of 5ml cultures grown in LB @ 32°C, 200rpm
The terms U & I refer to uninduced and induced cultures respectively.
Edward Hibbert
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Figure 6-21: G1 & C4 fractions, 5ml, 32°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant G1 & C4 during the course of a 5ml 
fermentation in LB, held at 32°C, 200rpm. Lanes 2-9 hold samples from G1, lanes 9-12 contain 
samples from C4. Lanes 2-5 hold culture that was induced with IPTG to a final conc. of 1mM, lanes 
6-9 contain culture that was not induced. Lanes: 1 -  7.5pg of commercial trypsin; 2 -  soluble 
fraction of culture, 3hrs after induction; 3 -  insoluble fraction of culture, 3hrs after induction; 4 -  
soluble fraction of culture, 16hrs after induction; 5 -  insoluble fraction of culture, 16hrs after 
induction; 6 -  soluble fraction of culture, 3hrs after induction of test cultures; 7 -  insoluble fraction 
of culture, 3hrs after induction of test culture; 8 -  soluble fraction of culture, 16hrs after induction of 
test culture; 9 -  insoluble fraction of culture, 16hrs after induction of test culture; 10 -  (C4) soluble 
fraction of culture, 3hrs after induction; 11 -  (C4) insoluble fraction of culture, 3hrs after induction; 
12 -  (C4) soluble fraction of culture, 3hrs after induction of test culture.
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Figure 6-22: D1 fractions, 5ml, 32°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant D1 during the course of a 5ml 
fermentation in LB, held at 32°C, 200rpm. Lanes 2-5 hold culture that was induced with IPTG to a 
final conc. of 1mM, lanes 6-9 contain culture that was not induced. Lanes: 1 -  7.5^ig of commercial 
trypsin; 2 -  soluble fraction of culture, 3hrs after induction; 3 -  insoluble fraction of culture, 3hrs 
after induction; 4 -  soluble fraction of culture, 16hrs after induction; 5 -  insoluble fraction of culture, 
16hrs after induction; 6 -  soluble fraction of culture, 3hrs after induction of test cultures; 7 -  
insoluble fraction of culture, 3hrs after induction of test culture; 8 -  soluble fraction of culture, 16hrs 
after induction of test culture; 9 -  insoluble fraction of culture, 16hrs after induction of test culture.
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Figure 6-23: D2 & C4 fractions, 5ml, 32°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant D2 & C4 during the course of a 5ml 
fermentation in LB, held at 32°C, 200rpm. Lanes 2-9 hold samples from D2, lanes 9-12 contain 
samples from C4. Lanes 2-5 hold culture that was induced with IPTG to a final conc. of 1mM, lanes 
6-9 contain culture that was not induced. Lanes: 1 -  7.5pg of commercial trypsin; 2 -  soluble 
fraction of culture, 3hrs after induction; 3 -  insoluble fraction of culture, 3hrs after induction; 4 -  
soluble fraction of culture, 16hrs after induction; 5 -  insoluble fraction of culture, 16hrs after 
induction; 6 -  soluble fraction of culture, 3hrs after induction of test cultures; 7 -  insoluble fraction 
of culture, 3hrs after induction of test culture; 8 -  soluble fraction of culture, 16hrs after induction of 
test culture; 9 -  insoluble fraction of culture, 16hrs after induction of test culture; 10 -  (C4) insoluble 
fraction of culture, 3hrs after induction of test culture; 11 -  (C4) soluble fraction of culture, 16hrs 
after induction; 12 -  (C4) soluble fraction of culture, 16hrs after induction of test culture.
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Figure 6-24: D4 & C4 fractions, 5ml, 32°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant D4 & C4 during the course of a 5ml 
fermentation in LB, held at 32°C, 200rpm. Lanes 2-9 hold samples from D4, lanes 9-11 contain 
samples from C4. Lanes 2-5 hold culture that was induced with IPTG to a final conc. of 1mM, lanes 
6-9 contain culture that was not induced. Lanes: 1 -  7.5^g of commercial trypsin; 2 -  soluble 
fraction of culture, 3hrs after induction; 3 -  insoluble fraction of culture, 3hrs after induction; 4 -  
soluble fraction of culture, 16hrs after induction; 5 -  insoluble fraction of culture, 16hrs after 
induction; 6 -  soluble fraction of culture, 3hrs after induction of test cultures; 7 -  insoluble fraction 
of culture, 3hrs after induction of test culture; 8 -  soluble fraction of culture, 16hrs after induction of 
test culture; 9 -  insoluble fraction of culture, 16hrs after induction of test culture; 10 -  (C4) insoluble 
fraction of culture, 16hrs after induction; 11 -  (C4) insoluble fraction of culture, 16hrs after induction 
of test culture.
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Figure 6-25: Activity of 5ml cultures grown in LB @ 37°C, 200rpm
The terms U & I refer to uninduced and induced cultures respectively.
Figure 6-25 illustrates the total soluble enzyme activity obtained from each of the five isolates. In 
order to determine the location of the active enzyme within the cell, all soluble fractions 
(supernatant, periplasm & cytoplasm) were then purified and assayed. Results shown in Figure 
6-26.
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Figure 6-26: Activity of fractionated 5ml culture grown in LB @ 37°C, 200rpm 
All results blanked against the activity of the appropriate fraction from an uninduced culture. 
Fractions tested were: supernatant (Super); periplasm (Peri); cytoplasm (Cyto). The terms 1,4 & 
ON (overnight) refer to cultures tested 1,4 & 16 hours after induction respectively. Results were
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not blanked against uninduced culture as such cultures exhibited almost identical levels of activity 
and thus could not be considered background.
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Figure 6-27: G1 & C4 fractions, 5ml, 37°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant G1 & C4 during the course of a 5ml 
fermentation in LB, held at 37°C, 200rpm. Lanes 3-10 hold samples from G1, lanes 11-12 contain 
samples from C4. Lanes 2-5 hold culture that was induced with IPTG to a final conc. of 1mM, lanes 
6-9 contain culture that was not induced. Lanes: 1 -  commercial protein ladder A; 2 -  7.5^g of 
commercial trypsin; 3 -  soluble fraction of culture, 3hrs after induction; 4 -  insoluble fraction of 
culture, 3hrs after induction; 5 -  soluble fraction of culture, 16hrs after induction; 6 -  insoluble 
fraction of culture, 16hrs after induction; 7 -  soluble fraction of culture, 3hrs after induction of test 
cultures; 8 -  insoluble fraction of culture, 3hrs after induction of test culture; 9 -  soluble fraction of 
culture, 16hrs after induction of test culture; 10 -  insoluble fraction of culture, 16hrs after induction 
of test culture; 11 -  (C4) soluble fraction of culture, 3hrs after induction; 12 -  (C4) insoluble fraction 
of culture, 3hrs after induction.
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Figure 6-28: D1 & C4 fractions, 5ml, 37°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant D1 & C4 during the course of a 5ml 
fermentation in LB, held at 37°C, 200rpm. Lanes 2-9 hold samples from D1, lanes 9-11 contain 
samples from C4. Lanes 2-5 hold culture that was induced with IPTG to a final conc. of 1mM, lanes 
6-9 contain culture that was not induced. Lanes: 1 -  7.5jig of commercial trypsin; 2 -  soluble 
fraction of culture, 3hrs after induction; 3 -  insoluble fraction of culture, 3hrs after induction; 4 -  
soluble fraction of culture, 16hrs after induction; 5 -  insoluble fraction of culture, 16hrs after 
induction; 6 -  soluble fraction of culture, 3hrs after induction of test cultures; 7 -  insoluble fraction 
of culture, 3hrs after induction of test culture; 8 -  soluble fraction of culture, 16hrs after induction of 
test culture; 9 -  insoluble fraction of culture, 16hrs after induction of test culture; 10 -  (C4) soluble 
fraction of culture, 3hrs after induction of test culture; 11 -  (C4) insoluble fraction of culture, 3hrs 
after induction of test culture.
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Figure 6-29: D2 & C4 fractions, 5ml, 37°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant D2 & C4 during the course of a 5m! 
fermentation in LB, held at 37°C, 200rpm.. Lanes 3-10 hold samples from D2, lanes 11-12 contain 
samples from C4. Lanes 2-5 hold culture that was induced with IPTG to a final conc. of 1mM, lanes 
6-9 contain culture that was not induced. Lanes: 1 -  commercial protein ladder A; 2 -  7.5pg of 
commercial trypsin; 3 -  soluble fraction of culture, 3hns after induction; 4 -  insoluble fraction of 
culture, 3hrs after induction; 5 -  soluble fraction of culture, 16hrs after induction; 6 -  insoluble 
fraction of culture, 16hrs after induction; 7 -  soluble fraction of culture, 3hrs after induction of test 
cultures; 8 -  insoluble fraction of culture, 3hrs after induction of test culture; 9 -  soluble fraction of 
culture, 16hrs after induction of test culture; 10 -  insoluble fraction of culture, 16hrs after induction 
of test culture; 11 -  (C4) soluble fraction of culture, 16hrs after induction; 12 -  (C4) insoluble 
fraction of culture, 16hrs after induction.
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Figure 6-30: D4 fractions, 5ml, 37°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant D4 during the course of a 5ml 
fermentation in LB, held at 37°C, 200rpm. Lanes 2-9 hold samples from D4, lanes 9-12 contain 
samples from C4. Lanes 2-5 hold culture that was induced with IPTG to a final conc. of 1mM, lanes 
6-9 contain culture that was not induced. Lanes: 1 -  7.5pg of commercial trypsin; 2 -  soluble 
fraction of culture, 3hrs after induction; 3 -  insoluble fraction of culture, 3hrs after induction; 4 -  
soluble fraction of culture, 16hrs after induction; 5 -  insoluble fraction of culture, 16hrs after 
induction; 6 -  soluble fraction of culture, 3hrs after induction of test cultures; 7 -  insoluble fraction 
of culture, 3hrs after induction of test culture; 8 -  soluble fraction of culture, 16hrs after induction of 
test culture; 9 -  insoluble fraction of culture, 16hrs after induction of test culture; 10 -  (C4) soluble 
fraction of culture, 16hrs after induction of test culture; 11 -  (C4) insoluble fraction of culture, 16hrs 
after induction of test culture; 12 -  (C4) repeat of lane 11.
6.3.3.3 Expression profile & activity of library on L-BAPNA after 100ml fermentation
In order to expand upon the results obtained from the 5ml fermentation of the 5 selected isolates, 
an attempt was made to scale the fermentations up to 100ml. The obvious advantage gained from 
such a move would be the increase in material available for protein analysis and the increased
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ease by which the growth profile of a larger culture could be measured (i.e. the possibility of on-line 
turbidity or dissolved oxygen measurements). Such refinements could prove crucial if plasmid 
stability or recombinant protein autotoxicity were indeed proving to be a problem, requiring control 
of the fermentation. Once again a profile of trypsin expression levels and activity in LB at 37°C, 
200rpm over the course of a 100ml fermentation was built by means of growth plots, L-BAPNA 
activity testing of ceiiular fractions & SDS-PAGE gels.
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Figure 6-31: Growth rates of the 5 selected variants in 100ml LB cultures @ 37°C, 200rpm 
Key: A (— -) = isolate G1; B ( - * - )  = D1; C ( ) = D2; D (-< H  = D4; E (--♦-•) = C4. Blanked
against uninfected media.
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Figure 6-32: Activity of fractionated 100ml cultures grown in LB @ 37°C, 200rpm
Fractions tested were: supernatant (Super); periplasm (Peri); cytoplasm (Cyto). All culture tested 
was harvested 16hrs after induction.
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Figure 6-33: G1 fractions, 100ml, 37°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant G1 during the course of a 100ml 
fermentation in LB, held at37°C, 200rpm. Lanes 2-6 hold uninduced culture, lanes 8-12 contain 
induced culture. Lanes: 1 -  7.5fig commercial trypsin; 2 -  total protein from culture, 3hrs after 
induction of test culture; 3 -  supernatant from culture, 3hrs after induction of test culture; 4 -  
periplasmic fraction, 3hrs after induction of test culture; 5 -  cytoplasmic fraction, 3hrs after 
induction of test culture; 6 -  insoluble fraction, 3hrs after induction of test culture; 7 -  7.5jxg 
commercial trypsin, 8 -  total protein from culture, 16hrs after induction; 9 -  supernatant from 
culture, 16hrs after induction; 10 -  periplasmic fraction, 16hrs after induction; 11 -  cytosolic 
fraction, 16hrs after induction; 12 -  insoluble fraction, 16hrs after induction.
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Figure 6-34: D1 fractions, 100ml, 37°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant D1 during the course of a 100ml 
fermentation in LB, held at 37°C, 200rpm. Lanes 2-6 hold uninduced culture, lanes 8-12 contain 
induced culture. Lanes: 1 -  7.5^g commercial trypsin; 2 -  total protein from culture, 3hrs after 
induction of test culture; 3 -  supernatant from culture, 3hrs after induction of test culture; 4 -  
periplasmic fraction, 3hrs after induction of test culture; 5 -  cytoplasmic fraction, 3hrs after 
induction of test culture; 6 -  insoluble fraction, 3hrs after induction of test culture; 7 -  7.5|j.g 
commercial trypsin, 8 -  total protein from culture, 16hrs after induction; 9 -  supernatant from 
culture, 16hrs after induction; 10 -  periplasmic fraction, 16hrs after induction; 11 -  cytosolic 
fraction, 16hrs after induction; 12 -  insoluble fraction, 16hrs after induction.
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Figure 6-35: D2 fractions, 100ml, 37°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant D2 during the course of a 100ml 
fermentation in LB, held at37°C, 200rpm. Lanes 2-6 hold uninduced culture, lanes 8-12 contain 
induced culture. Lanes: 1 -  7.5^g commercial trypsin; 2 -  total protein from culture, 3hrs after 
induction of test culture; 3 -  supernatant from culture, 3hrs after induction of test culture; 4 -  
periplasmic fraction, 3hrs after induction of test culture; 5 -  cytoplasmic fraction, 3hrs after 
induction of test culture; 6 -  insoluble fraction, 3hrs after induction of test culture; 7 -  7.5^g 
commercial trypsin, 8 -  total protein from culture, 16hrs after induction; 9 -  supernatant from 
culture, 16hrs after induction; 10 -  periplasmic fraction, 16hrs after induction; 11 -  cytosolic 
fraction, 16hrs after induction; 12 -  insoluble fraction, 16hrs after induction.
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Figure 6-36: D4 fractions, 100ml, 37°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant D4 during the course of a 100ml 
fermentation in LB, held at 37°C, 200rpm. Lanes 2-6 hold uninduced culture, lanes 8-12 contain 
induced culture. Lanes: 1 -  7.5ng commercial trypsin; 2 -  total protein from culture, 3hrs after 
induction of test culture; 3 -  supernatant from culture, 3hrs after induction of test culture; 4 -  
periplasmic fraction, 3hrs after induction of test culture; 5 -  cytoplasmic fraction, 3hrs after 
induction of test culture; 6 -  insoluble fraction, 3hrs after induction of test culture; 7 -  7.5^g 
commercial trypsin, 8 -  total protein from culture, 16hrs after induction; 9 -  supernatant from 
culture, 16hrs after induction; 10 -  periplasmic fraction, 16hrs after induction; 11 -  cytosolic 
fraction, 16hrs after induction; 12 -  insoluble fraction, 16hrs after induction.
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Figure 6-37: C4 fractions, 100ml, 37°C
Soluble & insoluble fractions of BL21(DE3):pET (T) variant C4 during the course of a 100ml 
fermentation in LB, held at 37°C, 200rpm. Lanes 2-6 hold uninduced culture, lanes 8-12 contain 
induced culture. Lanes: 1 -  7.5^g commercial trypsin; 2 -  total protein from culture, 3hrs after 
induction of test culture; 3 -  supernatant from culture, 3hrs after induction of test culture; 4 -  
periplasmic fraction, 3hrs after induction of test culture; 5 -  cytoplasmic fraction, 3hrs after 
induction of test culture; 6 -  insoluble fraction, 3hrs after induction of test culture; 7 -  7.5ng 
commercial trypsin, 8 -  total protein from culture, 16hrs after induction; 9 -  supernatant from 
culture, 16hrs after induction; 10 -  periplasmic fraction, 16hrs after induction; 11 -  cytosolic 
fraction, 16hrs after induction; 12 -  insoluble fraction, 16hrs after induction.
6.3.4 Sequencing of variants
The rtrypsin gene in all variants was sequenced using universal T7 promoter & terminator primers 
and the region immediately upstream was sequenced using an oligonucleotide complementary to 
the terminal portion of the pelB leader sequence (oligo 6 from Figure 5-2). The sequencing failed or 
produced poor results on the first four attempts with the apparent cause being poor plasmid quality.
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Variants D1, D2, D4 & C4 were eventually resolved but revealed no mutations from the original 
cloned pET(T) construct either within the coding region or in the control elements immediately 
upstream. Variant G1 continually failed to be sequenced, despite the isolation of mini-prep quality 
plasmid and the successful optimization of PCR conditions by this researcher.
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Figure 6-38: PCR of the 5 r-trypsin variants in conditions of varying [MgCh]
120ng of Plasmid pET(T) was amplified with T7 promoter & terminator oligonucleotides: expected 
product = 980 nucleotides. 1.2% agarose gel run at 50V, 80mA for 1hr. Lanes: 1 - G1 with 0.8mM 
MgCI2; 2 -  G1 with 1,5mM MgCI2; 3 -  G1 with 2.8mM MgCI2; 4 -  D1 with 0.8 mM MgCI2; 5 - D1 
with 1.2mM MgCI2; 6 — D1 with 2.8mM MgCI2; 7 -  D2 with 0.8mM MgCI2; 8 -  D2 with 1.5mM 
MgCI2; 9 -  D2 with 2.8mM MgCI2; 10 -  D4 with 0.8mM MgCI2; 11 -  D4 with 1,5mM MgCI2; 12 -  D4 
with 2.8mM MgCI2; 13 -  C4 with 0.8mM MgCI2; 14 -  C4 with 1.5mM MgCI2; 15 -  C4 with 2.8mM 
MgCI2.
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6.3.5 Testing of mutation rate of XL1-Red
In order to calibrate the mutation rate generated by XL1-Red, pET(T) plasmid was propagated 
through increasing generations of growth (growth and subculturing protocols in Section 6.2.3). 
Sequencing was performed using universal T7 primers and results are shown in Table 6-2.
XL1-Red:pET(T)
Generation
Mutations
G40A, B, C None within the sequenced range.
G50A None within the sequenced range.
G50B Possible single T  insertion @ nt position 943.
G50C Possible substitution ‘A->G’ @ nt 15
G60A None within the sequenced range.
G60B Possible substitution ‘T->C’ @ nt325.
G60C None within the sequenced range.
Table 6-2: XL1-Red induced mutations
Showing results from the XL1-Red:pET (T) growth experiment, listing mutations accumulated in the 
region between the T7 promoter & terminator (incl. r-typsin) over the course of 60 generations. The 
test region sequenced was 1006nt in length and was sequenced with in both directions, but the 
limitations of process meant that good resolution was only achieved over an average of 850nts. 
Total size of pETfT) = 6031 bp. Plasmid from three random isolates was purified & sequenced after 
40,50 & 60 generations. Possible mutations refer to those detected at a non-overlapping end of 
the sequence trace and thus may be signal artefacts.
6.4 Discussion
6.4.2 Microwell fermentations of un-mutated BL21(DE3):pET (T)
Comparison of the growth of BL21 (DE3):pET (T) in 1 ml of the two media types (LB & M9SD) over 
the course of a 20hr fermentation @ 37°C, 900rpm in a opiate showed that only LB was capable
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of supporting growth at an acceptable rate (see Figure 6-1). In LB, the induction point of A600 0.6- 
0.7 (blanked against uninfected medium) was reached after 4hrs.
Activity testing of the cellular fractions was performed on samples taken 4hrs & 16hrs after 
induction and blanked against those taken from uninduced n-plate cultures of a similar age (see 
Figure 6-2,Figure 6-3). The 4hr results yielded approximately 0.7jig/ml trypsin from the soluble 
fraction as a whole, based on an assay involving the simple lysis of the cell, while the periplasmic 
fraction yielded 0.51 ^ g/ml and the unlysed cell culture (supernatant plus cells) gave 0.76jxg/ml. 
Work with tow levels of urea appeared to give an elevated signal, possibly reflecting the release of 
r-trypsin from the insoluble fraction, but this could not be confirmed. 16hr results (Figure 6-4) 
showed an elevated basic activity of the unlysed cell culture to 1.9pg/ml and a similar rise in 
periplasmic activity to 1.86^g, but contrasted this with a severe drop in the activity of the total 
soluble fraction as opposed to that of the uninduced control.
The SDS-PAGE of the soluble and insoluble fractions from the deep-well fermentations of 
both media (Figure 6-4) clearly showed protein bands of approximately the correct molecular 
weight in the soluble & insoluble fraction, but, without an appreciable degree of overexpression or a 
activity-independent specific concentration assay (e.g. a dual layer ELISA), the identity of these 
bands could not be clarified.
6.4.3 Activity of library on L-BAPNA after microwell fermentation
The percentage of positive results from the first two plates screened from the initial XL1-Red 
mutant library was extremely high, with a full 47% of isolates on the ‘A’ plate and 27% of isolates 
on the ‘C’ plate exhibiting higher activity levels than the ‘wf BL21(DE3):pET (T) after a 20hr n-plate 
fermentation. The apparent statistical impossibility of such a result is mollified by the fact that a 
significant proportion of results were false positives arising form the open deep-well fermentation. 
From the isolates selected for further testing in tables 6.5 & 6.6, (A)G3, (A)D7 & (A)E9 were clearly 
false positives with a number of other isolates exhibiting only slight increases over wild-type 
activity. The still high numbers of positive isolates would appear to indicate that a significant 
mutation occurred within one of the first few generations of XL1-Red growth and was then 
propagated through the subsequent generations, eventually being represented in a high fraction of 
the library.
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6.4.4 Expression profile & activity of library on L-BAPNA after 5ml fermentation
Growth of the five selected isolates (G1, D1, D2, D4, C4) in 5ml LB cultures demonstrated a 
slightly enhanced rate of growth over that of the un-mutated strain in identical conditions (Figure 
6-11). During a fermentation held at 28°C (Figure 6-12), all five isolates achieved the induction 
point (blanked A6oo of 6-0.8) after 420 minutes as opposed to the 480 minutes required by the wild- 
type. A 32°C fermentation (Figure 6-13) demonstrated the isolates reaching induction point after 
360 minutes, with the wild-type again requiring 480 minutes. During the course of a 37°C 
fermentation (Figure 6-14), both the variants and the wild type achieved the required density after 
360 minutes. After induction at 360 minutes during the 37°C fermentation, the wild-type appeared 
to suffer a transient drop in cell growth rate & density, suggesting that induction placed a metabolic 
load upon the culture. No similar effect was visible in the growth kinetics of the mutant variants.
Activity testing of the cellular fractions from a 5ml culture held at 37°C (see Figure 6-26) 
appeared to reveal a particular pattern, namely that the concentration of r-trypsin in the periplasm 1 
hour after induction was approximately 2-4 fold that found in the supernatant, while the 
concentration in the cytoplasm read as less than that in the uninduced cultures. These levels, while 
remaining constant relative to each other, increased 34 fold in the fractions harvested 4 hours 
after induction. The fractions taken from the overnight cultures (approximately 16 hours after 
induction) were considerably lower, usually beneath the level of 1-hour readings.
The collection of whole cells from 5ml fermentations grown at 28°C, 32°C, 37°C and the 
subsequent testing of the total soluble protein (Figure 6-15, Figure 6-20, Figure 6-25) respectively) 
revealed a 30-50% drop in r-trypsin concentration with each increase in temperature. As with the 
previous results, there was minimal difference in protein concentration between the induced and 
uninduced cultures, although the levels in the uninduced culture did tend to exhibit a higher titre of 
approximately 1-5^g/ml.
Analysis of the SDS-PAGE gels run with extracts of the soluble & insoluble fractions of 
culture grown at each temperature (Figures 6.16-6.30) did not reveal any evidence of recombinant 
protein over-expression in either fraction of any of the isolates. There appeared to be no significant 
difference in the protein profile between the induced & uninduced cultures of the mutated variants 
and no visible relationship between expression levels and the activity readings obtained was 
evident
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6.4.5 Expression profile & activity of library on L-BAPNA after 100ml fermentation
All 5 variants performed abnormally in 100ml cultures with a severely depressed growth rate as 
compared to that of the wild-type strain. Variants G1, D1, D2 & C4 only achieved the cell density 
required for induction (blanked A6oo of 0.6-0.8) after 420 minutes (Figure 6-31), while un-mutated 
BL21(DE3):pET (T) reached the induction point after only 120 minutes (Figure 5.38). 16 hours after 
the induction of these isolates, the cultures were a muddy brown in colour, with a relatively low cell 
density (Aeoo of 1.2-1.36) and a high degree of aggregated insoluble matter in suspension, 
suggesting that a considerable degree of cellular lysis had occurred. Isolate D4 grew at a 
comparable rate to the wild-type, yet demonstrated no transient reduction of growth rate upon 
induction. After 16hrs, this culture was the usual turbid, deep-yellow colour.
Activity readings of the cellular fractions after a 20-hour 100ml fermentation held at 37°C
(Figure 6-32) appeared relatively similar to those recorded after the 37°C 5ml fermentations of the 
5 variants, with the exception that slightly elevated levels of r-trypsin were present in the 
supernatant Once again, there was no appreciable difference in the concentration of r-trypsin 
between the induced & uninduced cultures.
The SDS-PAGE gels of the fractionated 37°C 100ml fermentation (Figures 6.33-6.37) 
show fractions from cultures at the point of induction and 16 hours afterwards, but show no 
significant over-expression or translocation of any protein of the correct molecular weight.
6.4.6 General
The results show a clear but puzzling progressive drop in activity in all mutant variants since their 
initial isolation. The second n-plate fermentation demonstrated a 2-10 fold drop in protein 
concentration from the first screening. This trend was exacerbated in un-shown work that recorded 
subsequent n-plate fermentations tending towards almost untraceable concentrations. Scale-up of 
the test cultures brought further complications as cultures became increasingly prone to failure (no 
growth or heavily retarded), although the reduction in metabolic rate caused by holding the 
temperature of a 5ml fermentation down to 28°C did bring activity levels back up to half of their 
initially screened value. The apparent loss or suppression of enzyme after the procedure of 
fractionation was most likely due to the increase in dilution factor, a statement difficult to quantify 
as no attempt was made to estimate the volume of soluble protein in the cytoplasm and the
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periplasm. A suppression of activity was observed but compensated for by the use of commercial 
trypsin controls in each of the buffers. Attempts to scale-up the cultures by a further factor of 20 
increased their apparent instability, resulting in severely retarded growth rates and an apparent 
high degree of lysis in the cultures, although recombinant protein remained at low but detectable 
levels, with a predictably increased supernatant titre.
The five isolate tested appeared to fall into two distinct groups: G1 & D1 showing 
comparably high levels of activity in the 5ml tow-temperature fermentations; and D2, D4 & C4 
exhibiting consitently tower levels of activity. The reproducibility of these results would appear to 
point towards the presence of two disintinct mutations, but this could only be confirmed by 
sequencing. For detailed discussion of the the characteristics of the five isolates, please see 
Chapter 7.
6.4.7 Solubility of rtrypsin following mutation & scale-up issues
The presence of no mutations within r-trypsin and its immediate upstream control elements, 
coupled with the clear reduction in specific protein yield shown by the various SDS-PAGE gels 
when compared to the fractionated gels made from un-mutated BL21(DE3):pET (T) cultures, 
implied that either elements influencing plasmid stability had been altered or that expression was 
being influenced by a remote mutation. Selective pressures brought about by the autotoxicity of the 
now soluble recombinant mature trypsin were also clearly compromising plasmid stability. Although 
it was not possible to observe this directly, due to the apparent disabling/deregulating of the 
induction mechanism, indirect evidence was presented by the increasingly poor growth 
performance of the strain as fermentation conditions improved as a result of scale-up. On the basis 
of the evidence presented here, it would therefore seem reasonable to assume the following: 1) 
that plasmid variants tested had accmed through XL1-Red fermentation one or more identical or 
functionally identical nucleotide mutations, none of which were detected in the gene itself or in the 
upstream ribosome binding site, -35 or-10 motifs; 2) these mutations suppressed T7 based 
expression to such a degree that induction of the strain was now functionally irrelevant; 3) despite 
this, the apparent degree of expression cassette ‘leakage’ from these variants appeared to be 
significantly higher than that of un-mutated BL21(DE3):pET (T), while remaining at a low enough 
level to allow the recombinant enzyme to fold naturally into an active conformation in the soluble
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fraction of the ceil; 4) partial translocation of the now soluble pelB sequence-tagged protein 
between the cytoplasm & periplasm was hinted at in the fractionation results at all scales, but could 
not be accurately assessed, or indeed regarded as a fully genuine result, as no fraction specific 
protein 'markers’ were available as thus the integrity of both fractions collected was in doubt. While 
a series of tests was run using periplasmic extraction buffers containing progressively less 
lysozyme, there could be no confirmation in this system that a certain percentage of cells were 
simply being lysed and thus contaminating the sample.
Although no protein bands of the same molecular weight as r-trypsin were detected in the 
gels, there did appear to be a range of new lower molecular weight bands in both the soluble and 
insoluble fractions. The possible significance of these bands is discussed in Section 7.1.2.
6.4.8 XL1-Red mutation rates
For any mutator strain, the rate of spontaneous mutagenesis would be directly proportional to the 
number of generations that the DNA of interest was propagated and thus, although strain doubling 
time is significant, the copy number of the target plasmid would be equally important This fact is 
ignored in Stratagen company literature, which states only the mutation rate determined by the 
developers usingacolEI vector (Greener et a/., 1996). pBluescriptcolEI variant (top deletion) 
cloning vectors exhibit a copy-number of ~100, total size = 4kb, while pBR322 vectors (on which 
pET(T) was based) have a copy-number of 15-25 per cell, total size of pET(T) = -6.1 kb 
(Sambrook, 1989). To generate the same mutation rate per kb, an experimental protocol would 
thus require pET(T) to be propagated for four to five times the number of generations as stated in 
the manufacture’s notes, with a rate of 2nt substitutions per kb requiring approximately 150 
generations. As 30 generations can be accomplished through a pooling and overnight growth step, 
but each successive sub-culturing (1:1000 dilution and allowed to grow to stationary phase: 
approximately 10 generations) involves a 15 hour fermentation step, any advantages in speed and 
ease of manipulation gained through the use of the mutator strain are negated. The size of the 
vector possess an additional problem as any mutation has only a 1:6 chance of lying within the 
region of interest and thus a high mutation rate must be pursued to avoid a library composed 
almost entirely of wild-type enzyme. pBR322 vectors can thus not be recommended for use with 
the XL1-Red strain unless a strategy of selection could be implemented. Viable alternatives would
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be any of the pUC-based plasmids which are based on the same mutated colE1 origin as the 
vector used by the developers and would thus exhibit a similar copy number.
6.5 Conclusions
High levels of r-trypsin activity achieved in microwell fermentation of multiple mutants generated 
through XL1-Red mutagenesis.
Subsequent testing revealed approximately 80% of the positive mutations generated to be 
false positives. Such false positives would have arisen through cross-contamination of the 
microwells during open fermentation.
The five isolates tested performed increasingly poorly when scaled up to 5ml and then 
100ml fermentations, exhibiting raised levels of plasmid instability and culture lysis.
Activity appeared to be temperature and scale sensitive, with a 5ml fermentation held at 
28°C being the only experiment to show comparable levels of activity with the initial microwell 
fermentations.
No protein bands of the correct molecular weight as trypsin were detected in fractionated 
protein gels made from each fermentation, but new bands of a range of lower molecular weights 
were apparent.
X11-Red should be considered an inefficient method of mutagenesis for the majority of pET 
vectors due to their size and copy number.
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7 Discussion
7.1 Further analysis of pET(T):BL21(DE3) behaviour
7.1.1 Unking activity & plasmid stability to culturing steps
All five selected clones from the first pET(T) library, see Section 6.3.3, demonstrated high levels of 
plate to plate variation in terms of activity and plasmid instability (difficulty in obtaining good quality 
plasmid or culture failure), with sequential repeats of an experiment yielding progressively poorer 
results. The principle example of this was the failure to replicate the initial high activity levels 
obtained from the clones in the first screen (Figure 6-6) in subsequent rounds of microplate 
fermentation and testing, and in the repeated failure of 5ml cultures to reach an acceptable cell 
density (un-shown work). Upon examination of the sequence of experiments it became clear that 
experiments demonstrating the highest levels of enzyme activity (any fraction) and the lowest level 
of well variability were those where the fermentation was inoculated directly from the original 
glycerol stocks (replica fermentation plates from ‘A’ & ‘B’, see Section 6.2.4) and that the 
decreasing fitness of each clone could be approximately correlated with the degree of propagation 
away from these stocks.
A significant point was that for each non-microplate fermentation mn (5ml, 100ml), in the 
interests of a standardised inoculum and thus limited variability in growth rates and induction point, 
an initial 5ml overnight fermentation was performed. While this would be good practise in an 
established system when attempting to maximise mn reproducibility, in an evidently unstable 
experimental strain such as pET(T):BL21(DE3), forcing cultures to grow to saturation an additional 
time before commencing the monitored fermentation and activity assay could have greatly added 
to the problems encountered. The second major issue was that, with the exception of the final 
round of 5ml fermentations, experimental inoculum overnight cultures were themselves inoculated 
from ‘live culture' spread plates as oppose to directly from glycerol stock. The agar (LB) spread 
plate cultures were refreshed once per month and held at4°C throughout, with the concept being 
that the use of such plates would prevent continual accessing of the stocks, with the possibility of 
contamination and the continual slight degradation of quality that this would bring. Analysis of the 
scheduling of particularly the replicates of the 5ml experimental runs showed that the highest levels 
of activity, coupled with low in-test variation, were obtained from cultures inoculated from spread-
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plates only 1-4 days old. Clearly, the autotoxicity of whatever soluble protein was being produced, 
coupled with the documented ‘leakiness’ of the 17 promoter (Komai et a/., 1997), was sufficient to 
rapidly degrade the fitness of any standing culture, even with metabolism being repressed at 4°C.
7.1.2 Location of expressed r-trypsin
As variable activity readings were detectable from all fermentations it was reasonable to conclude 
that some levels of soluble trypsin was being expressed in the culture (despite the comparable 
activity levels between induced and uninduced strains, see Section 7.1.5), but the fractionated 
SDS-PAGE gels run after every fermentation (see Chapter 6) showed very little expressed enzyme 
of the correct molecular weight. Comparison of induced and uninduced cellular fractions proved 
futile as there was no significant difference in the banding profile between the two, but analysis of 
gels mn from the fermentation products of the wild-type strain under identical conditions (Chapter 
5) showed that several new protein bands were evident, encompassing a range of molecular 
weights from ~ 20kDa to 2kDa. The most significant addition, present in the soluble and insoluble 
fractions of all variants, at each scale and temperature, was a dense low molecular weight band, 
which appeared to contain increasing amounts of material as the fermentation temperature 
increased. The band was also usually stronger in the soluble fraction for the early part of the 
fermentation (1-4hrs), while the four other new bands (ranging in size from slightly below the 
23kDa of mature trypsin, to just above the dominant trace) were uniformly stronger in the insoluble 
fraction. Comparisons of growth temperature and clones also revealed that these four ‘middle 
molecular weight’ bands were strongest in fractions mn from variants G1 and D1 at 28° and 32°C, 
which correlates with the high activity readings obtained from these two particular clones. As 
cytosolic and periplasmic trypsin activity was confirmed by a comprehensively blanked assay and 
yet no mature enzyme was visible, it was reasonable to assume that the new bands were digestion 
products of the mature enzyme, resulting from attack of native proteolytic enzymes or through 
autohydrolysis. An attempt to examine the autohydrolysis products of trypsin was made by allowing 
the slight degradation of the marker protein used (storage at 4°C overnight before freezing as 
stock). The resultant digestion bands from the commercial trypsin approximately match those seen 
in the experimental lanes although certain of them appear slightly smaller, a fact which could point 
to failure in the release of the pelB leader sequence from the recombinant protein. The pelB
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sequence contains 20 amino acids with a molecular weight of 2.026kDa and thus could account for 
a slight visible size discrepancy in certain fragments, and would indicate that those enzyme 
digestion products contained the N-terminal region of the protein.
Bovine trypsin contains 16 potential sites for autohydrolysis (15 lysine residues and 2 
arginine), excluding the lysine found in the cleavage site of the trypsinogen prosequence (please 
see Figure 1-7 for an annotated trypsin sequence). If auto-digestion were allowed to run to 
completion then 17 fragments would result, ranging in length from 2 amino acids to 63 (extended 
section of beta-sheet plus pelB leader), the accessibility of each cutting site would significantly 
influence the rate and order of product formation, but, if allowed to proceed for long enough, all 
sites would eventually become accessible through the gradual dissolution of the molecule. The 
potential theoretical number of partially digested enzyme fragments would be extremely large, but it 
was likely, that within a limited time frame, a few forms would predominate based on certain 
exposed arginine or lysine residues. Potentially favourable cutting sites were hard to predict 
however as only one arginine residue and two lysine residues are completely hidden below the 
surface of the molecule, while the rest participate in surface helices, sheets ands loops.
7.1.3 Linking activity readings to autohydrolysis
The apparently partially digested state of the expressed enzyme raises the question of how any 
trypsin activity was recorded from the cultures, particularly as care was taken that samples 
intended forSDS-PAGE were processed (denatured) immediately upon collection, and thus should 
accurately reflect the internal state of the cells. At an IPTG concentration of 0.4 -1 mM, a T7 
promoter system is capable of mediating rapid expression of a recombinant enzyme, such that 
after 2-4hrs it can comprise -50% of the total cellular protein (Studier ,1991; Studier and Moffatt, 
1986), and thus even a high rate of autohydrolysis would leave a steady-state level of active 
enzyme in the cell.
An additional point would be that partial autohydrolysis need not destroy the functionality of 
the protease as, depending on the location of the digestion point, the forces involved in secondary 
structure may often prove sufficient to maintain a protein in the correct conformation. In possible 
confirmation of this, of the surface exposed cutting sites, 6 of the lysine are structural components 
of anti-parallel beta-sheets, where strong lateral hydrogen bonding can provide a stabilising
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‘scaffold’ against chain breakage (Creighton, 2000), and 2 lysine residues and the sole exposed 
arginine are present in short loops between anti-parallel sheets, which could again compensate for 
any loss in stability due to cleavage. As a robust digestive-tract enzyme, trypsin possesses six 
disulphide bonds, four of which span at least half the sequence length of the protein (see Figure 
1-7), and these may also provide a stabilising influence, allowing a peptidase with one or two 
primary sequence cuts to remain active, assuming that they were able to form correctly in the 
cytoplasm or periplasm. If the above suggestions were in some way accurate, and that primary 
sequence cuts were accumulating on the protease molecules but that forces of secondary and 
tertiary structure were acting to maintain the integrity of the substrate binding pocket and catalytic 
sites, then ihe proteins would appear as multiple small fragments under SDS-PAGE, as sample 
preparation conditions are sufficiently denaturing to dissolve all bonds except the covalent peptide 
bond.
7.1.4 Cleavage of pelB
Fractionation activity tests of the five variants gave ambiguous results as to whether translocation 
of the expressed enzyme into the periplasm was occurring at an appreciable rate, but gel 
electrophoresis appeared to show trypsin autodigestion products still bonded to the pelB leader 
sequence in the soluble fraction (see Section 7.1.2). As a ‘signal-recognition particle’ (SRP) 
independent signal sequence translocated through the Sec system (Martoglio and Dobberstein, 
1998), pelB is known to be cleaved by the membrane bound Spase I  and released back into the 
cytoplasm. It could thus be reasonable to assume that those ffagements that are still connected to 
the leader sequence did not undergo active, Sec-mediated transport through the cytoplasmic 
membrane. There are multiple documented cases of failure in the translocation of fusion proteins, 
with commonly cited reasons being a propensity of the recombinant protein to aggregate, possibly 
leading inclusion body formation, or high rates of proteolysis, with the added factor that high 
expression rates can exacerbate both effects (Mujacic et a/., 1999; Wickner et al., 1991). Improved 
expression levels do not necessarily translate into higher yields of periplasmic protein as it has 
been demonstrated that export efficiency decreases significantly when protein overexpression is 
sufficient to saturate elements of the system (Mujacic, Cooper, and Baneyx, 1999). It is entirely 
possible that the failure to sufficiently reduce the expression rate (even the ‘enhanced leakage’ rate
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evident in the mutants, see Section 7.1.5) caused a bottleneck at the level of SecB binding and 
thus allowed the rate of proteolytic digestion (including autodigestion) of the enzyme to increase to 
an effective V max. Upregulated secretion rates, with an accompanying drop in levels of insoluble 
cytoplasmic recombinant protein, have been achieved by the supplementation of additional copies 
of the genes secY & secE, elements of the sec translocation machinery, showing that periplasmic 
transport can indeed act as a rate-limiting step (Perez-Perez et a l., 1994).
Signal sequences that remain exposed within the cytoplasm have been shown to be 
processed by a number of prokaryotic peptidases, principally membrane-bound protease IV  and 
cytosolic oligopeptidase A (Martoglio and Dobberstein, 1998). These peptidases can cleave the 
majority of signal peptides at certain conserved regions and can also act to degrade the sequence 
while still fused to a recombinant enzyme if the hybrid is retained within the cytoplasm. The fact 
that a number of r-trypsin fragments appear to remain bonded to fragments possessing 
approximately the correct molecular weight as the complete pelB sequence could be explained in 
two ways. Firstly, the attached leader sequences have been unevenly degraded at a number of 
sites, so as to produce several distinct species of r-trypsin N-terminal fragments with pro­
sequences of varying lengths, some still bonded to undigested pelB. The fact that only four 
conserved new bands were visible on the protein gels, rather than a smear across a range of 
molecular weights which would be expected to occur if a population of r-trypsin N-terminal 
autodigestion products were bonded to a number of pelB fragments of different lengths, would 
indicate that this would be an unlikely explanation. The second possibility would be that the leader 
sequence had become associated with the bound enzyme, folding inwards and possibly becoming 
involved in the r-trypsin tertiary structure binding interactions, and thus was protected from rapid 
digestion.
7.1.5 Loss of induction control
Activity profiles and protein gels run from induced and uninduced fermentations of the five selected 
isolates clearly demonstrate that the mutants constitutively express r-trypsin, irrespective of the 
addition of IPTG. The fact that no nucleotide mutations were found in either r-trypsin, the 
prosequence or the immediate upstream transcription elements (-10 & -35 consensus sequences, 
RBS, lac operator region or the T7 promoter binding site) would seem to indicate that the
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mutation(s) is influencing some other aspect of the T7 control mechanism on a remote region of 
the plasmid. The mutation must be carried on the plasmid (both plasmid and XL1-Red genome 
were mutated, but the vector was transformed into BL21(DE3) for propagation and expression), 
and the only other plasmid encoded T7 control element is the lac /  sequence which spans 
positions 764-1843 (see Figure 5-6). The T7 system is based on the standard lac operon, a system 
of negative promoter control, and thus dependant upon the constitutive expression of the lac 
repressor from the la c lgene, which binds to the lac operator region and sterically hinders the 
binding of the T7 polymerase. A mutation which disabled the la c l promoter and thus prevented or 
lowered expression, or within the body of gene, acting to lower its affinity for the lac operator would 
have the effect of reducing negative control of T7 polymerase binding, thus allowing expression 
levels to reach inducer-saturated conditions. This clearly has not occurred as r-trypsin expression 
levels were seen to be considerably lower than those of ‘wt1 pET(T):BL21(DE3), while still higher 
than the slight leakage of protein visible under uninduced conditions. The most convincing 
explanation would be that a mutation had occuned within the body of the lac /  gene, which alters 
the structure of the protein so as to lower its affinity towards an inducer (allolactose or IPTG) and 
thus shifting the equilibrium of the reaction so that the majority of repressor molecules remain 
bound to the operator, with only a small percentage at any one time binding to the inducer and 
altering their conformation to release the operator. As induction does not appear to result in any 
increase in recombinant protein production (conclusion arrived at by examination of fractionated 
SDS-PAGE gels and activity readings) then the repressor has been mutated so as to posses no 
affinity for the inducer molecule at all and this structural mutation (assuming the presence of just a 
single substitution) has an additional effect of distorting the conformation of the DNA-binding 
region, resulting in a higher basic rate of disassociation, i.e. lowering the stability of the repressor- 
DNA complex. This would allow ‘enhanced leakage’ through the T7 system while still ensuring a 
low level of protein expression.
7.1.6 Possible unified theory
Viewing the effects discussed in Sections 7.1.3- 7.1.4 in the light of the probable lac I mutation 
(Section 7.1.5) it becomes possible to link the apparent expression rates of the five mutants with 
the r-trypsin activity detected in each cellular fraction. The model proposed in Figure 7-1 has the
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expression rate of the system acting as a motive force, driving unfolded wild-type enzyme into 
inclusion body aggregates. The reduction in ‘pressure’ caused by the lac/mutation causes a 
variety of different target locations to become accessible, including periplasmic translocation, but 
the presence of soluble cytoplasmic enzyme also allows for protease-related autotoxicity to emerge 
and equally exposes the enzyme to cell-mediated degradation and autohydrolysis. The rate of 
degradation of r-trypsin was clearly reduced at the lower fermentation temperatures, hence the 
high activity levels recorded when grown at 28°C, and this could be explained in terms of the 
reduced expression rate at this temperature leading to a bwer overall quantity of enzyme in the 
cytoplasm, and thus reduced rates of proteolysis. The relationship between enzyme concentration 
and the rate of degradation could possibly be seen as directly proportional up to a point, with high 
level of r-trypsin saturating native degradative proteases and also with each molecule of trypsin 
have an increased chance of contact with a second, thus enhancing the rate of autohydrolysis. As 
G1 & D1 showed consistently high activity during low-temperature fermentations but possibly 
exhibited lower concentrations of r-trypsin digest fragments on the fractionated SDS-PAGE gels, it 
is possible that these two isolates possessed a mutation which depressed their expression rates 
even below that of the others (D2, D4 & C4). The resultant ‘trickle’ of enzyme would thus remain 
soluble and active longer than if expressed at a higher rate, effectively allowing a strong signal to 
be assayed from a significantly autotoxic and labile recombinant product
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Inclusion bodies
A
Destination of wild-type 
Fast expression: all mutants
Expression -------------- >
Influenced by: temperature 
scale?
lac I mutation?
r-trypsin soluble 
in cytoplasm
Slow expression: significant concentration 
of mutant enzyme
Autodigestion
Figure 7-1: Possible model for behaviour of mutants
Relating activity and concentrations of r-trypsin mutants to expression rates.
7.1.6 General
The generation of pET vector mutants as opposed to trypsin mutants was a severe blow in terms of 
the project goals, but it should be noted that they provide a perfectly valid solution to the problem of 
r-trypsin insolubility. They also illustrate both the principle danger and advantage of random 
mutagenesis, namely that unexpected solutions are actively encouraged to arise, and it is 
dependant upon the researcher to design a mutagenic strategy and screen which will most focus 
the possibilities in his or her favour. The use of a mutator strain lays open the possibility of a 
favourable mutation occurring outside the target gene and, with protein solubility being influencd by 
a wide variety of factors, an expression-rate suppressing mutation should not, in hindsight, have 
been unexpected.
The first rule of directed evolution is “you get what you screen for” (Arnold, 1996), and 
refers to the fact that the researcher is essentially mining sequence space for all possible solutions 
to a specific question posed by the screen. In the case of the work described in Chapter 6, the 
question was “what mutation would allow soluble, active trypsin to be expressed in detectable 
levels during a deep-well microplate fermentation?” and we were, in the classic sense of making
____________  Solubie in _______________^
Slow periplasm G1 & D1 autolyse slower
expression as at lower conc.
*  Autodigestion
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wish, given exactly what we asked for but in an unexpected form. The supposed lac I mutation 
allowed the autotoxic, labile mature protease to be expressed at detectable levels during deep-well 
fermentation, but proved intolerant to scale-up and, of course, not an enzyme mutation at all. The 
system does, however, present a potentially useful platform for the expression of toxic recombinant 
enzymes within E. coli and methods for characterisation and improvement are discussed in Section 
8.
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8 Conclusions
A practical methodology for the high-throughput culturing and screening of cells expressing 
recombinant trypsin was developed and tested, with the capacity of the system limited only by the 
lack of more than two microplate thermomixers.
A high-throughput screening protocol involving the microplate solubilisation and refolding 
of inclusion bodies could not be established due to the inability to sufficiently purify the insoluble 
fraction, dilution factors being limited by the need to screen for activity without a means of 
concentrationg the enzyme, and the complexity of the trypsin structure. The use of certain 
additional co-factors, particularity PEG300 and glycerol, was shown to be effective in enhancing 
the regenerated yield of commercial trypsin and thus may reward further work in this area.
A mutant library of the pET(T) construct was prepared through propogation for 30 
generations with XL1-Red. Two mutations would appear to be present in the lac I gene 
(unconfirmed by sequencing as yet) which disable induction control and retard expression, while 
still allowing the production of assayable levels of protease. Instability of the mutants prevented full 
characterisation.
Despite this result XL1-Red has been shown to be statistically a poor choice for a 
mutagenic strategy involving a mid-sized, medium to low copy-number plasmid, with an attempted 
mutation versus doubling generations calibration failing to generate sufficient hits to be a useful 
tool.
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9 Future work
The essential next step in the work would be the sequencing of the la c l gene (nucleotides 
764-1843) and its immediate upstream control elements on the five pET(T) mutants. The 
expression characteristics of the mutants would point to this region as being the most logical 
position for the putative mutation (see Section 7.1.5), but, should sequencing fail to show any 
abnormalities, then sequencing would be extended over the entire plasmid. It is quite likely that 
there are only two distinct mutations, one found in clones G1 & D1, and the other in clones D2, 
D4, C4 based on their differing small fermentation volume activities (see Section 6.3). After a 
mutation had been identified, its influence would be confirmed by using point mutagenesis to 
introduce it into a ‘wild-type’ pET(T) vector.
The problems encountered in characterising the variants, namely their apparently 
variable growth characteristics and r-trypsin yields, are a direct result of the autotoxicity of the 
mature protease and, conversely, the susceptibility of the enzyme to autohydrolysis and 
possible attack by native cytosolic proteases. The ‘enhanced leakage’ of the pET(T) mutants 
could provide a useful system for the soluble expression of difficult recombinant enzymes, 
however, in the case of r-trypsin, ways must be found to disable the autotoxicity of the protease 
and decrease its susceptibility to autohydrolysis. The following solutions could be attempted in 
parallel as each would present a slightly different set of advantages and would need to 
consider the industrial or research context of the enzyme.
•  Work on optimising the expression of r-trypsinogen in the yeast Pichia pastoris
found that autoactivation of the protease, and the subsequent autotoxic effect on the 
host, could be prevent by alteration of the pro-sequence cleavage site ([Asp]4 -  Lys>l<). 
The lysine residue was replaced by an additional aspartic acid, with the result that no 
mature protease was detectable within the celluar soluble fraction. Activation of the 
pro-enzyme was then accomplished through the use of dDAP. As the pET(T) mutation 
would appear to be within the lac I,  excision of r-trypsin and replacement with r- 
trypsinogen would allow the low-level expression of the zymogen. The construction of 
an r-trypsinogen strain with a Lys8Asp mutation, thus making it inactivatable, and 
parallel testing with the ‘wild-type’ r-trypsinogen and r-trypsin strains would allow 
precise determination of the degree of active autotoxicity presented by the mature
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protease and any deleterious metabolic effects arising from T7 expression of a 
recombinant protein.
•  The interactions of the catalytic triad of His57, Asp102 & Seri 95 are key to the
nucleophilic attack at the C-terminus of an Arg or Lys residue and this charge relay 
system can present a target for protein engineering for the precise control of catalysis.
. It has been established through comparative studies of diverse serine proteases that, 
while the presence of all three amino acids is essential, their relationship with each 
other does not depend on being rigidly held in constant positions relative to each other, 
i.e. the charge relay system between the three (see Section 1.6.6) can be established 
as long as they are in close proximity with each other, with considerable flexibility 
apparently being allowed in terms of bond angles and relative alignment. The 
researchers in question removed the catalytic histidine residue from the protease and 
substituted a histidine in the substrate near the cutting site (P2 & P1 ’ sites) so that the 
act of binding that region of the substrate completed the catalytic triad (Corey et a/., 
1995). The subtilisin H64A variant constructed (subtilisin numbering, corresponds to 
the trypsin His 57 residue) showed very high specificity for hydrolysis at H X i and X lH  
peptide linkages, where X corresponded to a small hydrophobic amino acid, typically 
alanine. Similar engineering in r-trypsin could eliminate all types of protease-based 
autotoxicity and autohydrolysis, and complete specificity in substrate cleavage sites. 
Mutation of the enzyme for enhanced specificity towards extended sequence motifs in 
the now tightly regulated protease would however be restrained in terms of sequence 
diversity.
•  Expression levels, cytoplasmic solubility and also periplasmic translocation of 
r-trypsin could all possibly be improved by certain combinations of fusion proteins and 
commercially available specialist expression strains. Fusion proteins (alternative signal 
sequences, N- or C- fusions of small native proteins) would be tested in a factorial 
manner with alternative expression strains. Certain tags would also enable rapid 
purification of the recombinant protein from either media or cell lysate through the use 
of microplate wells coated with an appropriate antibody or ligand. Such methods were 
not explored in this work but would present an effective high-throughput purification 
methodology, enabling both a more sensitive screening procedure and concentration 
of the enzyme.
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Tag or fusion Size Location Functionpartner
Disulphide Enhanced expression & periplasmic
oxidoreductase 208aa N- translocation. Increased copy No of foldase
(DsbA) genes may increase folding yields.
Disulphide isomerase 236aa N- As above.
(DsbC)
Streptavidin 15kDa N-orC-
Possibly enhanced secretion, effective 
purification.
Omp A o rT 21aa/22aa N- Sec, SRP independent Secretion tags, possibly improved action over pelB. 
Periplasmic folding chaperone. Chaperone
PapD 28.5kDa N- activity believed to be specific to pili subunits 
but may enhance translocation. 
Mutation in thioredoxin reductase (trxB)
AD494 (Novagen) N/A Host allows for a more oxidising cytoplasmicstrain environment to encourage folding of proteins 
with multiple Cys-Cys.
Host
strain
Double mutant in thioredoxin reductase (trxB)
Origami (Novagen) N/A and glutathione reductase {got), effect as for
AD494 above.
Figure 9-1: Possible approaches to r-trypsin expression/folding
Fusion tags and proteins that may enable enhanced expression and/or secretion of r-trypsin 
while repressing autotoxicity, and two engineered strains designed to encourage folding of low- 
levels of eukaryotic proteins in E. coli cytoplasm. All references taken from (Gething, 1997).
•  Use of an alternative promoter with a lower base expression rate could allow greater
levels of translocation as well as lowering levels of autohydrolysis by decreasing the 
concentration of peptidase in the cytoplasm. Figure 6-15 showed that higher yields of 
active enzyme were obtained at 28°C, presumably due to both the depression in 
expression rate and the reduced activity of r-trypsin at this growth temperature 
(enzyme activity from fractions assayed at room temperature), and with the possible 
benefit of up-regulation of cold-shock chaperones at this temperature (Georgiou and 
Valax, 1996). The best characterised £  coli cold-shock promoter is cspA, which has 
been previously used for the successful low-temperature expression of both toxic and 
proteolytically sensitive fusion proteins (Mujacic etal., 1999). An alternative low-level 
£  coli system would be the nutritionally inducible arabinose promoter (araBAD), which 
allows graded levels of protein expression down to trace levels by means of titration of 
the L-arabinose inducer (Keasling et al., 2000). Investigation of both systems could
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provide a means of low-level enzyme expression which, coupled with molecular 
engineering to reduce autohydrolysis, could present a stable base for further rounds of 
mutagenesis.
Nomenclature Edward Hibbert
Nomenclature
g Extinction coefficient M-1cnrr1.
/ i  Number of mutations on individual strand
A Absorbance
Cn Overall mutation rate matrix after n extension steps from parent
cP Protein concentration pg*mM
f  Overall expected error frequency (equation 1.1)
/ Number
]  Number
I Optical pathlength of solution cm
M Matrix of individual nucleotide substitution probabilities
M Total number of mutations throughout population
n Number of extension steps required to produce a DNA strand
N Number of PCR cycles
p Error rate per PCR cycle
Tannealing Annealing temperature of double-stranded oligonucleotide °C
Tm Melting temperature of double-stranded oligonucleotide °C
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11 Appendix A
11.1 Design of a specificity screen
11.2 Introduction
In the context of enzymology, the term ‘specificity’ has a highly precise meaning in that it refers to 
both the activity of an enzyme and its affinity to a substrate, and it is inherently competitive, 
intended to describe the discrimination of protein between alternate targets. Specificity is thus a 
function of both the competitive substrate binding (Km) and catalytic rates (/feat) used in describing 
the associations of an enzyme in a solution with a desirable and less-desirable substrates. 
Improvements in one process can balance out reductions in the other and thus the ratio of /rcat/Kju 
is used as the kinetic constant in describing enzyme specificity. The crucial point is that true kat/KM 
values can only be by means of competitive assays rather than in vitro testing against single 
substrates species.
A goal of this project was to devise a practical strategy by which the specificity of bovine 
trypsin mutant variants could be rapidly and accurately evaluated in a high-throughput manner. As 
the value of this screen would lie in its capacity to detect both unnatural substrate specificities (P1 
amino acids other than Arg or Lys) and enhanced extended specificities (evaluation of optimal 
amino acids in P2 and P3 positions) it was clear that the screen must be based on a library of 
tripeptides. The synthesis of hundreds (at the very least) of defined tripeptides would prove costly 
and immensely time consuming and so a combinatorially generated library designed expressly for 
positional scanning was the obvious solution. Combinatorial approaches have been used to probe 
the optimal consensus sequences for binding to the substrate-recognition regions of several 
proteases and the process involves three fundamental steps: 1) the generation of the library (by 
biological or synthetic methods); 2) proteolysis of the substrates; and 3) identification of optimal 
substrate sequence (Backes et a/, 2000). These will be discussed here in turn.
Biological methods tor generating a combinatorial peptide library include classic 
filamentous phage display (Matthews and Wells, 1993), for which a number of partially randomised 
cDNA libraries with defined P1, P2 or P3 positions must be produced, and the use of such cDNA 
libraries in in vitro expression systems (Lustig K.D., 1997). Both methods would allow for effective 
and flexible library production with the potential for easy scale-up of material, although the cost
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effectiveness of in vitro transcription/translation reagents would require evaluation against synthetic 
methods for each positionally defined peptide produced. There would be several apparent 
disadvantages of the biological methods for this work, the first being the cost and technical difficulty 
involved in preparing the cDNA library consisting of defined and randomised positions. This would 
involve either the bulk manufacture of the partially randomised oligonucleotides by a contract 
manufacturer or the preparation of a heterologous primer ‘mini-library’ for each peptide mix, which 
could then be amplified by PCR. Each oligonucleotide would contain 9 base pairs in length coding 
for the relevant amino acids, with N- & C-terminal extensions containing appropriate restriction 
sites and also promoter elements if required. The second issue that arises when employing any 
host expression system is that of potential discrepancies in expression levels as well as the 
inability to incorporate unnatural amino acids into the peptide if required. Expression level 
variations could be influenced by codon usage of the strain (impact depending on the promoter 
strength of the gene, but virtually certain to be encountered at some point in a randomised library) 
and the possibility of insolubility (unlikely when seeking the expression of such small peptides). The 
use of in vitro systems can compensate for variations in expression levels by means of balanced 
pools of available amino acids and would also allow multiple solutions for dealing with insolubility 
(Lustig K.D., 1997). The third problem is critical, in that it concerns the detection of substrate 
hydrolysis with the emphasis being on speed. Proteolytic cleavage from a display library can most 
accurately be determined by means of chromatography and mass spectrometry (Backes et al, 
2000), but these methods, while providing accurate qualitative data as to substrate acceptability, 
require time-consuming work after the event, forming a potential bottle-neck for a high-throughput 
assay and also fail to capture the kinetics of the reaction, essential for specificity analysis.
Synthetic methods of peptide library construction involve support-bound peptides 
generated by the sequential addition of a-amino and side-chain protected amino acid residues to 
an initial residue bound to an insoluble, polymeric support (Figure 7.1). When the design of the 
assay allows for a chromo- or fluorophore to be attached to the N-terminus of the chain then the 
generation of signal, and thus the kinetics of the reaction, can be measured on-line. The problem 
arising in this case is that trypsin cuts at the C-terminus of strongly basic amino-acids and thus 
would require a chromophore to be located at this position (see L-BAPNA design, Chapter 2). Work 
has been done involving a fluorescence-quenched support resin which evolved a signal upon 
proteolysis of the displayed peptide (Lam and Lebl, 2003), but the synthesis of such a library was
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technically complex. An additional problem with small, resin-bound substrates is that research has 
shown that the digestion kinetics of such substrates can differ from those of sequence-identical 
soluble molecules and, although the two data sets were related in a linear manner, thus allowing 
for the support-bound substrates to yield useful qualitative data, the knowledge of such effect does 
diminish the usefulness of the library. In order benefit directly from the enzymic assay data 
generated from the initial testing work on L-BAPNA (Chapter 2) and the screening of ‘enhanced 
solubility’ mutants (Chapter 6), it seemed evident that a variation of the standard solid phase 
peptide synthesis method was required which would allow for the synthesis of a similar soluble 
peptide with a C-terminal pNA group.
11.3 Solid phase peptide synthesis
As mentioned previously, the classical method of solid phase peptide synthesis (SPPS) involves 
the sequential addition of amino acids, blocked at the N-terminus and with protected side-chains, to 
a an initial amino add which is bound to a support resin by a C-terminal linker (Figure 7.1). The N- 
a  blocking group is removed from the newly coupled amino acid by means of a specific 
deprotection procedure (dependant on the nature of the blocking group) and the reaction is 
repeated until the desired length is reached. The side-chain protecting groups and the blocking 
group are then removed and the mature peptide may be uncoupled from the resin by means of 
cleavage of the linker region or held if the resin is to form a part of the display library. The choice of 
the linker agent used determines whether deavage yields a C-terminal peptide acid or an amide 
(Novabiochem, 2000).
The chemistry of the N-a blocking group determines the reagents required for the 
extension of the peptide chain (steps 3 & 4 in Figure 7.1) and thus the bulk of the chemical steps 
as the resin can be easily bought with the first amino acid attached (thus ensuring the integrity of 
the linker region). There are two main variants of blocking group chemistry, namely the older 
Butoxycarbonyl (Boc) scheme and the now more common protocol utilising a 9- 
Fluroenylmethoxycarbonyl (Fmoc) group. Cleavage of a Boc-protection group requires trifluroacetic 
acid and side-chain deprotection requires a strong add such as hydrogen fluoride (HF) or 
trifluoromethanesulfbnic acid (TFMSA). Fmoc chemistry requires the use of less hazardous 
reagents, needing only treatment with the mild base piperidine tor un-blocking the leading residue
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and only a single, final treatment with HF for side-chain deprotection. Purity comparisons of short 
peptides synthesised using the two strategies showed comparable results, but with slightly higher 
levels of side-chain degradation and truncation in samples prepared using Boc chemistry (Smith, 
1992). For these reasons only Fmoc chemistry was considered when preparing the strategy of 
combinatorial library synthesis.
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Figure 11-1: General scheme of solid phase peptide synthesis
Side-chain protecting groups and blocking groups refer to those used in both Boc and Fmoc 
chemistry. (1) Attachment of C-terminal of initial peptide to linker, usually by esterification; (2) 
Formation of ester bond; (3) Removal of N-a blocking group; (4) coupling of 2nd activated amino 
acid; (5) repeat of un-blocking and coupling, steps 3 & 4 until all chain reaches desired length; (6) 
Deprotection of side-chains and cleavage of linker-peptide bond. Figure adapted from 
(Novabiochem, 2000).
11.4 Positional-scanning synthetic combinatorial libraries
Synthetic combinatorial libraries are a tool by which vast numbers of closely related peptides may 
be generated for screening, either in mixtures or as automated parallel reactions, in the time 
usually required to prepare a handful of analogues by conventional methodologies. All 
combinatorial libraries based on SPPS involve the principle of portioning-mixing, which simply
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describes the splitting of the resin and growing chain into aliquots and then the coupling and 
combining with the various activated amino acid mixtures. A full combinatorial library of all possible 
tripeptides from a complete pool of the 20 amino acids would require 320 peptides, a huge number 
but not beyond the capacity of an automated setup. The complexity of each peptide mixture in such 
an experiment must be carefully planned to balance ease of synthesis with the resolution by which 
a positive result could be pinpointed, i.e. how much was known about the composition of each 
mixture and so how much data could be gained from a positive signal. When generating a library 
for the purpose of determining the optimum substrate sequence for an enzyme it can be 
advantageous to use a step-wise synthetic combinatorial library (SCL), as this reduces the number 
of analogous peptides involved and its more controlled, incremental nature, allows for accurate 
determination of the P1, P2, P3, etc positions. The library is based on the principle of serial 
deconvolution, by which groups of related mixtures, each with one or two defined positions and the 
remainder randomised, are generated and screened in solution (Novabiochem, 2000). Those 
sequences generating the highest signal are carried to the next level of the screen and the defined 
positions are used as the base for further portioning and mixing. A good variation of this technique 
reduces the need for the continual resynthesis of the various sub-libraries used in each mixing 
step, by using a technique known as recursive deconvolution (Figure 11-2). By this method, sub- 
libraries composed of peptides at each stage of synthesis, and thus at each length, are retained 
and used in subsequent synthesis steps. A true positional scanning synthetic peptide library (PS- 
SCL) eliminates the need for iterative synthesis and screening completely as it may be synthesised 
in a single step. A tripeptide PS-SCL would be composed of 3 positional sublibraries, with each 
library acting to define one position in the peptide. Each sublibrary would be separated into well 
containing tripeptides with one position occupied by a known amino acid (thus a full library would 
require 19 or 20 divisions for each sublibrary, depending if troublesome residues such as cysteine 
or methionine were excluded) and with the other positions filled with randomised amino acids.
It is important to note that a PS-SCL libraries is not a full factorial peptide library, i.e. while 
it must contain an equimolar mixture of every possible peptide, these peptides are not grown in 
discrete reactions allowing for defined quantities to be added to each mix, but rather are 
synthesised by the addition of a solution of amino acids at each coupling step. Work into the 
kinetics of SPPS has shown that the relative reaction (coupling) rates of each amino acid varies by 
type up to a factor of 10 (Ostresh et al 1994). The initial resin-bound amino acid was also found to
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exert a significant influence on the coupling rates of incoming amino acids, but this appeared to be 
a constant effect, acting with the same proportional effect on all types, and thus unlikely to present 
a problem fora library synthesised from a defined P1, P2, etc (Figure 11-2) (Ostresh etal., 1994). 
Thus, although the relative coupling rates are largely independent of the resin-bound amino acid, a 
mixture of protected amino acids must be carefully composed if the iterative competitive coupling of 
the mix to a growing peptide is to produce an un-biased, randomised library, containing 
approximately equimolar concentrations of each peptide. For position X in Figure 11-2 & Figure 
11-3 to be truly random, the mix of single, activated residues used in each coupling step must be 
present in the proportions indicated in Table 11.1, the ratios were determined by competitive, 
fractional-factorial coupling experiments compensating for resin effects (Ostresh et al., 1994). The 
proportions within the mixture would seem intuitive as those amino acids requiring greater 
concentrations if they are to be represented equally in the peptide library are those with bulky 
sidechains, which would act to sterically hinder the formation of complexes.
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(1) AXX BXX CXX DXX
S c re e n  &  s e le c t b e s t s u b lib ra ry  
to  d e te rm n e  1st p o s itio n
(2)
DXX
R e tr ie v e  &  u s e  in te rm e d ia te  
d ip e p tid e  s u b iib ra n e s
B C o u p le  B  su b lib ra ry  
to  e a c h  d ip e p tid e  m ix
BDX
S c re e n  & s e le c t b e s t su b lib ra ry  
to  d e te rm in e  2 n d  p os itio n
(3)
BAX BBX BDX
R e tr ie v e  &  u s e  in te rm e d ia te  
m o n o m e r s u b iib ra n e s
(4)
B C
BCA
B C
BCB
B C
BCC
B C  C o u p le  B C  to  
e a c h  su b lib ra ry
BCD
Figure 11-2: General scheme of a synthetic combinatorial tripeptide library (SCL) using 
recursive deconvolution
X = randomised position containing an equimolar mixture of amino acids (in this example A, B, C & 
D). Steps: 1) screening of initial tripeptide library with only the P1 position defined, selection of 
‘best’ substrate to form base of 2nd round of screening; 2) Coupling of intermediate dipeptides, 
saved from midway through the synthesis of the sublibrary in step 1, to the empirically determined 
optimum P1; 3) determination of optimal P1 and P2 sequence by screening, resynthesis of peptide 
and coupling to monomer sublibrary retained from step 1; 4) screening for the optimal complete 
sequence. Figure adapted from (Novabiochem, 2000).
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oxx xox xxo
AXX XAX xx@ -
ixx XBX XXB
cxx x@x xxc
Figure 11-3: General scheme of a positional scanning synthetic combinatorial library (PS- 
SCL).
Illustrates a tripeptide library from a mixture of 3 amino acids (A, B, C), X = randomised position 
containing an equimolar mixture of amino acids, 0  = defined position. Figure adapted from (Backes 
etal., 2000).
Ala (A)
3.58
Arg(R)
6.87
Asn(N)
5.64
Asp (D)
3.70
Gin (Q)
5.61
Glu (E)
3.84
Gly(G)
3.04
His (H)
3.76
lie (I)
18.3
Leu (L)
5.23
Lys(K)
6.56
Met (M)
2.42
Phe (F)
2.66
Pro (P)
4.56
Ser(S)
2.93
Thr(T)
5.04
Tyr (Y)
4.36
Val (V)
11.9
Table 11.1: Isokinetic rates if individual amino acids
Showing the mole percentage of amino acid derivative required for equimolar coupling using a 10- 
fold excess of protected amino acid mixture to resin-bound residue. Table adapted from (Ostresh 
etal., 1994).
11.5 Analysis of hydrolysis products
In order for it to be possible to determine the kinetic constants of substrate consumption (WKm), 
essential if a specificity profile of enzyme variants is the target, then a method must obviously be in 
place to follow substrate concentration over time. This could be accomplished via continuous 
adsorption (Yano et al., 1998) or fluorescent (Backes et a/., 2000; Kurth et al., 1998)
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measurements, gas chromatography, N-or C - terminal sequence analysis (Birkett, 1997) or by 
high-performance liquid chromatography (Antal etal., 2001; Schellenbergeref a/., 1994). The data 
would be used to calculate the relative second-order rate constants with the power of the analysis 
being dependant upon the technique, i.e. quantitative amino acid analysis from H P L C  would 
provide useful data on the digested states of a mix of peptides, depending on the degree of 
randomisation in the library, while monitoring the release of an absorbent or fluorescent leaving 
group would provide information on the hydrolysis of only the tagged peptide. A further limitation of 
such methods requiring the release of a reporter group is that the tag must be attached to either 
the C - or N- terminal end of the cutting site, depending on the activity of the tested enzyme, 
meaning that only the influence of the P i, P 2,...,P n  or the P ’i, P ^ . - .P m  sites respectively could be 
monitored. These methods also leave open the possibility for the leaving group to interact with the 
substrate-binding region of the enzyme in some manner, skewing results away from those based 
on the hydrolysis of larger peptides.
To fully assess the contribution to specificity of each amino acid within the protease- 
binding site of the substrate, methods which allow for the evaluation of positions P4 -  P*4 
(dependant upon size of protease-binding region, determined for a wide range of peptides by 
means of small-molecule inhibitors or defined substitution experiments, e.g. alanine scanning) are 
required, and various HPLC based protocols have been proven to deliver comprehensive results 
within complex mixtures of potential substrates. Schellenbergeref. al. have devised a method for 
the accurate testing of extended P positions based on the blocking of the P1-2 positions with a 
preferred substrate and then using the P’ peptide to trigger an acyl transfer reaction, i.e. reversing 
the peptide hydrolysis reaction and using nucleophilic P peptides along with an acyl transfer ester, 
yielding data comparable with conventional hydrolysis (Schellenberger et al., 1993b; 
Schellenberger, Turck, and Rutter, 1994). The resultant peptide products are monitored at 
continuous intervals by HPLC and fluorescence detection. Reverse-phase HPLC has a proved a 
particularly effective method is studying both hydrolysis rates and points of cleavage with a semi­
randomised competitive peptide library (Antal etal., 2001). Optimisation of buffers ensures well­
spaced retention times of the various peptide cleavage products and UV quantification of peaks 
previously analysed by conventional HPLC provided a simple and rapid method of establishing 
enzyme preference. The accuracy and reproducibility of this method make it an effective qualitative 
specificity test for uncharacterised or mutant proteases, with the crucial advantage that potential
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multiple reaction types may be followed within a mixture (a feat possible with adsorption or 
fluorescence assays only through the use of diverse-wavelength leaving groups), but the time-lag 
of analysis and the possibility that the complex data acquired may need secondary rounds of 
analysis could prove problematic for a true high-throughput screen. A further issue is that of the 
need to purify the sample prior to the digestion reaction, in order to prevent contamination, and 
thus degradation, of the column. Providing that the target strain had been engineered to express 
soluble protein, then, in a direct-measurement spectroscopic assay, the peptide mix could be 
added directly to the cellular lysate and measurements started immediately. For a chromatographic 
assay, the soluble protein must first be separated from the remainder of the cellular soluble 
fraction, a simple matter if appreciable levels of secreted material have been obtained, but 
considerable more complicated if the target protein was retained in either the periplasm or 
cytoplasm. Release of periplasmic proteins could be effected by the use of lysozyme buffers (as 
discussed in Section 5.2.5), essentially creating a suspension of periplasts, which may then be 
pelletted by gentle centrifugation. The use of specialist 96-format filter plates (with the filtrate being 
retained) could also prove useful for such methodologies. If the target protein was contained 
predominantly in soluble form within the cytoplasm, then high-throughput methods available for 
purification are reduced to antibody-mediated affinity binding, either onto nitrocellulose membrane 
or through specially coated wells. An effective methodology would involve the tagging the C- 
terminus of r-trypsin with a 6His motif, followed by a suitable protease digestion site, and 
purification via a nickel-algenate resin coated well-plate. Although such methods have been proven 
to be viable, and with the added advantage of working with now purified protein, they are usually 
coupled with a simple activity screen and, in a screen involving a complex, partially randomised 
peptide library, the added complexity could prove a deterrent.
In terms of direct measurements, discarding the use of radioisotopes which require 
specialised handling, synthesis and disposal and are used only when exceptional degrees of 
sensitivity are needed, chromogenic and fluorescent substrates allow for simple, rapid quantitative 
analysis of a single reaction type. Chromogenic substrate types are discussed in depth in Chapter 
2, and have the advantage of being able to be employed in both solution-based screening and also 
in semi-quantitative initial agar-based selection procedures, providing of course that the target 
enzyme is accessible and it is possible to tie its activity either to cell viability or simply to generate a 
halo. Fluorescence provides a considerably more sensitive assay method and probably constitutes
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the majority of modem bioassays. Such assays are similar to chromogenic methods in that the 
fluonophore, typically 7-hydroxycoumarin (umbellifenone) or 7-amino 4-methylcoumarin (AMC), is 
attached to the C-terminus of the P1 amino acid by an ester or amide bond, and the release of the 
fluorescent group can be monitored continuously be measuring at its signature wavelengths. Free 
AMC exhibits the characteristics of Aex 345nm, Aem 445 and allows for sensitivity of detection 
approximately two orders of magnitude higher than assays based on classic chromogenic leaving 
groups, such as nitrophenol or nitroanilide (John, 1992). A variety of intramolecular quenching 
methodologies, where a quenching agent is incorporated within the substrate and the fluorophore 
comprises part of the scissile bond or within a distinct portion of the substrate binding region of the 
enzyme, have been developed (Auld, 1999), and allow for the collection of detailed data on both 
the release of product and the formation of the ES complex. This can provide an excellent method 
for the accurate and rapid determination of the <Km& values, and thus the competitive substrate 
preferences of an enzyme.
11.6 Use of an alkanesulfonamide linker
The requirement of a C-terminal chromophore on the tripeptides of the proposed SCL presented a 
problem as standard protocols for SPPS allowed for only N-terminal modification of the growing 
peptide. “Safety-catch" linkers, linker groups composed of relatively stable bonds that can be 
cleaved only by a specific 2-step activation-release procedure, were developed for use with a 
number of alternative synthesis strategies. Such synthesis strategies included methods which 
require only increasingly mild or altered chemical conditions, frequently designed so as to minimise 
the incidence of damaged side-chains during mid to long polypeptide synthesis (Backes and 
Ellman, 1999; Novabiochem, 2000). An important additional feature is that while the linkage is 
stable during the extension of the chain, ‘activation’ of the linker can then provide a reactive, labile 
bond susceptible to nucleophilic attack and subsequent displacement by an appropriate group. 
Numerous strategies for alternative ‘non-safety-catch’ displaceable linkers do exist, with possible 
the most relevant to this work being the use of a modified CMtr linker (Furlong et al., 2002), which 
has already proven to be suitable for the synthesis of pNA tagged peptides, but presents stability 
issues during synthesis. The alkanesulfonamide “safety-catch" linker was originally developed by 
Kenner et al. (Kenner et al., 1976), and activation by diazomethane treatment rendered the bond
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receptive to aminolysis, hydrazinolysis and saponification, resulting in C-terminal primary amides, 
hydrazones and carboxylic acids respectively. Modified versions of the linker were devised with 
refined functionality, such as improved loading efficiency and, particularly, enhanced reactivity 
following activation. The current version of sulfamylbutyryl resins, in which activation is 
accomplished by A/-alkylation of the A/-acylsulfonamide linker with a haloacetonitrile, results in a 
bond reactive enough to be displaced by a nucleophilic amine (Backes and Ellman, 1999; 
Novabiochem, 2000). The cleavage of the linker region thus releases an amide product into 
solution, a structurally correct peptide, and this strategy allows for the attachment of a chromogenic 
(or fluorogenic) leaving group to the peptide through the nucleophilic addition of an appropriately 
derivatised amino acid at the P1 position (Backes etal., 2000; Backes and Ellman, 1999) (see 
Figure 11-4).
The current generation of sulfamybutyryl resins (Novabiochem, cat. No. 01-64-0152) are 
constructed so that, prior to activation, they form a stable linker bond, resistant to extremes of pH 
or strongly nucleophilic reagents, thus making them compatible with a wide range of reaction 
conditions. Activation is achieved by addition of either diazomethane, iodoacetonitrile orTMSN2 
(Backes etal., 2000; Backes and Ellman, 1999).
R1 O
aa1 p-nitroanilide group
Nucleophilic attack leading to displacement 
after activation of linker
R3 O R2 O
— C— H jN -j NH  HN —  (CHj)*— i
aa3 aa2 4-suifamylbutyryl AM resin
J
Fmoc group
Figure 11-4: SPPS using linker resin
Construction of a tripeptide with a C-terminal pNA group by means of standard SPPS and 
subsequent displacement of sulfonamide group with a nucleophilic amine.
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11.7 Competitive screening strategy
11.7.1 Pooling of library elements
Based on the methodologies described in sections 11.4 & 11.6, a strategy was developed for the 
synthesis and competitive screening of enzyme mutants against a substantial tripeptide array, 
capable of determining the P1, P2 & P3 specificities of a library of trypsin variants. The exact 
nature of the library was obviously dependant upon the ‘question’ that the screen was designed to 
ask, and equally by the limitations imposed by the demands of a high-throughput process. This 
implies that each enzyme mutant should initially be tested as quickly as possible, i.e. by assaying 
in the minimum number of library wells, and, likewise, the various tripeptide permutations forming 
the library must be pooled to the highest degree possible, while still allowing for meaningful results. 
‘Pooling’ would be the process of combining a certain number of discrete library tests into a single 
microplate-well test, but must be done in such a manner that a positive result yields useful 
information. If the test is qualitative in nature, i.e. it seeks to examine variations in reaction rate of 
the enzyme on a selection of substrates, then the result from a pooled well would be useless 
except to indicate that at least one (but equally possible, all) presented substrates were acceptable 
to the enzyme. An example of this would be the classic form of the PS-SCL (Figure 11-3), where, 
except possibly for the P1 position, all substrates should be screened separately to folly tease out 
enzyme specificity. A quantitative test, were reaction kinetics are, at least initially, irrelevant and a 
positive signal would be considered a rare occurrence, a high degree of pooling, and thus a 
particularly rapid screening procedure, would be possible. An example of this would be a situation 
in which one was screening for unnatural substrate specificities, i.e. in the case of trypsin, 
substrates that did not contain either arginine or lysine at the P1 position, and thus would result in 
no signal from the wild-type enzyme. Peptides with an OXX sequence (0 being any amino acid 
except arg & lys, X possibly being folly randomised -  bearing in mind that only cleavage at the C- 
terminal of ‘O’ would release the chromophore) could be pooled in a controlled manner to almost 
any degree allowing for rapid processing of enzyme variants. A positive result in a single well 
would require subsequent screening on ‘sub-pools’ of substrates from the original mix, eventually 
refining the screen down to individual peptides. Pooling, when appropriate, thus allows for rapid 
initial screening of large numbers of enzyme variants, with the requirement of secondary and 
possibly tertiary rounds of screening on a greatly reduced number of mutants.
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11.7.2 Analysis of multiple substrate kinetics in regards to assessing enzyme specificity
The consumption of a substrate can be modelled through second-order kinetics (Equation 11.1) 
where [E] is the concentration of unbound (free) enzyme, [S/] is the concentration of the /th 
substrate form (assuming the presence of multiple substrate analogues) and k  is the rate constant 
(WKm) (Schellenberger et al., 1993a).
Equation 11.1
Consumption of competing substrates by second-order kinetics.
As discussed previously, the specificity of an enzyme can only be determined in context with 
competing substrates, and so it is useful to derive an expression which allows for the comparison 
of reaction rates between substrate types. The kinetics of a pair of substrates competing for a 
single enzyme active site can be described through a variation of the Michaelis-Menten mechanism 
(Figure 1 1 -5 ) .  The figure shows the free enzyme ([E]) associating with two forms of substrate (S a  &  
S b)  and passing through the acyl-intermediate complex (EAc) characteristic of serine proteases 
prior to the regeneration of the enzyme.
E
E
Figure 11-5: Competition of two substrates for active site of enzyme.
Adapted from (Fersht, 1999).
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In order to relate the kinetic constants of the action of the enzyme on both substrates, it is 
necessary to adjust the standard Michaelis-Menten equation into a form by which the two ratios 
may be directly compared. A variation of the standard form, treating Km as an apparent 
dissociation constant, is shown in Equation 11.2.
v = ^ M s ]
A M
Equation 11.2
Relating the concentration of free enzyme [E] and substrate [S] to the kinetic constants. Assumes 
conditions of low substrate concentrations where enzyme is largely unbound, i.e. [E]« [E]0 (total 
enzyme concentration).
If two substrates, [S a ]  &  [S b ] ,  then compete for the active site of the enzyme, the equations may be 
written as derivatives (Equation 11.3), and then combined as shown in Equation 11.4. The 
important points of this equation are that it allows enzyme specificity to be described in terms of the 
kcaJKM ratios, thus avoiding discussion of intermediate states or non-productive binding, and, 
crucially, it does not require measurement of the concentration of free enzyme at any point, [E], 
which can be difficult to establish (Antal et al., 2001; Schellenberger, Siegel, and Rutter, 1993a).
4 a ]
dt
=  V A =
4 b ]  _
d t
=  Vo =
cat
\ K M /a 
r k Ncat
\ K m j s
[E lS j
[E lS„]
Equation 11.3
Describing the separate rates of consumption of two forms of substrate, S a  &  S b .
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Va ( ^ / ^ ) a [Sa ]
V B ( ^ a a  ^ b ) b [ ^ b ]
Equation 11.4
Combined form of Equation 11.3 , describing the competition of two substrates, S a  &  S b , for 
molecules of free enzyme.
A simple rearrangement of Equation 11.4 to form Equation 11.5 allows for accurate quantification 
of the discrimination of the enzyme between substrates. If the kinetic values of the wild-type 
enzyme can be determined for a substrates then this can be used as a reference point and the 
ratios obtained from the screening of variants could be used to construct a meaningful specificity 
profile.
V B / [ S B ]  ty c a t / ) b
Equation 11.5
Describing the ‘specificity ratio’ between two competing substrates, S a  &  S b .
11.8 Library designs
One of the goals of this work was to develop a series of screens by which potential alterations in 
mutant enzyme specificity could be assessed, i.e. to investigate the plasticity and thus suitability of 
a serine protease as a target for directed evolution specificity engineering. Aside from this no 
directive was given, and thus there was considerable flexibility in how this was to be approached, 
both in terms of whether to assign substrate targets to evolve towards and how best to structure a 
peptide library to make use of the automated systems available. Although these libraries were 
never synthesised due to time constraints, two diverse setups are described below, each designed 
to act as proof-of-concept for a different method of evolving an enzyme for altered substrate 
specificity.
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11.8.1 Screening for unnatural substrate specificities
An unnatural substrate in this case would be defined as one that lacked arginine or lysine in the P1 
position. The narrow slot presented by the substrate binding pocket at this position (please see 
Section 1.4.5) with its basal, positively charged asparagine residue, demands a long, negatively 
charged side-chain on the P1 residue if the reaction is to be sterically favourable. Acceptance of an 
alternatively structured, bulky side-chain at this position would require a substantial alteration in the 
conformation of the pocket, and, similarly, the substitution for a small uncharged, relatively 
innocuous residue (e.g. alanine) has been shown to dramatically reduce the rate of proteolysis by 
decreasing the strength of the initial enzyme-substrate complex. A question arises as to whether 
bar arginine and lysine from the P2 & P3 positions as, although cleavage at the C-terminal of either 
position would not result in the release of the chromophore, it could be argued that the presence of 
such unproductive cleavage products in each well could somehow compromise the effectiveness of 
the assay.
Initial tripeptide ^  0
X ,X 2 0  - pNA
T
random ised:aa except 
M&C
16 master sublibraries: 
pooled into single wel for initial screen
i
Positive result on pooled substrates screening of 
mutant on each subkbrary to determine P1
i
Recycle monomer library aid screen 
to determine P2 & P3 sequentially
X2- 0  - P, - pNA
0 -P 2 -P ,-pN A  
Figure 11-6: Screening for unnatural specificities
Schematic of library design for the screening of unnatural substrate specificities in enzyme mutant 
variants. ‘Pi -  P i refer to the ‘protease-binding’ position on the substrate, ‘X’ denotes a
X2-X 1c = J - #
Sulfonamide
linker
i
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randomised position, ‘O’ refers to a position carrying a defined amino acid. Design is a variant of 
the standard SCL format (Figure 10.2) and is based on the exclusion of the enzyme’s preferred 
amino acids (Arg & Lys in the case of trypsin) from the P1 position. Cysteine and methionine were 
excluded from the library because of the problems they present in the batch synthesis of small 
peptides (see section 11.8.1).
The synthesis and screening of the library would proceed as illustrated in Figure 11-6. A pre­
prepared 4-sulfamybutyryl AM resin would undergo two rounds of coupling to an isokinetic mixture 
of activated amino acids (see Figure 10.4), before displacement of the linker by a defined residue 
with a C-terminal nitroanilide group. The resultant 16 discrete sublibraries would thus represent 
every amino acid in the P1 position except for arginine & lysine (natural P1 determinants), and 
cysteine & methioine (specialist synthesis protocols required, please see below).
As no background signal beyond gradual substrate auto-hydrolysis would be expected 
from such libraries, and the initial screen would be purely qualitative in nature, i.e. merely testing 
for the release of any chromophore molecules, a high degree of pooling would be possible. All 
libraries could be pooled into a single well, allowing 96 enzyme variants to be screened per 
standard microplate. The principle constraint on the degree of pooling possible would be the 
required concentration of each tripeptide permutation within the mix, i.e. should the new specificity 
of the mutant be selective for a single P1-P2-P3 combination, could the release of the nitroanilide 
group from such a small fraction of the pooled mix be detected? Evidence suggests that such a 
tight specificity would be highly unlikely to emerge from a single round of mutagenesis and that, 
although the P1 acts as the prime specificity determinant, the upstream positions usually 
demonstrate a degree of flexibility.
11.8.2 Screening for enhanced specificity towards a targeted substrate
The targeted mutation of enzyme specificity towards a defined sequence represents the most 
directly useful applications of this technology, allowing for the development of precisely tailored 
tools for bioprocessing reactions. A library based on the enhancement of specificity to a specific 
tripeptide would not follow the pattern of positional scanning laid out in Figure 10.2& 10.3, but 
rather would focus on a competitive assay based on the target sequence and a series of close,
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mon-nitroanilide tagged analogues. Such an assay would be qualitative in nature, as its success 
would depend on its ability to distinguish variants that hydrolysed the target sequence, and thus 
released the chromophore, at a rate significantly greater than the wild-type enzyme. Parallel 
reactions with two varieties of peptide mixes (mixes ©  & ©  in Figure 11-7) would complementary 
data on the kinetic rates in a strictly and loosely competitive environment respectively.
Initial tripeptide 
P3-P2-Pi -pNA
Example from BHI: 
T - R - R - p N A  -
T - R - K  ----------
XX ---------------
©
Synthesis of target peptide Oy safety-catch resin 
Synthesis of analogue(s) by standard SPPS 
Synthesis of isokinetic dipeptide library by standard SPPS
i
Reactions ©  & (?) performed in parallel 
Blanked against activity of wt
©
F ig u r e  1 1 -7 :  C o m p e t i t i v e  s c r e e n in g
Schematic of competitive assay designed to test for enhanced specificity towards a targeted 
sequence. ‘Pi -  P3’ refer to ‘protease-binding’ positions on substrate, ‘X’ refers to a randomised 
position, all other letters denote the single-letter amino acid abbreviations. ‘BHI’ stands for 
biosynthetic human insulin and the sequence used (TRR4.) corresponds to an optimal cleavage 
point on the molecule (please see Section 1.1.4).
The methods presented here provide a practical and rapid series of approaches for the screening 
of enzyme substrate specificity in a high-throughput format. The use of a context independent 
library (PS-SCL) versus a progressive, adaptive library (SCL) is dependant upon a number of 
factors, most notably the time required for library synthesis, through-put capacity and the ‘depth’ of 
the data acquired. Clearly, the time required for the continual resynthesis of a progressive SCL 
library, moulding the next step of the library based on the results from the previous and reusing 
existing monomer pools, makes the process unwieldy and impractical for the processing any large 
number of clones. The variant suggested in Figure 11-6, where unnatural substrate specificities are 
screened for and thus the number of expected ‘hits’ would be greatly reduced, has the advantage
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over a PS-SCL scheme in that unique structural interactions between neighbouring amino acids 
may be examined. The complexity of side-chain interactions within the substrate-protease binding 
region has been the topic of intense study, with an example being the sterically favourable 
interaction between the prime specificity determinant, Asp189, at the base of the substrate-binding 
pocket of the protease and Ser190. Replacement of Ser190 with any other amino acid results in a 
significant decrease in the stability of the ES complex, an effect speculated to occur because of the 
loss of an additional hydrogen bond to the P1 Arg or Lys residue (Sichler et al., 2002). Further work 
by this author, examining binding site interactions as a binary matrix reinforced the concept of 
complex, context dependant relationships, and thus the more work intensive SCL format may yield 
more a more accurate picture of an enzyme mutants’ substrate selectivity, providing that the initial 
screening ‘hurdle’ is set high enough to limit the number of clones requiring processing.
One point of note was that none of these methods made allowances for the physical 
characterization of the putative positional scanning library. Libraries would be characterised 
biochemically (functionally) through the course of the work, but rest on the assumption that the use 
of isokinetic mixtures in the synthesis steps (see Table 10.1) has resulted in equimolar 
representation of each possible peptide combination. These rates were determined empirically and 
extensive validation has shown them to be robust (Ostresh et al., 1994), but they may be 
influenced by unusual protocol chemistries or, conceivably, by operator inexperience. As the 
interpretation of the results from the biological evaluation of a substrate library is dependent upon 
ithe synthetic fidelity of the library, it has been argued that some method of initial structural 
validation should be considered a prerequisite to screening (Backes et al., 2000; Furlong et al., 
2002). MALDI-TOF mass spectrometry has been shown to provide a rapid method for the 
validation of a proposed equimolar peptide mix and involves analysing the spectral data for the 
distribution of certain distinctive amino acid motifs (selection of a molecular weight ‘ladder* of 
ftripeptide motifs, but with the clearest resolution being obtained from those at the high & low 
extremes of the mixture), and comparing the data to a computationally simulated MALDI-TOF 
spectrum for a tripeptide sublibrary following an even (regular) distribution (Furlong et al., 2002). 
(Initial analysis of a partially randomised peptide library in this manner would allow for confidence in 
results, and also aid in the design of individual, robust synthesis protocols.
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1 1 .9  L i b r a r y  C o m p le x i t y  &  o v e r s a m p l in g
Mathematical descriptions of error-prone PCR and gene shuffling have been discussed elsewhere 
(please see Section 1.4) both in terms of their mechanisms and the expected levels of variety that 
each could introduce into a gene. What is presented here is a simple mechanism establishing 
library size and also levels of sampling redundancy, i.e. how many clones must be assayed from a 
gene library before there exists a 95% probability that each possible variant has been sampled at 
least once.
In an ideal system, where nucleotide mutations occurred without either positional bias 
(either through degeneracy at any particular position, so-called ‘mutational hot-spots’ or through 
untreated secondary structure ‘sequestering’ certain regions of sequence) or dNTP substitution 
bias (as can occur when performing PCR under conditions of unequal [dNTP]), nucleotide, and 
thus amino acid mutations would accumulate as described in Equation 11.6. The resultant library 
sizes from this factorial expression and dependant mainly on the numbers of simultaneous 
mutations induced in the target region, are illustrated in Table 11.2.
No. amino acid variants = 19M[N!/(N-M)!M!]
No. nucleotide variants = 4M[N!/(N-M)!MI]
E q u a t io n  1 1 .6
Expressions describing peptide or nucleic acid library sizes, determined by length of sequence I 
target region exposed to mutagenesis (N), and number of mutations introduced simultaneously 
(M ).
Sequence length (N)
100n t 5 a a 200a a 2 3 3 a a
No. amino acids / 1 400 95 3800 4 4 2 7
nucleotides 2 79200 3610 7183900 ?
changed
simultaneously
3 10348800 68590 9.01*109 ?
m 4 1.00*109 651605 8.43*1012
?
5 7.71*1010 2476099 6.28*1015 ?
T a b le  1 1 .2 :  I l l u s t r a t i n g  a b s o lu t e  p r o t e in  l i b r a r y  s iz e  b y  t a r g e t  s e q u e n c e  le n g t h  a n d  t h e  
n u m b e r  o f  a m in o  a c id  s u b s t i t u t i o n s  in d u c e d  s im u l t a n e o u s l y
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Numbers derived through Equation 11.6. Model assumes that nucleotide mutations occurred 
randomly on the original gene, with no positional degeneracy or dNTP bias. Frameshift mutations 
(resulting in truncated proteins) are ignored. The figures shaded dark grey indicate where the 
number of clones is low enough to allow for complete screening of the library by the high- 
throughput screening protocol proposed in this work. Figures shaded light grey indicate library 
sizes which would become practical if a method of nutritional selection could be implemented. 
Values for N = 233 (length of r-trypsin) could not be calculated beyond M = 1 because of size of 
factorial statements required. Table (values for N = 200) adapted from (Kuchner and Arnold, 1997)
When screening a library of mutants, the target is of course it to assay all possible variants against 
the particular substrate in order to exploit the full power of the library, and thus bring to light any 
potentially beneficial mutations which may have been generated. As all forms of mutation, whether 
epPCR or by mutator strain, are performed as a controlled mixture, it follows that the resultant 
gene variants exist as a mix, containing (providing excess quantities of the gene were used) 
multiple copies of all possible variants. After transformation and plating, the colonies comprising 
the protease library will represent duplications, triplications, etc of each variant and thus, in order to 
be sure of screening each unique variant at least once, a degree of oversampling is required above 
the theoretical size of the library. In any sampling of a mutant library the majority of clones would 
be represented only once (variants identified by sequencing of target region of gene from purified 
plasmid obtained after protein expression in individual well-cultures), with a certain percentage 
being identified two or three times, and this degree of library redundancy can be used to calculate 
approximately: a) the total complexity of the library (already known as a theoretical value, see 
Table 11.2, but a useful additional guide as to the validity the model); and b) the degree of 
oversampling required if all unique variants are to be screened. The method relies on the 
frequency distribution of a library sampling fitting a poisson function, the form of which is shown in 
Equation 11.7.
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P(Y ) = ( e " / / ) / Y !
Equation 11.7
Formula for the poisson distribution: Expected relative frequency of a rare event, P(Y), where Y = 
the number of occurrences of a particular type in a sample, p = the population mean, i.e. average 
number of occurrences per sampling, and e is a constant, 2.71828 (the base of natural logarithms)
The poisson distribution is a form of the binomial, optimised for the representation of extremely 
large data sets, where the probability of a particular event occurring is relatively small (typically p < 
1.0). The validity of this extreme form of binomial distribution is dependant upon the results 
(distribution of sequences within the clone library and the absence of bias in mutagenesis) being 
purely random, i.e. sample variance I mean *  1 (Heath 1998). Bias, in either sampling or the initial 
mutagenesis, may be indicated by the occurrence of contagious dispersion, i.e. variance I mean > 
1, where data can appear ‘clumped’, possibly because of biological factors restricting the range of 
the library.
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Figure 11-8: Representation of the distribution of unique sequences in a sampling from a 
statistically random library
This frequency histogram illustrates the number of independent clones sequenced following 
screening, results show that, from a sampling of 4631 clones, 2632 non-overlapping (unique) 
sequences were identified, ‘p’ refers to the frequency with which unique sequences were identified 
in terms of the poisson distribution (Equation 11.7). Representational data set adapted from (Lin et 
al 1999) and unpublished data from the Arnold group.
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12 Appendix B
12.1 Suppliers
Lome Laboratories, Ltd. (UK distributor for Worthington Biochemicals)
7, Tavistock Estate, Ruscombe Business Park, Ruscombe Lane, Twyford, Reading, 
Berkshire RG10 9NJ. Phone 118 9342400, fax 118 9342788, e-mail lome.labs@virgin.net
Merck Biosciences, Ltd. (also UK distributor for Novagen)
Boulevard Industrial Park, Padge Road, Beeston, Nottingham NG9 2JR. Phone 0800 
622935, fax 0115 9430951
National Diagnostics (UK), Ltd.
Unit 4 Fleet Business Park, Itlings Lane, Hessle, East Riding of Yorkshire HU139LX. 
Phone 1482 646020, fax 1482 646013, e-mail customer@nduk.clara.ne
Promega UK, Ltd.
Delta House, Chilworth Research Centre, Southampton S016 7NS. Phone 0800
378994.
Sigma -Aldrich Company, Ltd.
Dorset, England. Phone: 441202 733114, fax: 44 1202 715460, E-mail: 
ukcustsv@eumotes.sial.com,
Techno-Path, Ltd. (closest distributor for Stratagene)
Rosse Center, Holland Rd. National Technological Park, Plassey, Limerick, Ireland. 
Phone 353 61 335844, fax 353 61 203 034, e-mail pn@technopath.iol.ie.
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